(S1 (S (NP (NP (NP (JJ Tissue-specific) (NN regulation)) (PP (IN of) (NP (DT the) (NP (JJ rabbit) (NN 15-lipoxygenase) (NN gene)))) (PP (IN in) (NP (JJ erythroid) (NNS cells))) (PP (IN by) (NP (DT a) (NP (JJ transcriptional) (NN silencer)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN 15-lipoxygenase) (-LRB- -LRB-) (NN lox) (-RRB- -RRB-) (NN gene))) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT a) (JJ tissue-specific) (NN manner))) (, ,) (PP (PP (ADVP (RB predominantly)) (IN in) (NP (JJ erythroid) (NNS cells))) (CC but) (PP (RB also) (IN in) (NP (NP (NN airway) (JJ epithelial) (NNS cells)) (CC and) (NP (NNS eosinophils))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (PP (IN in) (NP (DT this) (NN report))) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ 5') (JJ flanking) (NN DNA))) (PP (IN of) (NP (DT the) (NP (NN 15-lox) (NN gene))))) (VP (VBZ contains) (NP (NP (NNS sequences)) (SBAR (WHNP (WDT which)) (S (VP (VBP down-regulate) (NP (PRP$ its) (NN activity)) (PP (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ non-erythroid) (NN cell) (NNS lines))))) (CC but) (PP (RB not) (IN in) (NP (CD two) (NP (JJ erythroid) (NN cell) (NNS lines))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN element)) (VP (VBZ has) (NP (NP (NNS characteristics)) (PP (IN of) (NP (DT a) (NP (JJ transcriptional) (`` ') (NN silencer) ('' '))))) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ functions) (PP (IN in) (NP (DT both) (NNS orientations))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ main) (NN activity)) (PP (IN of) (NP (DT the) (NP (NN silencer))))) (VP (VBZ has) (VP (VBN been) (VP (VBN mapped) (PP (TO to) (NP (NP (DT the) (JJ first) (CD 900) (NN bp)) (PP (IN of) (NP (NP (JJ 5') (JJ flanking) (NN DNA)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (CD nine) (VBG binding) (NNS sites)) (PP (IN for) (NP (DT a) (NP (JJ nuclear) (NN factor)))) (ADJP (JJ present) (PP (PP (IN in) (NP (JJ non-erythroid) (NNS cells))) (CC but) (PP (RB not) (IN in) (NP (JJ erythroid) (NNS cells)))))))))))))))) (. .))))
(S1 (S (S (S (NP (DT These) (NP (VBG binding) (NNS sites))) (VP (VBP have) (NP (JJ similar) (NNS sequences)))) (CC and) (S (NP (NP (JJ multiple) (NNS copies)) (PP (IN of) (NP (DT the) (VBG binding) (NNS sites)))) (VP (VBP confer) (NP (JJ tissue-specific) (NN down-regulation)) (SBAR (WHADVP (WRB when)) (S (VP (VBN attached) (PP (TO to) (NP (DT a) (NP (JJ minimal) (NN lox) (NN promoter) (NN fragment))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ 5') (JJ flanking) (NN DNA))) (ADVP (RB also)) (VP (VBZ contains) (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (CD three) (NP (VBG binding) (NNS sites)))) (PP (IN for) (NP (NP (DT the) (NP (NN GATA) (NN family))) (PP (IN of) (NP (NN transcription) (NNS factors))))))) (. .))))
(S1 (S (S (S (NP (JJ Staphylococcal) (NNS enterotoxins)) (VP (VBP modulate) (NP (NP (NP (NN interleukin) (CD 2) (NN receptor)) (NN expression)) (CC and) (NP (NP (JJ ligand-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN Janus) (NN protein-tyrosine) (NN kinase) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN Jak3)) (-RRB- -RRB-)))) (CC and) (NP (NP (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription)) (PRN (-LRB- -LRB-) (NP (NN Stat) (NNS proteins)) (-RRB- -RRB-)))))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Staphylococcal) (NN enterotoxins)) (PRN (-LRB- -LRB-) (NP (NNS SE)) (-RRB- -RRB-))) (VP (VP (VBP stimulate) (NP (NP (NN T) (NNS cells)) (VP (VBG expressing) (NP (DT the) (JJ appropriate) (NP (JJ variable) (NN region) (NN beta) (NN chain) (IN of) (-LRB- -LRB-) (NN V) (NN beta) (-RRB- -RRB-) (NN T-cell) (NNS receptors)))))) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (JJ several) (JJ autoimmune) (NNS diseases))))))))) (. .)))))
(S1 (S (S (PP (VBG Depending) (PP (IN on) (NP (JJ costimulatory) (NNS signals)))) (, ,) (NP (NNS SE)) (VP (VBP induce) (NP (NP (CC either) (NP (NN proliferation)) (CC or) (NP (NN anergy))) (PP (IN in) (NP (NN T) (NNS cells))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS SE)) (VP (MD can) (VP (VB induce) (NP (NP (DT an) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (JJ nonresponsive) (NN state)) (CC and) (NP (NN apoptosis))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NNS SE)) (VP (VBP induce) (NP (NP (JJ dynamic) (NNS changes)) (PP (IN in) (NP (NP (NP (DT the) (NN expression)) (PP (IN of))) (CC and) (NP (NP (NN signal) (NN transduction)) (PP (IN through))) (NP (NP (DT the) (NP (NP (NN IL-2) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-2R)) (-RRB- -RRB-))) (NP (NN beta)) (CC and) (NP (NN gamma)) (NP (NNS chains))) (PRN (-LRB- -LRB-) (NP (NP (NN IL-2R) (NN beta)) (CC and) (NP (NN IL-2R) (NN gamma))) (-RRB- -RRB-))))) (PP (IN in) (NP (JJ human) (JJ antigen-specific) (JJ CD4+) (NN T-cell) (NNS lines)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (PP (IN after) (NP (NP (CD 4) (NN hr)) (PP (IN of) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (NN SEA)) (CC and) (NP (NN SEB)))))))) (, ,) (S (S (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN IL-2R) (NN beta)))) (VP (VBD was) (VP (VBN down-regulated)))) (, ,) (S (NP (NN IL-2R) (NN gamma)) (VP (VBD was) (ADVP (RB slightly)) (VP (VBN up-regulated)) (, ,) (SBAR (IN while) (S (NP (NN IL-2R) (NN alpha)) (VP (VBD remained) (ADJP (RB largely) (JJ unaffected)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN composition)) (PP (IN of) (NP (NNS IL-2Rs)))))) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ IL-2-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN Janus) (NN protein-tyrosine) (NN kinase) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN Jak3)) (-RRB- -RRB-)))) (CC and) (NP (NP (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription)) (VP (VBN called) (S (NP (NP (NN Stat3)) (CC and) (NP (NN Stat5)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ parallel) (NNS experiments))) (, ,) (NP (JJ IL-2-driven) (NN proliferation)) (VP (VBD was) (VP (VBN inhibited) (ADVP (RB significantly)))) (. .))))
(S1 (S (S (S (PP (IN After) (NP (NP (CD 16) (NN hr)) (PP (IN of) (NP (NP (NN exposure)) (PP (TO to) (NP (NNS SE))))))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN IL-2R) (NN beta)))) (VP (VBD remained) (ADJP (JJ low)) (, ,) (SBAR (IN while) (S (NP (NP (DT that)) (PP (IN of) (NP (NP (NN IL2R) (NN alpha)) (CC and) (NP (NN IL2R) (NN gamma))))) (VP (VBD was) (ADVP (RB further)) (VP (VBN up-regulated))))))) (, ,) (CC and) (S (NP (NP (JJ ligand-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN Jak3)) (CC and) (NP (NN Stat) (NNS proteins))))) (VP (VBD was) (ADVP (RB partly)) (VP (VBN normalized)))) (. .))))
(S1 (S (S (RB Yet) (, ,) (NP (JJ IL-2-driven) (NN proliferation)) (VP (VBD remained) (VP (ADVP (RB profoundly)) (JJ inhibited)) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN signaling) (NNS events)) (CONJP (JJ other) (IN than)) (NP (NN Jak3/Stat) (NN activation))) (VP (VBD had) (ADVP (RB also)) (VP (VBN been) (VP (VBN changed) (PP (VBG following) (NP (NP (NNS SE)) (NN stimulation))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS SE)) (VP (MD can) (VP (VB modulate) (NP (NP (NP (NP (NN IL-2R)) (NN expression)) (CC and) (NP (NP (NN signal) (NN transduction)) (VP (VBG involving) (NP (NP (DT the) (NP (NN Jak/Stat)) (NN pathway)))))) (PP (IN in) (NP (JJ CD4+) (NN T-cell) (NNS lines))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Mutation)) (PP (IN of) (NP (NN Jak3))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN SCID))))) (: :)) (NP (NP (JJ essential) (NN role)) (PP (IN of) (NP (NP (NN Jak3)) (PP (IN in) (NP (JJ lymphoid) (NN development)))))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Males)) (PP (IN with) (NP (NP (JJ X-linked) (JJ severe) (JJ combined) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN XSCID)) (-RRB- -RRB-))))) (VP (VBP have) (NP (NP (NNS defects)) (PP (IN in) (NP (NP (DT the) (JJ common) (NP (NN cytokine) (NN receptor) (NN gamma) (NN chain) (-LRB- -LRB-) (NN gamma) (NN c) (-RRB- -RRB-) (NN gene))) (SBAR (WHNP (WDT that)) (S (VP (VBZ encodes) (NP (NP (DT a) (ADJP (ADJP (JJ shared)) (, ,) (ADJP (JJ essential))) (NN component)) (PP (IN of) (NP (NP (DT the) (NNS receptors)) (PP (IN of) (NP (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (, ,) (NP (NN IL-4)) (, ,) (NP (NN IL-7)) (, ,) (NP (NN IL-9)) (, ,) (CC and) (NP (NN IL-15)))))))))))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (NP (NN Janus) (NN family) (NN tyrosine) (NN kinase)) (NP (NN Jak3)))) (VP (VBZ is) (NP (NP (DT the) (JJ only) (VBG signaling) (NN molecule)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NN gamma) (NN c))))))))) (, ,) (SBAR (IN so) (S (NP (PRP it)) (VP (VBD was) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (NNS defects)) (PP (IN in) (NP (NN Jak3)))) (VP (MD might) (VP (VB cause) (NP (DT an) (JJ XSCID-like) (NN phenotype))))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN girl)) (PP (IN with) (NP (NP (JJ immunological) (NNS features)) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (NN XSCID))))))))) (VP (VBD was) (ADVP (RB therefore)) (VP (VBN selected) (PP (IN for) (NP (NN analysis))))) (. .))))
(S1 (S (S (NP (NP (DT An) (NP (JJ Epstein-Barr) (NN virus) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ -transformed) (NN cell) (NN line))) (VP (VBN derived) (PP (IN from) (NP (PRP$ her) (NP (NNS lymphocytes)))))) (VP (VP (VP (VBD had) (NP (JJ normal) (NP (NN gamma) (NN c)) (NN expression))) (CC but) (VP (VBD lacked) (NP (NN Jak3) (NN protein)))) (CC and) (VP (VBD had) (NP (ADJP (RB greatly) (VBN diminished)) (NP (NN Jak3) (NN messenger) (NN RNA))))) (. .))))
(S1 (S (S (S (NP (NN Sequencing)) (VP (VBD revealed) (NP (NP (DT a) (JJ different) (NN mutation)) (PP (IN on) (NP (DT each) (NN allele)))))) (: :) (NP (NP (DT a) (JJ single) (NN nucleotide) (NN insertion)) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (NP (DT a) (NN frame) (NN shift)) (CC and) (NP (JJ premature) (NN termination))) (PP (IN in) (NP (DT the) (NP (NN Jak3) (NN JH4) (NN domain))))) (CC and) (NP (NP (DT a) (JJ nonsense) (NN mutation)) (PP (IN in) (NP (DT the) (NP (NN Jak3)) (NN JH2) (NN domain)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN lack)) (PP (IN of) (NP (NP (NN Jak3)) (NN expression)))) (VP (VBD correlated) (PP (IN with) (NP (JJ impaired) (NN B) (NN cell) (NN signaling))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN inability)) (PP (IN of) (NP (NN IL-4))) (S (VP (TO to) (VP (VB activate) (NP (NN Stat6)) (PP (IN in) (NP (NP (DT the) (NP (JJ EBV-transformed) (NN cell) (NN line))) (PP (IN from) (NP (DT the) (NN patient)))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (NNS functions)) (PP (IN of) (NP (NN gamma) (NN c)))) (VP (VBP are) (ADJP (JJ dependent) (PP (IN on) (NP (NN Jak3))))))) (CC and) (SBAR (IN that) (S (NP (NN Jak3)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ lymphoid) (NP (NN development)) (CC and) (NP (NN signaling)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Costimulation) (NN requirement)) (PP (IN for) (NP (NP (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappa) (NN B))) (NN transcription) (NN factor) (NN activation)) (PP (IN in) (NP (NN T) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN promoter))))) (VP (VBZ requires) (NP (NP (NP (NN T-cell)) (NN costimulation)) (VP (VBN delivered) (PP (IN by) (NP (NP (DT the) (NP (NN TCR))) (CC and) (NP (DT the) (NP (JJ auxiliary) (NN receptor) (NN CD28)))))))) (. .)))))
(S1 (S (S (NP (JJ Several) (NP (NN transcription) (NNS factors))) (VP (VBP participate) (PP (IN in) (NP (NP (NP (NN IL-2)) (NN promoter) (NN activation)) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (SINV (VP (VBP are) (NP (NP (JJ AP-1-like) (NNS factors)) (CC and) (NP (NN NF-kappa) (NN B))))))))) (. .))))
(S1 (S (S (S (NP (NN Protein) (NN phosphorylation)) (VP (VBZ has) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT these) (CD two) (NNS factors))))))) (: :) (S (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (PRP it)) (VP (VBZ induces) (NP (NP (DT the) (NN transactivating) (NN capacity)) (PP (IN of) (NP (DT the) (NP (NP (NN AP-1) (NN protein)) (NP (NN c-Jun)))))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (PRP it)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (DT the) (NP (NP (JJ cytoplasmic) (NN inhibitor)) (, ,) (NP (NN I) (NN kappa) (NN B))))) (, ,) (PP (IN from) (NP (NN NF-kappa) (NN B)))))) (, ,) (S (VP (VBG allowing) (NP (NP (NN translocation)) (PP (IN of) (NP (DT the) (JJ latter))) (PP (IN into) (NP (DT the) (NN nucleus))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN shown) (SBAR (IN that) (S (NP (DT both) (NN phosphorylation) (NNS processes)) (VP (VBP require) (NP (NN T-cell) (NN costimulation))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells))) (, ,) (NP (NP (DT the) (NNS kinetics)) (PP (IN of) (NP (DT the) (CD two) (NN phosphorylation) (NNS events)))) (VP (VBP are) (ADJP (RB essentially) (JJ similar))) (. .))))
(S1 (S (S (PP (VBG According) (PP (TO to) (NP (PRP$ our) (NNS results)))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (DT the) (NNS kinases)) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (CD two) (NNS processes))))) (VP (VBP are) (NP (JJ distinct) (NNS entities))) (. .))))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NN TPCK)) (VP (VBZ inhibits) (NP (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B)))) (CC and) (, ,) (ADVP (RB consequently)) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))))) (, ,) (S (NP (PRP it)) (ADVP (RB markedly)) (VP (VBZ enhances) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NN JNK)) (, ,) (NP (DT the) (NP (NP (NN MAP) (JJ kinase-related) (NN kinase)) (SBAR (WHNP (WDT that)) (S (VP (VBZ phosphorylates) (NP (NP (DT the) (NP (NN transactivation) (NN domain))) (PP (IN of) (NP (NN c-Jun)))))))))))))) (. .))))
(S1 (S (S (NP (PRP We) (, ,)) (ADVP (RB therefore)) (, ,) (VP (VBP propose) (NP (NP (DT the) (NN activation) (NN scheme)) (VP (VBN presented) (PP (IN in) (NP (NN FIGURE) (CD 3))))) (PP (IN for) (NP (NN T-cell) (NN costimulation)))) (. .))))
(S1 (S (S (NP (NN Costimulation)) (VP (VBZ results) (PP (IN in) (NP (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT a) (NN signaling) (NN pathway)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (JJ simultaneous) (NN induction)) (PP (IN of) (NP (NP (DT the) (CD two) (NP (NN transcription) (NNS factors))) (, ,) (NP (NP (NN AP-1)) (CC and) (NP (NN NF-kappa) (NN B))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Integration)) (PP (IN of) (NP (NP (DT the) (NNS signals)) (VP (VBN generated) (PP (IN by) (NP (NP (NP (NN TCR)) (CC and) (NP (NN CD28))) (NN engagement))))))) (VP (VBZ occurs) (PP (IN along) (NP (NP (DT this) (NN pathway)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB then)) (VP (VBZ bifurcates) (S (VP (TO to) (VP (VB induce) (NP (NP (NP (NP (NN I) (NN kappa) (NN B)) (NN phosphorylation)) (CC and) (NP (NP (NN NF-kappa) (NN B)) (NN activation))) (PP (IN on) (NP (DT the) (CD one) (NN hand))) (, ,) (CC and) (NP (NP (NP (NN JNK)) (NN activation)) (CC and) (NP (NP (NN c-Jun)) (NN phosphorylation))) (PP (IN on) (NP (DT the) (ADJP (JJ other)))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP are) (ADVP (RB currently)) (VP (VBN engaged) (PP (IN in) (S (VP (VBG defining) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (CD two) (NNS signals)) (VP (VBP integrate) (PP (IN along) (NP (DT the) (NN AP-1/NF-kappa) (NN B) (NN pathway))))))))))) (. .))))
(S1 (S (S (S (NP (NN Interleukin-7)) (VP (MD can) (VP (VB induce) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN Jak) (CD 1)) (, ,) (NP (NN Jak) (CD 3)) (CC and) (NP (NN STAT) (CD 5) (NNS proteins)))) (PP (IN in) (NP (JJ murine) (NP (NN T) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NP (NP (NN Janus) (NN protein) (NN tyrosine) (NNS kinases)) (PRN (-LRB- -LRB-) (NP (NN Jak)) (-RRB- -RRB-))) (CC and) (NP (NN STAT) (-LRB- -LRB-) (NN signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription) (-RRB- -RRB-) (NNS proteins))))) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN linked) (PP (TO to) (NP (NP (DT the) (NN signal) (NN transduction) (NN mechanism)) (PP (IN of) (NP (JJ several) (NP (NNS cytokines))))))))) (. .)))))
(S1 (S (S (NP (NN IL-7)) (VP (VBD was) (VP (VBN observed) (S (VP (TO to) (VP (VB induce) (NP (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (NP (JJ dose-dependent))) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN Jak) (CD 1)) (CC and) (NP (NN Jak) (CD 3))))) (CC and) (ADVP (RB concomitantly)) (, ,) (NP (NP (DT the) (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NN DNA) (NN binding) (NN activity))) (PP (IN of) (NP (JJ multiple) (NP (NN STAT) (NNS proteins))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN STAT) (NNS proteins))) (VP (VBN utilized) (PP (IN by) (NP (NN IL-7))))) (VP (VP (VBD were) (ADJP (JJ identical) (PP (TO to) (NP (NP (DT those)) (VP (VBN induced) (PP (IN by) (NP (NN IL-2)))))))) (CC and) (VP (MD could) (VP (VB be) (VP (VBN identified) (PP (IN as) (NP (JJ various) (NP (NN STAT) (CD 5) (NNS isoforms)))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (CC both) (NN Jak) (NP (CD 1)) (CC and) (NP (CD 3))))) (, ,) (CC and) (NP (NP (NN STAT) (CD 5)) (NN activity))) (ADVP (RB strongly)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (JJ growth-promoting) (NNS effects)) (PP (IN of) (NP (NN IL-7))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT this) (NN signal) (NN transduction) (NN mechanism)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (JJ IL-7-induced) (NN proliferation)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Oncogenicity)) (PP (IN of) (NP (JJ human) (NP (ADJP (NN papillomavirus-))) (CC or) (NP (ADJP (JJ adenovirus-transformed))) (NP (NNS cells))))) (VP (VBZ correlates) (PP (IN with) (NP (NP (NN resistance)) (PP (TO to) (NP (NP (NN lysis)) (PP (IN by) (NP (JJ natural) (NN killer) (NNS cells)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NNS reasons)) (PP (IN for) (NP (NP (DT the) (JJ dissimilar) (NNS oncogenicities)) (PP (IN of) (NP (NP (NP (JJ human) (NNS adenoviruses)) (CC and) (NP (NP (JJ human) (NNS papillomaviruses)) (PRN (-LRB- -LRB-) (NP (NNS HPV)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NNS humans)))))) (VP (VP (VBP are) (ADJP (JJ unknown))) (CC but) (VP (MD may) (VP (VB relate) (PP (TO to) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (DT the) (NNS capacities)) (PP (IN of) (NP (DT the) (NP (NP (NN E1A))) (CC and) (NP (NN E7) (NNS proteins)))) (S (VP (TO to) (VP (VB target) (NP (NNS cells)) (PP (IN for) (NP (NP (NN rejection)) (PP (IN by) (NP (DT the) (NP (NN host) (JJ natural) (NN killer) (-LRB- -LRB-) (NN NK) (-RRB- -RRB-) (NN cell)) (NN response))))))))))))))) (. .)))))
(S1 (S (S (PP (IN As) (NP (NP (CD one) (NN test)) (PP (IN of) (NP (DT this) (NN hypothesis))))) (, ,) (NP (PRP we)) (VP (VBD compared) (NP (NP (DT the) (NNS abilities)) (PP (IN of) (NP (NP (ADJP (ADJP (ADJP (NN E1A-)) (CC and) (ADJP (JJ E7-expressing))) (ADJP (JJ human) (JJ fibroblastic)))) (CC or) (NP (ADJP (JJ keratinocyte-derived) (JJ human))) (NP (NNS cells)))) (S (VP (TO to) (VP (VB be) (ADVP (RB selectively)) (VP (VBN killed) (PP (IN by) (NP (CC either) (NP (ADJP (NP (JJ unstimulated)))) (CC or) (NP (NN interferon) (-LRB- -LRB-) (NN IFN) (-RRB- -RRB-) (JJ -activated) (NN NK) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Cells)) (VP (VBG expressing) (NP (DT the) (NP (NN E1A) (NN oncoprotein))))) (VP (VBD were) (ADVP (RB selectively)) (VP (VBN killed) (PP (IN by) (NP (JJ unstimulated) (NN NK) (NNS cells)))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (JJ same) (NP (JJ parental) (NNS cells))) (CC but) (NP (VP (VBG expressing) (NP (DT the) (NP (NP (NNS HPV) (NN type) (CD 16)) (PRN (-LRB- -LRB-) (NP (NN HPV-16)) (-RRB- -RRB-))) (CC or) (NP (NN HPV-18) (NP (NN E7) (NN oncoprotein))))))) (VP (VBD were) (ADJP (JJ resistant) (PP (TO to) (NP (NN NK) (NN cell) (NN lysis)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (JJ IFN-activated) (NN NK) (NNS cells))) (S (PP (TO to) (ADVP (RB selectively)) (VP (VB kill) (NP (RB virally) (VBN transformed) (NNS cells)))))) (VP (VBZ depends) (PP (IN on) (NP (NP (NP (NP (NN IFN)) (POS 's)) (NN ability)) (S (VP (TO to) (VP (VB induce) (NP (NP (NN resistance)) (PP (TO to) (NP (NN NK) (NN cell) (NN lysis)))) (PP (IN in) (NP (NP (ADJP (ADJP (JJ normal)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (ADJP (NP (JJ non-viral) (JJ oncogene-expressing))) (-RRB- -RRB-)))) (CONJP (CC but) (RB not)) (NP (RB virally) (VBN transformed) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NN E1A)) (VP (VBD blocked) (NP (NP (NP (NP (NN IFN)) (POS 's)) (NN induction)) (PP (IN of) (NP (JJ cytolytic) (NN resistance)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (JJ selective) (NN lysis)) (PP (IN of) (NP (JJ adenovirus-transformed) (NNS cells))) (PP (IN by) (NP (JJ IFN-activated) (NN NK) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NP (JJ IFN-induced) (NN NK) (NN cell) (NN killing)) (PP (IN of) (NP (JJ E1A-expressing) (NNS cells)))))) (VP (VP (VBD was) (ADJP (JJ proportional) (PP (TO to) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN E1A)) (NN expression))))))) (CC and) (VP (VBN correlated) (PP (IN with) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN E1A))) (S (VP (TO to) (VP (VB block) (NP (NP (JJ IFN-stimulated) (NN gene) (NN expression)) (PP (IN in) (NP (NN target) (NNS cells))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN E7)) (VP (VBD blocked) (NP (CC neither) (NP (JJ IFN-stimulated) (NN gene) (NN expression)) (CC nor) (NP (NP (NP (NP (NN IFN)) (POS 's)) (NN induction)) (PP (IN of) (NP (JJ cytolytic) (NN resistance))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG precluding) (NP (NP (DT the) (JJ selective) (NN lysis)) (PP (IN of) (NP (JJ HPV-transformed) (NNS cells))) (PP (IN by) (NP (JJ IFN-activated) (NN NK) (NNS cells))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (NN E1A)) (NN expression)) (VP (VBZ marks) (NP (NNS cells)) (PP (IN for) (NP (NP (NN destruction)) (PP (IN by) (NP (DT the) (NN host) (NP (NN NK) (NN cell)) (NN response))))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (NP (NN E7) (NN oncoprotein))) (VP (VBZ lacks) (NP (DT this) (NN activity)))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Identification)) (PP (IN of) (NP (NP (DT an) (NP (NN I) (NN kappa) (NN B) (JJ alpha-associated) (NN protein) (NN kinase))) (PP (IN in) (NP (DT a) (NP (JJ human) (JJ monocytic) (NN cell) (NN line))))))) (CC and) (NP (NP (NN determination)) (PP (IN of) (NP (NP (PRP$ its) (NP (NN phosphorylation) (NNS sites))) (PP (IN on) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ stored) (PP (IN in) (NP (DT the) (NN cytoplasm))) (PP (IN as) (NP (DT an) (JJ inactive) (NN form))) (PP (IN through) (NP (NP (NN interaction)) (PP (IN with) (NP (NN I) (NN kappa) (NN B))))))) (. .)))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NNS cells)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (DT a) (JJ rapid) (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN presumed) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (DT the) (JJ subsequent) (NN degradation)))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN reported) (NP (NP (DT the) (NN establishment)) (PP (IN of) (NP (NP (DT a) (ADJP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -dependent) (JJ cell-free)) (NN activation) (NN system)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN phosphorylation)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN identified) (NP (NP (NP (DT a) (NP (NN kinase))) (PP (IN in) (NP (NP (NN cell) (NNS extracts)) (PP (IN from) (NP (DT the) (NP (NP (JJ LPS-stimulated) (JJ human) (JJ monocytic) (NN cell) (NN line)) (, ,) (NP (NN THP-1)))))))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (ADVP (RB specifically)) (VP (VBZ binds)) (CC and) (VP (VBZ phosphorylates)) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))))) (. .))))
(S1 (S (S (NP (NN LPS) (NN stimulation)) (ADVP (RB transiently)) (VP (VBD enhanced) (NP (NP (DT the) (NN I) (NN kappa) (NN B) (JJ alpha-bound) (NN kinase) (NN activity)) (PP (IN in) (NP (NN THP-1) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Mutational) (NNS analyses)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B)) (NN alpha)))) (CC and) (NP (NP (NN competition) (NNS experiments)) (PP (IN with) (NP (DT the) (JJ synthetic) (NNS peptides))))) (VP (VBD identified) (NP (JJ major) (NP (NN phosphorylation) (NNS sites))) (PP (IN by) (NP (DT the) (VBN bound) (NP (NN kinase)))) (PP (IN as) (NP (NP (NN Ser)) (CC and) (NP (NN Thr)) (NP (NNS residues)))) (PP (IN in) (NP (NP (DT the) (NP (JJ C-terminal) (JJ acidic) (NN domain))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NN peptide) (, ,)) (S (VP (VBG corresponding) (PP (TO to) (NP (NP (DT the) (NP (JJ C-terminal) (JJ acidic) (NN domain))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))))))) (, ,) (VP (VBD blocked) (NP (NP (DT the) (JJ LPS-induced) (NP (NN NF-kappa) (NN B)) (NN activation)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ inducible) (NN phosphorylation)) (PP (IN of) (NP (JJ endogenous) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (PP (IN in) (NP (NP (DT a) (JJ cell-free) (NN system)) (VP (VBG using) (NP (NN THP-1) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBD suggested) (SBAR (IN that) (S (NP (DT the) (NP (JJ bound) (NN kinase))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN signaling) (NN pathway)) (PP (IN of) (NP (NN LPS))))) (PP (IN by) (S (VP (VBG inducing) (NP (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (DT the) (NP (JJ C-terminal) (NN region))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (CC and) (NP (NP (JJ subsequent) (NN dissociation)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B.I) (NN kappa) (NN B) (NN alpha) (NN complex))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Triggering)) (PP (IN of) (NP (DT the) (JJ human) (NN interleukin-6) (NN gene))) (PP (IN by) (NP (NP (NP (NN interferon-gamma)) (CC and) (NP (NN tumor) (NN necrosis) (NN factor-alpha))) (PP (IN in) (NP (JJ monocytic) (NNS cells)))))) (VP (VBZ involves) (NP (NP (NN cooperation)) (PP (IN between) (NP (NP (NP (NN interferon) (JJ regulatory) (NN factor-1))) (, ,) (NP (NP (NN NF) (NN kappa) (NN B))) (, ,) (CC and) (NP (NP (NN Sp1))) (NP (NN transcription) (NNS factors)))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VP (VBD investigated) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN of) (NP (NP (DT the) (JJ synergistic) (NN induction)) (PP (IN by) (NP (NP (NP (NP (NN interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (NP (NP (NN /tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-)))) (PP (IN of) (NP (NP (JJ human) (NN interleukin-6) (-LRB- -LRB-) (NN IL-6) (-RRB- -RRB-) (NN gene)) (PP (IN in) (NP (NN THP-1) (JJ monocytic) (NNS cells))))))))))) (, ,) (CC and) (VP (VBD compared) (NP (PRP it)) (PP (IN with) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (DT this) (NN induction)) (PP (IN by) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Functional) (NNS studies)) (PP (IN with) (NP (NN IL-6) (NN promoter)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (CD three) (NNS regions)) (VP (VBP are) (NP (NP (DT the) (NNS targets)) (PP (IN of) (NP (DT the) (NP (NP (NN IFN-gamma)) (CC and/or) (NP (NN TNF-alpha))) (NN action)))) (, ,) (SBAR (IN whereas) (S (NP (NP (RB only) (CD one)) (PP (IN of) (NP (DT these) (NNS regions)))) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NN LPS) (NN activation)))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (CD three) (NNS regions)) (VP (VBN concerned))) (VP (VBP are))) (: :) (NP (NP (LST (LS 1) (-RRB- -RRB-)) (NP (NP (DT a) (NN region)) (PP (IN between) (NP (QP (CD -73) (CC and) (CD -36))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (NP (JJ minimal) (NN element))) (ADJP (JJ inducible) (PP (IN by) (NP (NP (NN LPS)) (CC or) (NP (NN TNF-alpha)))))))))) (: ;) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (NP (DT an) (NN element)) (ADJP (JJ located) (PP (IN between) (NP (QP (CD -181) (CC and) (CD -73)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NP (NN IFN-gamma)) (CC and) (NP (NN TNF-alpha))))) (ADVP (RB negatively))))))))) (: ;) (CC and) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (NP (DT a) (NP (JJ distal) (NN element) (JJ upstream))) (PP (IN of) (NP (CD -224)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJ inducible) (PP (IN by) (NP (NP (NN IFN-gamma)) (ADVP (RB alone)))))))))) (. .))))
(S1 (S (S (NP (NN LPS) (NN signaling)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB involve) (NP (NP (NN NF) (NN kappa) (NN B)) (NN activation)) (PP (IN by) (NP (DT the) (NP (NN p50) (NN /p65) (NNS heterodimers))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Synergistic) (NN induction)) (PP (IN of) (NP (DT the) (NP (NN IL-6) (NN gene)))) (PP (IN by) (NP (NP (NN IFN-gamma)) (CC and) (NP (NN TNF-alpha)))) (, ,) (PP (IN in) (NP (JJ monocytic) (NNS cells))) (, ,)) (VP (VBD involved) (NP (NP (NN cooperation)) (PP (IN between) (NP (NP (DT the) (NP (NN IRF-1))) (CC and) (NP (NN NF) (NN kappa) (NN B) (NN p65) (NNS homodimers))))) (PP (IN with) (NP (NP (JJ concomitant) (NN removal)) (PP (IN of) (NP (NP (DT the) (JJ negative) (NN effect)) (PP (IN of) (NP (NP (DT the) (NP (NN retinoblastoma) (NN control) (NN element))) (ADJP (JJ present) (PP (IN in) (NP (DT the) (NP (NN IL-6) (NN promoter)))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN removal)) (VP (VBD occurred) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NP (JJ constitutive) (NN Sp1) (NN factor))) (, ,) (SBAR (WHNP (WP$ whose) (NP (VBN increased) (NP (NN binding) (NN activity)) (CC and) (NP (NN phosphorylation)))) (S (VP (VBD were) (VP (VBN mediated) (PP (IN by) (NP (NN IFN-gamma)))))))))))) (. .))))
(S1 (S (S (S (NP (NN Steel) (NN factor)) (VP (VBZ affects) (NP (NP (NN SCL)) (NN expression)) (PP (IN during) (NP (ADJP (ADJP (JJ normal)) (ADJP (JJ erythroid))) (NN differentiation)))) (. .)))))
(S1 (S (S (S (S (NP (NN Steel) (NN factor)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (NP (NN growth) (NNS factors)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ controls) (NP (NP (DT the) (NP (NN proliferation)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (JJ hematopoietic) (NNS cells)))))))))) (CC and) (S (NP (NP (NN SCL)) (, ,) (ADVP (RB also)) (VP (VBN known) (PP (IN as) (NP (NP (NN Tcl-5)) (CC or) (NP (NN Tal-1))))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (NP (NN transcription) (NN factor))) (VP (VBN involved) (PP (IN in) (NP (NN erythropoiesis))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN SCL))) (PP (IN in) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ human) (JJ peripheral) (NN blood) (JJ burst-forming) (NN unit-erythroid)) (PRN (-LRB- -LRB-) (NP (NN BFU-E)) (-RRB- -RRB-))))))) (CC and) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN Steel) (NN factor))) (PP (IN on) (NP (NP (NN SCL)) (NN expression))) (PP (IN in) (NP (VBG proliferating) (JJ erythroid) (NNS cells)))))) (. .))))
(S1 (S (S (NP (JJ BFU-E-derived) (NNS colonies)) (VP (VBP increase) (ADVP (RB progressively)) (PP (IN in) (NP (NN size))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NN cell) (NN number))))))) (, ,) (PP (PP (IN from) (NP (NN day) (CD 7))) (PP (TO to) (NP (NN day) (CD 14))) (PP (IN of) (NP (NN culture)))) (, ,) (PP (IN with) (NP (NP (NP (NP (DT the) (JJS greatest) (NN increase)) (PP (IN in) (NP (NN colony) (NN size)))) (PRN (-LRB- -LRB-) (NP (JJ 10-fold) (NN expansion)) (-RRB- -RRB-))) (VP (VBG occurring) (PP (IN between) (NP (NP (NN day) (CD 7)) (CC and) (NP (NN day) (CD 10)))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN SCL) (NN protein)) (NNS levels)) (PP (IN in) (NP (JJ BFU-E-derived) (NNS cells)))) (VP (VBD were) (UCP (ADJP (JJS highest) (PP (IN in) (NP (NN day) (CD 7) (NNS cells)))) (CC and) (VP (VBD decreased) (ADVP (RB progressively)) (PP (PP (IN from) (NP (NN day) (CD 7))) (PP (TO to) (NP (NN day) (CD 14))) (PP (IN of) (NP (NN culture)))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (NN SCL))) (PP (IN with) (NP (JJ erythroid) (NN proliferation))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN SCL) (NN mRNA)) (NNS levels)) (VP (VBD did) (RB not) (VP (VB decrease) (ADVP (RB significantly)) (PP (IN between) (NP (NP (NN day) (CD 7)) (CC and) (NP (NN day) (CD 14)) (NP (NNS cells))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ posttranscriptional) (NNS mechanisms)) (VP (VBP are) (ADJP (RB largely) (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (NN SCL) (NN protein)) (VP (VBN observed))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NN SCL))) (PP (IN in) (NP (NN Steel) (JJ factor-induced) (JJ erythroid) (NN proliferation)))) (VP (VBD was) (ADVP (RB then)) (VP (VBN examined))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (JJ BFU-E-derived) (NNS colonies)) (VP (VBN cultured) (PP (IN with) (NP (NN Steel) (NN factor)))))) (, ,) (NP (NN colony) (NN size)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (VBN compared) (PP (TO to) (NP (NN control)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NP (NN day) (CD 7)) (CC and) (NP (NN day) (CD 10)) (NP (JJ erythroid) (NNS precursors))) (VP (VBN cultured) (PP (IN with) (NP (NN Steel) (NN factor)))))) (, ,) (NP (NN SCL) (NN protein)) (VP (VBD was) (VP (VBN increased) (ADVP (RB significantly)) (PP (VBN compared) (PP (TO to) (NP (NN control)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NP (NP (NN SCL)) (NN protein) (NNS levels)) (PP (IN in) (NP (NP (JJ early) (NP (JJ erythroid) (NNS precursors))) (VP (VBD stimulated) (PP (IN with) (NP (NN Steel) (NN factor))))))))) (VP (VBZ suggests) (NP (NP (CD one) (NN mechanism)) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NN Steel) (NN factor)) (VP (MD may) (VP (VB enhance) (NP (ADJP (ADJP (JJ normal)) (ADJP (JJ erythroid))) (NN proliferation)))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN SCL) (NN mRNA)) (NNS levels)) (VP (VBN assessed) (PP (IN by) (NP (NN Northern) (NN blot))) (PP (IN in) (NP (NN day) (CD 7) (NNS cells))))) (VP (VBD did) (RB not) (VP (VB increase) (ADVP (RB significantly)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN Steel) (NN factor)) (NN stimulation)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ posttranscriptional) (NNS mechanisms)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN SCL) (NN protein)) (VP (VBN observed) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN Steel)))))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Cross-linking) (NP (NN CD40))) (PP (IN on) (NP (NN B) (NNS cells)))) (ADVP (RB rapidly)) (VP (VBZ activates) (NP (JJ nuclear) (NN factor-kappa) (NN B))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN B) (JJ cell-associated) (NN surface) (NN molecule) (NN CD40))) (VP (VBZ functions) (S (VP (TO to) (VP (VB regulate) (NP (NN B) (NN cell) (NNS responses)))))) (. .)))))
(S1 (S (S (NP (NP (JJ Cross-linking) (NP (NN CD40))) (PP (IN on) (NP (NN B) (NNS cells)))) (VP (MD can) (VP (VB lead) (PP (PP (TO to) (NP (NP (JJ homotypic) (NN cell) (NN adhesion)) (, ,) (NP (NP (NN IL-6)) (NN production)))) (, ,) (CC and) (, ,) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS cytokines))))) (, ,) (PP (TO to) (NP (NN Ig) (NN isotype) (NN switching)))))) (. .))))
(S1 (S (S (NP (NN Tyrosine) (NN kinase) (NN activity)) (VP (VBZ is) (VP (VBN increased) (ADVP (RB shortly)) (PP (IN after) (NP (NP (NN engagement)) (PP (IN of) (NP (DT this) (NN receptor))))))) (. .))))
(S1 (S (S (NP (JJ Little)) (VP (VBZ is) (VP (VBN known))) (PP (IN about) (SBAR (WHADVP (WRB how)) (S (NP (NP (DT the) (ADJP (RB very) (JJ early)) (NNS events)) (VP (VBN induced) (PP (IN by) (NP (NP (NN CD40)) (NN cross-linking))))) (VP (VBP link) (PP (TO to) (NP (JJ cellular) (NNS responses))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B)) (CC and) (NP (NN NF-kappa) (JJ B-like) (NN transcription) (NNS factors))) (VP (VBP are) (VP (VBN activated) (PP (IN after) (NP (NP (JJ cross-linking) (NP (NN CD40))) (PP (PP (IN on) (NP (VBG resting) (NP (JJ human) (JJ tonsillar) (NN B) (NNS cells)))) (CC and) (PP (IN on) (NP (NN B) (NN cell) (NNS lines))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN activation)) (VP (VP (VBZ is) (ADJP (JJ rapid))) (CC and) (VP (VBZ is) (VP (VBN mediated) (PP (IN through) (NP (DT a) (NN tyrosine) (JJ kinase-dependent) (NN pathway)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS complexes)) (VP (VBN detected) (PP (IN in) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))) (VP (VBP contain) (NP (NP (NN p50)) (, ,) (NP (NP (NN p65)) (PRN (-LRB- -LRB-) (NP (NN RelA)) (-RRB- -RRB-))) (, ,) (NP (NN c-Rel)) (, ,) (CC and) (ADVP (RBS most) (RB likely)) (NP (JJ other) (NNS components)))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (JJ transient) (NN transfection) (NNS assays))))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (JJ cross-linking) (NP (NN CD40))) (VP (VBZ supports) (NP (NN NF-kappa) (JJ B-dependent) (NN gene) (NN expression)))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP define) (NP (DT the) (NP (NN NF-kappa) (NN B)) (NN system)) (PP (IN as) (NP (NP (DT an) (JJ intermediate) (NN event)) (PP (IN in) (NP (NP (NN CD40)) (NN signaling)))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NN CD40)) (NN pathway)) (VP (MD can) (VP (VB influence) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN B) (JJ cell-associated) (NNS genes)))) (PP (IN with) (NP (NN NF-kappa) (NN B) (NN consensus) (NNS sites))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Separation)) (PP (IN of) (NP (NP (NP (ADJP (JJ oxidant-initiated))) (CC and) (NP (ADJP (JJ redox-regulated))) (NP (NNS steps))) (PP (IN in) (NP (DT the) (NP (NN NF-kappa) (NN B)) (NN signal) (NN transduction) (NN pathway))))) (. .)))))
(S1 (S (S (S (NP (NP (NNS Studies)) (VP (VBN presented) (ADVP (RB here)))) (VP (VBP show) (SBAR (IN that) (S (NP (JJ overall) (NP (NN NF-kappa) (NN B)) (NN signal) (NN transduction)) (VP (VBZ begins) (PP (IN with) (NP (NP (NP (DT a) (JJ parallel) (NN series)) (PP (IN of) (NP (JJ stimuli-specific) (NNS pathways)))) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS oxidants)) (PRN (-LRB- -LRB-) (NP (NP (NN hydrogen) (NN peroxide)) (CC and) (NP (NN mitomycin) (NN C))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN phorbol) (NN ester)) (PRN (-LRB- -LRB-) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (-RRB- -RRB-)))) (ADVP (RB individually)) (VP (VBP initiate) (NP (NN signaling))))))))))) (. .)))))
(S1 (S (S (NP (DT These) (JJ initial) (NNS pathways)) (VP (VBP culminate) (PP (IN in) (NP (NP (DT a) (JJ common) (NN pathway)) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NP (DT all)) (PP (IN of) (NP (DT the) (VBG stimulating) (NNS agents)))) (ADVP (RB ultimately)) (VP (VBP signal) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP distinguish) (NP (DT the) (JJ stimuli-specific) (NNS pathways)) (PP (IN by) (S (VP (VBG showing) (SBAR (IN that) (S (NP (DT the) (JJ oxidative) (NNS stimuli)) (VP (VBP trigger) (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (NP (CD two) (NP (JJ human) (NN T-cell) (NNS lines))) (PRN (-LRB- -LRB-) (NP (NP (NN Wurzburg)) (CONJP (CC but) (RB not)) (NP (NN Jurkat))) (-RRB- -RRB-)))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (CC and) (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate))) (ADVP (RB readily)) (VP (VBP stimulate) (PP (IN in) (NP (DT both) (NNS lines))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (NP (DT the) (JJ common) (NN pathway)) (PP (IN as) (NP (NP (DT the) (JJS simplest) (NN way)) (PP (IN of) (S (VP (NN accounting) (PP (IN for) (NP (NP (DT the) (ADJP (JJ common)) (NP (NNS requirements)) (CC and) (NP (NNS properties))) (PP (IN of) (NP (DT the) (NN signaling) (NN pathway))))))))))) (. .))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP include) (NP (DT a) (JJ redox-regulatory) (NN mechanism) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (PP (IN in) (NP (DT this) (JJ common) (NN pathway))) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (DT the) (ADJP (RB previously) (VBN demonstrated)) (NN redox) (NN regulation)) (PP (IN of) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (NP (NN Jurkat) (NNS cells)) (PRN (-LRB- -LRB-) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NNS oxidants)) (VP (VBP do) (RB n't) (VP (VB activate) (NP (NN NF-kappa) (NN B)))))) (-RRB- -RRB-))))))))))))) (: ;) (S (NP (PRP we)) (VP (VBP put) (NP (NN tyrosine) (NN phosphorylation)) (PP (IN in) (NP (DT the) (JJ common) (NN pathway))) (PP (IN by) (S (VP (VBG showing) (SBAR (IN that) (S (NP (NP (NN kinase) (NN activity)) (PRN (-LRB- -LRB-) (ADJP (JJ inhibitable) (PP (IN by) (NP (NP (NN herbimycin) (NN A)) (CC and) (NP (NN tyrphostin) (CD 47))))) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN by) (NP (NP (DT all) (NNS stimuli)) (VP (VBN tested) (PP (IN in) (NP (DT both) (NN cell) (NNS lines))))))))))))))))) (. .))))
(S1 (S (S (SBAR (SBAR (IN Since) (S (NP (NP (JJ internal) (NNS sites)) (PP (IN of) (NP (NN oxidant) (NN production)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ cytokine-stimulated) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))))))) (, ,) (CC and) (SBAR (IN since) (S (NP (NP (NN tyrosine) (NN kinase)) (CC and) (NP (NN phosphatase)) (NP (NNS activities))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN altered) (PP (IN by) (NP (NNS oxidants)))))))))))) (, ,) (S (NP (DT these) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ intracellular) (NN redox) (NN status)) (VP (VBZ controls) (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN by) (S (VP (VBG regulating) (NP (NN tyrosine) (NN phosphorylation) (NN event) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (PP (IN within) (NP (NP (DT the) (JJ common) (NN step)) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B)) (NN signal) (NN transduction) (NN pathway))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Transcription-independent) (NN turnover)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (PP (IN during) (NP (NN monocyte) (NN adherence))) (: :)) (NP (NP (NNS implications)) (PP (IN for) (NP (NP (DT a) (JJ translational) (NN component)) (VP (VBG regulating) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)) (NNS levels)))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD identified) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3)) (PP (IN as) (NP (NP (DT an) (NP (JJ immediate-early) (NN gene))) (PP (IN in) (NP (JJ human) (NNS monocytes))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS signals)) (, ,) (PP (VBG including) (NP (NP (NN adhesion)) (, ,) (NP (NN lipopolysaccharide)) (, ,) (CC and) (NP (NN phorbol) (NN myristate) (NN acetate))))))))))))))))) (. .)))))
(S1 (S (S (PP (IN Within) (NP (NP (CD 5) (NN min)) (PP (IN of) (NP (NN monocyte) (NN adhesion))))) (, ,) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (NP (NN I) (NN kappa) (NN B) (NN alpha) (NN protein))))) (VP (VP (VBZ is) (ADVP (RB markedly)) (VP (VBN diminished))) (CC but) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN replaced) (PP (IN in) (NP (DT a) (JJ cycloheximide-sensitive) (NN manner))) (PP (IN within) (NP (CD 20) (NN min)))))) (. .))))
(S1 (S (SINV (VP (VBG Accompanying) (NP (NP (DT the) (JJ rapid) (NN turnover)) (PP (IN of) (NP (DT the) (NP (NN I) (NN kappa) (NN B) (NN alpha) (NN protein)))))) (VP (VBZ is)) (NP (NP (JJ simultaneous) (NN translocation)) (PP (IN of) (NP (NN NF-kappa) (JJ B-related) (NN transcription) (NNS factors))) (PP (TO to) (NP (NP (NNS nuclei)) (PP (IN of) (NP (JJ adhered) (NNS monocytes)))))) (. .))))
(S1 (S (S (NP (DT The) (NN demonstration) (SBAR (IN that) (S (NP (NN NF-kappa) (NN B)) (VP (MD can) (VP (VB regulate) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN gene)) (NN transcription)) (PP (IN in) (NP (JJ other) (NN cell) (NNS types)))))))) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (NP (DT the) (JJ rapid) (NN increase)) (PP (IN in) (NP (JJ steady-state) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)) (NNS levels)))) (SBAR (S (NP (PRP we)) (VP (VBD observed) (PP (IN within) (NP (NP (CD 30) (NN min)) (PP (IN of) (NP (NN monocyte) (NN adherence))))))))) (VP (MD would) (VP (VB result) (PP (IN from) (NP (NP (NN NF-kappa) (JJ B-dependent) (JJ transcriptional) (NN stimulation)) (PP (IN of) (NP (DT the) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN gene))))))))))) (. .))))
(S1 (S (S (NP (ADJP (ADJP (JJ Nuclear)) (ADJP (JJ run-on))) (NNS analyses)) (VP (VBD indicated) (SBAR (IN that) (S (, ,) (ADVP (RB instead)) (, ,) (SBAR (IN while) (S (NP (NP (JJ several) (NP (JJ immediate-early) (NN cytokine) (NNS genes))) (, ,) (PP (JJ such) (IN as) (NP (DT the) (NP (NN interleukin) (CD 1) (NN beta) (-LRB- -LRB-) (NN IL-1) (NN beta) (-RRB- -RRB-) (NN gene)))) (, ,)) (VP (VBD were) (ADVP (RB transcriptionally)) (VP (VBN activated) (PP (IN during) (NP (NN monocyte) (NN adhesion))))))) (, ,) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN gene)) (NN transcription)))) (VP (VBD remained) (ADJP (JJ constant))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ adherence-dependent) (NN increase)) (PP (IN in) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)) (NNS levels)))) (VP (VBD was) (ADVP (RB also)) (RB not) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (NN mRNA)) (NN stabilization) (NNS events))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (SBAR (IN while) (S (NP (NP (NNS increases)) (PP (IN in) (NP (CC both) (NP (NN IL-1) (NN beta)) (CC and) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)) (NP (NNS levels))))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (NNS nuclei)) (PP (IN of) (NP (JJ adherent) (NNS monocytes))))))))) (, ,) (S (NP (NP (JJ cytoplasmic) (NNS levels)) (PP (IN of) (NP (NN IL-1) (NN beta) (NN mRNA)))) (VP (VBN increased) (PP (IN during) (NP (NN adherence))) (SBAR (IN whereas) (S (NP (NP (DT those)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)))) (VP (VBD did) (RB not)))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (CD two) (JJ interactive) (NNS mechanisms)) (VP (VBP regulate) (NP (NP (JJ monocytic) (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)) (NNS levels))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (JJ adherent) (NNS monocytes)) (VP (VBP regulate) (NP (NP (JJ nuclear) (NP (NN processing)) (PRN (-LRB- -LRB-) (CC or) (NP (NN decay)) (-RRB- -RRB-))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG increasing) (NP (NN mRNA) (NNS levels)) (PP (IN without) (S (VP (VBG stimulating) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN gene)) (NN transcription))))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (SBAR (IN since) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NN protein) (NN synthesis)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN accumulation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA))))) (PP (IN without) (S (VP (VBG stimulating) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN gene)) (NN transcription)))))))) (, ,) (S (NP (PRP we)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ low) (JJ cytoplasmic) (NNS levels)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha/MAD-3) (NN mRNA)))) (VP (VBP are) (VP (VBN maintained) (PP (IN by) (NP (DT a) (JJ translation-dependent) (NN degradation) (NN mechanism))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN E2F-1)) (CC and) (NP (NP (DT a) (NP (JJ cyclin-like) (NN DNA) (NN repair) (NN enzyme))) (, ,) (NP (NN uracil-DNA) (NN glycosylase))) (, ,)) (VP (VBP provide) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (DT an) (JJ autoregulatory) (NN mechanism)) (PP (IN for) (NP (NN transcription))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN cell) (JJ cycle-dependent) (NN transcription) (NN factor))) (, ,) (NP (NN E2F-1)) (, ,)) (VP (VBZ regulates) (NP (NP (DT the) (JJ cyclin-like) (NNS species)) (PP (IN of) (NP (DT the) (NP (NP (NN DNA) (NN repair) (NN enzyme)) (NP (NN uracil-DNA) (NN glycosylase) (-LRB- -LRB-) (NN UDG) (-RRB- -RRB-) (NN gene)))))) (PP (IN in) (NP (JJ human) (NN osteosarcoma) (-LRB- -LRB-) (NN Saos-2) (-RRB- -RRB-) (NNS cells)))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (, ,) (PP (IN through) (NP (NP (DT the) (NN deletion)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN UDG) (NN promoter) (NNS sequences)))))) (, ,) (SBAR (IN that) (S (NP (NP (NN expression)) (PP (IN of) (NP (NN E2F-1)))) (VP (VBZ activates) (NP (DT the) (NP (NN UDG) (NN promoter))) (PP (IN through) (NP (JJ several) (NP (NN E2F) (NNS sites)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (JJ major) (JJ putative) (JJ downstream) (NN site))) (PP (IN for) (NP (NN E2F))) (, ,) (ADJP (JJ located) (PP (IN in) (NP (DT the) (NP (JJ first) (NN exon))))) (, ,)) (VP (VBZ serves) (PP (IN as) (NP (NP (DT a) (NN target)) (PP (IN for) (NP (NP (NP (NN E2F-1/DP1) (NN complex)) (NN binding)) (ADVP (FW in) (FW vitro))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP provide) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (DT the) (JJ functional) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NP (JJ cyclin-like) (NN UDG) (NN gene) (NN product))) (CC and) (NP (NN E2F)))))))) (. .))))
(S1 (S (S (NP (NP (JJ High) (NNS levels)) (PP (IN of) (NP (NP (NN UDG)) (NN expression))) (PP (IN in) (NP (DT a) (JJ transient) (NN transfection) (NN assay)))) (VP (VBP result) (PP (IN in) (NP (NP (DT the) (NN down-regulation)) (PP (IN of) (NP (NP (JJ transcriptional) (NN activity)) (PP (IN through) (NP (NP (NNS elements)) (ADJP (JJ specific) (PP (IN for) (NP (JJ E2F-mediated) (NN transcription))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Overexpression)) (PP (IN of) (NP (NN UDG))) (PP (IN in) (NP (NN Saos) (CD 2) (NNS cells)))) (VP (VBD was) (VP (VBN observed) (S (VP (TO to) (VP (VP (VB delay) (NP (NN growth)) (ADVP (RB late)) (PP (IN in) (NP (NN G1) (NN phase)))) (CC and) (ADVP (RB transiently)) (VP (VB arrest) (NP (DT these) (NNS cells)) (PP (IN from) (S (VP (VBG progressing) (PP (IN into) (NP (DT the) (NN S) (NN phase)))))))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ hypothetical) (NN model)) (VP (VBZ integrates) (NP (NP (CD one) (NN mechanism)) (PP (IN of) (NP (NN DNA) (NN repair)))) (PP (IN with) (NP (NP (DT the) (NN cell) (NN cycle) (NN control)) (PP (IN of) (NP (NN gene) (NN transcription))))) (, ,) (ADVP (RB likely)) (PP (IN through) (NP (NN E2F)))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ implicates) (NP (NN E2F)) (PP (IN as) (NP (NP (DT a) (JJ multifunctional) (NN target)) (PP (IN for) (NP (NP (NP (NNS proteins)) (CC and) (NP (NNS enzymes))) (, ,) (ADVP (RB possibly)) (, ,) (ADJP (JJ responsive) (PP (TO to) (NP (NP (NN DNA) (NN damage)) (PP (IN through) (NP (NP (DT the) (JJ negative) (NN effect)) (PP (IN of) (NP (NN UDG))) (PP (IN on) (NP (JJ E2F-mediated) (JJ transcriptional) (NN activity))))))))))))) (. .))))
(S1 (S (S (S (NP (NN Aspirin)) (VP (VBZ inhibits) (NP (NP (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (NN mobilization)) (CC and) (NP (NN monocyte) (NN adhesion))) (PP (IN in) (NP (VBN stimulated) (JJ human) (JJ endothelial) (NNS cells))))) (. .)))))
(S1 (S (NP (NP (NN BACKGROUND) (: :)) (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (NP (JJ vascular) (NN cell) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN VCAM-1)) (-RRB- -RRB-))) (CC and) (NP (NN E-selectin)))) (PP (IN by) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NN mobilization)) (PP (IN of) (NP (DT the) (NP (NP (NN transcription) (NN factor)) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (SBAR (IN Since) (S (NP (NNS salicylates)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN by) (S (VP (VBG preventing) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (PRP$ its) (NN inhibitor) (NP (NN I) (NN kappa) (NN B)))))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (DT a) (JJ potential) (NN inhibition)) (PP (IN of) (NP (DT this) (NN pathway))) (PP (IN by) (NP (NP (NN acetylsalicylate)) (PRN (-LRB- -LRB-) (NP (NN aspirin)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS HUVECs)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (NP (NP (NP (NNS METHODS)) (CC AND) (NP (NNS RESULTS) (: :))) (S (NP (JJ Gel-shift) (NNS analyses)) (VP (VBD demonstrated) (NP (NP (JJ dose-dependent) (NN inhibition)) (PP (IN of) (NP (JJ TNF-induced) (NP (NN NF-kappa) (NN B)) (NN mobilization))) (PP (IN by) (NP (NP (NN aspirin)) (PP (IN at) (NP (NP (NNS concentrations)) (VP (VBG ranging) (NP (QP (IN from) (CD 1) (TO to) (CD 10)) (NN mmol/L)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (NP (NN VCAM-1)) (CC and) (NP (NP (NN E-selectin))) (NP (NN surface) (NN expression)))) (PP (IN by) (NP (NN TNF)))) (VP (VBD was) (ADVP (RB dose-dependently)) (VP (VBN reduced) (PP (IN by) (NP (NN aspirin))) (PP (IN over) (NP (DT the) (JJ same) (NN range)))) (, ,) (SBAR (IN while) (S (NP (NP (NN induction)) (PP (IN of) (NP (NP (JJ intercellular) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN ICAM-1)) (-RRB- -RRB-))))) (VP (VBD was) (ADVP (RB hardly)) (VP (VBN affected)))))) (. .))))
(S1 (S (S (NP (NN Aspirin)) (VP (VBD appeared) (S (VP (TO to) (VP (VB prevent) (NP (NP (NN VCAM-1)) (NN transcription))))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (ADVP (RB dose-dependently)) (VP (VBD inhibited) (NP (NP (NN induction)) (PP (IN of) (NP (NN VCAM-1) (NN mRNA))) (PP (IN by) (NP (NN TNF)))))))) (. .))))
(S1 (S (S (PP (IN As) (NP (DT a) (JJ functional) (NN consequence))) (, ,) (NP (NP (NN adhesion)) (PP (IN of) (NP (NN U937) (NNS monocytes))) (PP (TO to) (NP (JJ TNF-stimulated) (NNS HUVECs)))) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN reduced) (PP (IN by) (NP (NN aspirin))) (PP (JJ due) (TO to) (NP (NP (NN suppression)) (PP (IN of) (NP (NP (NN VCAM-1)) (CC and) (NP (NP (NN E-selectin)) (NP (NN upregulation))))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS effects)) (PP (IN of) (NP (NN aspirin)))) (VP (VBD were) (RB not) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NN cyclooxygenase)) (NN activity)))))) (, ,) (SBAR (IN since) (S (NP (NN indomethacin)) (VP (VBD was) (ADJP (JJ ineffective)))))) (. .))))
(S1 (S (NP (NP (NNS CONCLUSIONS) (: :)) (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN aspirin)) (VP (VBZ inhibits) (NP (NP (NP (NP (NN NF-kappa) (NN B)) (NN mobilization)) (, ,) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN VCAM-1)) (CC and) (NP (NN E-selectin))))) (, ,) (CC and) (NP (JJ subsequent) (NN monocyte) (NN adhesion))) (PP (IN in) (NP (NP (JJ endothelial) (NNS cells)) (VP (VBN stimulated) (PP (IN by) (NP (NN TNF)))))))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG providing) (NP (NP (DT an) (JJ additional) (NN mechanism)) (PP (IN for) (NP (NP (JJ therapeutic) (NNS effects)) (PP (IN of) (NP (NN aspirin)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN CD30)))) (VP (VBZ induces) (NP (NN HIV) (NN expression)) (PP (IN in) (NP (ADJP (RB chronically) (JJ infected)) (NP (NN T) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (NN CD30)) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN receptor) (NN family)))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB constitutively)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN T) (NN cell) (NN line) (NN ACH-2)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB chronically)) (VP (VBN infected) (PP (IN with) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type-1) (-LRB- -LRB-) (NN HIV) (-RRB- -RRB-) (CD -1))))))))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (S (VP (JJ cross-linking) (NP (NN CD30)) (PP (IN with) (NP (NP (DT an) (JJ anti-CD30-specific) (JJ monoclonal) (NN antibody)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ mimics) (NP (NP (DT the) (VBN described) (JJ biological) (NNS activities)) (PP (IN of) (NP (DT the) (NP (NP (NN CD30) (NN ligand)) (PRN (-LRB- -LRB-) (NP (NN CD30L)) (-RRB- -RRB-))))))))))))) (, ,) (VP (VBZ results) (PP (IN in) (NP (NN HIV) (NN expression))))))) (. .))))
(S1 (S (S (S (NP (NP (NN CD30)) (NN cross-linking)) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (NN proliferation)) (PP (IN of) (NP (NN ACH-2) (NNS cells))))))) (CC and) (S (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN HIV) (NN expression)))) (VP (VBZ is) (RB not) (VP (VBN mediated) (PP (IN by) (NP (JJ endogenous) (NP (NN TNF) (NN alpha/beta))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN cross-linking)) (PP (IN of) (NP (NN CD30)))) (VP (VBZ leads) (PP (TO to) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (CC and) (NP (VBN enhanced) (NN HIV) (NN transcription))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (JJ CD30-CD30L) (NNS interactions)) (VP (VBP mediate) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN HIV) (NN expression)))) (PP (IN by) (NP (NP (DT a) (NN kappa) (JJ B-dependent) (NN pathway)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NN TNF)))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN mechanism)) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN HIV) (NN expression))) (PP (IN from) (NP (NP (ADJP (RB latently) (JJ infected)) (NP (JJ CD4+) (NN T) (NNS cells))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (JJ lymphoid) (NNS organs)) (SBAR (WHADVP (WRB where)) (S (NP (NP (NP (NN cell)) (PP (TO to) (NP (NN cell)))) (NN contact)) (VP (VBZ is) (ADJP (JJ conducive) (PP (TO to) (NP (JJ receptor-ligand) (NNS interactions)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Integrin-mediated) (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN cytokine)) (NN message) (NN induction))) (PP (IN in) (NP (JJ monocytic) (NNS cells))) (. .)))))
(S1 (S (NP (NP (DT A) (JJ possible) (NN signaling) (NN role)) (PP (IN for) (NP (DT the) (NP (NN Syk) (NN tyrosine) (NN kinase)))) (. .))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (JJ cytoplasmic) (NN tyrosine) (NNS kinases)))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN aspect)) (PP (IN of) (NP (NP (NN signal) (NN transduction)) (VP (VBN mediated) (PP (IN by) (NP (NNS integrins)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT the) (NP (JJ human) (JJ monocytic) (NN cell) (NN line) (NN THP-1)))) (, ,) (NP (CC either) (NP (NP (JJ integrin-dependent) (NN cell) (NN adhesion)) (PP (TO to) (NP (NN fibronectin)))) (CC or) (NP (NP (NN ligation)) (PP (IN of) (NP (NN beta) (CD 1) (NNS integrins))) (PP (IN with) (NP (NNS antibodies))))) (VP (VBZ causes) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ intense))) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (CD two) (NNS sets)) (PP (IN of) (NP (NP (NNS proteins)) (PP (IN of) (NP (RB about) (NP (QP (CD 65-75))) (CC and) (NP (QP (CD 120-125))) (NP (NN kDa)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN integrin)) (NN ligation)) (VP (VBZ leads) (PP (PP (TO to) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (NP (DT the) (NP (NN p50))) (CC and) (NP (NN p65) (NNS subunits))) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B) (NN transcription) (NN factor)))))))) (, ,) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (DT a) (NP (NN reporter) (NN gene)))) (VP (VBN driven) (PP (IN by) (NP (NP (DT a) (NP (NN promoter))) (VP (VBG containing) (NP (NN NF-kappa) (NN B) (NNS sites)))))))) (, ,) (CC and) (PP (TO to) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (NNS mRNAs)) (PP (IN for) (NP (NP (JJ immediate-early) (NNS genes)) (, ,) (PP (VBG including) (NP (DT the) (NP (NN cytokine) (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -1) (NN beta)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN tyrosine) (NN kinase) (NNS inhibitors)) (NP (NP (NN genistein)) (CC and) (NP (NN herbimycin) (NN A)))) (VP (VBP block) (NP (CC both) (NP (JJ integrin-mediated) (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN IL-1) (NN beta)) (NN message) (NNS levels))))) (, ,) (S (VP (VBG indicating) (NP (NP (DT a) (JJ causal) (NN relationship)) (PP (IN between) (NP (DT the) (CD two) (NNS events))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS components)) (VP (NN tyrosine) (VBN phosphorylated) (ADJP (JJ subsequent) (PP (TO to) (NP (NN cell) (NN adhesion)))))) (VP (VBP include) (NP (NP (NN paxillin)) (, ,) (NP (NN pp125FAK)) (, ,) (CC and) (NP (DT the) (NP (NN SH2) (NN domain) (VBG containing) (NN tyrosine) (NN kinase) (NN Syk))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (NN integrin)) (NN ligation)) (PP (IN with) (NP (NNS antibodies)))) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (PP (IN of) (NP (NN Syk))) (CC but) (PP (RB not) (IN of) (NP (NP (NN FAK)) (CC or) (NP (NN paxillin))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ adhering) (NNS cells))) (, ,) (NP (NP (NN pre-treatment)) (PP (IN with) (NP (NN cytochalasin) (NN D)))) (VP (VBZ suppresses) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (PP (IN of) (NP (NP (NN FAK)) (CC and) (NP (NN paxillin)))) (CC but) (PP (RB not) (IN of) (NP (NN Syk))))) (, ,) (SBAR (IN while) (S (NP (NP (NN IL-1) (NN beta)) (NN message) (NN induction)) (VP (VBZ is) (ADJP (JJ unaffected)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS observations)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (NP (NN Syk)) (NN tyrosine) (NN kinase)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (NN component)) (PP (IN of) (NP (NP (DT an) (NP (NN integrin)) (NN signaling) (NN pathway)) (PP (IN in) (NP (JJ monocytic) (NNS cells))) (, ,) (VP (VBG leading) (PP (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (CC and) (PP (TO to) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (NN cytokine)) (NNS messages))))))))))))))) (. .))))
(S1 (S (S (S (S (NP (DT The) (NP (NN Ah) (NN receptor))) (VP (VBZ recognizes) (NP (NP (NN DNA) (NN binding) (NNS sites)) (PP (IN for) (NP (DT the) (NP (NP (NN B) (NN cell) (NN transcription) (NN factor)) (, ,) (NP (NN BSAP)))))))) (: :) (NP (NP (DT a) (JJ possible) (NN mechanism)) (PP (IN for) (NP (NP (JJ dioxin-mediated) (NN alteration)) (PP (IN of) (NP (NP (NP (NN CD19) (NN gene)) (NN expression)) (PP (IN in) (NP (JJ human) (NN B) (NNS lymphocytes)))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN 2,3,7,8-tetrachlorodibenzo-p-dioxin)) (PRN (-LRB- -LRB-) (NP (NN TCDD)) (-RRB- -RRB-))) (VP (VBZ inhibits) (NP (NP (ADJP (JJ murine))) (CC and) (NP (JJ human)) (NP (NN B) (NN lymphocyte) (NN immunoglobulin) (NN production))) (PP (IN through) (NP (DT an) (JJ unknown) (NN mechanism)))) (. .)))))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN TCDD))) (PP (IN on) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NN CD19) (NN gene)))) (PP (IN in) (NP (DT a) (NP (JJ human) (NN B) (NN lymphocyte) (NN cell) (NN line)))))))) (. .))))
(S1 (S (S (NP (NN Northern) (NN blot) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN TCDD) (NN treatment)) (VP (VBD decreased) (NP (NP (JJ steady) (NN state) (NNS levels)) (PP (IN of) (NP (NN CD19) (NN mRNA)))) (PP (IN by) (NP (CD 67) (NN %))) (PP (IN in) (NP (DT the) (NP (NN IM-9) (NN cell) (NN line)))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (DT a) (NN gel) (NN mobility) (NN shift) (NN assay)))) (, ,) (S (NP (PRP we)) (VP (VBD identified) (NP (NP (DT a) (NP (NN DNA-binding) (NN complex))) (PP (IN in) (NP (NN IM-9) (JJ nuclear) (NNS extracts))) (SBAR (WHNP (WDT that)) (S (PP (IN by) (NP (JJ several) (NNS criteria))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (DT the) (NP (NN Ah) (NN receptor)))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NP (NN Ah) (NN receptor) (NN complex))) (VP (VBD recognized) (NP (NP (DT a) (NP (NN DNA) (NN binding) (NN site))) (PP (IN for) (NP (NP (NP (NN B) (NN cell) (JJ lineage-specific) (NN activator) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN BSAP)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NP (NN promoter) (NN region))) (PP (IN of) (NP (DT the) (JJ human) (NP (NN CD19) (NN gene)))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (DT the) (NP (NN consensus) (NN Ah) (NN receptor) (NN DNA) (NN binding) (NN site)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NN AhR))) (VP (MD could) (VP (VB interfere) (PP (IN with) (NP (JJ BSAP-stimulated) (NP (NN CD19) (NN gene)) (NN transcription))) (PP (IN by) (NP (NP (NN competition)) (PP (IN for) (NP (DT a) (JJ common) (NP (NN DNA) (NN binding) (NN site))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Nitric) (NN oxide)) (VP (VBZ decreases) (NP (JJ cytokine-induced) (JJ endothelial) (NN activation))) (. .)))))
(S1 (S (S (NP (JJ Nitric) (NN oxide)) (ADVP (RB selectively)) (VP (VBZ reduces) (NP (NP (JJ endothelial) (NN expression)) (PP (IN of) (NP (NP (NN adhesion) (NNS molecules)) (CC and) (NP (JJ proinflammatory) (NNS cytokines)))))) (. .))))
(S1 (S (S (S (S (VP (TO To) (VP (VB test) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (JJ nitric) (NN oxide)) (PRN (-LRB- -LRB-) (NP (NN NO)) (-RRB- -RRB-))) (VP (VBZ limits) (NP (JJ endothelial) (NN activation))))))))) (, ,) (S (NP (PRP we)) (VP (VP (VBD treated) (NP (JJ cytokine-stimulated) (JJ human) (JJ saphenous) (NN vein) (JJ endothelial) (NNS cells)) (PP (IN with) (NP (JJ several) (NN NO) (NNS donors)))) (CC and) (VP (VBD assessed) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (NP (DT the) (JJ inducible) (NN expression)) (PP (IN of) (NP (NP (JJ vascular) (NN cell) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN VCAM-1)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT a) (JJ concentration-dependent) (NN manner))) (, ,) (NP (NN NO)) (VP (VBD inhibited) (NP (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -1)) (JJ alpha-stimulated) (NP (NN VCAM-1)) (NN expression)) (PP (IN by) (NP (QP (CD 35-55)) (NN %))) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (NN cell) (NN surface) (NN enzyme) (NNS immunoassays)) (CC and) (NP (NN flow) (NN cytometry)))))))) (. .))))
(S1 (S (S (NP (DT This) (NN inhibition)) (VP (VP (VBD was) (VP (VBN paralleled) (PP (IN by) (NP (NP (VBN reduced) (NN monocyte) (NN adhesion)) (PP (TO to) (NP (JJ endothelial) (NNS monolayers))) (PP (IN in) (NP (JJ nonstatic) (NNS assays))))))) (, ,) (VP (VBD was) (ADJP (JJ unaffected) (PP (IN by) (NP (NN cGMP) (NNS analogues))))) (, ,) (CC and) (VP (VBD was) (ADJP (RB quantitatively) (JJ similar) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN by) (NP (CC either) (NP (NN IL-1) (NN alpha)) (, ,) (NP (NN IL-1) (NN beta)) (, ,) (NP (NN IL-4)) (, ,) (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF) (NN alpha)) (-RRB- -RRB-))) (, ,) (CC or) (NP (JJ bacterial) (NN lipopolysaccharide))))))))) (. .))))
(S1 (S (S (NP (NN NO)) (ADVP (RB also)) (VP (VBD decreased) (NP (NP (DT the) (JJ endothelial) (NN expression)) (PP (IN of) (NP (NP (NP (JJ other) (NP (NN leukocyte) (NN adhesion) (NNS molecules))) (PRN (-LRB- -LRB-) (NP (NP (NN E-selectin)) (CC and) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (, ,) (NP (JJ intercellular) (NN adhesion) (NN molecule-1))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ secretable) (NP (NNS cytokines))) (PRN (-LRB- -LRB-) (NP (NP (NN IL-6)) (CC and) (NP (NN IL-8))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ endogenous) (NN NO) (NN production))) (PP (IN by) (NP (NN L-N-monomethyl-arginine)))) (VP (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN VCAM-1))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (VB augment) (NP (JJ cytokine-induced) (NP (NN VCAM-1)) (NN expression))))) (. .))))
(S1 (S (S (NP (NP (JJ Nuclear) (JJ run-on) (NNS assays)) (, ,) (NP (NP (NN transfection) (NNS studies)) (VP (VBG using) (NP (JJ various) (NP (NN VCAM-1) (NN promoter) (NN reporter) (NN gene) (NNS constructs))))) (, ,) (CC and) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN NO)) (VP (VBZ represses) (NP (NP (NN VCAM-1)) (NN gene) (NN transcription)) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (IN by) (S (VP (VBG inhibiting) (NP (NN NF-kappa) (NN B))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NN NO) (POS 's) (NN ability) (S (VP (TO to) (VP (VP (VB limit) (NP (JJ endothelial) (NN activation))) (CC and) (VP (VB inhibit) (NP (NN monocyte) (NN adhesion))))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT some)) (PP (IN of) (NP (NP (PRP$ its) (NP (ADJP (JJ antiatherogenic))) (CC and) (NP (ADJP (JJ antiinflammatory))) (NP (NNS properties))) (PP (IN within) (NP (DT the) (NN vessel) (NN wall)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Signalling)) (PP (IN via) (NP (NP (NN CD28)) (PP (IN of) (NP (JJ human) (JJ naive) (JJ neonatal) (NN T) (NNS lymphocytes))))) (. .)))))
(S1 (S (S (S (NP (JJ Accessory) (NNS molecules)) (VP (VBP play) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT the) (NN T) (NN cell) (NN response)) (PP (TO to) (NP (JJ antigenic) (NN challenge)))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN CD28))) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (ADJP (`` ') (JJ naive) ('' ') (JJ neonatal)) (NN T) (NN cell) (NN response)) (PP (TO to) (NP (JJ anti-CD2-mediated) (NN activation)))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB compare) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN CD28))))))) (, ,) (S (NP (NP (NP (JJ neonatal))) (CC and) (NP (JJ adult) (NN T) (NNS cells))) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (DT a) (NN pair)) (PP (IN of) (NP (JJ mitogenic) (JJ anti-CD2) (NNS antibodies))))) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (JJ anti-CD28) (NN MoAb)))))))) (. .))))
(S1 (S (S (PP (IN With) (NP (NP (NN anti-CD2)) (ADVP (RB alone)))) (, ,) (NP (JJ neonatal) (NN T) (NNS cells)) (VP (VP (VBD proliferated) (ADVP (RB slightly))) (CC but) (VP (VBD produced) (NP (DT no) (JJ detectable) (NP (NN IL-2)))) (, ,) (SBAR (IN whereas) (S (NP (JJ adult) (NP (NN T) (NNS cells))) (VP (VBD proliferated) (ADVP (RB vigorously)) (, ,) (PP (IN with) (NP (JJ significant) (NP (NN IL-2)) (NN production))))))) (. .))))
(S1 (S (S (NP (NP (NN Costimulation)) (PP (IN with) (NP (JJ anti-CD28) (NN MoAb)))) (ADVP (RB greatly)) (VP (VBD enhanced) (NP (NP (DT the) (JJ proliferative) (NN response)) (PP (IN of) (NP (JJ neonatal) (NN T) (NNS cells)))) (PP (TO to) (NP (NP (NNS levels)) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (JJ adult) (NN T) (NNS cells)))))))) (, ,) (SBAR (IN whereas) (S (NP (JJ adult) (NN T) (NNS cells)) (VP (VBD showed) (NP (ADJP (RB only) (JJ slight)) (NNS increases)))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN IL-2)) (NN secretion)) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ anti-CD28) (NN MoAb))))))))) (, ,) (S (NP (NP (JJ neonatal) (NN T) (NN cell)) (NP (NN IL-2)) (NN production)) (VP (VBD remained) (ADJP (ADJP (JJR lower)) (PP (IN than) (NP (PP (IN in) (NP (NNS adults)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN enhancement)) (PP (IN of) (NP (NP (NN IL-2) (NN mRNA)) (NN expression))) (PP (IN in) (NP (NNS neonates)))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (JJ adult) (NNS levels))))) (. .))))
(S1 (S (S (NP (JJ Anti-CD28) (NN MoAb) (NN costimulation)) (VP (VBD increased) (NP (NP (NP (NN NF) (NN kappa) (NN B)) (NNS levels)) (PP (IN in) (NP (NNS neonates)))) (, ,) (PP (IN albeit) (PP (TO to) (NP (NP (NNS levels)) (ADJP (JJR lower) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NNS adults)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ cellular) (NN mechanism)) (VP (VBG governing) (NP (NP (DT the) (VBN diminished) (JJ proliferative) (NN response)) (PP (IN of) (NP (JJ neonatal) (NN T) (NNS lymphocytes))) (PP (TO to) (NP (NN anti-CD2)))))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (VBN decreased) (NP (NN NF) (NN kappa) (NN B)) (NN induction)) (, ,) (NP (VBN reduced) (NP (NN IL-2) (NN mRNA)) (NN expression)) (CC and) (NP (JJ deficient) (NP (NN IL-2)) (NN production))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ anti-CD28) (NN MoAb)) (NN costimulation)) (VP (VBZ enhances) (NP (NP (DT all)) (PP (IN of) (NP (DT the) (JJ above) (NNS signals))))))) (, ,) (S (NP (NP (NN NF) (NN kappa) (NN B)) (CC and) (NP (NN IL-2)) (NP (NNS levels))) (VP (VBP remain) (ADJP (ADJP (JJR lower)) (PP (IN than) (NP (PP (IN in) (NP (NNS adults)))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (JJ further) (NN activation) (NNS requirements)) (PP (IN in) (NP (DT the) (NN neonate)))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (CC and) (NP (NN cytokine) (NN gene))) (NN expression)) (PP (IN in) (NP (JJ myeloid) (NNS cells))))) (PP (IN by) (NP (NP (NN NF-kappa) (NN B) (NN /Rel)) (NP (NN transcription) (NNS factors)))) (. .)))))
(S1 (S (S (S (NP (NP (JJ CD4+) (NNS macrophages)) (PP (IN in) (NP (NP (NP (NNS tissues)) (PP (JJ such) (IN as) (NP (NP (NN lung)) (, ,) (NP (NN skin)) (, ,) (CC and) (NP (NN lymph) (NNS nodes))))) (, ,) (NP (NP (NP (JJ promyelocytic) (NNS cells)) (PP (IN in) (NP (NN bone) (NN marrow)))) (, ,) (CC and) (NP (JJ peripheral) (NN blood) (NNS monocytes)))))) (VP (VBP serve) (PP (IN as) (NP (NP (ADJP (JJ important)) (NP (NNS targets)) (CC and) (NP (NNS reservoirs))) (PP (IN for) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN replication)))))) (. .)))))
(S1 (S (S (NP (JJ HIV-1-infected) (NP (JJ myeloid) (NNS cells))) (VP (VBP are) (ADVP (RB often)) (VP (VBN diminished) (PP (IN in) (NP (NP (PRP$ their) (NN ability)) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NP (NN chemotaxis)) (, ,) (NP (NN phagocytosis)) (, ,) (CC and) (NP (JJ intracellular) (NN killing))))))))))) (. .))))
(S1 (S (S (NP (NP (NN HIV-1) (NN infection)) (PP (IN of) (NP (JJ myeloid) (NNS cells)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN surface) (NNS receptors)) (VP (VBN associated) (PP (IN with) (NP (ADJP (JJ cellular)) (NP (NN activation)) (CC and/or) (NP (NN differentiation))))))) (SBAR (WHNP (WDT that)) (S (VP (VBP increase) (NP (NP (DT the) (NN responsiveness)) (PP (IN of) (NP (DT these) (NNS cells))) (PP (PP (TO to) (NP (NP (NNS cytokines)) (VP (VBN secreted) (PP (IN by) (NP (VBG neighboring) (NNS cells)))))) (CONJP (RB as) (RB well) (IN as)) (PP (TO to) (NP (NP (NNS bacteria)) (CC or) (NP (JJ other) (NNS pathogens))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Enhancement)) (PP (IN of) (NP (NN HIV-1) (NN replication)))) (VP (VBZ is) (ADJP (JJ related) (PP (IN in) (NP (NN part))) (PP (TO to) (NP (NP (VBN increased) (JJ DNA-binding) (NN activity)) (PP (IN of) (NP (NP (JJ cellular) (NN transcription) (NNS factors)) (PP (JJ such) (IN as) (NP (NN NF-kappa) (NN B))))))))) (. .))))
(S1 (S (S (NP (NN NF-kappa) (NN B)) (VP (VP (VBZ binds) (PP (TO to) (NP (NP (DT the) (NP (NN HIV-1) (NN enhancer)) (NN region)) (PP (IN of) (NP (DT the) (NP (JJ long) (JJ terminal) (NN repeat))))))) (CC and) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (NN inducibility)) (PP (IN of) (NP (NN HIV-1) (NN gene) (NN expression))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ multiple) (VBG activating) (NNS agents))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Phosphorylation)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (DT the) (NP (NP (JJ cytoplasmic) (NN inhibitor)) (NP (NP (NN I) (NN kappa) (NN B)) (NN alpha)))))) (VP (VBP are) (NP (NP (JJ crucial) (JJ regulatory) (NNS events)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (JJ DNA-binding) (NN activity))))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NP (NN N-)) (CC and) (NP (JJ C-terminal)) (NP (NNS residues))) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B)) (NN alpha)))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (JJ inducer-mediated) (NN degradation))))) (. .))))
(S1 (S (S (NP (NP (JJ Chronic) (NN HIV-1) (NN infection)) (PP (IN of) (NP (JJ myeloid) (NNS cells)))) (VP (VP (VBZ leads) (PP (TO to) (NP (JJ constitutive) (NP (NN NF-kappa) (NN B)) (JJ DNA-binding) (NN activity)))) (CC and) (VP (VBZ provides) (NP (NP (DT an) (JJ intranuclear) (NN environment)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG perpetuating) (NP (NN HIV-1) (NN replication))))))))) (. .))))
(S1 (S (S (NP (NP (VBN Increased) (JJ intracellular) (NNS stores)) (PP (IN of) (NP (JJ latent) (NN NF-kappa) (NN B)))) (VP (MD may) (ADVP (RB also)) (VP (VB result) (PP (IN in) (NP (NP (JJ rapid) (NN inducibility)) (PP (IN of) (NP (NN NF-kappa) (JJ B-dependent) (NP (NN cytokine)) (NN gene) (NN expression))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN response)) (PP (TO to) (NP (ADJP (JJ secondary)) (NP (JJ pathogenic) (NNS infections)) (CC or) (NP (JJ antigenic) (NN challenge)))))) (, ,) (NP (NP (NN cytokine)) (NN gene) (NN expression)) (VP (VBZ is) (UCP (VP (ADVP (RB rapidly)) (VBN induced)) (, ,) (VP (VBN enhanced)) (, ,) (CC and) (ADJP (JJ sustained) (PP (RP over) (NP (JJ prolonged) (NNS periods)))) (PP (IN in) (NP (JJ HIV-1-infected) (JJ myeloid) (NNS cells))) (PP (VBN compared) (PP (IN with) (NP (JJ uninfected) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (JJ Elevated) (NNS levels)) (PP (IN of) (NP (JJ several) (NP (JJ inflammatory) (NNS cytokines))))) (VP (VBP have) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NN sera)) (PP (IN of) (NP (JJ HIV-1-infected) (NNS individuals)))))))) (. .))))
(S1 (S (S (NP (NP (NN Secretion)) (PP (IN of) (NP (JJ myeloid) (JJ cell-derived) (NNS cytokines)))) (VP (MD may) (VP (CC both) (VP (VB increase) (NP (NN virus) (NN production))) (CC and) (VP (VB contribute) (PP (TO to) (NP (JJ AIDS-associated) (NNS disorders)))))) (. .))))
(S1 (S (NP (NP (NP (DT A) (JJ central) (NN role)) (PP (IN for) (NP (NP (DT a) (NP (JJ single) (NN c-Myb) (NN binding) (NN site))) (PP (IN in) (NP (DT a) (NP (JJ thymic) (NN locus) (NN control) (NN region)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Locus) (NN control) (NNS regions)) (PRN (-LRB- -LRB-) (NP (NNS LCRs)) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (JJ powerful) (NNS assemblies)) (PP (IN of) (NP (NP (JJ cis) (NNS elements)) (SBAR (WHNP (WDT that)) (S (VP (VBP organize) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (JJ cell-type-specific) (JJ trans-acting) (NNS factors))))))))))) (. .)))))
(S1 (S (S (NP (NP (NP (DT A) (NP (JJ 2.3-kb) (NN LCR))) (PP (IN in) (NP (DT the) (NP (JJ human) (NN adenosine) (NN deaminase) (-LRB- -LRB-) (NN ADA) (-RRB- -RRB-) (NN gene) (JJ first) (NN intron))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ controls) (NP (NN expression)) (PP (IN in) (NP (NNS thymocytes)))))) (, ,)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (NP (NP (DT a) (NP (JJ 200-bp) (NN enhancer) (NN domain))) (CC and) (NP (JJ extended) (NN flanking) (NNS sequences))) (SBAR (WHNP (WDT that)) (S (VP (VBP facilitate) (NP (NN activation)) (PP (IN from) (PP (IN within) (NP (NN chromatin))))))))))) (. .))))
(S1 (S (S (NP (RB Prior) (NNS analyses)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (DT the) (NP (NN enhancer))) (VP (VBZ contains) (NP (NP (DT a) (NP (JJ 28-bp) (NN core) (NN region))) (CC and) (NP (ADJP (JJ local) (JJ adjacent) (JJ augmentative)) (NP (JJ cis) (NNS elements))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB now)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NN core)) (VP (VBZ contains) (NP (DT a) (JJ single) (JJ critical) (NP (NN c-Myb) (NN binding) (NN site))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (CC both) (NP (RB transiently) (VBN cotransfected) (JJ human) (NNS cells)) (CC and) (NP (JJ stable) (NP (JJ chromatin-integrated) (NN yeast) (NNS cells))))) (, ,) (NP (NN c-Myb)) (ADVP (RB strongly)) (VP (VBD transactivated) (NP (NP (NN reporter) (NNS constructs)) (SBAR (WHNP (WDT that)) (S (VP (VBD contained) (NP (JJ polymerized) (NN core) (NNS sequences))))))) (. .))))
(S1 (S (S (NP (NN c-Myb) (NN protein)) (VP (VBD was) (ADJP (RB strongly) (JJ evident) (PP (IN in) (NP (NP (NN T) (NNS lymphoblasts)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NP (NN enhancer))) (VP (VP (VBD was) (ADJP (JJ active))) (CC and) (VP (VBD was) (ADJP (JJ localized) (PP (IN within) (NP (JJ discrete) (JJ nuclear) (NNS structures)))))))))))) (. .))))
(S1 (S (S (NP (JJ Fetal) (NN murine) (NN thymus)) (VP (VBD exhibited) (NP (NP (DT a) (JJ striking) (NN concordance)) (PP (IN of) (NP (JJ endogenous) (NP (NN c-myb)) (NN expression))) (PP (IN with) (NP (NP (NP (DT that)) (PP (IN of) (NP (NN mouse) (NN ADA)))) (CC and) (NP (JJ human) (NN ADA) (JJ LCR-directed) (NN transgene) (NN expression)))))) (. .))))
(S1 (S (S (NP (NP (NN Point) (NN mutation)) (PP (IN of) (NP (NP (DT the) (NP (NN c-Myb) (NN site))) (PP (IN within) (NP (DT the) (JJ intact) (NP (JJ 2.3-kb) (NN LCR))))))) (ADVP (RB severely)) (VP (VBD attenuated) (NP (NP (NP (NN enhancer) (NN activity)) (PP (IN in) (NP (NNS transfections)))) (CC and) (NP (NP (NP (NN LCR)) (NN activity)) (PP (IN in) (NP (JJ transgenic) (NNS thymocytes)))))) (. .))))
(S1 (S (S (PP (IN Within) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (DT a) (NP (NN complex) (NN enhancer))) (CC and) (NP (NN LCR)))))) (, ,) (NP (NN c-Myb)) (VP (MD can) (VP (VB act) (PP (IN as) (NP (NP (DT an) (NN organizer)) (PP (IN of) (NP (NP (JJ thymocyte-specific) (NN gene)) (NN expression))))) (PP (IN via) (NP (DT a) (JJ single) (VBG binding) (NN site))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Immunosuppression)) (PP (IN by) (NP (NNS glucocorticoids))) (: :)) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NN activity))) (PP (IN through) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B)) (NN synthesis)))))) (S (-LRB- -LSB-) (VP (VB see) (NP (NNS comments))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (NNS Glucocorticoids)) (VP (VBP are) (PP (IN among) (NP (DT the) (ADJP (RBS most) (JJ potent)) (ADJP (ADJP (JJ anti-inflammatory)) (CC and) (ADJP (JJ immunosuppressive))) (NNS agents)))) (. .)))))
(S1 (S (S (S (NP (PRP They)) (VP (VBP inhibit) (NP (NP (NN synthesis)) (PP (PP (IN of) (NP (ADJP (RB almost) (DT all) (JJ known)) (NP (NNS cytokines)))) (CC and) (PP (IN of) (NP (NP (JJ several) (NP (NN cell) (NN surface) (NNS molecules))) (VP (VBN required) (PP (IN for) (NP (JJ immune) (NN function)))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NN mechanism)) (VP (VBG underlying) (NP (DT this) (NN activity)))) (VP (VBZ has) (VP (VBN been) (ADJP (JJ unclear))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP it)) (VP (VBZ is) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS glucocorticoids)) (VP (VBP are) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (NN activation)))) (PP (IN in) (NP (NP (NNS mice)) (CC and) (NP (VBN cultured) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN inhibition)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NN induction)) (PP (IN of) (NP (NP (DT the) (NP (NN I) (NN kappa) (NN B)) (NN alpha) (JJ inhibitory) (NN protein)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ traps) (NP (VBN activated) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (JJ inactive) (JJ cytoplasmic) (NNS complexes)))))))))))) (. .))))
(S1 (S (S (SBAR (IN Because) (S (NP (NN NF-kappa) (NN B)) (VP (VBZ activates) (NP (JJ many) (NP (JJ immunoregulatory) (NNS genes))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ pro-inflammatory) (NNS stimuli)))))))) (, ,) (S (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (PRP$ its) (NN activity)))) (VP (MD can) (VP (VB be) (NP (NP (DT a) (JJ major) (NN component)) (PP (IN of) (NP (NP (DT the) (JJ anti-inflammatory) (NN activity)) (PP (IN of) (NP (NNS glucocorticoids))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Pathogenesis)) (PP (IN of) (NP (NN atherosclerosis))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJS earliest) (NN lesion)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT an) (JJ atherosclerotic) (NN plaque)))))) (VP (VBZ is) (NP (DT the) (JJ fatty) (NN streak))) (. .)))))
(S1 (S (S (NP (DT This) (ADJP (ADJP (JJ chronic)) (ADJP (JJ inflammatory))) (NN reaction)) (VP (VBZ results) (PP (IN from) (NP (NP (DT a) (NN sequence)) (PP (IN of) (NP (NNS events))) (SBAR (WHNP (WDT that)) (S (VP (VBZ begins) (PP (IN with) (NP (NP (DT the) (NN trapping)) (PP (IN of) (NP (NP (JJ low) (NN density) (NN lipoprotein)) (PRN (-LRB- -LRB-) (NP (NN LDL)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (JJ subendothelial) (NN space)) (PP (IN of) (NP (DT the) (NN artery) (NN wall))))))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (VBN trapped) (NN LDL)) (VP (VBZ is) (VP (VBN seeded) (PP (IN with) (NP (NP (JJ oxidative) (NNS species)) (VP (VBN released) (PP (IN by) (NP (DT the) (VBG overlying) (NN endothelium))))))))) (, ,) (CC and) (S (NP (NN lipid) (NN oxidation)) (VP (VBZ is) (VP (VBN initiated) (PP (IN within) (NP (DT the) (NN LDL) (NN particle)))))) (. .))))
(S1 (S (S (NP (NP (NP (DT Some)) (PP (IN of) (NP (DT the) (NNS lipids)))) (SBAR (WHNP (WDT that)) (S (VP (VBP result))))) (VP (VBP lead) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (JJ NFkB-like) (NN transcription) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WP$ whose) (NP (NN protein) (NNS products))) (S (VP (VBP mediate) (NP (NP (NP (NN monocyte)) (NN binding)) (, ,) (NP (NP (NN monocyte) (NN chemotaxis)) (PP (IN into) (NP (DT the) (JJ subendothelial) (NN space)))) (, ,) (CC and) (NP (NP (NN conversion)) (PP (IN into) (NP (NNS macrophages))))))))))))))))))) (. .))))
(S1 (S (S (NP (QP (IN At) (JJS least) (CD 1)) (NP (JJ major) (NN gene))) (VP (VBZ modulates) (NP (NP (NP (DT the) (NN oxidation)) (PP (IN of) (NP (NN LDL) (NNS lipids)))) (CC and/or) (NP (NP (DT the) (JJ biologic) (NN response)) (PP (TO to) (NP (DT these) (NNS lipids)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ inverse) (NN relation)) (PP (IN between) (NP (NP (NP (JJ high) (NN density) (NN lipoprotein)) (PRN (-LRB- -LRB-) (NP (NN HDL)) (-RRB- -RRB-))) (CC and) (NP (JJ atherosclerotic) (NNS events))))) (VP (MD may) (PP (IN in) (NP (NN part))) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS enzymes)) (VP (VBN associated) (PP (IN with) (NP (NN HDL)))) (SBAR (WHNP (WDT that)) (S (VP (VBP destroy) (NP (NP (DT the) (ADJP (RB biologically) (JJ active)) (NNS lipids)) (VP (VBN generated) (PP (IN in) (NP (NN LDL))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (NN IFN-gamma)) (NN priming)) (PP (IN of) (NP (NNS monocytes)))) (VP (VBZ enhances) (NP (JJ LPS-induced) (NP (NN TNF)) (NN production)) (PP (IN by) (S (VP (VBG augmenting) (NP (CC both) (NP (NN transcription)) (CC and) (NP (NN MRNA) (NN stability))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (NN cytokine)) (NN expression))) (PP (IN in) (NP (NNS monocytes/macrophages))) (PP (IN by) (NP (NP (JJ bacterial) (NN endotoxin)) (CC or) (NP (NN lipopolysaccharide))))) (VP (VBZ is) (NP (DT a) (ADJP (ADJP (JJ critical)) (, ,) (ADJP (RB highly) (VBN regulated))) (NN host) (NN defence) (NN response))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN augmentation)) (PP (IN of) (NP (NN LPS) (NNS responses))) (PP (IN by) (NP (NP (NN interferon) (NN gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-)))) (, ,) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NN priming)))) (, ,)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN established))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN mechanism) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN priming)) (VP (VBZ occurs))))) (VP (VBZ is) (ADVP (RB poorly)) (VP (VBN defined))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (NP (NN tumour) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (NN induction)) (PP (IN as) (NP (DT a) (NN model))))) (, ,) (S (NP (NNS experiments)) (VP (VBD were) (VP (VBN designed)) (S (VP (TO to) (VP (VB analyse) (PP (IN in) (NP (NN detail))) (NP (NP (DT the) (NN priming) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN LPS) (NN response)) (PP (IN in) (NP (JJ human) (NNS monocytes))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Priming)) (PP (IN by) (NP (NN IFN-gamma)))) (VP (VBD was) (ADVP (RB primarily)) (VP (VBN manifested) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN TNF) (NN mRNA)) (NN accumulation))))))) (. .))))
(S1 (S (S (NP (NP (NN IFN-gamma)) (NN pre-treatment)) (VP (VBD affected) (NP (NP (NP (DT the) (NN magnitude)) (CONJP (RB rather) (IN than)) (NP (DT the) (NN sensitivity))) (PP (IN of) (NP (DT the) (NN LPS) (NN response))))) (. .))))
(S1 (S (S (S (NP (NN Priming)) (VP (VBD occurred) (PP (IN after) (NP (NP (JJ several) (NNS hours)) (PP (IN of) (NP (NN treatment))))))) (, ,) (CC and) (S (NP (DT the) (JJ primed) (NN state)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (CC either) (NP (NP (NN IFN-gamma)) (CC or) (NP (NN GM-CSF))) (, ,) (CONJP (CC but) (RB not)) (NP (NN M-CSF))))))) (. .))))
(S1 (S (S (NP (VBN Primed) (NP (NNS monocytes))) (VP (VBD transcribed) (NP (NN TNF) (NN mRNA)) (PP (IN at) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN than) (NP (ADJP (RB freshly) (VBN isolated)) (NP (NNS monocytes)))))) (PP (IN upon) (NP (NP (NN activation)) (PP (IN with) (NP (NN LPS)))))) (. .))))
(S1 (S (S (NP (DT The) (VBN increased) (JJ transcriptional) (NN rate)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (NN activity)) (PP (IN in) (NP (DT these) (NNS cells))))))) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (DT a) (NP (NN consensus) (NN NF-kappa) (NN B) (NN oligonucleotide)))))))))) (. .))))
(S1 (S (S (NP (DT An) (ADJP (ADJP (JJ additional)) (ADJP (JJ significant))) (NN finding)) (VP (VBD was) (SBAR (IN than) (S (NP (NP (NN TNF) (NN mRNA)) (VP (VBN induced) (PP (IN in) (NP (VBN primed) (NNS cells))))) (VP (VBD was) (ADJP (ADJP (ADJP (ADVP (RB much) (RBR more)) (JJ stable)) (PP (IN than) (PP (IN in) (NP (JJ unprimed) (NNS cells))))) (PRN (-LRB- -LRB-) (S (NP (NN T1/2)) (VP (VBN increased) (NP (RB 6-8-fold)))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (ADVP (JJ Consistent) (PP (IN with) (NP (DT the) (VBN increased) (NP (NN mRNA)) (NN stability)))) (, ,) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN mRNA)) (NN accumulation)))) (VP (VBD was) (ADJP (RBR longer) (PP (VBG following) (NP (NP (NN LPS) (NN stimulation)) (PP (IN in) (NP (VBN primed) (NP (NNS monocytes))))))) (, ,) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (S (VP (VBG being) (PP (IN of) (NP (JJR greater) (NN magnitude)))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (VBN primed)) (CC and) (NP (JJ unprimed)) (NP (NNS cells))) (VP (VBD possessed) (NP (NP (DT a) (JJ differential) (NN sensitivity)) (PP (TO to) (NP (DT the) (NN kinase) (NN inhibitor) (NN H-89))))) (. .))))
(S1 (S (S (NP (NN H-89)) (VP (ADVP (RB substantially)) (VP (VBD suppressed) (NP (NP (JJ LPS-induced) (NP (NN TNF) (NN mRNA)) (NN accumulation)) (PP (IN in) (NP (JJ unprimed) (NNS cells))))) (, ,) (CC but) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (VBN primed) (NNS monocytes)))) (PP (VBG following) (NP (NN LPS) (NN stimulation))))) (. .))))
(S1 (S (PRN (-LRB- -LRB-) (NP (NP (NN ABSTRACT)) (VP (VBN TRUNCATED) (PP (IN AT) (NP (CD 250) (NNS WORDS))))) (-RRB- -RRB-))))
(S1 (S (S (S (NP (NP (NP (NP (NN Prolactin))) (CC and) (NP (NN interleukin-2) (NNS receptors))) (PP (IN in) (NP (NN T) (NNS lymphocytes)))) (VP (VBP signal) (PP (IN through) (NP (DT a) (NP (JJ MGF-STAT5-like) (NN transcription) (NN factor))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN cell) (NN surface) (NNS receptors)) (PP (IN for) (NP (NP (NN PRL)) (CC and) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-)))))) (VP (VP (VBP are) (ADJP (RB structurally) (JJ distinct))) (, ,) (CC but) (VP (VBP share) (NP (NP (JJ regulatory) (NNS tasks)) (PP (IN in) (NP (NN T) (NNS lymphocytes)))))) (. .)))))
(S1 (S (S (NP (PRP They)) (VP (MD can) (VP (VP (VB stimulate) (NP (NN proliferation))) (CC and) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (JJ over-lapping) (NNS sets)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN of) (NP (NN T) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (NP (NN PRL)) (CC and) (NP (NN IL-2)) (NP (NN receptor) (NN activation))) (VP (VBP are) (DT both) (VP (VBN linked) (PP (TO to) (NP (DT the) (NP (NP (NN Jak/Stat)) (PRN (-LRB- -LRB-) (NP (NN signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription)) (-RRB- -RRB-))) (NN pathway))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NN PRL)) (CC and) (NP (NN IL-2)))) (S (VP (TO to) (VP (VB activate) (NP (NP (NN Stat) (NNS proteins)) (PP (IN in) (NP (JJ different) (NP (NN T) (NN cell) (NNS lines)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN DNA) (NN binding) (NNS specificities)) (, ,) (NP (NP (DT the) (NNS reactivities)) (PP (IN toward) (NP (JJ Stat-specific) (NNS antisera)))) (, ,) (CC and) (NP (NP (DT the) (NN mol) (NN wt)) (PP (IN of) (NP (NP (NP (NN IL-2-)) (CC and) (NP (JJ PRL-induced) (JJ DNA-binding) (NNS proteins))) (PP (IN in) (NP (NP (NN Nb2)) (CC and) (NP (NN C196)) (NP (NN T) (NN cell) (NNS lines)))))))) (VP (VBD were) (VP (VBN investigated))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN comparison)) (PP (IN with) (NP (NP (DT the) (NP (NN Stat) (NNS proteins))) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NN interferon-gamma)) (, ,) (NP (NN PRL)) (, ,) (CC and) (NP (NN IL-6))) (PP (IN in) (NP (NN T47D) (JJ mammary) (NN tumor) (NNS cells))))))))) (VP (VBD was) (VP (VBN made))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (DT these) (NNS parameters)) (VP (VBD were) (ADJP (JJ indistinguishable) (PP (IN for) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (NP (NN PRL-)) (CC and) (NP (JJ IL-2-induced)) (NP (NNS factors))))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN transcription) (NN factor)) (ADJP (RB closely) (JJ related) (PP (TO to) (NP (JJ mammary) (NN gland) (NN factor-Stat5))))) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN activated) (PP (IN upon) (NP (NP (NN interaction)) (PP (IN of) (NP (NP (NN IL-2)) (CC and) (NP (NN PRL)))) (PP (IN with) (NP (PRP$ their) (JJ respective) (NNS receptors))))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (DT a) (JJ second) (NN protein)) (ADJP (JJ related) (PP (TO to) (NP (NN Stat1))))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP emphasize) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN PRL))) (PP (IN as) (NP (NP (DT a) (NN regulator)) (PP (IN of) (NP (DT the) (JJ immune) (NN response))))))) (CC and) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (NP (NP (NN Stat) (NNS factors)) (NP (NP (JJ mammary) (NN gland) (NN factor-Stat5)) (CC and) (NP (NP (NN Stat1)))))) (VP (VBP play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN gene) (NN expression))) (PP (IN during) (NP (NN T) (NN cell) (NN development)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN CD30)) (NN ligation)) (VP (VBZ induces) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (JJ human) (NN T) (NN cell) (NNS lines)))) (. .)))))
(S1 (S (S (S (NP (NN CD30)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB recently) (VBN described)) (NN member)) (PP (IN of) (NP (DT the) (NP (NN tumor) (NN necrosis) (NN factor/nerve) (NN growth) (NN factor) (NN receptor) (NN superfamily)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (PP (VBG following) (NP (NP (NN incubation)) (PP (IN of) (NP (NP (NN L540) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN Hodgkin) (POS 's) (JJ disease-derived) (, ,) (NN T) (JJ cell-like) (, ,) (JJ CD30+) (NNS cells)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (DT the) (NP (NP (JJ agonistic) (JJ anti-CD30) (JJ monoclonal) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NN mAb)) (-RRB- -RRB-)))) (NP (NP (NN M44)) (CC and) (NP (NN M67))))))) (, ,) (NP (CD two) (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B)) (NN DNA) (NN binding) (NNS activities)) (VP (VBD were) (VP (VBN induced) (PP (IN in) (NP (JJ nuclear) (NNS extracts)))) (, ,) (SBAR (IN as) (S (VP (VBN determined) (PP (IN in) (NP (NN gel) (NN retardation) (NNS assays)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (DT the) (NP (NN mAb)))) (PP (IN towards) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))) (VP (VBD was) (ADJP (JJ rapid)) (, ,) (SBAR (IN as) (S (NP (PRP it)) (VP (VP (VBD occurred) (PP (IN within) (NP (CD 20) (NN min)))) (, ,) (CC and) (VP (VBD was) (ADJP (JJ sustained) (PP (IN for) (NP (QP (RB up) (TO to) (CD 6)) (NN h))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN comparison))) (, ,) (NP (DT an) (NP (JJ isotype-matched) (NN antibody))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (PP (IN in) (NP (NP (JJ human) (NN T) (NN helper) (-LRB- -LRB-) (NN Th) (-RRB- -RRB-) (NNS clones)) (VP (ADVP (RB functionally)) (VBN characterized) (PP (IN as) (S (VP (VBG being) (PP (IN of) (NP (NP (DT the) (NP (NN type) (CD 0)) (, ,) (NP (NN type) (CD 1)) (CC and) (NP (NN type) (CD 2))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 28) (NN %)) (, ,) (NP (ADJP (QP (JJR &lt;) (CD 1)) (NN %))) (CC und) (NP (CD 93) (NN %)) (NP (JJ CD30+))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))))))))) (, ,) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (JJ CD30-mediated) (NP (NN NF-kappa) (NN B)) (NN activation)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (JJ CD30+) (NNS cells)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT all) (NN cell) (NNS lines)) (VP (VBN investigated)))) (, ,) (NP (NP (DT the) (NP (NN NF-kappa) (NN B) (NNS complexes))) (VP (VBN induced) (PP (VBG following) (NP (NP (NN CD30)) (NN engagement))))) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB contain) (NP (NP (NN p50) (NN NF-kappa) (NN B1)) (, ,) (NP (NN p65) (NN RelA)) (, ,) (CC and) (NP (ADVP (RB possibly)) (JJ other) (NP (NN transcription) (NNS factors))))))))) (. .))))
(S1 (S (S (ADVP (RB Collectively)) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (JJ nuclear) (NP (NN translocation)) (CC and) (NP (NN activation))) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (NN rank) (PP (IN among) (NP (NP (DT the) (JJ short-term) (JJ cellular) (NNS responses)) (VP (VBD elicited) (PP (VBG following) (NP (NP (NN CD30)) (NN ligation)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Constitutive) (NP (NN NF-kappa) (NN B)) (NN activation)) (, ,) (NP (VBN enhanced) (NN granulopoiesis)) (, ,) (CC and) (NP (JJ neonatal) (NN lethality))) (PP (IN in) (NP (NN I) (NN kappa) (NN B) (JJ alpha-deficient) (NNS mice))) (. .)))))
(S1 (S (S (S (NP (NP (NN Transcription) (NNS factors)) (VP (VBG belonging) (PP (TO to) (NP (DT the) (NP (NN NF-kappa) (NN B) (NN family)))))) (VP (VBP are) (VP (VBN controlled) (PP (IN by) (NP (NP (JJ inhibitory) (NN I) (NN kappa) (NN B) (NNS proteins)) (, ,) (ADVP (RB mainly)) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC and) (NP (NN I) (NN kappa) (NN B) (NN beta))))))) (. .)))))
(S1 (S (S (ADVP (RB Apparently) (JJ normal) (PP (IN at) (NP (NN birth)))) (, ,) (S (NP (NN I) (NN kappa) (NN B) (JJ alpha-/-) (NNS mice)) (VP (VBP exhibit) (NP (NP (JJ severe) (NN runting)) (, ,) (NP (NN skin) (NNS defects)) (, ,) (CC and) (NP (NP (JJ extensive) (NN granulopoiesis)))) (ADVP (RB postnatally)) (, ,) (S (ADVP (RB typically)) (VP (VBG dying) (PP (IN by) (NP (CD 8) (NNS days))))))) (. .))))
(S1 (S (S (NP (NP (JJ Hematopoietic) (NNS tissues)) (PP (IN from) (NP (DT these) (NNS mice)))) (VP (VBP display) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (CC both) (NP (JJ nuclear) (NN NF-kappa) (NN B)) (CC and) (NP (NNS mRNAs)) (PP (IN of) (NP (NP (DT some)) (, ,) (CC but) (NP (RB not) (DT all)) (, ,) (NP (NP (NNS genes)) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN regulated) (PP (IN by) (NP (NN NF-kappa) (NN B))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN NF-kappa) (NN B)) (NN elevation)) (VP (VBZ results) (PP (IN in) (NP (DT these) (JJ phenotypic) (NNS abnormalities))) (SBAR (IN because) (S (NP (NP (NNS mice)) (VP (VBG lacking) (NP (CC both) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC and) (NP (NP (DT the) (NP (NN p50) (NN subunit))) (PP (IN of) (NP (NN NF-kappa) (NN B))))))) (VP (VBP show) (NP (NP (DT a) (ADJP (RB dramatically) (VBN delayed)) (NN onset)) (PP (IN of) (NP (NNS abnormalities)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (JJ hematopoietic) (NNS cells))))) (, ,) (NP (NN I) (NN kappa) (NN B) (JJ alpha-/-) (JJ embryonic) (NNS fibroblasts)) (VP (VBP show) (NP (NP (JJ minimal) (NP (JJ constitutive) (NN NF-kappa) (NN B))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (ADJP (ADJP (JJ normal)) (ADJP (JJ signal-dependent))) (NP (NN NF-kappa) (NN B)) (NN activation)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ concomitant) (PP (IN with) (NP (NP (NN I) (NN kappa) (NN B) (NN beta)) (NN degradation)))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN I) (NN kappa) (NN b) (NN beta)) (, ,) (CONJP (CC but) (RB not)) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (, ,)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (JJ signal-dependent) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NNS fibroblasts)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (JJ postinduction) (NN repression)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NNS fibroblasts))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP define) (NP (NP (JJ distinct) (NNS roles)) (PP (IN for) (NP (NP (DT the) (CD two) (NNS forms)) (PP (IN of) (NP (NN I) (NN kappa) (NN B))))))) (CC and) (VP (VBP demonstrate) (NP (NP (DT the) (NN necessity)) (PP (IN for) (NP (NP (JJ stringent) (NN control)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Attenuation)) (PP (IN of) (NP (NN gamma) (JJ interferon-induced) (NN tyrosine) (NN phosphorylation))) (PP (IN in) (NP (NP (JJ mononuclear) (NNS phagocytes)) (VP (VBN infected) (PP (IN with) (NP (FW Leishmania) (FW donovani)))))) (: :)) (NP (NP (JJ selective) (NN inhibition)) (PP (IN of) (NP (NP (NN signaling)) (PP (IN through) (NP (NP (NN Janus) (NNS kinases)) (CC and) (NP (NN Stat1))))))) (. .)))))
(S1 (S (S (S (S (NP (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NN gene) (NN transcription)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN gamma) (NN interferon)))))) (VP (VBZ is) (ADJP (JJ impaired) (PP (IN in) (NP (NP (JJ mononuclear) (NNS phagocytes)) (VP (VBN infected) (PP (IN with) (NP (FW Leishmania) (FW donovani))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS mechanisms)) (VP (VBN involved))) (VP (VBP are) (RB not) (ADVP (RB fully)) (VP (VBN understood)))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NNS changes)) (PP (IN in) (NP (NN gene) (NN expression))) (VP (VBN brought) (PRT (RP about)) (PP (IN by) (NP (NN gamma) (NN interferon))))) (VP (VBP are) (VP (VBN thought) (S (VP (TO to) (VP (VB involve) (NP (NP (JJ transient) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NNS activities)) (PP (IN of) (NP (NP (JJ cellular) (NN protein) (NN tyrosine) (NNS kinases)) (, ,) (PP (VBG including) (NP (NP (DT the) (NP (NN Janus) (NNS kinases))) (NP (NP (NN Jak1)) (CC and) (NP (NN Jak2)))))))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NP (NN transcription) (NN factor) (NN Stat1))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NNS mechanisms)) (VP (VBG accounting) (PP (IN for) (NP (NP (DT the) (JJ impaired) (NNS responses)) (PP (TO to) (NP (NN gamma) (NN interferon)))))))))) (, ,) (S (NP (NP (DT a) (JJ model) (NN system)) (PP (IN for) (S (VP (VBG examining) (NP (NP (NP (JJ overall) (NNS changes)) (PP (IN in) (NP (NN protein) (NN tyrosine) (NN phosphorylation)))) (, ,) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN Jak1)) (CC and) (NP (NN Jak2))))) (CC and) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Stat1))))))))) (VP (VBD was) (VP (VBN developed) (PP (IN in) (NP (NN phorbol) (NN 12-myristate) (JJ 13-acetate-differentiated) (NN U-937) (NNS cells)))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (JJ whole-cell) (NNS lysates))) (PP (IN by) (NP (NN antiphosphotyrosine) (NN immunoblotting)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN incubation)) (PP (IN with) (NP (NN gamma) (NN interferon)))) (VP (VBD brought) (ADVP (RP about)) (NP (NP (JJ specific) (NNS increases)) (PP (IN in) (NP (NP (NN phosphotyrosine) (NN labeling)) (PP (IN of) (NP (JJ several) (NNS proteins)))))))))) (. .))))
(S1 (S (S (NP (NP (VBN Increased) (NN labeling)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBD occurred) (PP (TO to) (NP (JJ similar) (NNS extents))) (PP (PP (IN in) (NP (JJ control) (NNS cells))) (CC and) (PP (IN in) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN been) (VP (VBN infected) (PP (IN with) (NP (FW L.) (FW donovani))) (PP (IN for) (NP (CD 16) (NN h)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (CC and) (NP (NN Stat1))) (VP (VBD were) (VP (VBN immunoprecipitated) (PP (IN from) (NP (NP (JJ control)) (CC and) (NP (JJ interferon-treated) (NNS cells))))))) (, ,) (CC and) (S (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT these) (NNS proteins))) (, ,) (VP (VBN detected) (PP (IN by) (NP (NN antiphosphotyrosine) (NN immunoblotting))))) (VP (VBD was) (VP (VBN used)) (S (VP (TO to) (VP (VBN measured) (NP (PRP$ their) (NN activation))))))) (. .))))
(S1 (S (S (NP (NP (NN Tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (CC and) (NP (NN Stat1))))) (VP (VBD increased) (ADVP (RB markedly)) (, ,) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))) (, ,) (PP (IN in) (NP (NP (NN U-937) (NNS cells)) (VP (VBN incubated) (PP (IN with) (NP (NN gamma) (NN interferon))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN infected) (PP (IN with) (NP (FW L.) (FW donovani)))))) (, ,) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NN Jak1)) (, ,) (NP (NN Jak2)) (, ,) (CC and) (NP (NN Stat1))))) (VP (VBD was) (ADJP (RB markedly) (JJ impaired))) (. .))))
(S1 (S (S (NP (DT This) (NN effect)) (VP (VP (VBD was) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN exposure)) (PP (TO to) (NP (FW L.) (FW donovani))))))))) (CC and) (VP (VBD was) (ADJP (ADJP (JJ maximal)) (CC and) (ADJP (JJ complete)) (PP (IN at) (NP (CD 16) (NN h)))))) (. .))))
(S1 (S (S (NP (NP (NNS Results)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (PP (IN with) (NP (NN U-937) (NNS cells)))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN obtained) (PP (IN with) (NP (JJ human) (JJ peripheral) (NN blood) (NNS monocytes))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN infection)) (PP (IN of) (NP (JJ human) (JJ mononuclear) (NNS phagocytes))) (PP (IN with) (NP (FW L.) (FW donovani)))) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ impaired) (NN gamma) (JJ interferon-mediated) (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (JJ selective) (NNS effects)) (PP (IN on) (NP (DT the) (NN Jak-Stat1) (NN pathway)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Unresponsiveness)) (PP (TO to) (NP (NN gamma) (NN interferon))) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT this) (NN pathway)))))) (VP (MD may) (VP (VB explain) (NP (NP (JJ impaired) (JJ transcriptional) (NNS responses)) (PP (IN in) (NP (JJ leishmania-infected) (NNS cells)))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (RB Mutually) (JJ exclusive)) (NN interaction)) (PP (IN of) (NP (NP (DT a) (JJ novel) (NP (NN matrix) (NN attachment) (NN region) (NN binding) (NN protein))) (CC and) (NP (DT the) (NP (NN NF-muNR) (NN enhancer) (NN repressor))))) (. .)))))
(S1 (S (NP (NP (NNS Implications)) (PP (IN for) (NP (NP (NN regulation)) (PP (IN of) (NP (NP (NN immunoglobulin) (JJ heavy) (NN chain)) (NN expression))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (NP (NN immunoglobulin) (NN heavy) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN IgH)) (-RRB- -RRB-))) (JJ intronic) (NN enhancer)) (VP (VBZ stimulates) (NP (NP (NN transcription)) (PP (IN from) (NP (NP (JJ functional) (NNS promoters)) (PP (IN in) (NP (NP (NN B) (NNS lymphocytes)) (CONJP (CC but) (RB not)) (NP (JJ other) (NN cell) (NNS types)))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NN observation) (SBAR (IN that) (S (NP (NP (VBG binding) (NNS sites)) (PP (IN for) (NP (DT the) (NP (JJ nuclear) (NN factor-mu) (JJ negative) (NN regulator) (-LRB- -LRB-) (NN NF-muNR) (-RRB- -RRB-) (NN enhancer) (NN repressor))))) (VP (VBP overlap) (NP (NP (NP (JJ nuclear) (NN matrix) (NN attachment) (NNS regions)) (PRN (-LRB- -LRB-) (NP (NNS MARs)) (-RRB- -RRB-))) (PP (IN in) (NP (DT this) (NP (NN enhancer))))))))) (VP (VBZ has) (VP (VBN lead) (PP (TO to) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (DT the) (NN cell) (NN type) (NN specificity)) (PP (IN of) (NP (DT the) (NP (NN enhancer))))) (VP (MD might) (VP (VB be) (VP (VBN controlled) (PP (IN by) (S (VP (VBG regulating) (NP (JJ nuclear) (NN matrix) (NN attachment))))))))))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Scheuermann)) (, ,) (NP (NNP R.) (NNP H.)) (, ,) (CC and) (NP (NNP Chen) (, ,) (NNP U.))) (PRN (-LRB- -LRB-) (NP (CD 1989)) (-RRB- -RRB-)) (NP (NNP Genes) (CC &amp;) (NNP Dev.) (CD 3)) (, ,) (NP (CD 1255-1266))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB understand) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS MARs))) (PP (IN in) (NP (NP (NN IgH) (NN enhancer)) (NN regulation))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN identified) (NP (NP (DT a) (JJ novel) (NP (JJ MAR-binding) (NN protein))) (, ,) (NP (NN MAR-BP1))) (, ,) (PP (IN from) (NP (ADJP (JJ soluble) (JJ nuclear)) (NN matrix) (NNS preparations))) (PP (VBN based) (PP (IN on) (NP (NP (PRP$ its) (NN ability)) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (DT the) (NP (NNS MARs))) (VP (VBN associated) (PP (IN with) (NP (DT the) (NP (NN IgH) (NN enhancer)))))))))))))))) (. .))))
(S1 (S (S (S (NP (VBN Purified) (NP (NN MAR-BP1))) (VP (VBZ migrates) (PP (IN as) (NP (DT a) (NP (JJ 33-kDa) (NN protein)))))) (, ,) (CC and) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (NP (JJ nuclear) (NN matrix) (NNS preparations)) (PP (IN from) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ different) (NNS types)) (PP (IN of) (NP (JJ lymphoid) (NN cell) (NNS lines))))))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (JJ specific) (VBG binding) (NNS sites)) (VP (VBP have) (VP (VBN been) (ADJP (JJ difficult)) (SBAR (S (VP (TO to) (VP (VB localize) (PP (IN by) (NP (NP (ADJP (JJ chemical))) (CC or) (NP (ADJP (JJ enzymatic))) (NP (NN footprinting) (NNS procedures)))))))))))) (, ,) (S (NP (NP (NN NF-muNR)) (NN binding) (NNS sites)) (VP (VBP are) (ADJP (JJ critical) (PP (IN for) (NP (JJ efficient) (NP (NN MAR-BP1)) (NN binding)))))) (. .))))
(S1 (S (S (ADVP (RB Indeed)) (, ,) (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (NP (NN IgH) (NN enhancer)))) (PP (PP (TO to) (CC either) (NP (ADJP (JJ intact) (JJ nuclear)) (NN matrix) (NNS preparations))) (CC or) (PP (TO to) (NP (NN MAR-BP1))))) (VP (VBZ is) (ADJP (RB mutually) (JJ exclusive) (PP (TO to) (NP (NP (NN NF-muNR)) (NN binding))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN model)) (PP (IN for) (NP (NP (ADJP (JJ cell-type) (JJ specific)) (NN regulation)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN binding)) (PP (IN of) (NP (DT the) (NP (NN NF-muNR) (NN repressor)))) (PP (TO to) (NP (DT the) (NP (NN IgH) (NN enhancer))))) (VP (VBZ prevents) (NP (NP (JJ nuclear) (NN matrix) (NN attachment)) (PP (IN in) (NP (JJ inappropriate) (NNS cells)))) (PP (IN by) (S (VP (VBG interfering) (PP (IN with) (NP (NN MAR-BP1/enhancer) (NN interaction))))))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Multiple) (NNS proteins)) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NP (JJ nuclear) (JJ inhibitory) (NN protein) (NN repressor) (NN element))) (PP (IN in) (NP (DT the) (NP (JJ human) (NN interleukin-3) (NN promoter))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN T) (NN cell) (NN expression)) (PP (IN of) (NP (NP (NN interleukin) (CD 3)) (PRN (-LRB- -LRB-) (NP (NN IL-3)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN directed) (PP (IN by) (NP (NP (NP (ADJP (JJ positive))) (CC and) (NP (ADJP (JJ negative))) (NP (JJ cis-acting) (NN DNA) (NNS elements))) (ADJP (JJ clustered) (PP (IN within) (NP (NP (CD 300) (NN base) (NNS pairs)) (PP (IN of) (NP (DT the) (NP (JJ transcriptional) (NN start) (NN site))))))))))) (. .)))))
(S1 (S (S (NP (NP (DT A) (JJ strong) (NP (NN repressor) (NN element))) (, ,) (VP (VBN termed) (S (NP (NP (JJ nuclear) (JJ inhibitory) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN NIP)) (-RRB- -RRB-))))) (, ,)) (VP (VBD was) (ADVP (RB previously)) (VP (VBN mapped) (PP (TO to) (NP (NP (DT a) (NN segment)) (PP (IN of) (NP (NP (DT the) (NP (NN IL-3) (NN promoter))) (PP (IN between) (NP (NNS nucleotides) (CD -271) (CC and) (CD -250))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Functional) (NN characterization)) (PP (IN of) (NP (DT this) (NN element)))) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VB mediate) (NP (NN repression))) (SBAR (WHADVP (WRB when)) (S (VP (VBN linked) (PP (IN in) (NP (NN cis))) (PP (TO to) (NP (DT a) (NP (JJ heterologous) (NN promoter))))))))))) (. .))))
(S1 (S (S (NP (NN DNA) (NN binding) (NNS experiments)) (VP (VBD were) (VP (VBN carried) (PRT (RP out))) (S (VP (TO to) (VP (VB characterize) (NP (DT the) (NN repressor) (NN activity)))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (JJ varying) (NNS conditions)))) (, ,) (S (NP (CD three) (JJ distinct) (NNS complexes)) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (ADVP (RB specifically)) (IN with) (NP (DT the) (NP (NN NIP) (NN region)))))))) (, ,) (PP (IN although) (NP (QP (RB only) (CD one))) (VP (VBZ correlates) (PP (IN with) (NP (NN repressor) (NN activity))))))) (. .))))
(S1 (S (S (NP (NN Complex) (CD 1)) (VP (VBZ results) (PP (IN from) (NP (NP (NN binding)) (PP (IN of) (NP (NP (DT a) (JJ ubiquitous) (NN polypeptide)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ recognizes) (NP (NP (DT the) (NP (JJ 3') (NN portion))) (PP (IN of) (NP (DT this) (NN sequence))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN required) (PP (IN for) (NP (NN repression))))))))))))) (. .))))
(S1 (S (S (NP (NN Complex) (CD 2)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (NN binding)) (PP (IN of) (NP (NP (NN transcription) (NN factor)) (PRN (-LRB- -LRB-) (NP (JJ upstream) (JJ stimulatory) (NN factor)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (DT an) (NP (NN E-box) (NN motif))) (PP (IN in) (NP (NP (DT the) (NP (JJ 5') (NN portion))) (PP (IN of) (NP (DT the) (NP (NN NIP) (NN region))))))))))) (. .))))
(S1 (S (S (NP (NP (NN DNA) (NN binding) (NN specificity)) (PP (IN of) (NP (NN complex) (CD 3)))) (VP (VP (VBZ overlaps) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ upstream) (JJ stimulatory) (NN factor)))))) (CC but) (VP (VBZ is) (ADJP (RB clearly) (JJ distinct)))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (WHNP (WHNP (WDT which)) (PP (IN of) (NP (DT the) (JJ latter) (CD two) (NNS complexes)))) (S (VP (VBZ represents) (NP (NP (NN NIP)) (NN activity)))))))) (, ,) (S (NP (PRP we)) (VP (VP (VBD incorporated) (NP (JJ small) (NNS alterations)) (PP (IN into) (NP (NP (DT the) (NP (NN NIP) (NN site))) (PP (IN of) (NP (DT an) (NP (NN IL-3) (JJ promoter-linked) (NN reporter) (NN construct))))))) (CC and) (VP (VBD examined) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (JJ NIP-mediated) (NN repression))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Functional) (NN specificity)) (PP (IN for) (NP (NN repression)))) (VP (VBZ matches) (NP (NP (DT the) (NN DNA) (NN binding) (NN specificity)) (PP (IN of) (NP (NN complex) (CD 3)))))) (: ;) (S (NP (DT both) (NP (NN repressor) (NN activity)) (CC and) (NP (NP (NN complex) (CD 3)) (NN binding))) (VP (VBP require) (NP (DT the) (NP (NN consensus) (NN sequence)) (NN CTCACNTNC)))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Activation)) (PP (IN of) (NP (NP (NP (NP (DT the) (NN signal) (NN transducer)) (CC and) (NP (NN transcription))) (PRN (-LRB- -LRB-) (NP (NN STAT)) (-RRB- -RRB-))) (NN signaling) (NN pathway))) (PP (IN in) (NP (DT a) (JJ primary) (NN T) (NN cell) (NN response)))) (. .)))))
(S1 (S (NP (NP (JJ Critical) (NN role)) (PP (IN for) (NP (NN IL-6))) (. .))))
(S1 (S (S (S (NP (DT The) (NN T) (NN cell) (NN activation)) (VP (VBZ is) (VP (VBN initiated) (PP (IN by) (NP (NP (NN interaction)) (PP (IN of) (NP (JJ specific) (NP (NNS Ags)))) (PP (IN with) (NP (NN TCR)))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ intracellular) (JJ biochemical) (NNS events)) (VP (VBG leading) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (JJ several) (NNS genes))))))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NP (NP (JJ signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (-LRB- -LRB-) (NN STAT) (-RRB- -RRB-) (NNS proteins))))) (PP (IN in) (NP (NP (DT a) (JJ primary) (JJ TCR-mediated) (NN activation)) (PP (IN of) (NP (NN T) (NNS cells)))))) (VP (VBP have) (VP (VBN been) (VP (VBN explored)))) (. .))))
(S1 (S (S (PP (IN In) (NP (VBN purified) (JJ human) (JJ peripheral) (NN blood) (NN T) (NNS cells))) (, ,) (NP (JJ nuclear) (NN STAT) (NNS proteins)) (VP (VBD were) (VP (VBN activated) (PP (NP (QP (RB approximately) (CD 3)) (NN h)) (IN after) (NP (NP (NN activation)) (PP (IN by) (NP (JJ cross-linked) (NP (JJ anti-CD3) (NNS Abs)))))))) (. .))))
(S1 (S (S (NP (DT These) (NP (NN STAT) (NNS proteins))) (VP (VBD were) (VP (VBN detected) (PP (IN by) (S (VP (VBG using) (NP (NP (DT the) (NP (NP (JJ IFN-gamma-activated) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN GAS)) (-RRB- -RRB-)))) (CC and) (NP (JJ related) (NNS oligonucleotides))) (PP (IN as) (NP (NNS probes))) (PP (IN in) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (DT the) (JJ nuclear) (NNS extracts)) (PP (IN with) (NP (JJ anti-STAT) (NNS Abs)))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (PRP they)) (VP (VBD contained) (NP (NP (NN STAT-3)) (CC and) (NP (NP (JJ additional) (NNS proteins)) (ADJP (JJ crossreactive) (PP (IN with) (NP (DT the) (NP (NN STAT) (NN family))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN induction)) (PP (IN of) (NP (NP (NN STAT)) (NN activity)))) (VP (VBD was) (VP (VBN inhibited) (PP (ADVP (RB completely)) (IN by) (NP (NP (NN pretreatment)) (PP (IN with) (NP (CC either) (NP (NN cycloheximide)) (CC or) (NP (NN cyclosporin) (NN A))))))) (, ,) (S (ADVP (RB thus)) (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (NN induction)) (VP (VBD was) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NP (JJ secondary) (NN factor))) (VP (VBN produced) (PP (IN by) (NP (DT the) (VBN activated) (NP (NN T) (NNS cells)))))))))))))) (. .))))
(S1 (S (S (SBAR (SBAR (IN As) (S (NP (NN neutralizing) (JJ anti-IL-6) (NNS Abs)) (ADVP (RB effectively)) (VP (VBD down-regulated) (NP (NP (DT the) (JJ early) (NN induction)) (PP (IN of) (NP (NN STAT) (NNS proteins))))))) (CC and) (SBAR (IN as) (S (NP (ADJP (RB exogenously) (VBN added)) (NP (NN IL-6))) (ADVP (RB rapidly)) (VP (VBD activated) (NP (NP (NN DNA) (NN binding)) (ADJP (JJ similar) (PP (TO to) (JJ TCR-mediated) (NNS bindings)))))))) (, ,) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN concluded) (SBAR (IN that) (S (NP (NN IL-6)) (VP (VBZ is) (NP (NP (DT the) (NN factor)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN STAT) (NNS proteins))) (PP (IN in) (NP (DT a) (JJ primary) (NN T) (NN cell) (NN response)))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (NN phosphorylation))) (PP (IN by) (NP (NP (NN PKC-)) (CC and) (NP (ADJP (JJ Ca-LRB-2+-RRB--dependent))) (NP (NN signal) (NN transduction) (NNS pathways)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ Ca-LRB-2+-RRB--dependent) (NN phosphatase)) (NP (NN calcineurin))) (, ,) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (NP (NN FK506)) (CC and) (NP (NN CsA))))) (, ,)) (VP (VBZ synergizes) (PP (IN with) (NP (NP (JJ PKC-induced) (NN activation)) (PP (IN of) (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B))) (PP (IN in) (NP (NN T) (NN cell) (NNS lines)))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN investigated) (UCP (SBAR (IN whether) (S (NP (DT this) (NN synergy)) (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (JJ other) (NN cell) (NNS types))))))) (CC and) (NP (NP (DT the) (NN mechanism) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (DT these) (CD two) (NNS pathways)) (VP (VBP lead) (PP (TO to) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))))))))) (. .))))
(S1 (S (S (SBAR (IN While) (S (NP (DT this) (NN synergy)) (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (JJ other) (NN cell) (NNS types))))))) (, ,) (S (PP (IN in) (NP (DT the) (NP (JJ monocytic) (NN cell) (NN line) (NN U937)))) (NP (NN calcineurin)) (VP (VBZ is) (ADVP (RB also)) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB activate) (NP (NN NF-kappa) (NN B))))))) (. .))))
(S1 (S (S (S (VP (VBG Having) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN Ca-LRB-2+-RRB--)) (CC and) (NP (NN PKC-)) (NP (JJ dependent) (NNS pathways))) (VP (VBP synergize) (PP (IN by) (S (VP (VBG accelerating) (NP (NP (DT the) (NN degradation)) (PP (IN of) (NP (NN IkB) (NN alpha))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD focused) (PP (IN on) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (NN phosphorylation))))))) (. .))))
(S1 (S (S (SBAR (IN While) (S (NP (JJ PKC-dependent) (NNS pathways)) (ADVP (RB sequentially)) (VP (VBP result) (PP (PP (IN in) (NP (DT the) (NN phosphorylation))) (CC and) (PP (IN in) (NP (DT an) (JJ incomplete) (NN degradation))) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (PP (IN in) (NP (NN T) (NN cell) (NNS lines))))))))) (, ,) (S (NP (NP (NN co-activation)) (PP (IN of) (NP (JJ Ca-LRB-2+-RRB--dependent) (NNS pathways)))) (VP (VP (VBZ accelerates) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (NN phosphorylation))))) (CC and) (VP (VBZ results) (PP (IN in) (NP (PRP$ its) (JJ complete) (NN degradation)))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (JJ Ca-LRB-2+-RRB--dependent) (NNS pathways)) (ADVP (RB alone))))) (VP (VBP do) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT the) (NP (NN phosphorylation)) (CC and/or) (NP (NN degradation))) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (PP (PP (IN in) (NP (NN Jurkat) (NN T))) (CC or) (PP (IN in) (NP (NN U937) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN with) (NP (DT the) (JJ selective) (NP (NN PKC)) (NN inhibitor) (NN GF109203X)))) (VP (VBZ abrogates) (NP (NP (NP (DT the) (JJ PMA-induced) (NP (NN IkB) (NN alpha)) (NN phosphorylation/degradation)) (ADJP (JJ irrespective) (PP (IN of) (NP (NP (NN activation)) (PP (IN of) (NP (JJ Ca-LRB-2+-RRB--dependent) (NNS pathways))))))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT the) (NP (NN phosphorylation)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (VP (VBN induced) (PP (IN by) (NP (NP (NN TNF-alpha)) (, ,) (NP (DT a) (JJ PKC-independent) (NN stimulus)))))))))) (. .))))
(S1 (S (S (ADVP (JJ Contrary) (PP (TO to) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN PKC)))))) (, ,) (S (NP (JJ Ca-LRB-2+-RRB--dependent) (NNS pathways)) (VP (VBP synergize) (PP (IN with) (NP (NN TNF-alpha))) (PP (PP (RB not) (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (NN phosphorylation))))) (, ,) (CC but) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (PRP$ its) (NN degradation)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (JJ Ca-LRB-2+-RRB--dependent) (NNS pathways)) (, ,) (PP (VBG including) (NP (DT the) (NP (NN phosphatase)) (NP (NN calcineurin)))) (, ,)) (VP (VP (VBP participate) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (PP (IN in) (NP (DT a) (NN cell) (JJ specific) (NN fashion)))) (CC and) (VP (VBP synergize) (PP (IN with) (NP (NP (ADJP (JJ PKC-dependent))) (CC and) (NP (ADJP (JJ -independent))) (NP (NNS pathways)))) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN IkB) (NN alpha)) (NP (NN phosphorylation)) (CC and) (NP (NN degradation))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Triggering)) (PP (IN of) (NP (NP (NN complement) (NNS receptors)) (NP (NP (NP (NN CR1)) (PRN (-LRB- -LRB-) (NP (NN CD35)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CR3)) (PRN (-LRB- -LRB-) (NP (NN CD11b/CD18)) (-RRB- -RRB-))))))) (VP (VP (VBZ induces) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN p50) (NN /p65)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (CC and) (VP (VBZ enhances) (NP (NP (JJ viral) (NN replication)) (PP (IN in) (NP (JJ HIV-infected) (JJ monocytic) (NNS cells)))))) (. .)))))
(S1 (S (S (S (NP (NNS Monocyte/macrophages)) (VP (MD may) (VP (VB harbor) (NP (NN HIV)) (PP (IN in) (NP (DT a) (JJ nonproductive) (NN fashion))) (PP (IN for) (NP (NP (JJ prolonged) (NNS periods)) (PP (IN of) (NP (NN time))))))) (. .)))))
(S1 (S (S (NP (JJ Viral) (NN gene) (NN expression)) (VP (MD may) (VP (VB be) (VP (VBN reactivated) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (IN with) (NP (NP (NN LPS)) (CC or) (NP (NP (NNS cytokines)) (PP (JJ such) (IN as) (NP (NN TNF-alpha)))))))) (ADVP (FW in) (FW vitro))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NN LPS)) (CC and) (NP (NN TNF-alpha))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (PRP$ their) (NN ability)) (S (VP (TO to) (VP (VB induce) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (DT the) (NP (NP (JJ DNA-binding) (NN heterodimer)) (NP (NP (NN NF-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN p50) (NN /p65)) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ binds) (PP (TO to) (NP (NP (DT a) (JJ specific) (NN sequence)) (PP (IN in) (NP (DT the) (NP (JJ HIV-long) (JJ terminal) (NN repeat))))))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NN triggering)) (PP (IN of) (NP (NP (NN complement) (NNS receptors)) (NP (NP (NP (NN CR1)) (PRN (-LRB- -LRB-) (NP (NN CD35)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CR3)) (PRN (-LRB- -LRB-) (NP (NN CD11b/CD18)) (-RRB- -RRB-))))))) (VP (VBZ enhances) (NP (NP (JJ viral) (NN replication)) (PP (IN in) (NP (JJ HIV-infected) (JJ human) (JJ monocytic) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Monocytic) (NN cell) (NNS lines)) (CC and) (NP (JJ normal) (JJ peripheral) (NN blood) (NNS monocytes))) (VP (VBD were) (VP (VP (VBN infected) (PP (IN with) (NP (NN HIV-1))) (ADVP (FW in) (FW vitro))) (CC and) (VP (VBN cultured) (PP (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (NP (NP (NN F-LRB-ab'-RRB-2) (NNS fragments)) (PP (IN of) (NP (NP (NP (JJ monoclonal) (JJ anti-CR1))) (CC or) (NP (NP (JJ anti-CR3) (NNS Abs)))))))))) (CC or) (PP (IN with) (NP (NN C3) (NNS fragments))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NP (NN CR1)) (CC or) (NP (NN CR3))))) (VP (VBZ induces) (NP (NP (DT a) (ADJP (CD two-) (TO to) (JJ fourfold)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (ADJP (ADJP (JJ cell-associated)) (CC and) (ADJP (VBN released))) (NP (NN p24) (NN Ag)))) (PP (IN in) (NP (NN cell) (NNS cultures))))) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN in) (NP (NP (JJ control) (NNS cultures)) (VP (VBN triggered) (PP (IN with) (NP (NN LPS))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD observed) (SBAR (IN that) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NN CR1)) (CC or) (NP (NN CR3))))) (VP (VBZ induces) (NP (NP (DT the) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NP (NN p50) (NN /p65)))) (PP (IN in) (NP (JJ infected) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (NN Translocation)) (PP (IN of) (NP (NP (NN NF-kappa) (NN B)) (NP (NN p50) (NN /p65))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NP (NN CR1)) (CC or) (NP (NN CR3))) (PP (IN of) (NP (NP (JJ uninfected) (JJ peripheral) (NN blood) (NNS monocytes)) (PP (IN from) (NP (JJ HIV-seronegative) (NNS donors))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NP (NN protein)) (VP (VBN translocated))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NNS cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NN rhTNF-alpha)))))))))))) (. .))))
(S1 (S (S (NP (NN TNF-alpha)) (VP (VBD did) (RB not) (VP (VB mediate) (NP (NP (DT the) (NN translocation)) (PP (IN of) (NP (NP (NP (NN NF-kappa) (NN B)) (NP (NN p50) (NN /p65))) (VP (VBN induced) (PP (IN by) (NP (NP (NN triggering)) (PP (IN of) (NP (NN complement) (NNS receptors))))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS observations)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN HIV) (NN gene) (NN expression)) (VP (MD may) (VP (VB be) (VP (VBN activated) (PP (IN in) (NP (JJ infected) (NNS monocytes))) (PP (IN through) (NP (NP (NN interaction)) (PP (IN of) (NP (DT the) (NNS cells))) (PP (IN with) (NP (JJ complement-opsonized) (NNS particles)))))))))) (CC and) (SBAR (IN that) (S (NP (VBN enhanced) (JJ viral) (NN replication)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN C3) (JJ receptor-mediated) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B) (NN complex))))))))))))) (. .))))
(S1 (S (NP (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (DT the) (JJ Jak-STAT) (CD 1) (NN signaling) (NN pathway))) (PP (IN by) (NP (NN IL-5))) (PP (IN in) (NP (NNS eosinophils))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ intracellular) (NN signal) (NN transduction)) (PP (IN of) (NP (NN IL-5))) (PP (IN in) (NP (NNS eosinophils)))) (VP (VBZ is) (ADJP (JJ unknown))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (DT the) (ADJP (RB newly) (VBN discovered)) (JJ Jak-STAT) (NN pathway)))) (PP (IN in) (NP (DT the) (NP (NN IL-5)) (NN signal) (NN transduction) (NN mechanism))))))) (. .))))
(S1 (S (S (NP (NNS Eosinophils)) (VP (VBD were) (VP (VP (VBN purified) (PP (IN from) (NP (JJ peripheral) (NN blood))) (PP (IN by) (NP (JJ discontinuous) (NN Percoll) (NNS gradients)))) (CC and) (VP (VBN stimulated) (PP (IN with) (NP (NN IL-5)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN involvement)) (PP (IN of) (NP (NN Jak) (CD 2)))) (VP (VBD was) (VP (VBN investigated) (PP (IN by) (NP (NN immunoprecipitation)))) (S (VP (VBN followed) (PP (IN by) (NP (NP (VBG immunoblotting)) (PP (IN for) (NP (NN tyrosine) (NN phosphorylation)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NN Jak) (CD 2)))) (VP (VBD was) (VP (VBN studied) (PP (IN by) (NP (NP (NN autophosphorylation)) (PP (IN of) (NP (DT the) (NP (VBN immunoprecipitated) (NN kinase)))))))) (. .))))
(S1 (S (S (NP (NN Jak) (CD 2)) (VP (VBD was) (ADJP (NN tyrosine) (JJ phosphorylated) (PP (IN within) (NP (NP (QP (CD 1) (TO to) (CD 3)) (NN min)) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN of) (NP (NNS eosinophils))) (PP (IN with) (NP (NN IL-5))))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (NP (NP (DT the) (NP (VBN immunoprecipitated) (NN Jak) (CD 2))) (VP (VBN obtained) (PP (IN from) (NP (JJ IL-5-stimulated) (NNS cells))))) (VP (VBD underwent) (NP (NN autophosphorylation))) (. .))))
(S1 (S (S (NP (NN Jak) (CD 2)) (VP (VBD coprecipitated) (PP (IN with) (NP (NP (DT the) (NN beta-subunit)) (PP (IN of) (NP (DT the) (NP (NN IL-5) (NN receptor)))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ physical) (NN association)) (PP (IN of) (NP (DT the) (NP (NN kinase)))) (PP (IN with) (NP (DT the) (NN receptor))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NP (JJ nuclear) (NN factor) (NN STAT-1)) (PRN (-LRB- -LRB-) (NP (NN p91)) (-RRB- -RRB-)))) (VP (VBD was) (VP (VBN investigated) (PP (IN by) (NP (NN immunoprecipitation)))) (S (VP (VBN followed) (PP (IN by) (NP (NP (VBG immunoblotting)) (PP (IN for) (NP (NN tyrosine) (NN phosphorylation)))))))) (. .))))
(S1 (S (S (NP (NN STAT-1)) (VP (VBD was) (ADJP (NN tyrosine) (JJ phosphorylated) (PP (IN within) (NP (NP (CD 15) (NN min)) (PP (IN of) (NP (NP (NN IL-5)) (NN stimulation))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN STAT-1))) (PP (IN in) (NP (DT the) (JJ nuclear) (NN extract)))) (VP (VBD was) (VP (VBN studied) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay))))) (. .))))
(S1 (S (S (NP (NN IL-5)) (VP (VBD induced) (NP (NP (CD two) (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBD bound) (PP (TO to) (NP (DT the) (NP (JJ gamma-activating) (NN sequence))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT an) (NP (JJ anti-STAT-1) (NN Ab)))))) (, ,) (NP (DT the) (NN band)) (VP (VBD was) (VP (VBN supershifted))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN IL-5)) (VP (VBD activated) (NP (DT the) (NN Jak) (NN 2-STAT) (CD 1) (NN signaling) (NN pathway)) (PP (IN in) (NP (NNS eosinophils))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP speculate) (SBAR (IN that) (S (NP (DT the) (NN Jak) (NN 2-STAT) (CD 1) (NN pathway)) (VP (MD may) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ IL-5-inducible) (NNS genes))) (PP (IN in) (NP (NNS eosinophils))))))))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (RB Constitutively) (VBN activated)) (JJ Jak-STAT) (NN pathway)) (PP (IN in) (NP (NP (NN T) (NNS cells)) (VP (VBN transformed) (PP (IN with) (NP (NN HTLV-I)))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Human) (NN T) (NN cell) (JJ lymphotropic) (NN virus) (NN I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (JJ etiological) (NN agent)) (PP (IN for) (NP (NP (JJ adult) (NN T) (NN cell) (NN leukemia)) (CC and) (NP (NP (ADJP (JJ tropical) (JJ spastic)) (NN paraparesis)) (PRN (-LRB- -LRB-) (ADVP (RB also)) (VP (VBN termed) (S (NP (JJ HTLV-I-associated) (NN myelopathy)))) (-RRB- -RRB-))))))) (. .)))))
(S1 (S (S (S (NP (JJ HTLV-I-infected) (JJ peripheral) (NN blood) (NN T) (NNS cells)) (VP (VBP exhibit) (NP (NP (DT an) (JJ initial) (NN phase)) (PP (IN of) (NP (NP (NN interleukin-2)) (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-) (JJ -dependent) (NN growth)))))) (: ;) (S (PP (IN over) (NP (NN time))) (, ,) (PP (IN by) (NP (DT an) (JJ unknown) (NN mechanism))) (, ,) (NP (DT the) (NNS cells)) (VP (VBP become) (ADJP (JJ IL-2-independent)))) (. .))))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NP (NP (DT the) (NP (NN Jak) (NNS kinases))) (NP (NP (NN Jak1)) (CC and) (NP (NN Jak3)))) (CC and) (NP (NP (NP (DT the) (NN signal) (NP (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription) (NNS proteins)))) (NP (NP (NN Stat3)) (CC and) (NP (NN Stat5))))) (VP (VBP are) (VP (VBN activated) (PP (IN in) (NP (JJ normal) (NN T) (NNS cells))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN IL-2))))))))) (, ,) (S (NP (DT this) (NN signaling) (NN pathway)) (VP (VBD was) (ADVP (RB constitutively)) (VP (VBN activated) (PP (IN in) (NP (JJ HTLV-I-transformed) (NNS cells)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ HTLV-I-infected) (NN cord) (NN blood) (NNS lymphocytes))) (, ,) (NP (NP (DT the) (NN transition)) (PP (IN from) (NP (ADJP (JJ IL-2-dependent)))) (PP (TO to) (NP (JJ IL-2-independent) (NN growth)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN acquisition)) (PP (IN of) (NP (DT a) (ADJP (RB constitutively) (JJ activated)) (JJ Jak-STAT) (NN pathway))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (NN pathway)) (VP (VBZ participates) (PP (IN in) (NP (JJ HTLV-I-mediated) (NN T) (NN cell) (NN transformation)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (ADJP (JJ Positive))) (CC and) (NP (ADJP (JJ negative))) (NP (NN regulation))) (PP (IN of) (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (NN promoter) (NN activity))) (PP (IN by) (NP (NP (JJ AML1-related) (NN transcription) (NN factor)) (, ,) (NP (NN PEBP2)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor) (-LRB- -LRB-) (NN GM-CSF) (-RRB- -RRB-) (NN gene) (NN promoter))) (VP (VBZ contains) (NP (NP (DT a) (NN consensus) (NN sequence)) (PP (IN for) (NP (NP (DT the) (NP (NN polyomavirus) (NN enhancer) (NN binding-protein) (CD 2) (-LRB- -LRB-) (NN PEBP2) (-RRB- -RRB-) (NN transcription) (NN factor))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ consists) (PP (IN of) (NP (NP (NN alpha)) (CC and) (NP (NN beta)) (NP (NNS subunits))))))))))) (. .)))))
(S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (QP (IN at) (JJS least) (CD two)) (NNS genes)) (, ,) (NP (NP (NN alpha) (NN A)) (CC and) (NP (NN alpha) (NN B))) (, ,) (VP (VBG encoding) (NP (DT the) (NP (NN alpha) (NN subunit)))))) (. .))))
(S1 (S (S (NP (NN alpha) (NN B)) (VP (VBZ is) (NP (NP (DT the) (NP (NN mouse) (NN homologue))) (PP (IN of) (NP (NP (JJ human) (NN AML1) (NN gene)) (VP (VBN detected) (PP (IN at) (NP (NP (DT the) (NNS breakpoints)) (PP (IN of) (NP (NP (NN t) (-LRB- -LRB-) (CD 8) (: ;) (CD 21) (-RRB- -RRB-)) (CC and) (NP (NN t) (-LRB- -LRB-) (CD 3) (: ;) (CD 21) (-RRB- -RRB-)) (NP (JJ myeloid) (NNS leukemias))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (NP (NP (NP (NN alpha) (NN A1)) (PRN (-LRB- -LRB-) (NP (DT an) (NP (NN alpha) (JJ A-gene) (NN product))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN alpha) (NN B1)) (CC and) (NP (NN alpha) (NN B2))) (PRN (-LRB- -LRB-) (NP (CD two) (NP (NN alpha) (JJ B-encoded) (NNS isomers))) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (DT the) (NP (NN GM-CSF) (NN promoter))))))) (. .))))
(S1 (S (S (NP (NP (NN PEBP2) (NN alpha) (NN A1)) (, ,) (NP (NN alpha) (NN B1)) (, ,) (CC and) (NP (NN alpha) (NN B2) (NNS proteins))) (VP (VBD bound) (NP (NP (DT the) (NP (NN PEBP2) (NN site))) (PP (IN within) (NP (DT the) (NP (NN mouse) (NN GM-CSF) (NN promoter)))))) (. .))))
(S1 (S (S (NP (NP (NN PEBP2) (NN alpha) (NN A1)) (CC and) (NP (NN alpha) (NN B1))) (VP (VBD enhanced) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN GM-CSF) (JJ promoter-driven) (NN reporter) (NN plasmid)))) (PP (IN in) (NP (NP (ADJP (JJ unstimulated))) (CC and) (NP (NN 12-O-tetradecanoylphorbol) (JJ 13-acetate/phytohemagglutinin-stimulated)) (NP (JJ human) (NN Jurkat) (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NN promoter) (NN activity)) (VP (VBD was) (VP (VBN suppressed) (PP (IN by) (NP (NN alpha) (NN B2))))) (. .))))
(S1 (S (S (NP (NP (NN Coexpression)) (PP (IN of) (NP (NP (NN alpha) (NN B1)) (CC and) (NP (NN alpha) (NN B2))))) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN promoter) (NN activity)) (VP (MD could) (VP (VB be) (VP (VBN determined) (PP (IN by) (NP (DT the) (NN alpha) (NN B1/alpha) (NN B2) (NN ratio))))))))) (. .))))
(S1 (S (S (NP (NN Jurkat) (NN cell) (NN extract)) (VP (VBD contained) (NP (NP (NP (NN PEBP2) (JJ site-binding) (NN protein)) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD cross-reacted) (PP (IN with) (NP (JJ antimouse) (NN alpha) (NN A1) (NNS antibodies)))))))) (. .))))
(S1 (S (S (NP (NN Northern) (NN blot) (NN analysis)) (VP (VBD indicated) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ human) (NP (NN PEBP2) (NN alpha) (NN A))) (, ,) (NP (NP (NN alpha) (NN B)) (PRN (-LRB- -LRB-) (NP (NN AML1)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN beta) (NNS genes)))) (PP (IN in) (NP (NN Jurkat) (NNS cells))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (JJ further) (NNS studies)) (VP (VBP are) (VP (VBN required)) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ precise) (NN role)) (PP (IN of) (NP (NN PEBP2))) (PP (IN in) (NP (DT the) (NP (NN GM-CSF)) (NN promoter) (NN activity)))))))))) (, ,) (S (NP (DT the) (JJ present) (NNS findings)) (VP (VBD suggested) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (NP (DT the) (JJ relative) (NN ratio)) (PP (IN of) (NP (JJ different) (NP (NN PEBP2) (NNS isoforms)))))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT the) (NN promoter) (NN activity)))))))))) (. .))))
(S1 (S (SQ (SQ (VBZ Does) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN TAL1) (NN gene))))) (VP (VB occur) (PP (IN in) (NP (NP (DT a) (NN majority)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN T-cell) (JJ acute) (JJ lymphoblastic) (NN leukemia)))))))) (. ?)))))
(S1 (S (NP (DT A) (JJ pediatric) (NN oncology) (NN group) (NN study) (. .))))
(S1 (S (S (S (NP (NP (QP (RB Almost) (CD 25)) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN T-cell) (JJ acute) (JJ lymphoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN T-ALL)) (-RRB- -RRB-))))))) (VP (VBP have) (NP (NP (JJ tumor-specific) (NNS rearrangements)) (PP (IN of) (NP (DT the) (NP (NN TAL1) (NN gene)))))) (. .)))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN TAL1)) (NN expression)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (JJ normal) (NNS lymphocytes)))))))) (, ,) (S (NP (NN TAL1) (NN gene) (NNS products)) (VP (VBP are) (ADVP (RB readily)) (VP (VBN detected) (PP (IN in) (NP (NP (JJ leukemic) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP harbor) (NP (DT a) (NP (VBN rearranged) (NN TAL1) (NN allele))))))))))) (. .))))
(S1 (S (S (ADVP (RB Hence)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (JJ ectopic) (NN expression)) (PP (IN of) (NP (NN TAL1)))) (VP (VBZ promotes) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN T-ALL)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN TAL1)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (NP (DT the) (NP (JJ leukemic) (NNS cells))) (PP (IN of) (NP (NP (JJS most) (NNS patients)) (PP (IN with) (NP (NN T-ALL)))))) (, ,) (PP (VBG including) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB display) (NP (DT an) (JJ apparent) (NP (NN TAL1) (NN gene)) (NN alteration))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ polymorphic) (NN dinucleotide) (NN repeat)) (PP (IN in) (NP (NP (DT the) (VBN transcribed) (NNS sequences)) (PP (IN of) (NP (NN TAL1)))))) (VP (VBD was) (VP (VBN used)) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN allele) (NN specificity)) (PP (IN of) (NP (NP (NP (NN TAL1)) (NN transcription)) (PP (IN in) (NP (JJ primary) (NN T-ALL) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Monoallelic) (NN expression)) (PP (IN of) (NP (NN TAL1)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NP (JJ leukemic) (NNS cells))) (PP (IN of) (NP (NP (DT all) (NNS patients)) (PRN (-LRB- -LRB-) (NP (QP (CD 8) (IN of) (CD 8))) (-RRB- -RRB-)))) (VP (VBG bearing) (NP (DT a) (NP (NN TAL1) (NN gene)) (NN rearrangement))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NP (JJ leukemic) (NNS cells))) (PP (IN of) (NP (NNS patients))) (PP (IN without) (NP (JJ detectable) (NP (NN TAL1)) (NNS rearrangements))))) (, ,) (NP (NP (NN TAL1)) (NN transcription)) (VP (VBD occurred) (PP (IN in) (NP (CC either) (NP (NP (DT a) (ADJP (JJ monoallelic))) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (IN of) (CD 7)) (NNS patients)) (-RRB- -RRB-))) (CC or) (NP (NP (DT a) (ADJP (JJ biallelic))) (PRN (-LRB- -LRB-) (NP (QP (CD 4) (IN of) (CD 7) (NNS patients))) (-RRB- -RRB-))) (NP (NN fashion))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (NN TAL1)) (NN activation)) (PP (IN in) (NP (DT these) (NNS patients)))) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (NP (JJ subtle) (NNS alterations)) (PP (IN in) (NP (NP (JJ cis-acting) (JJ regulatory) (NNS sequences)) (PRN (-LRB- -LRB-) (VP (VBG affecting) (NP (NP (NN expression)) (PP (IN of) (NP (DT a) (NP (JJ single) (NN TAL1) (NN allele)))))) (-RRB- -RRB-))))) (CC or) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NP (JJ trans-acting) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP control) (NP (NP (NN TAL1)) (NN transcription)))))) (PRN (-LRB- -LRB-) (VP (VBG affecting) (NP (NP (NN expression)) (PP (IN of) (NP (DT both) (NP (NN TAL1) (NNS alleles)))))) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NN interleukin-5/receptor) (NN interaction)) (VP (VP (VBZ activates) (NP (NP (NN Lyn)) (CC and) (NP (NN Jak2)) (NP (NN tyrosine) (NNS kinases)))) (CC and) (VP (VBZ propagates) (NP (NNS signals)) (PP (IN via) (NP (NP (NP (DT the) (NP (NN Ras-Raf-1-MAP) (NN kinase))) (CC and) (NP (DT the) (JJ Jak-STAT) (NNS pathways))) (PP (IN in) (NP (NNS eosinophils))))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -5))) (PP (IN with) (NP (DT the) (NN receptor)))) (VP (VBZ activates) (NP (NN Lyn) (NN tyrosine) (NN kinase)) (PP (IN within) (NP (CD 1) (NN min))) (CC and) (NP (NN Jak2) (NN tyrosine) (NN kinase)) (PP (IN within) (NP (QP (CD 1-3)) (NN min)))))))) (. .)))))
(S1 (S (S (NP (NN IL-5)) (ADVP (RB also)) (VP (VBZ stimulates) (NP (NP (NN GTP)) (VP (VBG binding) (PP (TO to) (NP (NN p21ras)))))) (. .))))
(S1 (S (S (NP (DT The) (NN signal)) (VP (VBZ is) (ADVP (RB subsequently)) (VP (VBN propagated) (PP (IN through) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN Raf-1)) (, ,) (NP (NN MEK)) (, ,) (CC and) (NP (NN MAP) (NNS kinases))))))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (PRP$ their) (VBN increased) (NP (NP (NN autophosphorylation)) (ADVP (FW in) (FW vitro))) (CC and) (NP (NP (NN phosphorylation)) (ADVP (FW in) (FW situ))))))))) (. .))))
(S1 (S (S (NP (NN Jak2) (NN kinase)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB phosphorylate) (NP (NN STAT) (JJ nuclear) (NNS proteins)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NN STAT) (JJ nuclear) (NNS factors)))) (VP (VBD was) (VP (VBN studied) (PP (IN by) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)) (VP (VBG using) (NP (DT a) (NP (NP (NN gamma) (NN activation) (NN site)) (PRN (-LRB- -LRB-) (NP (NN GAS)) (-RRB- -RRB-))) (NN probe))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN IL-5)) (VP (VBZ induces) (NP (NP (NP (CD two) (NP (JJ GAS-binding) (NNS proteins))) (PP (IN in) (NP (NNS eosinophils)))) (, ,) (SBAR (WHNP (NP (CD one)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBZ is) (NP (NN STAT1)))))))))) (. .))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NN IL-5)) (JJ induced) (NNS signals)) (VP (VBP are) (VP (VBN propagated) (PP (IN through) (NP (CD two) (JJ distinct) (NNS pathways))))))))) (: :) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (NN Lyn)) (ADJP (TO --&gt;) (NP (NP (NN Ras)) (ADJP (TO --&gt;) (NP (NP (NN Raf-1)) (ADJP (TO --&gt;) (NP (NP (NN MEK)) (ADJP (TO --&gt;) (NP (NN MAP) (NN kinase)))))))))) (CC and) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NN Jak2)) (ADJP (TO --&gt;) (NP (NN STAT1))))) (. .))))
(S1 (S (S (S (NP (NN Thapsigargin)) (VP (VBZ induces) (NP (NP (NN IL-2) (NN receptor) (NN alpha-chain)) (PP (IN in) (NP (NP (JJ human) (JJ peripheral)) (CC and) (NP (NN Jurkat) (NN T) (NNS cells))))) (PP (IN via) (NP (DT a) (NN protein) (NN kinase) (JJ C-independent) (NN mechanism)))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NN Thapsigargin)) (PRN (-LRB- -LRB-) (NP (NN TG)) (-RRB- -RRB-))) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN Ca-LRB-2+-RRB--ATPase)))) (, ,)) (VP (VP (VBZ depletes) (NP (JJ intracellular) (NN Ca2+) (NNS stores))) (CC and) (VP (VBZ induces) (NP (DT a) (JJ sustained) (NN Ca2+) (NN influx))) (PP (IN without) (S (VP (VBG altering) (NP (JJ phosphatidyl) (NN inositol) (NNS levels)))))) (. .)))))
(S1 (S (S (NP (NP (NP (NN TG)) (CC plus) (NP (NP (NN phorbol) (NN myristate) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-)))) (CONJP (CC but) (RB not)) (NP (NP (NN TG)) (ADVP (RB alone)))) (VP (VBD induced) (NP (NP (NN IL-2)) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN TG)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN TG)) (VP (VBD induced) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NP (NN IL-2R) (NN alpha) (NN protein)) (CONJP (RB as) (RB well) (IN as)) (NP (NN IL-2R) (NN alpha) (NN mRNA))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ similar) (NN increase)) (PP (IN in) (NP (NN IL-2R) (NN alpha))) (PP (IN by) (NP (NN TG)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (JJ human) (JJ peripheral) (NN T) (NNS cells))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (PP (IN like) (NP (NN PMA))) (, ,) (NP (NN TG)) (ADVP (RB markedly)) (VP (VBD induced) (NP (NP (NN NF) (NN kappa) (NN B)) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN TG)) (CC and) (NP (NN PMA))) (VP (VBD exhibited) (NP (DT a) (JJ synergistic) (NN action)) (PP (IN on) (NP (NP (NN IL-2R) (NN alpha)) (NN expression))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN TG)) (CC and) (NP (NN PMA))) (VP (VBP induce) (NP (NN IL-2R) (NN alpha)) (PP (IN through) (NP (JJ distinct) (NNS pathways))))))))) (. .))))
(S1 (S (S (NP (NP (NN PMA-)) (CONJP (CC but) (RB not)) (NP (ADJP (JJ TG-induced))) (NP (NN IL-2R) (NN alpha))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (DT the) (NP (NN PKC)) (NN inhibitor) (NN H7)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN TG-)) (CONJP (CC but) (RB not)) (NP (ADJP (JJ PMA-induced))) (NP (NN IL-2R) (NN alpha))) (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN cholera) (NN toxin)) (, ,) (NP (NN forskolin)) (CC and) (NP (JJ 1,9-dideoxy) (NN forskolin))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN toto))) (, ,) (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN TG)) (VP (VBZ induces) (NP (NP (NN IL-2R) (NN alpha)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells)))) (PP (IN through) (NP (DT a) (JJ PKC-independent) (NN pathway))))))) (. .))))
(S1 (S (S (S (NP (DT A) (JJ functional) (NP (NN T-cell) (NN receptor)) (NN signaling) (NN pathway)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN p95vav)) (NN activity))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NP (DT the) (NP (NN T-cell) (NN antigen) (NN receptor))) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))))) (VP (VBZ induces) (NP (NP (NN activation)) (PP (IN of) (NP (JJ multiple) (NP (NN tyrosine) (NNS kinases))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (JJ numerous) (JJ intracellular) (NNS substrates)))))))) (. .)))))
(S1 (S (S (NP (CD One) (NN substrate)) (VP (VBZ is) (NP (NP (NN p95vav)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN expressed) (ADVP (RB exclusively)) (PP (IN in) (NP (NP (ADJP (JJ hematopoietic))) (CC and) (NP (NN trophoblast)) (NP (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ contains) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ structural) (NNS motifs)) (, ,) (PP (VBG including) (NP (NP (NN Src) (NN homology) (CD 2) (, ,) (NN Src) (NN homology) (CD 3) (, ,) (CC and) (NN pleckstrin) (NN homology) (NNS domains)) (CC and) (NP (DT a) (NP (JJ putative) (NN guanine) (NN nucleotide) (NN exchange) (NN domain))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NN p95vav))) (PP (IN in) (NP (JJ TCR-mediated) (NN signaling) (NNS processes)))) (VP (VBZ is) (ADJP (JJ unclear))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (NP (NN p95vav)) (ADVP (RB alone)))) (PP (IN in) (NP (NN Jurkat) (NP (NN T) (NNS cells))))) (VP (VBZ leads) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NP (JJ nuclear) (NNS factors))) (, ,) (PP (VBG including) (NP (NP (NN NFAT)) (, ,) (VP (VBN involved) (PP (IN in) (NP (NP (NN interleukin-2)) (NN expression)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN p95vav)) (VP (VBZ synergizes) (PP (IN with) (NP (NP (NN TCR)) (NN stimulation))) (PP (IN in) (S (VP (VBG inducing) (NP (NP (NN NFAT-)) (CC and) (NP (JJ interleukin-2-dependent)) (NP (NN transcription))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (NN NFAT)) (NN activation)) (PP (IN by) (NP (DT a) (NP (JJ G-protein-coupled) (NN receptor))))) (VP (VBZ is) (RB not) (VP (VBN modulated) (PP (IN by) (NP (NP (NN p95vav)) (NN overexpression)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN effect)) (VP (VBZ is) (ADJP (JJ specific) (PP (TO to) (NP (DT the) (NP (NN TCR)) (NN signaling) (NNS pathways)))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN removal)) (PP (IN of) (NP (NP (DT the) (NP (JJ first) (CD 67) (NN amino) (NNS acids))) (PP (IN of) (NP (NN p95vav)))))) (VP (VBZ activates) (NP (NP (PRP$ its) (NN transforming) (NN potential)) (PP (IN in) (NP (NN NIH) (NN 3T3) (NNS cells))))))) (, ,) (S (NP (DT this) (NN region)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (PRP$ its) (NN function)) (PP (IN in) (NP (NN T) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (JJ p95vav-induced) (NP (NN NFAT)) (NN activation)) (VP (VBZ is) (RB not) (VP (VBN mimicked) (PP (IN by) (NP (NP (NN Ras)) (NN activation)))) (, ,) (SBAR (IN though) (S (NP (PRP$ its) (NN function)) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (NN Ras)) (CC and) (NP (NN Raf)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN activating) (NN function)) (PP (IN of) (NP (NN p95vav)))) (VP (VBZ is) (VP (VBN blocked) (PP (IN by) (NP (NN FK506)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP$ its) (NN activity)) (ADVP (RB also)) (VP (VBZ depends) (PP (IN on) (NP (NN calcineurin))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB dissect) (NP (NP (NP (NN p95vav)) (NN involvement)) (PP (IN in) (NP (NP (NN TCR)) (NN signaling))))))) (, ,) (S (NP (PRP we)) (VP (VP (VBD analyzed) (NP (NP (JJ various) (NP (NN Jurkat) (NNS mutants))) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NP (NN TCR)) (NN signaling) (NN function)) (CC or) (NP (NP (NN TCR)) (NN expression))))))) (CC and) (VP (VBD showed) (SBAR (IN that) (S (NP (DT an) (JJ intact) (NP (NN TCR)) (NN signaling) (NN pathway)) (VP (VBZ is) (VP (VBN required) (SBAR (IN for) (S (NP (NN p95vav)) (VP (TO to) (VP (VB function)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN overexpression)) (PP (IN of) (NP (NN p95vav)))) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB influence) (NP (NP (JJ TCR-induced) (NN protein) (NN tyrosine) (NN phosphorylation)) (CC or) (NP (NP (NNS increases)) (PP (IN in) (NP (JJ cytoplasmic) (JJ free) (NN calcium)))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN p95vav)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN at) (NP (NP (DT an) (ADJP (RB yet) (JJ unidentified)) (JJ proximal) (NN position)) (PP (IN in) (NP (DT the) (NP (NN TCR)) (NN signaling) (NN cascade)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN by) (NP (NP (NN phosphatase)) (NNS inhibitors)))) (VP (VBZ involves) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (PP (IN at) (NP (NN phosphatase) (JJ 2A-sensitive) (NNS sites))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN by) (NP (JJ various) (JJ cellular) (NNS stimuli)))) (VP (VBZ involves) (NP (NP (DT the) (NP (NN phosphorylation)) (CC and) (NP (JJ subsequent) (NN degradation))) (PP (IN of) (NP (NP (PRP$ its) (NN inhibitor)) (, ,) (NP (NN I) (NN kappa) (NN B) (NN alpha))))) (, ,) (SBAR (IN although) (S (NP (DT the) (VBG underlying) (NN mechanism)) (VP (VBZ remains) (ADJP (JJ unclear)))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN serine/threonine) (NNS phosphatases))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN phosphorylation)))))) (VP (VBD was) (VP (VBN investigated))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN incubation)) (PP (IN of) (NP (JJ human) (NN T) (NNS cells))) (PP (IN with) (NP (NP (NP (JJ low) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 1-5)) (NN nM)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (NN calyculin) (NN A)) (CC or) (NP (JJ okadaic) (NN acid))) (, ,) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NP (NP (NP (NN protein) (NN phosphatase)) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN PP-1)) (-RRB- -RRB-))) (CC and) (NP (NP (NN type) (NN 2A)) (PRN (-LRB- -LRB-) (NP (NN PP-2A)) (-RRB- -RRB-)))))))))) (, ,)) (VP (VBZ induces) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (ADVP (RB even)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT any) (JJ cellular) (NN stimulus))))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT This) (NN action)) (PP (IN of) (NP (DT the) (NN phosphatase) (NNS inhibitors)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN RelA.p50) (NN NF-kappa) (NN B) (NN heterodimer)))))))))) (, ,)) (VP (VBZ is) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP block) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN phosphorylation))) (PP (IN by) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (DT the) (NP (VBN phosphorylated) (NN I) (NN kappa) (NN B) (NN alpha))) (PP (IN from) (NP (NN calyculin) (JJ A-treated) (NNS cells)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT that)) (PP (IN from) (NP (JJ TNF-alpha-stimulated) (NNS cells)))) (, ,)) (VP (VBZ is) (ADJP (JJ sensitive) (PP (TO to) (NP (NN PP-2A))) (ADVP (FW in) (FW vitro))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (JJ fundamental) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (VP (VBN induced) (PP (IN by) (NP (DT the) (CD two) (JJ different) (NP (NN NF-kappa) (NN B)) (NNS inducers)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN phosphorylation))) (PP (IN by) (NP (CC both) (NP (NN TNF-alpha)) (CC and) (NP (DT the) (NN phosphatase) (NNS inhibitors))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ subsequent) (NN degradation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN TNF-alpha-)) (CC and) (NP (NN calyculin) (JJ A-induced)) (NP (NN I) (NN kappa) (NN B) (NN alpha) (NN degradation))) (VP (VBZ exhibits) (NP (NP (ADJP (ADJP (JJ similar)) (CONJP (CC but) (RB not)) (ADJP (JJ identical))) (NNS sensitivities)) (PP (TO to) (NP (DT a) (JJ proteasome) (NN inhibitor)))))))) (. .))))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (, ,) (VP (VBN mediated) (PP (IN through) (NP (NP (CC both) (DT the) (JJ TNF-alpha-inducible)) (CC and) (NP (DT the) (NP (JJ PP-2A-opposing) (NNS kinases)))))) (, ,)) (VP (MD may) (VP (VB serve) (S (VP (TO to) (VP (NN target) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (PP (IN for) (NP (JJ proteasome-mediated) (NN degradation))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NP (NN RB)) (CC and) (NP (DT a) (JJ novel) (NP (NN E2F-1) (NN binding) (NN protein)))) (PP (IN in) (NP (NN MHC) (NN class) (CD II) (JJ deficient) (NN B-cell) (NNS lines)))) (CC and) (NP (NP (JJ normal) (NP (NN IFN-gamma)) (NN induction)) (PP (IN of) (NP (DT the) (NP (NN class) (NN IL) (NN transactivator)) (NP (NN CIITA)))) (PP (IN in) (NP (NN class) (CD II) (JJ non-inducible) (JJ RB-defective) (NN tumor) (NNS lines)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ major) (NN histocompatibility) (-LRB- -LRB-) (NN MHC) (-RRB- -RRB-) (NN class) (CD II) (NNS genes))) (VP (VBP encode) (NP (NP (NN cell) (NN surface) (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (NP (JJ antigenic) (NN peptide)) (PP (IN for) (NP (NP (NN presentation)) (PP (TO to) (NP (NNS T-cells)))))))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (NN class) (CD II) (NNS proteins))) (VP (VP (VBP are) (VP (VBN expressed) (ADVP (RB constitutively)) (PP (IN on) (NP (NP (NNS B-cells)) (CC and) (NP (JJ EBV-transformed) (NNS B-cells) (, ,)))))) (CC and) (VP (VBP are) (ADJP (JJ inducible) (PP (IN by) (NP (NP (NN IFN-gamma)) (PP (IN on) (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NN cell) (NNS types)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Retinoblastoma) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN RB)) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (DT a) (NN tumor) (NN suppressor))) (CC and) (VP (VBZ functions) (PP (IN as) (NP (DT a) (NP (JJ transcriptional) (NN repressor)))) (PP (IN by) (S (VP (VP (VBG binding)) (CC and) (VP (VBG inactivating)) (NP (DT the) (NP (NN transactivator) (NN E2F-I)))))))) (. .))))
(S1 (S (S (S (NP (JJ RB-defective) (NN tumor) (NNS lines)) (VP (VBP are) (ADJP (ADJP (JJ non-inducible) (PP (IN for) (NP (NN MHC) (NN class) (CD II))) (PP (IN by) (NP (NN IFN-gamma)))) (, ,) (CC or) (ADJP (RB very) (RB weakly) (JJ inducible))))) (, ,) (CC but) (S (NP (NP (NN transfection)) (PP (IN of) (NP (CD 2) (JJ different) (NNS lines))) (PP (IN with) (NP (NN RB) (NN expression) (NNS vectors)))) (VP (VP (VBZ re-establishes)) (CC or) (ADVP (RB substantially)) (VP (VBZ enhances)) (NP (NN class) (CD II) (NN inducibility)))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NP (NN RB)) (NN status)) (PP (IN of) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NN B-cell) (NNS mutants)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ defective) (PP (IN in) (NP (NN class) (CD II) (NN expression)))) (, ,) (S (VP (VP (VBN generated) (CC either) (ADVP (FW in) (FW vitro))) (CC or) (VP (VBN derived) (PP (IN from) (NP (NP (NP (NN Bare) (NN Lymphocyte) (NN Syndrome)) (PRN (-LRB- -LRB-) (NP (NN BLS)) (-RRB- -RRB-))) (NNS patients))))))))))))))) (. .))))
(S1 (S (S (NP (ADJP (JJ Nuclear) (JJ matrix-bound)) (NP (NN RB))) (VP (VBD was) (ADJP (JJ detectable) (PP (IN in) (NP (DT all) (NNS cases)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN loss)) (PP (IN of) (NP (NN RB)))) (VP (VBZ is) (RB not) (ADJP (JJ responsible) (PP (IN for) (NP (NP (VBN decreased) (NN class) (CD II) (NN expression)) (PP (IN in) (NP (DT these) (NNS lines)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ second) (NN E2F-I) (NN binding) (NN protein)) (, ,) (NP (ADVP (RBS most) (RB likely)) (NP (NN DP-I))) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADJP (RB apparently) (JJ normal) (PP (IN in) (NP (CC both) (NN class) (NP (ADJP (JJ II-positive))) (CC and) (NP (ADJP (JJ -negative))) (NP (NN B-cell) (NNS lines)))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD examined) (NP (NP (DT the) (NP (NN IFN-gamma)) (NN induction)) (PP (IN of) (NP (NN CIITA))) (PP (IN in) (JJ RB-defective) (NNS lines)))) (. .))))
(S1 (S (S (NP (NN CIITA)) (VP (VBZ is) (NP (NP (DT a) (NP (NN class) (CD II) (NN gene) (NN transactivator))) (VP (VBN known) (S (VP (VP (TO to) (VP (VB be) (ADJP (JJ defective) (PP (IN in) (NP (NP (CD one) (NN form)) (PP (IN of) (NP (NN BLS)))))))) (CC and) (VP (TO to) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN MHC) (NN class) (CD II))) (PP (IN by) (NP (NN IFN-gamma))))))))))))) (. .))))
(S1 (S (S (S (NP (NN CIITA) (NN mRNA)) (VP (VBZ is) (ADJP (RB normally) (JJ inducible) (PP (IN by) (NP (NN IFN-gamma))) (PP (IN in) (NP (NN class) (CD II) (JJ non-inducible) (, ,) (JJ RB-defective) (NNS lines)))))) (, ,) (CC and) (S (PP (IN in) (NP (CD one) (NN line))) (, ,) (NP (NP (NN re-expression)) (PP (IN of) (NP (NN RB)))) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN CIITA) (NN mRNA)) (NN induction) (NNS levels))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN block)) (PP (IN in) (NP (NP (NN MHC) (NN class) (CD II) (NN inducibility)) (PP (IN in) (NP (JJ RB-defective) (NNS cells)))))) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN block)) (PP (IN in) (NP (NP (NN CIITA)) (NN inducibility))))))) (. .))))
(S1 (S (S (S (NP (JJ Latent) (NN membrane) (NN protein-1)) (VP (VBZ induces) (NP (NP (NP (NP (NN cyclin) (NN D2)) (NN expression)) (, ,) (NP (NP (NN pRb)) (NN hyperphosphorylation)) (, ,) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (NN TGF-beta) (JJ 1-mediated) (NN growth) (NN inhibition))))) (PP (IN in) (NP (JJ EBV-positive) (NN B) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (DT The) (JJ normal) (NN cell) (NN cycle)) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (JJ several) (NNS molecules)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (NP (JJ tumor-suppressor) (NN protein) (NN pRb))) (, ,) (NP (DT the) (NP (NN G1) (NNS cyclins))) (, ,) (NP (DT the) (NP (JJ cyclin-dependent) (NNS kinases))) (, ,) (CC and) (NP (PRP$ their) (NNS inhibitors)))))))) (. .)))))
(S1 (S (S (NP (DT These) (NNS regulators)) (VP (VBP are) (VP (VBN targeted) (PP (IN by) (NP (NP (JJ negative) (NN growth) (JJ regulatory) (NNS signals)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT that)) (VP (VBN provided) (PP (IN by) (NP (NN TGF-beta)))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (CC either) (NP (JJ wild-type) (NN EBV)) (CC or) (NP (PRP$ its) (NP (NP (VBG transforming) (JJ latent) (NN membrane) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN LMP-1)) (-RRB- -RRB-))))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN TGF-beta) (JJ 1-mediated) (NN growth) (NN inhibition))) (PP (IN in) (NP (JJ human) (NN B) (NNS cells))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Chemical) (NN cross-linking)) (PP (IN with) (NP (JJ 125I-labeled) (NN TGF-beta) (CD 1)))) (VP (VBD showed) (NP (DT an) (ADJP (RB essentially) (JJ normal)) (NP (NN TGF-beta) (NN receptor)) (NN profile)) (PP (IN in) (NP (NP (ADJP (JJ EBV-positive))) (CC and) (NP (ADJP (JJ EBV-negative))) (NP (NN Burkitt) (POS 's) (NN lymphoma) (NN cell) (NNS lines)))))) (, ,) (CC and) (S (NP (DT these) (NNS receptors)) (VP (VBD were) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ functional) (PP (IN in) (S (VP (VBG transducing) (NP (NNS signals)))))))))) (, ,) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (DT the) (NN TGF-beta) (JJ 1-mediated) (NN modulation)) (PP (IN of) (NP (NP (NN junB) (NN gene)) (NN expression)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN TGF-beta) (CD 1)) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (NN dephosphorylation)) (PP (IN of) (NP (NN pRb)))) (PP (IN in) (NP (NN EBV) (-LRB- -LRB-) (CC or) (NN LMP-1) (-RRB- -RRB-) (JJ -positive) (NNS cells)))) (SBAR (SBAR (IN as) (S (VP (VBN opposed) (PP (TO to) (NP (JJ EBV) (JJ -negative) (NNS cells)))))) (, ,) (SBAR (VP (VBG suggesting) (NP (NP (NP (DT a) (NN dichotomy)) (PP (IN in) (NP (DT the) (NP (NN TGF-beta) (CD 1)) (NN signaling) (NN pathway)))) (VP (VBG leading) (PP (TO to) (NP (JJ separable) (NN gene) (NP (ADJP (JJ regulatory))) (CC and) (NP (NN growth) (JJ inhibitory)) (NP (NNS responses)))))))))) (. .))))
(S1 (S (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN LMP-1)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB induce) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN cyclin) (NN D2)))))))))) (: ;) (S (NP (NP (JJ normal) (NP (NN B) (NNS cells))) (CC or) (NP (JJ EBV-negative) (NN Burkitt) (POS 's) (NN lymphoma) (NNS cells))) (VP (VBP do) (RB not) (VP (VB express) (NP (JJ D-type) (NNS cyclins))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP point) (PP (TO to) (NP (NP (DT a) (JJ potential) (NN mechanism)) (VP (VBG underlying) (NP (NP (JJ EBV-mediated) (NN B) (NN cell) (NN transformation)) (SBAR (WHADVP (WRB whereby)) (S (NP (NP (JJ constitutive) (NN induction)) (PP (IN of) (NP (JJ key) (NN cell) (NN cycle) (NNS regulators))) (PP (IN by) (NP (NN LMP-1)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (NP (NN pRb)) (NN hyperphosphorylation)) (CC and) (NP (JJ uncontrolled) (NN cell) (NN proliferation)))))))))))))) (. .))))
(S1 (S (S (S (NP (NN C/EBP) (NNS proteins)) (VP (VBP activate) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (JJ long) (JJ terminal) (NN repeat)))) (PP (IN in) (NP (NNS macrophages/monocytes))))) (. .)))))
(S1 (S (S (S (S (NP (NP (CD Three) (VBG binding) (NNS sites)) (PP (IN for) (NP (NN C/EBP) (NNS proteins)))) (VP (VBP are) (VP (VBN found) (PP (IN in) (NP (DT the) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (-LRB- -LRB-) (NN HIV-1) (-RRB- -RRB-) (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-)))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP V.M.) (NNP Tesmer)) (, ,) (NP (NNP A.Rajadhyaksha)) (, ,) (NP (NNP J.Babin)) (, ,) (CC and) (NP (NNP M.Bina))) (, ,) (NP (NNP Proc.Natl.Acad.Sci.) (NNP USA) (CD 90)) (: :) (NP (CD 7298-7302)) (, ,) (NP (CD 1993))) (-RRB- -RRB-)) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN determined) (NP (NP (DT the) (JJ functional) (NN role)) (PP (IN of) (NP (NP (NN C/EBP) (NNS proteins)) (CC and) (NP (NN C/EBP) (NNS sites)))) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NP (NN HIV-1) (NN LTR)))) (PP (IN in) (NP (NNS monocytes/macrophages)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ endogenous) (NN C/EBP) (NNS proteins))) (, ,) (VP (VBG using) (NP (CC either) (NP (NP (DT an) (NN excess)) (PP (IN of) (NP (NN C/EBP) (NN binding) (NNS sites)))) (CC or) (NP (DT a) (NP (JJ trans-dominant) (JJ negative) (NN inhibitor))))) (, ,)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN C/EBP) (NNS proteins)) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (NP (ADJP (JJ basal))) (CC and) (NP (VBN activated)) (NP (NNS levels))) (PP (IN of) (NP (NP (NP (NN HIV-1) (NN LTR)) (NN transcription)) (PP (IN in) (NP (DT the) (NP (JJ promonocytic) (NN cell) (NN line) (NN U937))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Northern)) (PRN (-LRB- -LRB-) (NP (NN RNA)) (-RRB- -RRB-))) (NP (NNS blots)) (CC and) (NP (NN binding)) (NP (NNS assays))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN NF-IL6)) (VP (VBZ is) (NP (NP (DT the) (RB only) (JJ known) (NP (NN C/EBP) (NN family) (NN member))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN increased)) (SBAR (WHADVP (WRB when)) (S (NP (NN U937) (NNS cells)) (VP (VBP are) (VP (VBN activated))))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Mutational) (NNS analyses)) (PP (IN of) (NP (DT the) (NP (NN HIV-1) (NN LTR))))) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (CD one) (NP (NN C/EBP) (NN site))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ normal) (NP (NN LTR)) (NN transcription)) (PP (CC both) (PP (IN before)) (CC and) (PP (IN after)) (NP (JJ cellular) (NN activation))))))))) (CC and) (SBAR (IN that) (S (NP (DT the) (CD two) (JJ 3') (NP (NN C/EBP) (NNS sites))) (VP (VBP are) (ADJP (RB functionally) (JJ equivalent))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN transcription)) (PP (IN from) (NP (NP (VBN crippled) (NN HIV-1) (NNS LTRs)) (VP (VBG lacking) (NP (NN C/EBP) (NNS sites)))))) (VP (MD can) (ADVP (RB still)) (VP (VB be) (VP (VBN induced) (PP (VBG following) (NP (NP (NN activation)) (PP (IN of) (NP (NN U937) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (JJ Several) (NNS models)) (VP (VBP are) (VP (VBN suggested) (PP (IN for) (SBAR (WHADVP (WRB how)) (S (NP (JJ elevated) (NP (NN NF-IL6))) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT an) (JJ autostimulatory) (NN loop)) (VP (VBG involving) (NP (NP (NN HIV) (NN infection)) (, ,) (NP (NN macrophage) (NN activation)) (, ,) (NP (NP (NN cytokine)) (NN expression)) (, ,) (CC and) (NP (NN HIV) (NN replication))))))))))))) (. .))))
(S1 (S (NP (NP (NP (DT An) (JJ IRF-1-dependent) (NN pathway)) (PP (IN of) (NP (NN DNA) (JJ damage-induced) (NN apoptosis))) (PP (IN in) (NP (JJ mitogen-activated) (NN T) (NNS lymphocytes))) (. .)))))
(S1 (S (S (S (NP (NNS Lymphocytes)) (VP (VBP are) (ADJP (RB particularly) (JJ susceptible) (PP (TO to) (NP (NP (NN DNA) (JJ damage-induced) (NN apoptosis)) (, ,) (NP (NP (DT a) (NN response)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN form)) (PP (IN of) (NP (`` ') (JJ altruistic) (NN suicide) ('' ')))))) (S (VP (TO to) (VP (VB counter) (NP (NP (PRP$ their) (ADJP (JJ intrinsic) (JJ high)) (NN potential)) (PP (IN for) (NP (NP (NN mutation)) (CC and) (NP (JJ clonal) (NN expansion)))))))))))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN tumour) (NN suppressor) (NN p53))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB regulate) (NP (NP (DT this) (NN type)) (PP (IN of) (NP (NP (NN apoptosis)) (PP (IN in) (NP (NNS thymocytes))))))))))))) (, ,) (CC but) (S (NP (DT an) (ADJP (RB as) (RB yet) (JJ unknown)) (, ,) (JJ p53-independent) (NN pathway) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VBZ appears) (S (VP (TO to) (VP (VB mediate) (NP (DT the) (JJ same) (NN event)) (PP (IN in) (NP (JJ mitogen-activated) (JJ mature) (NN T) (NNS lymphocytes)))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (NP (NP (NN DNA) (JJ damage-induced) (NN apoptosis)) (PP (IN in) (NP (DT these) (NP (NN T) (NNS lymphocytes))))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (DT the) (NP (NP (JJ antioncogenic) (NN transcription) (NN factor) (NN interferon) (JJ regulatory) (NN factor)) (NP (-LRB- -LRB-) (NN IRF) (-RRB- -RRB-) (CD -1)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (NP (NP (CD two) (JJ different) (NP (JJ anti-onco-genic) (NN transcription) (NNS factors))) (, ,) (NP (NP (NN p53)) (CC and) (NP (NN IRF-1))) (, ,)) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (JJ distinct) (JJ apoptotic) (NNS pathways)) (PP (IN in) (NP (NN T) (NNS lymphocytes))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN mitogen) (NN induction)) (PP (IN of) (NP (NP (DT the) (NP (NN interleukin-1) (NN beta) (NN converting) (NN enzyme) (-LRB- -LRB-) (NN ICE) (-RRB- -RRB-) (NN gene))) (, ,) (NP (NP (DT a) (NP (JJ mammalian) (NN homologue))) (PP (IN of) (NP (DT the) (NP (NP (FW Caenorhabditis) (FW elegans) (NN cell) (NN death) (NN gene)) (NP (NN ced-3)))))))) (, ,)) (VP (VBZ is) (ADJP (JJ IRF-1-dependent)))))) (. .))))
(S1 (S (S (NP (NP (JJ Ectopic) (NN overexpression)) (PP (IN of) (NP (NN IRF-1)))) (VP (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NP (JJ endogenous) (NN gene)))) (PP (IN for) (NP (NN ICE)))))) (CC and) (VP (VBZ enhances) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (NNS cells))) (PP (TO to) (NP (JJ radiation-induced) (NN apoptosis)))))) (. .))))
(S1 (S (S (S (NP (NN Sp1)) (VP (VBZ functions) (PP (IN in) (NP (DT a) (JJ chromatin-dependent) (NN manner))) (S (VP (TO to) (VP (VB augment) (NP (NP (JJ human) (NN alpha-globin) (NN promoter)) (NN activity)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (JJ 5') (JJ flanking) (NN region))) (PP (IN of) (NP (DT the) (NP (JJ human) (NN alpha-globin) (NN gene))))) (VP (VP (VBZ is) (ADJP (RB highly) (NN G+C) (JJ rich))) (CC and) (VP (VBZ contains) (NP (NP (JJ multiple) (NNS copies)) (PP (IN of) (NP (NP (DT the) (NP (NN consensus) (NN sequence))) (PP (IN for) (NP (DT the) (NP (NN Sp1) (NN binding) (NN site))))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT this) (NP (JJ G+C-rich) (NN region))))) (PP (IN in) (S (VP (VBG augmenting) (NP (NP (NN alpha-globin) (NN promoter)) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NP (NP (JJ far-upstream) (NN alpha-globin) (NN enhancer)) (, ,) (NP (NN HS-40))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (PP (IN in) (NP (RB transiently) (VBN transfected) (JJ erythroid) (NNS cells))) (, ,) (NP (NP (NN deletion)) (PP (IN of) (NP (DT the) (NP (NN alpha-globin) (JJ G+C-rich) (JJ 5') (JJ flanking) (NN region))))) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN alpha-globin) (NN promoter)) (NN activity))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (PP (IN upon) (NP (NP (JJ stable) (NN integration)) (PP (IN into) (NP (NN chromatin))))) (, ,) (NP (NP (NN deletion)) (PP (IN of) (NP (DT this) (NN region)))) (VP (VBZ causes) (NP (NP (DT a) (ADJP (QP (RB nearly) (CD 90)) (NN %)) (NN decrease)) (PP (IN in) (NP (NN promoter) (NN activity)))) (PP (VBN compared) (PP (IN with) (NP (NP (NN expression)) (PP (IN from) (NP (NP (DT an) (NP (NN alpha-globin) (NN promoter))) (VP (VBG retaining) (NP (DT this) (NN region))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NP (NN alpha-globin) (JJ G+C-rich) (JJ 5') (JJ flanking) (NN region))) (VP (VBZ augments) (NP (NP (NN alpha-globin) (NN promoter)) (NN activity)) (PP (IN in) (NP (DT a) (JJ chromatin-dependent) (NN manner))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP show) (SBAR (IN that) (S (NP (DT this) (NP (JJ G+C-rich) (NN region))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN alpha-globin) (NN gene)) (NN expression))))) (PP (IN during) (NP (JJ erythroid) (NN differentiation)))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP show) (PP (IN by) (NP (CC both) (NP (NN footprint) (NN analysis)) (CC and) (NP (JJ functional) (NNS assays)))) (SBAR (IN that) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT the) (NP (JJ G+C-rich) (NN region)))) (S (VP (TO to) (VP (VB increase) (NP (NP (NP (NN alpha-globin) (NN promoter)) (NN activity)) (PP (IN from) (NP (DT a) (ADJP (RB stably) (VBN integrated)) (NP (NN alpha-globin) (NN gene))))))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (PRP$ its) (NP (JJ multiple) (VBG binding) (NNS sites))) (PP (IN for) (NP (DT the) (NP (NP (NN transcription) (NN factor)) (NP (NN Sp1)))))))))))) (. .))))
(S1 (S (S (S (NP (NN Interleukin) (CD 12)) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NN STAT4))))) (PP (IN in) (NP (JJ human) (NNS lymphocytes)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Interleukin) (CD 12)) (PRN (-LRB- -LRB-) (NP (NN IL-12)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NP (JJ immunoregulatory) (NN cytokine))) (SBAR (WHNP (WP$ whose) (NN receptor)) (S (VP (VBZ is) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN hematopoietin) (NN receptor) (NN superfamily)))))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN stimulation)) (PP (IN of) (NP (JJ human) (NP (NN T)) (CC and) (NP (JJ natural) (NN killer)) (NP (NNS cells)))) (PP (IN with) (NP (NN IL-12)))) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NP (NP (NN Janus) (NN family) (NN tyrosine) (NN kinase)) (NP (NP (NN JAK2)) (CC and) (NP (NN Tyk2))))))) (, ,) (S (VP (VBG implicating) (NP (DT these) (NP (NNS kinases))) (PP (IN in) (NP (NP (DT the) (JJ immediate) (JJ biochemical) (NN response)) (PP (TO to) (NP (NN IL-12)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Recently)) (, ,) (NP (NP (NN transcription) (NNS factors)) (VP (VBN known) (PP (IN as) (NP (NP (NNS STATs)) (PRN (-LRB- -LRB-) (NP (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription)) (-RRB- -RRB-)))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (UCP (ADJP (NN tyrosine) (JJ phosphorylated)) (CC and) (VP (VBN activated) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS cytokines)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP bind) (NP (NN hematopoietin) (NNS receptors))) (CC and) (VP (VBP activate) (NP (NN JAK) (NNS kinases)))))))))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (NP (PRP we)) (VP (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN IL-12)) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (DT a) (ADJP (RB recently) (VBN identified)) (NP (NN STAT) (NN family) (NN member))) (, ,) (NP (NN STAT4))))))))) (, ,) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN STAT4)) (NN expression)) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NN T-cell) (NN activation))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NN IL-12)) (VP (VBZ stimulates) (NP (NP (NN formation)) (PP (IN of) (NP (NP (DT a) (NP (JJ DNA-binding) (NN complex))) (SBAR (WHNP (WDT that)) (S (VP (VBZ recognizes) (NP (NP (DT a) (NN DNA) (NN sequence)) (ADVP (RB previously)) (VP (VBN shown) (S (VP (TO to) (VP (VB bind) (NP (NN STAT) (NNS proteins)))))))))))))))) (CC and) (SBAR (IN that) (S (NP (DT this) (NN complex)) (VP (VBZ contains) (NP (NN STAT4))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS data)) (, ,) (CC and) (NP (NP (DT the) (JJ recent) (NN demonstration)) (PP (IN of) (NP (NP (NP (NN JAK)) (NN phosphorylation)) (PP (IN by) (NP (NN IL-12)))))) (, ,)) (VP (VBP identify) (NP (NP (DT a) (JJ rapid) (JJ signal-transduction) (NN pathway)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB mediate) (NP (JJ IL-12-induced) (NN gene) (NN expression)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NN c-jun) (NN mRNA)) (NN expression))) (PP (IN by) (NP (NN hydroxyurea))) (PP (IN in) (NP (JJ human) (NN K562) (NNS cells))) (PP (IN during) (NP (JJ erythroid) (NN differentiation)))) (S (-LRB- -LSB-) (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP Biochim) (NNP Biophys) (NNP Acta) (CD 1995) (NNP Dec) (CD 27)) (: ;) (NP (CD 1264) (-LRB- -LRB-) (CD 3) (-RRB- -RRB-)) (: :) (NP (CD 409))))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (NP (NN Hydroxyurea)) (PRN (-LRB- -LRB-) (NP (NN HU)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ antitumor) (NN agent)) (SBAR (WHNP (WDT which)) (S (ADVP (RB also)) (VP (VBZ induces) (NP (NN hemoglobinization)) (PP (IN during) (NP (JJ erythroid) (NN differentiation)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN HU)) (VP (VBZ stimulates) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (JJ fetal) (NN hemoglobin))) (PP (IN in) (NP (NN sickle) (NN cell) (NN anemia) (NNS patients))))) (. .))))
(S1 (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB understand) (NP (NP (PRP$ its) (NN mechanism)) (PP (IN of) (NP (NN action))))))) (, ,) (S (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN HU))) (PP (IN on) (NP (NP (NN regulation)) (PP (IN of) (NP (NP (NN c-jun)) (NN expression))))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (JJ erythroid) (NN differentiation)) (PP (IN of) (NP (NN K562) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (NN HU)) (VP (VBD induced) (NP (NP (DT a) (JJ dose-dependent) (NN stimulation)) (PP (IN of) (NP (NP (NN c-jun)) (NN synthesis))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS levels)) (PP (IN of) (NP (NN c-jun) (NN mRNA)))) (VP (VBD was) (VP (VBN elevated) (NP (CD 4) (TO to) (RB 7.5-fold)) (PP (IN by) (NP (NN HU))) (PP (IN within) (NP (CD 2) (NN h))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ gradual) (NN decline)) (PP (TO to) (NP (DT the) (JJ basal) (NN level))))) (PP (IN by) (NP (CD 24) (NN h))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (JJ nuclear) (JJ run-on)) (CC and) (NP (NN actinomycin) (NN D) (NN pulse)) (NP (NNS experiments))) (ADVP (RB strongly)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN HU)) (VP (VBZ regulates) (NP (NP (NN c-jun) (NN mRNA)) (NN expression)) (PP (IN by) (S (VP (VP (VBG increasing) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN synthesis))))) (CONJP (RB as) (RB well) (IN as)) (VP (VBG stabilizing) (NP (DT the) (NP (NN c-jun) (NN mRNA))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN jun) (NN protein)))) (VP (VBD was) (ADJP (JJ elevated) (PP (IN by) (NP (CD 2) (TO to) (NN 5-fold))) (PP (IN within) (NP (CD 4) (NN h))) (PP (IN in) (NP (NN HU) (JJ treated) (NNS cells))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NN HU))) (PP (IN below) (NP (CD 250) (NN microM)))) (ADVP (RB slightly)) (VP (VBD increased) (NP (DT the) (NN 5X) (NN AP-1/CAT) (NN activity))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (ADVP (RB strongly)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN HU)) (VP (VBZ induces) (NP (NP (CC both) (NP (ADJP (JJ transcriptional))) (CC and) (NP (ADJP (JJ post-transcription))) (NP (NN regulation))) (PP (IN of) (NP (NN c-jun))) (PP (IN during) (NP (JJ erythroid) (NN differentiation)))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (NP (NN IL-2) (NN gene)) (NN expression)) (CC and) (NP (NP (NN NF-kappa) (NN B)) (NN activation))) (PP (IN through) (NP (NN CD28)))) (VP (VBZ requires) (NP (NP (JJ reactive) (NN oxygen) (NN production)) (PP (IN by) (NP (NN 5-lipoxygenase))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NP (NN CD28) (NN surface) (NN receptor))))) (VP (VBZ provides) (NP (NP (DT a) (JJ major) (JJ costimulatory) (NN signal)) (PP (IN for) (NP (NN T) (NN cell) (NN activation))) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (VBN enhanced) (NN production)) (PP (IN of) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))))) (CC and) (NP (NN cell) (NN proliferation))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (JJ primary) (NN T) (NNS lymphocytes))) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN CD28)) (NN ligation)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (JJ rapid) (JJ intracellular) (NN formation)) (PP (IN of) (NP (NP (NP (JJ reactive) (NN oxygen) (NNS intermediates)) (PRN (-LRB- -LRB-) (NP (NNS ROIs)) (-RRB- -RRB-))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (NP (JJ CD28-mediated) (NN activation)) (PP (IN of) (NP (DT the) (NN NF-kappa) (JJ B/CD28-responsive) (NN complex)))) (CC and) (NP (NP (NN IL-2)) (NN expression)))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Delineation)) (PP (IN of) (NP (DT the) (NP (NN CD28)) (NN signaling) (NN cascade)))) (VP (VBD was) (VP (VBN found) (VP (TO to) (S (VP (VB involve) (NP (NP (NN protein) (NN tyrosine) (NN kinase)) (NN activity)) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN phospholipase) (NN A2)) (CC and) (NP (NN 5-lipoxygenase))))))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN lipoxygenase) (NNS metabolites)) (VP (VBP activate) (NP (NP (NN ROI) (NN formation)) (SBAR (WHNP (WDT which)) (S (ADVP (RB then)) (VP (VBP induce) (NP (NP (NN IL-2)) (NN expression)) (PP (IN via) (NP (NP (NN NF-kappa) (NN B)) (NN activation))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (MD should) (VP (VB be) (ADJP (JJ useful) (PP (IN for) (NP (NP (JJ therapeutic) (NNS strategies)) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS immunosuppressants)) (VP (VBG targeting) (NP (DT the) (NP (NN CD28)) (NN costimulatory) (NN pathway))))))))))) (. .))))
(S1 (S (S (S (S (NP (NN HIV-1) (NN envelope) (NNS glycoproteins)) (VP (VBP induce) (NP (NP (NN activation)) (PP (IN of) (NP (VBN activated) (NP (NN protein-1)))) (PP (IN in) (NP (JJ CD4+) (NN T) (NNS cells)))))) (S (-LRB- -LSB-) (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP J) (NNP Biol) (NNP Chem) (CD 1995) (NNP Dec) (CD 1)) (: ;) (NP (CD 270) (-LRB- -LRB-) (CD 48) (-RRB- -RRB-) (: :) (CD 29038))))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NN CD4) (JJ positive) (NN T) (NNS cells)))) (VP (VBZ is) (NP (NP (DT a) (JJ primary) (NN requirement)) (PP (IN for) (NP (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NP (NN entry))) (, ,) (NP (JJ efficient) (NN HIV) (NN replication)) (, ,) (CC and) (NP (NP (NN progression)) (PP (TO to) (NP (NN AIDS)))))))) (, ,)))))
(S1 (S (S (S (VP (VBG Utilizing) (NP (NP (NP (NN CD4) (JJ positive) (NN T) (NN cell) (NNS lines)) (CC and) (NP (VBN purified) (NN T) (NNS cells))) (PP (IN from) (NP (JJ normal) (NNS individuals)))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (JJ native) (NN envelope) (NNS glycoproteins)) (PP (IN of) (NP (NP (NN HIV)) (, ,) (NP (NN gp) (CD 160)) (, ,)))) (VP (MD can) (VP (VB induce) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN transcription) (NN factor) (, ,) (VBN activated) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ stimulatory) (NNS effects)) (PP (IN of) (NP (NN gp160)))) (VP (VBP are) (VP (VBN mediated) (PP (IN through) (NP (DT the) (NP (NN CD4) (NN molecule))))) (, ,) (SBAR (IN since) (S (S (NP (NP (NN treatment)) (PP (IN of) (NP (NN gp160))) (PP (IN with) (NP (JJ soluble) (NP (NN CD4-IgG))))) (VP (VBZ abrogates) (NP (PRP$ its) (NN activity)))) (, ,) (CC and) (S (NP (NN CD4) (JJ negative) (NN T) (NN cell) (NNS lines)) (VP (VBP fail) (S (VP (TO to) (VP (VB be) (VP (VBN stimulated) (PP (IN with) (NP (NN gp160)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunoprecipitation)) (PP (IN of) (NP (DT the) (NN gp) (JJ 160-induced) (JJ nuclear) (NNS extracts))) (PP (IN with) (NP (NP (JJ polyclonal) (NNS antibodies)) (PP (TO to) (NP (NP (NP (NN Fos))) (CC and) (NP (NN Jun) (NNS proteins))))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN AP-1) (NN complex)) (VP (VBZ is) (VP (VBN comprised) (PP (IN of) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT these) (NN family)) (PP (IN of) (NP (NNS proteins)))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ gp160-induced) (NN AP-1) (NN complex))) (VP (VP (VBZ is) (ADJP (JJ dependent) (PP (IN upon) (NP (NN protein) (NN tyrosine) (NN phosphorylation))))) (CC and) (VP (VBZ is) (ADJP (NN protein) (JJ synthesis-independent)))) (. .))))
(S1 (S (S (S (NP (DT This) (NN stimulation)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN abolished) (PP (IN by) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN protein) (NN kinase) (NN C))))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unaffected) (PP (IN by) (NP (NP (NN calcium) (NN channel) (NN blocker)) (CC or) (NP (NN cyclosporine) (NN A))))))) (. .))))
(S1 (S (S (S (NP (DT This) (NP (NN gp160)) (NN treatment)) (ADVP (RB adversely)) (VP (VBZ affects) (NP (NP (DT the) (JJ functional) (NNS capabilities)) (PP (IN of) (NP (NN T) (NNS cells)))))) (: :) (S (NP (NP (NN pre-treatment)) (PP (IN of) (NP (JJ CD4+) (NN T) (NNS cells))) (PP (IN with) (NP (NN gp160))) (PP (IN for) (NP (CD 4) (NN h))) (PP (IN at) (NP (CD 37) (NNS degrees) (NN C)))) (VP (VBD inhibited) (NP (JJ anti-CD3-induced) (NP (NN interleukin-2)) (NN secretion)))) (. .))))
(S1 (S (S (NP (NP (NNS Effects)) (ADJP (JJ similar) (PP (TO to) (NP (NN gp160))))) (VP (VBD were) (VP (VBN seen) (PP (IN with) (NP (JJ anti-CD4) (NN mAb))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ aberrant) (NN activation)) (PP (IN of) (NP (NN AP-1))) (PP (IN by) (NP (NN gp160))) (PP (IN in) (NP (NN CD4) (JJ positive) (NN T) (NNS cells)))) (VP (MD could) (VP (VP (VB result) (PP (IN in) (NP (NP (NN up-regulation)) (PP (IN of) (NP (NP (NNS cytokines)) (VP (VBG containing) (NP (NP (NN AP-1) (NNS sites)) (, ,) (PP (FW e.g.)) (NP (NP (NN interleukin-3)) (CC and) (NP (NN granulocyte) (NN macrophage) (JJ colony-stimulating) (NN factor)))))))))) (, ,) (CC and) (ADVP (RB concurrently)) (VP (VBP lead) (PP (TO to) (NP (NP (NN T) (NN cell)) (NN unresponsiveness))) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (NN interleukin-2)) (NN secretion)))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NP (NN Infection)) (CC and) (NP (NN replication))) (PP (IN of) (NP (JJ Tat-) (JJ human) (NN immunodeficiency) (NNS viruses))) (: :)) (NP (NP (JJ genetic) (NNS analyses)) (PP (IN of) (NP (NP (NP (NN LTR)) (CC and) (NP (NN tat)) (NP (NNS mutations))) (PP (IN in) (NP (NP (JJ primary)) (CC and) (NP (JJ long-term)) (NP (JJ human) (JJ lymphoid) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (NN Tat)) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NP (JJ regulatory) (NN protein))) (PP (IN for) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-)))))))) (. .)))))
(S1 (S (S (NP (NP (NNS Mutations)) (PP (IN in) (NP (DT the) (NP (NN tat) (NN gene))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB block) (NP (NN HIV) (NN replication)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))))))) (. .))))
(S1 (S (S (S (NP (JJ Several) (NNS studies)) (VP (VBP have) (VP (VBN established) (SBAR (IN that) (S (NP (NN Tat)) (VP (VBZ releases) (NP (NP (DT an) (NP (NN elongation) (NN block))) (PP (TO to) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (NP (NN HIV) (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))))))))))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (PRP it))) (VP (VBZ is) (RB not) (VP (VBN known)) (SBAR (IN whether) (S (NP (NP (DT this) (NN mechanism)) (ADVP (RB alone))) (VP (VBZ is) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB explain) (NP (NP (DT the) (NN block)) (PP (TO to) (NP (NP (NN HIV) (NN replication)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN Tat)) (VP (VBZ is) (ADJP (JJ absent)))))))))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NN Tat)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN needed) (PP (IN for) (NP (JJ other) (NNS functions))) (PP (IN during) (NP (NN HIV) (NN replication)))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB test) (NP (DT these) (NNS hypotheses))))) (, ,) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (JJ several) (NP (NN tat) (NNS mutants))) (, ,) (PP (VBG including) (NP (NP (CD two) (NP (NN stop) (NN codon) (NNS mutants))) (CC and) (NP (CD one) (NP (NN deletion) (NN mutant)))))) (S (VP (VBG using) (NP (NP (JJ replication-competent) (NN HIV-1) (NNS constructs)) (VP (VBG carrying) (NP (NP (NP (JJ wild-type)) (CC or) (NP (JJ mutant)) (NP (NNS LTRs))) (PP (IN with) (NP (NP (NNS modifications)) (PP (IN in) (NP (DT the) (NP (NN NF-kappa) (NN B)) (CC and/or) (NP (NN Sp1)) (NP (NN binding) (NNS sites))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (S (NP (NP (JJ Tat-) (NN HIV-1)) (PP (IN with) (NP (JJ wild-type) (NNS LTRs)))) (VP (MD can) (VP (VB replicate) (PP (IN in) (NP (NN HeLa) (NNS cells)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN virus)) (VP (VBN produced) (PP (IN from) (NP (NN HeLa) (NNS cells))))) (VP (MD can) (VP (VB infect) (NP (ADJP (JJ primary)) (NP (JJ peripheral) (NN blood) (NNS lymphocytes)) (CC and) (NP (NNS macrophages))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NP (DT the) (NN propagation)) (PP (IN of) (NP (NP (DT the) (NP (NN Tat) (NNS mutants))) (VP (VBG containing) (NP (JJ wild-type) (NNS LTRs)))))) (VP (VBD was) (ADJP (ADJP (RBR less) (JJ efficient)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NP (JJ LTR-modified) (NN Tat) (NNS mutants)))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Large) (NNS amounts)) (PP (IN of) (NP (NP (JJ viral) (NN RNA)) (CC and) (NP (NNS particles))))) (VP (VBD were) (VP (VBN synthesized) (PP (IN in) (NP (NP (NNS infections)) (VP (VBN established))))) (S (VP (VBG using) (NP (NP (DT the) (NP (NN tat) (NNS mutants))) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (VBN modified) (NNS LTRs))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT this) (JJ efficient) (NN propagation)) (PP (IN of) (NP (DT the) (NP (JJ LTR-modified) (NN tat) (NNS mutants))))) (VP (VBD was) (ADJP (JJ restricted) (PP (TO to) (NP (NP (DT some) (NP (JJ lymphoid) (NN cell) (NNS lines))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN transformed) (PP (IN with) (NP (JJ other) (NNS viruses)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (PP (IN despite) (NP (NP (PRP$ its) (JJ essential) (NN role)) (PP (IN for) (S (VP (VBG releasing) (NP (DT an) (NP (NN elongation) (NN block)))))))) (, ,) (NP (NN Tat)) (VP (VBZ is) (RB not) (ADVP (RB otherwise)) (ADVP (RB absolutely)) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN synthesis)) (PP (IN of) (NP (JJ full-length) (NN HIV) (NNS transcripts)))) (CC and) (NP (NP (NN assembly)) (PP (IN of) (NP (NN virus) (NNS particles)))))))) (. .))))
(S1 (S (S (NP (NP (NP (JJ Direct) (NN sequencing)) (PP (IN of) (NP (DT the) (NP (JJ viral) (NNS genomes))))) (CC and) (NP (NN reinfection) (NNS kinetics))) (VP (VBD showed) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (JJ wild-type) (NN reversion)))) (ADVP (RB even)) (PP (IN after) (NP (NP (JJ prolonged) (NN infection)) (PP (IN with) (NP (DT the) (JJ Tat-) (NN virus)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS implications)) (PP (IN for) (NP (NP (ADJP (FW in) (FW vivo)) (NN HIV-1) (NN replication)) (CC and) (NP (NP (JJ potential) (NN application)) (PP (IN of) (NP (DT this) (NN system))) (PP (TO to) (NP (NP (DT the) (NN study)) (PP (IN of) (NP (JJ alternative) (NP (NN Tat)) (NN function))))))))) (VP (VBP are) (VP (VBN discussed))) (. .))))
(S1 (S (NP (NP (NP (NN Restoration)) (PP (IN of) (NP (NP (DT the) (NP (JJ Epstein-Barr) (NN virus) (NN ZEBRA) (NN protein)) (POS 's) (NN capacity)) (S (VP (TO to) (VP (VB disrupt) (NP (NN latency))))))) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (JJ heterologous) (NN activation) (NNS regions))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN ZEBRA) (NN protein))) (VP (VBZ has) (NP (DT a) (JJ unique) (JJ biological) (NN function)) (PP (IN among) (NP (JJ herpesviral) (NNS proteins)))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NP (DT the) (NN disruption)) (PP (IN of) (NP (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (NN latency)))) (CC and) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (JJ lytic) (NN cycle)))))))) (. .))))
(S1 (S (S (NP (NN ZEBRA)) (VP (VBZ is) (NP (NP (DT a) (NP (NN bZIP) (JJ transcriptional) (NN activator))) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ binds) (PP (IN as) (NP (DT a) (NN dimer))) (PP (TO to) (NP (NP (JJ 7-bp) (NN response) (NNS elements)) (PP (IN within) (NP (NN EBV) (NNS promoters)))))) (CC and) (VP (VBZ is) (ADVP (RB directly)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NN virus) (NN replication))) (PP (IN at) (NP (DT the) (NP (NN EBV) (JJ lytic) (NN origin))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN employed) (NP (DT the) (NN ZEBRA/EBV) (JJ biological) (NN system))) (S (VP (TO to) (VP (VB test) (SBAR (IN whether) (S (NP (DT a) (NP (JJ heterologous) (NN activation) (NN domain))) (VP (MD can) (VP (VB substitute) (PP (IN for) (NP (NP (DT another) (NN activation) (NN domain)) (PRN (-LRB- -LRB-) (NP (DT the) (NP (NN ZEBRA) (NN domain))) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN ZEBRA) (NN activation) (NN region))) (VP (VBD was) (VP (VBN replaced) (PP (PP (IN with) (NP (NP (DT the) (JJ potent) (NP (NN acid) (NN activation) (NN region))) (PP (IN from) (NP (DT the) (NP (NN herpes) (JJ simplex) (NN virus) (NN VP16) (NN protein)))))) (CC or) (PP (IN with) (NP (NP (DT the) (NP (NN activation) (NN region))) (PP (IN of) (NP (DT the) (NP (NN EBV) (NN R) (NN protein))))))))) (. .))))
(S1 (S (S (NP (DT Both) (NNS chimeras)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB transactivate) (NP (NP (NN model)) (CC and) (NP (JJ native)) (NP (NNS promoters))) (PP (IN at) (NP (NP (JJ equivalent)) (CC or) (NP (JJR better)) (NP (NNS levels))))))))) (PP (IN than) (NP (NP (NN ZEBRA)) (NP (PRP itself)))) (. .))))
(S1 (S (S (S (NP (NN Activation)) (VP (VBD was) (RB not) (ADJP (ADJP (NP (NN target-))) (CC or) (ADJP (NP (NN cell-type))) (ADJP (JJ dependent))))) (, ,) (CC nor) (SINV (VBD was) (NP (PRP it)) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN virus))))))) (. .))))
(S1 (S (S (NP (DT These) (NN activation) (NNS domains)) (VP (VBD restored) (NP (NP (NP (NN ZEBRA)) (POS 's) (NN ability)) (S (VP (VP (TO to) (VP (VB induce) (NP (JJ early) (NN antigen)))) (CC and) (VP (TO to) (VP (VB stimulate) (NP (NN origin) (NN replication)) (PP (TO to) (NP (NP (NNS levels)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (ADJP (JJ equal) (PP (TO to))) (CC or) (ADJP (ADJP (JJR greater)) (PP (IN than))) (NP (NP (DT those)) (PP (IN of) (NP (JJ wild) (NN type)))))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NNS specificities)) (PP (IN of) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ known) (JJ biological) (NNS functions)) (PP (IN of) (NP (NN ZEBRA)))))))) (VP (VBP are) (RB not) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (NP (DT the) (NN activation) (NN domain)) (ADJP (JJ present) (PP (IN within) (NP (NN ZEBRA))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NP (NP (NN Activation)) (CC and) (NP (NN expression))) (PP (IN of) (NP (NP (NP (DT the) (NP (JJ nuclear) (NNS factors))) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (, ,) (NP (NP (NN NFATp)) (CC and) (NP (NN NFATc)))))) (, ,) (PP (IN in) (NP (JJ human) (JJ natural) (NN killer) (NNS cells))) (: :)) (NP (NP (NN regulation)) (PP (IN upon) (NP (NP (NN CD16)) (NN ligand) (NN binding)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ putative) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP couple) (NP (NP (DT the) (NN signal) (NN transduction)) (PP (IN from) (NP (NN surface) (NNS receptors))) (PP (TO to) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN cytokine)) (NN synthesis)))))) (PP (IN in) (NP (JJ natural) (NN killer) (-LRB- -LRB-) (NN NK) (-RRB- -RRB-) (NNS cells))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN elucidated)))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBP report) (ADVP (RB here)) (SBAR (IN that) (S (NP (NP (NP (NP (DT the) (NP (JJ nuclear) (NN factor))) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NFATp)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NN cyclosporin) (NN A) (-LRB- -LRB-) (NN CsA) (-RRB- -RRB-) (JJ -sensitive) (NN factor))) (SBAR (WHNP (WDT that)) (S (VP (VBZ regulates) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (JJ several) (NP (NNS cytokines))))))))) (, ,)) (VP (VBZ mediates) (NP (NP (JJ CD16-induced) (NN activation)) (PP (IN of) (NP (NN cytokine) (NNS genes))) (PP (IN in) (NP (JJ human) (NN NK) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (NN CD16)) (PRN (-LRB- -LRB-) (NP (NN Fc) (NN gamma) (NN RIIIA)) (-RRB- -RRB-))) (JJ -induced) (NN expression)) (PP (IN of) (NP (NN cytokine) (NN mRNA))) (PP (IN in) (NP (NN NK) (NNS cells)))) (VP (VBZ occurs) (PP (IN via) (NP (DT a) (ADJP (ADJP (JJ CsA-sensitive)) (CC and) (ADJP (JJ Ca-LRB-2+-RRB--dependent))) (NN mechanism)))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NN NK) (NNS cells))) (PP (IN with) (NP (NP (NN CD16)) (NNS ligands)))) (VP (VBZ induces) (NP (JJ NFAT-like) (NN DNA) (NN binding) (NN activity)) (PP (IN in) (NP (NP (DT the) (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (DT these) (NNS cells))))) (, ,) (SBAR (IN as) (S (VP (VBN detected) (PP (IN in) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ occurs) (PP (IN with) (NP (JJ fast) (NNS kinetics))) (PP (IN after) (NP (NN stimulation))) (, ,) (PP (IN via) (NP (NP (DT a) (ADJP (ADJP (JJ CsA-sensitive)) (CC and) (ADJP (JJ Ca-LRB-2+-RRB--dependent))) (NN mechanism)) (SBAR (WHNP (WDT that)) (S (VP (VBZ does) (RB not) (VP (VB require) (NP (ADJP (FW de) (FW novo)) (NN protein) (NN synthesis))))))))) (. .))))
(S1 (S (S (NP (NN NK) (NN cell) (NN NFAT)) (VP (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (NN cytosol)) (PP (IN of) (NP (JJ nonstimulated) (NNS cells))))))) (, ,) (VP (VBZ migrates) (PP (TO to) (NP (DT the) (NN nucleus))) (PP (IN upon) (NP (NN stimulation)))) (, ,) (CC and) (VP (MD can) (VP (VB associate) (PP (IN with) (NP (NN AP-1)))))) (. .))))
(S1 (S (S (NP (NP (CD Two) (JJ distinct) (NNS molecules)) (, ,) (NP (NP (NN NFATp)) (CC and) (NP (NN NFATc))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB mediate) (NP (NP (NN NFAT)) (NN activity)))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NN supershift) (NNS assays)) (VP (VBG using) (NP (NP (NN NFATp-)) (CC and) (NP (JJ NFATc-specific)) (NP (NNS antibodies))))))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN NK) (NN cell) (NN activation)) (ADVP (RB early)) (PP (IN after) (NP (NP (NN CD16)) (NN ligand) (NN binding)))) (VP (VBZ involves) (ADVP (ADVP (RB primarily)) (, ,) (CONJP (IN if) (RB not)) (ADVP (RB exclusively))) (, ,) (NP (NN NFATp))))))) (, ,) (CC and) (S (NP (NN Western) (NN blot) (NN analysis)) (VP (VBZ shows) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ has) (NP (NP (NP (DT the) (JJ same) (JJ electrophoretic) (NN mobility)) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 120)) (NN kD)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT that)) (PP (IN of) (NP (NN T) (NNS lymphocytes))))))))))) (. .))))
(S1 (S (S (S (NP (NN NK) (NNS cells)) (VP (VBP do) (RB not) (VP (VB express) (NP (NN NFATc)) (ADVP (RB constitutively))))) (, ,) (CC but) (S (NP (NP (NN NFATc) (NN mRNA)) (NN accumulation)) (VP (VBZ is) (VP (VBN induced) (PP (IN in) (NP (DT these) (NNS cells))) (PP (IN within) (NP (NP (CD 2) (NN h)) (PP (IN of) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN CD16) (NNS ligands)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN supershift) (NNS assays)) (VP (VBG using) (NP (NP (DT the) (JJ available) (NP (NN mAb))) (VP (VBG recognizing) (NP (DT the) (NP (NN T) (NN cell) (NN NFATc))))))) (VP (VBD revealed) (NP (DT no) (JJ detectable) (NP (NN NFATc)) (NN protein)) (PP (IN in) (NP (NP (NP (JJ nuclear)) (CC and) (NP (JJ cytoplasmic)) (NP (NNS extracts))) (PP (IN from) (NP (NP (NN CD16-)) (CC or) (NP (NN phorbol) (JJ ester-stimulated) (NNS cells)))))) (PP (IN at) (NP (NP (NP (DT any) (NN time)) (VP (VBN tested))) (, ,) (NP (NP (QP (RB up) (TO to) (CD 4)) (NN h)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (DT the) (JJ first) (JJ direct) (NN evidence) (SBAR (SBAR (IN that) (S (NP (NP (DT both) (NP (JJ CsA-sensitive) (NN transcription) (NNS factors))) (, ,) (NP (NP (NN NFATp)) (CC and) (NP (NN NFATc))) (, ,)) (VP (VBP are) (VP (VBN expressed) (PP (IN in) (NP (JJ human) (NP (NN NK) (NNS cells)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PRP$ their) (NP (NN activation)) (CC and/or) (NP (NN expression))) (VP (MD can) (VP (VB be) (VP (VBN regulated) (PP (IN in) (NP (JJ primary) (NNS cells))) (PP (IN by) (NP (NP (DT a) (JJ single) (NN stimulus)) (, ,) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (NN CD16)) (PP (IN in) (NP (NN NK) (NNS cells))))))) (, ,) (VP (VBZ results) (PP (IN in) (NP (NP (NP (JJ early) (NN activation)) (PP (IN of) (NP (NN NFATp)))) (CC and) (NP (NP (ADJP (RB subsequently) (VBN induced)) (NN expression)) (PP (IN of) (NP (NN NFATc) (NN mRNA))))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NP (NN HIV-1) (NN enhancer)))) (PP (IN by) (NP (NP (DT the) (NP (NN LEF-1) (NN HMG) (NN protein))) (PP (IN on) (NP (NP (JJ nucleosome-assembled) (NN DNA)) (ADVP (FW in) (FW vitro)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Lymphoid) (JJ enhancer-binding) (NN factor) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN LEF-1)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NP (JJ regulatory) (JJ high) (NN mobility) (NN group) (-LRB- -LRB-) (NN HMG) (-RRB- -RRB-) (NN protein))) (SBAR (WHNP (WDT that)) (S (VP (VBZ activates) (NP (DT the) (NP (NN T) (NN cell) (NN receptor) (NN alpha) (-LRB- -LRB-) (NN TCR) (NN alpha) (-RRB- -RRB-) (NN enhancer))) (PP (IN in) (NP (DT a) (JJ context-restricted) (NN manner))) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NP (DT the) (JJ distal) (NN region)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN immunodeficiency) (NN virus-1) (-LRB- -LRB-) (NN HIV-1) (-RRB- -RRB-) (NN enhancer))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ contains) (NP (NP (JJ DNA-binding) (NNS sites)) (PP (IN for) (NP (NP (NN LEF-1)) (CC and) (NP (NN Ets-1)))))))) (, ,)) (ADVP (RB also)) (VP (VBZ provides) (NP (NP (DT a) (JJ functional) (NN context)) (PP (IN for) (NP (NP (NN activation)) (PP (IN by) (NP (NN LEF-1)))))))))) (. .))))
(S1 (S (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NP (NNS mutations)) (PP (IN in) (NP (DT the) (NP (JJ LEF-1-binding) (NN site))))) (VP (VBP inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (JJ multimerized) (NNS copies)) (PP (IN of) (NP (DT the) (NP (NN HIV-1) (NN enhancer))))))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NN LEF-1/GAL4)) (VP (MD can) (VP (VB activate) (NP (DT a) (NP (JJ GAL4-substituted) (NN HIV-1) (NN enhancer))) (NP (NP (CD 80-)) (PP (TO to) (NP (RB 100-fold)))) (ADVP (FW in) (FW vivo)))))))) (. .))))
(S1 (S (S (ADVP (RB Second)) (, ,) (NP (JJ recombinant) (NN LEF-1)) (VP (VBZ is) (VP (VBN shown) (S (VP (TO to) (VP (VB activate) (NP (NP (NN HIV-1) (NN transcription)) (PP (IN on) (NP (JJ chromatin-assembled) (NN DNA)))) (ADVP (FW in) (FW vitro))))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG using) (NP (NP (DT a) (JJ nucleosome-assembly) (NN system)) (VP (VBN derived) (PP (IN from) (NP (FW Drosophila) (NNS embryos)))))))) (, ,) (NP (PRP we)) (VP (VBP find) (SBAR (SBAR (IN that) (S (NP (NP (NP (DT the) (NN packaging)) (PP (IN of) (NP (NN DNA))) (PP (IN into) (NP (NN chromatin)))) (ADVP (FW in) (FW vitro))) (ADVP (RB strongly)) (VP (VBZ represses) (NP (NN HIV-1) (NN transcription))))) (CC and) (SBAR (IN that) (S (NP (NN repression)) (VP (MD can) (VP (VB be) (VP (VBN counteracted) (ADVP (RB efficiently)) (PP (IN by) (NP (NP (NN preincubation)) (PP (IN of) (NP (DT the) (NN DNA))) (PP (IN with) (NP (NP (NP (NN LEF-1)) (PRN (-LRB- -LRB-) (CC or) (NP (NP (NN LEF-1)) (CC and) (NP (NN Ets-1))) (-RRB- -RRB-))) (VP (VBN supplemented) (PP (IN with) (NP (NP (NNS fractions)) (VP (VBG containing) (NP (DT the) (NP (NP (JJ promoter-binding) (NN protein)) (, ,) (NP (NN Sp1))))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (NP (NN TFE-3)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ binds) (PP (TO to) (NP (DT an) (NP (NN E-box) (NN motif)) (ADVP (JJ upstream) (PP (IN of) (NP (DT the) (NP (NN LEF-1)) (CC and) (NP (NN Ets-1)) (NP (NNS sites)))))))))))) (, ,)) (ADVP (RB further)) (VP (VBZ augments) (NP (NP (NN transcription)) (PP (IN in) (NP (DT this) (NN system))))) (. .))))
(S1 (S (S (ADVP (ADVP (RB Individually)) (CC or) (ADVP (RB collectively))) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (NP (DT the) (CD three) (NP (JJ enhancer-binding) (NNS proteins))) (PRN (-LRB- -LRB-) (NP (NP (NN LEF-1)) (, ,) (NP (NN Ets-1)) (, ,) (CC and) (NP (NN TFE-3))) (-RRB- -RRB-))))) (VP (MD could) (VP (VB activate) (NP (NN transcription)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN Sp1))))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (DT A) (NP (NN truncation) (NN mutant))) (PP (IN of) (NP (NN LEF-1)))) (PRN (-LRB- -LRB-) (NP (CD HMG-88)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ contains) (NP (DT the) (NP (NN HMG) (NN box)))) (CC but) (VP (VBZ lacks) (NP (DT the) (NP (JJ trans-activation) (NN domain))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN from) (NP (JJ nucleosomal) (NN DNA))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN bending)) (PP (IN of) (NP (NN DNA))) (PP (IN by) (NP (DT the) (NP (NN HMG) (NN domain))))) (VP (VBZ is) (RB not) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB activate) (NP (NN transcription)) (ADVP (FW in) (FW vitro))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NP (NN transcription) (NN activation)) (PP (IN by) (NP (NN LEF-1)))) (ADVP (FW in) (FW vitro))) (VP (VBZ is) (NP (NP (DT a) (JJ chromatin-dependent) (NN process)) (SBAR (WHNP (WDT that)) (S (VP (VBZ requires) (NP (DT a) (JJ functional) (NP (NN trans-activation) (NN domain))) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (DT the) (NP (NN HMG) (NN domain)))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN TCL1) (NN oncogene) (NN activation)) (PP (IN in) (NP (NP (JJ preleukemic) (NN T) (NNS cells)) (PP (IN from) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN ataxia-telangiectasia))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN TCL1) (NN oncogene))) (PP (IN on) (NP (NP (JJ human) (NN chromosome)) (NP (NN 14q32.1))))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN chromosome) (NP (NP (NNS translocations)) (PRN (-LRB- -LSB-) (NP (NP (NN t-LRB-14;14-RRB--LRB-q11;q32.1-RRB-)) (CC and) (NP (NN t-LRB-7;14-RRB--LRB-q35;q32.1-RRB-))) (-RRB- -RSB-))) (CC and) (NP (NP (NP (NNS inversions)) (PRN (-LRB- -LSB-) (NP (NN inv14-LRB-q11;q32.1-RRB-)) (-RRB- -RSB-))) (PP (IN with) (NP (NP (NN TCR) (NN alpha/beta) (NNS loci)) (PP (IN in) (NP (NP (NN T-cell) (NNS leukemias)) (, ,) (PP (JJ such) (IN as) (NP (NP (ADJP (JJ T-prolymphocytic))) (PRN (-LRB- -LRB-) (NP (NN T-PLL)) (-RRB- -RRB-))))))))))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN involved) (PP (IN in) (NP (NP (NP (JJ T-acute)) (CC and) (NP (JJ -chronic)) (NP (NNS leukemias))) (VP (VBG arising) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (NP (NN ataxia-telangiectasia)) (PRN (-LRB- -LRB-) (NP (NN AT)) (-RRB- -RRB-))) (, ,) (NP (DT an) (NN immunodeficiency) (NN syndrome))))))))))) (. .))))
(S1 (S (S (NP (JJ Similar) (JJ chromosomal) (NNS rearrangements)) (VP (VBP occur) (ADVP (RB also)) (PP (IN in) (NP (NP (DT the) (ADJP (RB clonally) (VBN expanded)) (NP (NN T) (NNS cells))) (PP (IN in) (NP (NN AT) (NNS patients))))) (PP (IN before) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT the) (JJ overt) (NN leukemia)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN analyzed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN TCL1) (NN mRNA)) (CC and) (NP (NN protein))))) (PP (IN in) (NP (NP (NP (JJ peripheral) (NN blood) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NNS PBLs)) (-RRB- -RRB-))) (PP (PP (IN from) (NP (CD four) (NN AT) (NNS cases))) (CC and) (PP (IN from) (NP (JJ healthy) (NNS controls)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (DT the) (NP (NN TCL1) (NN gene))) (VP (VBD was) (VP (VBN overexpressed) (PP (PP (IN in) (NP (NP (DT the) (NP (NNS PBLs))) (PP (IN of) (NP (NP (DT an) (NN AT) (NN patient)) (PP (IN with) (NP (NP (DT a) (NP (JJ large) (JJ clonal) (NN T-cell) (NN population))) (VP (VBG exhibiting) (NP (DT the) (NN t-LRB-14;14-RRB-) (NN translocation))))))))) (CC but) (PP (RB not) (IN in) (NP (NP (DT the) (NP (NNS lymphocytes))) (PP (IN of) (NP (DT the) (JJ other) (NNS cases))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Fluorescence) (ADJP (FW in) (FW situ)) (NN hybridization)) (PP (IN of) (NP (DT the) (NP (NN TCL1) (JJ genomic) (NN locus)))) (PP (TO to) (NP (NP (NN lymphocyte) (NNS metaphases)) (PP (IN from) (NP (NP (DT the) (NN AT) (NN patient)) (PP (IN with) (NP (DT the) (NN T-cell) (JJ clonal) (NN expansion)))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN breakpoint)) (PP (IN of) (NP (DT the) (NN t-LRB-14;14-RRB-) (NN translocation)))) (VP (VP (VBZ lies) (PP (IN within) (NP (DT the) (NP (NN TCL1) (NN locus))))) (CC and) (VP (VBZ is) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT an) (VBN inverted) (NN duplication)) (PP (IN of) (NP (NP (DT the) (NP (JJ distal) (NN part))) (PP (IN of) (NP (NN chromosome) (CD 14))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN TCL1)) (VP (VBZ is) (VP (VBN activated) (PP (IN in) (NP (JJ preleukemic) (JJ clonal) (NNS cells))) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (NN chromosome) (NN translocation)) (VP (NN involving) (NP (NP (NNS sequences)) (PP (IN from) (NP (NP (DT the) (NP (NN TCR) (NN locus))) (PP (IN at) (NP (NN 14q11)))))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Deregulation)) (PP (IN of) (NP (NN TCL1)))) (VP (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN event)) (PP (IN in) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN malignancy)))))) (PP (IN in) (NP (NP (DT these) (NNS types)) (PP (IN of) (NP (NNS leukemias)))))) (CC and) (VP (VBZ represents) (NP (NP (DT a) (JJ potential) (NN tool)) (PP (IN for) (NP (JJ clinical) (NN evaluation)))))) (. .))))
(S1 (S (NP (NP (NP (JJ Ubiquitin-mediated) (NN processing)) (PP (IN of) (NP (NP (NP (NN NF-kappa) (NN B)) (NP (JJ transcriptional) (NN activator) (NN precursor))) (NP (NN p105)))) (. .)))))
(S1 (S (NP (NP (NP (NN Reconstitution)) (PP (IN of) (NP (DT a) (JJ cell-free) (NN system)))) (CC and) (NP (NP (NN identification)) (PP (IN of) (NP (NP (NP (DT the) (NP (NP (JJ ubiquitin-carrier) (NN protein)) (, ,) (NP (NN E2)))) (, ,) (CC and) (NP (DT a) (JJ novel) (NP (JJ ubiquitin-protein) (NN ligase))) (, ,) (NP (NN E3))) (, ,) (VP (VBN involved) (PP (IN in) (NP (NN conjugation))))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (JJS most) (NNS cases))) (, ,) (NP (NP (DT the) (NP (JJ transcriptional) (NN factor))) (NP (NN NF-kappa) (NN B))) (VP (VBZ is) (NP (NP (DT a) (NP (NN heterodimer))) (VP (VBG consisting) (PP (IN of) (NP (NP (NP (CD two) (NNS subunits)) (, ,) (NP (NP (NN p50)) (CC and) (NP (NN p65)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN encoded) (PP (IN by) (NP (NP (CD two) (JJ distinct) (NNS genes)) (PP (IN of) (NP (DT the) (NP (NN Rel) (NN family))))))))))))))) (. .)))))
(S1 (S (S (NP (NN p50)) (VP (VBZ is) (VP (VBN translated) (PP (IN as) (NP (NP (DT a) (NN precursor)) (PP (IN of) (NP (CD 105) (NN kDa))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (JJ C-terminal) (NN domain))) (PP (IN of) (NP (DT the) (NN precursor)))) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN degraded)) (, ,) (S (VP (VBG forming) (NP (NP (DT the) (NP (JJ mature) (NN p50) (NN subunit))) (VP (VBN consisted) (PP (IN of) (NP (NP (DT the) (NP (JJ N-terminal) (NN region))) (PP (IN of) (NP (DT the) (NN molecule)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NP (NN generation)) (PP (IN of) (NP (NN p50)))))) (VP (VBZ is) (RB not) (VP (VBN known))) (. .))))
(S1 (S (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT the) (JJ ubiquitin-proteasome) (NN system)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (DT the) (NN process))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (NP (DT the) (JJ specific) (NP (NNS enzymes))) (VP (VBN involved))) (CC and) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (JJ limited) (NN proteolysis)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (NN half)) (PP (IN of) (NP (DT the) (NN molecule)))) (VP (VBZ is) (VP (VBN spared)))))))) (, ,)) (VP (VBP have) (VP (VBN been) (ADJP (JJ obscure))))) (. .))))
(S1 (S (S (NP (NP (NP (NNP Palombella)) (CC and) (NP (NNS colleagues))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Palombella) (, ,) (NNP V.J.)) (, ,) (NP (NNP Rando) (, ,) (NNP O.J.)) (, ,) (NP (NNP Goldberg) (, ,) (NNP A.L.)) (, ,) (CC and) (NP (NNP Maniatis) (, ,) (NNP T.))) (PRN (-LRB- -LRB-) (NP (CD 1994)) (-RRB- -RRB-)) (NP (NNP Cell) (CD 78)) (, ,) (NP (CD 773-785))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN ubiquitin)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN processing)) (PP (IN in) (NP (NP (DT a) (JJ cell-free) (NN system)) (PP (IN of) (NP (DT a) (ADJP (ADJP (VBN truncated)) (, ,) (ADJP (RB artificially) (VBN constructed))) (, ,) (NP (JJ 60-kDa) (NN precursor)))))))))))))) (. .))))
(S1 (S (S (NP (PRP They)) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN proteasome)) (NNS inhibitors)) (VP (VBP block) (NP (DT the) (NN processing)) (ADVP (CC both) (ADVP (FW in) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VP (VBP demonstrate) (NP (NP (NN reconstitution)) (PP (IN of) (NP (DT a) (JJ cell-free) (NN processing) (NN system))))) (CC and) (VP (VBP demonstrate) (ADVP (RB directly)) (SBAR (IN that) (S (: :) (S (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (DT the) (JJ ubiquitin-proteasome) (NN system)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (NN processing)) (PP (IN of) (NP (DT the) (JJ intact) (NP (NN p105)) (NN precursor)))))))) (, ,) (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (NN conjugation)) (PP (IN of) (NP (NN ubiquitin))) (PP (TO to) (NP (DT the) (NN precursor)))) (VP (VBZ is) (NP (DT an) (JJ essential) (JJ intermediate) (NN step)) (PP (IN in) (NP (DT the) (NN processing))))) (, ,) (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NP (NP (NP (DT the) (ADJP (RB recently) (VBN discovered) (JJ novel)) (NNS species)) (PP (IN of) (NP (DT the) (NP (JJ ubiquitin-carrier) (NN protein))))) (, ,) (NP (NN E2-F1))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NP (NN conjugation)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NN p53))))))))) (, ,)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (JJ limited) (NN processing)) (PP (IN of) (NP (DT the) (NP (NN p105) (NN precursor))))))))) (, ,) (CC and) (S (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (NP (NP (DT a) (JJ novel) (, ,) (RB approximately) (NP (CD 320-kDa) (NNS species))) (PP (IN of) (NP (JJ ubiquitin-protein) (NN ligase))) (, ,)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (DT the) (NN process)))))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ novel) (NN enzyme)) (VP (VBZ is) (ADJP (JJ distinct) (PP (PP (IN from) (NP (NP (NN E6-AP)) (, ,) (NP (DT the) (NP (NN p53-conjugating) (NN ligase))))) (, ,) (CC and) (PP (IN from) (NP (NP (NN E3) (NN alpha)) (, ,) (NP (DT the) (NP (`` ``) (JJ N-end) (NN rule) (NN ligase)))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NP (JJ hematopoietic) (NN transcription) (NN factor))) (NP (NN PU.1))) (VP (VBZ is) (VP (VBN downregulated) (PP (IN in) (NP (JJ human) (JJ multiple) (NN myeloma) (NN cell) (NNS lines))))) (. .)))))
(S1 (S (S (S (NP (NN PU.1)) (VP (VBZ is) (NP (NP (DT a) (NP (JJ hematopoietic) (NN transcription) (NN factor))) (VP (VBG belonging) (PP (TO to) (NP (DT the) (NP (NN Ets-family))))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ identical) (PP (TO to) (NP (NP (DT the) (NP (NN Spi-1) (NN oncogene))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN implicated) (PP (IN in) (NP (ADJP (ADJP (NN spleen) (JJ focus-forming)) (ADJP (JJ virus-induced)) (ADJP (JJ murine))) (NNS erythroleukemias))))))))))) (. .))))
(S1 (S (S (S (NP (NN PU.1)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (VBN required) (PP (IN for) (NP (NP (JJ early) (NN development)) (PP (IN of) (NP (JJ multiple) (JJ hematopoietic) (NNS lineages))))))))))) (, ,) (CC but) (S (NP (NP (PRP$ its) (NN expression)) (PP (IN in) (NP (JJ mature) (NNS cells)))) (VP (VBZ is) (ADVP (RB preferentially)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NP (NN B-cell-and) (NN monocyte/macrophage-differentiation) (NN lineage))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ binds) (NP (NP (DT the) (JJ so-called) (NP (NN Pu) (NN box))) (, ,) (NP (NP (DT an) (JJ important) (NP (JJ tissue-specific) (JJ regulatory) (NN DNA) (NN element))) (ADJP (JJ present) (PP (IN in) (NP (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS genes)))) (VP (VBN expressed) (PP (IN in) (NP (DT these) (NP (NN cell) (NNS lineages))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN analyzed) (NP (NP (DT the) (NP (NN expression)) (CC and) (NP (NN activity))) (PP (IN of) (NP (NN PU.1))) (PP (IN during) (NP (JJ human) (NN B-cell) (NN development))))) (S (VP (VBG using) (NP (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (NN B-cell) (NNS lines)))) (VP (VBG representing) (NP (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NN maturation)))) (, ,) (PP (IN from) (NP (JJ early) (NNS precursors))) (PP (TO to) (NP (VBN differentiated) (NN plasma) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (NN PU.1) (NN mRNA)) (NN expression)) (CC and) (NP (NP (NN PU.1)) (NN DNA) (NN binding) (NN activity))) (, ,)) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN Northern) (NN blot) (NN analysis)) (CC and) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))) (, ,) (ADVP (RB respectively))))) (, ,) (VP (VBD were) (ADJP (JJ evident) (PP (IN in) (NP (NP (NN cell) (NNS lines)) (VP (VBG representing) (NP (NP (JJ pro-B)) (, ,) (NP (JJ pre-B)) (, ,) (CC and) (NP (JJ mature) (NN B)) (NP (NNS cells)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (MD could) (ADVP (RB also)) (VP (VB show) (NP (NP (NN Pu) (JJ box-dependent) (NN transactivation)) (PP (IN of) (NP (DT a) (NN reporter) (NN gene))) (PP (IN in) (NP (NP (JJ transient) (NNS transfections)) (PP (IN in) (NP (DT these) (NP (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (PP (IN in) (NP (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ multiple) (NN myeloma) (NN cell) (NNS lines)))) (, ,) (VP (VBG representing) (NP (VBN differentiated) (, ,) (NN plasma) (JJ cell-like) (NN B) (NNS cells))))) (, ,) (NP (NP (NP (NN PU.1)) (NN DNA) (NN binding) (NN activity)) (, ,) (NP (NN mRNA) (NN expression)) (, ,) (CC and) (NP (NN Pu) (JJ box-dependent) (NN transactivation))) (VP (VBD were) (ADJP (ADJP (JJ absent)) (CC or) (ADJP (JJ detectable) (PP (IN at) (NP (DT a) (ADJP (RB very) (JJ low)) (NN level)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (JJ lymphoblastoid) (NN cell) (NNS lines)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP exemplify) (NP (NP (DT an) (JJ intermediate) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation))))))))) (, ,) (NP (DT a) (VBN reduced) (NP (NP (NN expression)) (CC and) (NP (NN activity)))) (VP (VBD were) (VP (VBN observed))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS findings)) (PP (IN in) (NP (DT the) (NP (JJ human) (JJ multiple) (NN myeloma) (NN cell) (NNS lines))))) (VP (VP (VBP represent) (NP (NP (DT the) (JJ first) (NNS examples)) (PP (IN of) (NP (NP (NN B) (NNS cells)) (PP (IN with) (NP (VBN downregulated) (NP (NN PU.1)) (NN expression))))))) (CC and) (ADVP (RB apparently)) (VP (VBP contradict) (NP (NP (NP (NNS observations)) (PP (IN in) (NP (DT the) (JJ murine) (NN system)))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN PU.1)) (VP (VBZ is) (UCP (VP (VBN expressed)) (CC and) (ADJP (JJ active))) (PP (IN in) (NP (NN plasmacytoma) (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (JJ present))) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN PU.1)) (NP (NN expression)) (CC and) (NP (NN activity)))) (PP (IN in) (NP (JJ human) (JJ multiple) (NN myeloma) (NN cell) (NNS lines)))) (VP (VP (VBZ represents) (NP (NP (DT a) (JJ malignancy-associated) (NN defect)) (PP (IN in) (NP (DT these) (NNS cells))))) (CC or) (VP (VBZ exemplifies) (NP (NP (DT a) (JJ normal) (JJ developmental) (NN regulation)) (PP (IN in) (NP (RB terminally) (VBN differentiated) (NN B) (NNS cells))))))))) (. .))))
(S1 (S (S (S (NP (NNS Microtubules)) (VP (VBP mediate) (NP (NP (JJ cellular) (NN 25-hydroxyvitamin) (NN D3) (NN trafficking)) (CC and) (NP (NP (DT the) (JJ genomic) (NN response)) (PP (TO to) (NP (NN 1,25-dihydroxyvitamin) (NN D3))))) (PP (IN in) (NP (JJ normal) (NP (JJ human) (NNS monocytes))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ genomic) (NNS actions)) (PP (IN of) (NP (NP (NN 1,25-dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LRB-) (NP (NN 1,25-LRB-OH-RRB-2D3)) (-RRB- -RRB-))))) (VP (VBP are) (VP (VBN mediated) (PP (IN by) (NP (DT the) (JJ intracellular) (NP (NP (NN vitamin) (NN D) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-))))))) (. .)))))
(S1 (S (S (SBAR (IN Although) (S (NP (NN immunocytochemistry)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN disruption)) (PP (IN of) (NP (JJ microtubular) (NN assembly)))) (VP (VBZ prevents) (NP (NP (JJ nuclear) (NN access)) (PP (IN of) (NP (DT the) (NP (NN sterol-VDR) (NN complex)))))))))))) (, ,) (S (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNS microtubules))) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN 1,25-LRB-OH-RRB-2D3)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (JJ viable) (NNS cells))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBD examined) (NP (NP (DT this) (NN interaction)) (PP (IN in) (NP (JJ normal) (NP (JJ human) (NNS monocytes)))))) (. .))))
(S1 (S (S (NP (NNS Monocytes)) (VP (VBP convert) (NP (NN 25-LRB-OH-RRB-D3)) (PP (PP (TO to) (NP (NN 1,25-LRB-OH-RRB-2D3))) (CC and) (PP (TO to) (NP (NP (JJ 24-hydroxylated) (NNS metabolites)) (ADJP (ADJP (RBR more) (JJ polar)) (PP (IN than) (NP (NN 1,25-LRB-OH-RRB-2D3)))))))) (. .))))
(S1 (S (S (NP (NN Microtubule) (NN disruption)) (ADVP (RB totally)) (VP (VBD abolished) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ exogenous) (NN 1,25-LRB-OH-RRB-2D3))) (S (VP (VP (TO to) (VP (VB suppress) (NP (PRP$ its) (JJ own) (NN synthesis)))) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (NN 24-hydroxylase) (NN mRNA)) (CC and) (NP (NN activity)))))))) (, ,) (PP (IN without) (S (VP (VBG affecting) (NP (CC either) (NP (JJ total) (NN 1,25-LRB-OH-RRB-2D3) (NN uptake)) (CC or) (NP (JJ maximal) (JJ 1,25-LRB-OH-RRB-2D3-VDR) (NN binding))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (JJ intact) (NP (NNS microtubules))) (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (NP (JJ 1,25-LRB-OH-RRB-2D3-dependent) (NN modulation)) (PP (IN of) (NP (NN gene) (NN transcription))))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NN microtubule)) (NN disruption)) (ADVP (RB also)) (VP (VBD decreased) (NP (NP (NN monocyte)) (NN 1,25-LRB-OH-RRB-2D3) (NN synthesis)) (, ,) (PP (RB not) (PP (IN by) (S (VP (VBG decreasing) (NP (NP (DT the) (NN Vmax)) (PP (IN of) (NP (NN monocyte) (JJ mitochondrial) (CD 1) (NN alpha-hydroxylase))))))) (CC but) (PP (IN through) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN Km)) (PP (IN for) (NP (NN 25-LRB-OH-RRB-2D3))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (NP (NN 25-LRB-OH-RRB-D3) (NN transport))) (. .))))
(S1 (S (S (NP (NN Microtubule) (NN disruption)) (VP (VP (VBD did) (RB not) (VP (VB affect) (NP (JJ total) (JJ cellular) (NN 25-LRB-OH-RRB-D3) (NN uptake)))) (CC but) (VP (VBD reduced) (NP (NP (PRP$ its) (JJ intracellular) (NN trafficking)) (PP (TO to) (NP (DT the) (NN mitochondria)))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (S (S (NP (NNS microtubules)) (VP (VBP participate) (PP (IN in) (NP (JJ intracellular) (NN 25-LRB-OH-RRB-D3) (NN transport))))) (, ,) (CC and) (S (NP (PRP$ their) (NN integrity)) (VP (VBZ determines) (NP (JJ normal) (NN 1,25-LRB-OH-RRB-2D3) (NN synthesis))))) (. .))))
(S1 (S (NP (NP (NP (JJ Functional) (NN characterization)) (PP (IN of) (NP (JJ novel) (NP (NN IL-2)) (JJ transcriptional) (NNS inhibitors))) (. .)))))
(S1 (S (S (S (NP (JJ IL-2-mediated) (NP (NN T) (NN cell)) (NN proliferation)) (VP (VBZ is) (NP (DT a) (ADJP (ADJP (JJ critical)) (ADJP (JJ early))) (NN event)) (PP (IN in) (NP (DT the) (JJ inflammatory) (NN process)))) (. .)))))
(S1 (S (S (NP (NP (NN Formation)) (PP (IN of) (NP (DT the) (NP (NN NFAT-1) (JJ transcriptional) (NN complex)))) (PP (IN on) (NP (DT the) (NP (NN IL-2) (NN promoter))))) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (NN IL-2)) (NN transcription))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (DT a) (NN cell) (NN line)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB stably)) (VP (VBN transfected) (PP (IN with) (NP (NP (DT a) (NN trimer)) (PP (IN of) (NP (NP (DT the) (NP (NN NFAT-1) (JJ regulatory) (NN element))) (VP (VBN linked) (PP (TO to) (NP (DT a) (NP (NN lac-Z) (NN reporter) (NN gene)))))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD screened) (PP (IN for) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (JJ NFAT-1-mediated) (NP (NN beta-galactosidase)) (NN activity))))))) (. .))))
(S1 (S (S (NP (NP (NN WIN) (CD 61058)) (CC and) (NP (NN WIN) (CD 53071))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (NN microM) (NNS inhibitors))))) (. .))))
(S1 (S (S (NP (DT These) (NNS compounds)) (ADVP (RB also)) (VP (VBD inhibited) (NP (NP (NN beta-galactosidase) (NN mRNA)) (NNS levels))) (. .))))
(S1 (S (S (NP (NP (JJ Similar) (NN inhibition)) (PP (IN of) (NP (JJ NFAT-1-mediated) (NN gene) (NN expression)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT a) (JJ second) (NP (NN cell) (NN line))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB stably)) (VP (VBN transfected) (PP (IN with) (NP (NP (NN NFAT-1) (JJ regulatory) (NNS elements)) (VP (VBN linked) (PP (TO to) (NP (DT the) (NP (NN reporter) (NN gene) (IN for) (NN sCD8))))))))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (CD 10) (NN microM))) (, ,) (NP (DT both) (NNS compounds)) (VP (VBD inhibited) (NP (NP (NN IL-2) (NN mRNA)) (CC and) (NP (NN protein)) (NP (NNS levels))) (PP (PP (IN in) (NP (DT the) (NP (JJ NFAT-1-linked) (NN lac-Z) (NNS transfectants)))) (, ,) (CC and) (PP (IN in) (NP (JJ human) (NNS lymphocytes))))) (. .))))
(S1 (S (S (S (NP (DT Both) (NNS compounds)) (VP (VBD inhibited) (NP (DT the) (JJ mixed) (NN lymphocyte) (NN reaction)))) (, ,) (CC and) (S (NP (DT this) (NN inhibition)) (VP (VBD was) (VP (VBN reversed) (PP (IN by) (NP (JJ exogenous) (NP (NN IL-2))))))) (. .))))
(S1 (S (S (NP (NN WIN) (CD 53071)) (VP (VBD inhibited) (NP (NP (NP (NN IL-2)) (NN production)) (VP (VBN induced) (PP (IN in) (NP (DT the) (ADJP (JJ calcium-dependent)) (NP (NN PMA)) (CC and) (NP (NN ionomycin)) (NP (NN pathway))))))) (. .))))
(S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (NP (NP (JJ calcium-independent) (JJ anti-CD28) (NN Ab)) (CC and) (NP (JJ PMA-induced) (NP (NN IL-2)))) (NN production)) (VP (VBD was) (ADJP (JJ resistant))) (. .))))
(S1 (S (S (NP (DT Both) (NNS compounds)) (VP (VBD altered) (NP (DT the) (NP (NN NFAT-1) (JJ transcriptional) (NN complex))) (, ,) (S (VP (VBG causing) (NP (NP (PRP$ its) (VBN retarded) (NN mobility)) (PP (IN on) (NP (NNS gels))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (DT these) (JJ functional) (NNS criteria))) (, ,) (NP (PRP we)) (VP (VBP believe) (NP (PRP we)) (VP (VBP have) (VP (VBN identified) (NP (NP (CD two) (ADJP (ADVP (RB structurally)) (ADJP (JJ distinct)) (, ,) (ADJP (JJ novel))) (NNS inhibitors)) (PP (IN of) (NP (JJ NFAT-1-mediated) (NN transcription))))))) (. .))))
(S1 (S (S (S (NP (JJ Platelet-activating) (NN factor)) (VP (VBZ stimulates) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NP (JJ heparin-binding) (JJ epidermal) (NN growth) (JJ factor-like) (NN growth) (NN factor)))) (PP (IN in) (NP (NNS monocytes))))) (. .)))))
(S1 (S (NP (NP (NN Correlation)) (PP (IN with) (NP (DT an) (VBN increased) (NN kappa) (NN B) (NN binding) (NN activity))) (. .))))
(S1 (S (S (S (NP (JJ Human) (JJ peripheral) (NN blood) (NP (NNS monocytes))) (VP (VBD responded) (PP (TO to) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (JJ platelet-activating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN PAF)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN up-regulation)) (PP (IN of) (NP (NP (DT the) (NN transcript)) (PP (IN for) (NP (NP (NP (JJ heparin-binding) (JJ epidermal) (NN growth) (JJ factor-like) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN HB-EGF)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (JJ potent) (NN mitogen))) (PP (IN for) (NP (JJ vascular) (JJ smooth) (NN muscle) (NNS cells))))))))))))) (. .)))))
(S1 (S (S (NP (NP (DT This) (NN function)) (PP (IN of) (NP (NN PAF)))) (VP (VBD was) (VP (VBN observed) (PP (IN at) (NP (NP (JJ nanomolar) (NNS concentrations)) (PP (IN of) (NP (DT the) (NN ligand)))))) (, ,) (S (VP (VBG starting) (PP (IN at) (NP (NP (CD 30) (NN min)) (PP (IN after) (NP (NN stimulation)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ PAF-induced) (NN up-regulation)) (PP (IN of) (NP (NN HB-EGF) (NN mRNA)))) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN kappa) (NN B) (NN binding) (NN activity))))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS functions)) (PP (IN of) (NP (NN PAF)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN through) (NP (DT the) (NP (NN cell) (NN surface) (NN PAF) (NNS receptors)))))))) (, ,) (SBAR (IN as) (S (NP (NP (CD two) (NP (NN PAF)) (NN receptor) (NNS antagonists)) (, ,) (NP (NP (NN WEB) (CD 2086)) (CC and) (NP (NN L-659) (, ,) (CD 989))) (, ,)) (VP (VBD blocked) (NP (NP (CC both) (NP (NP (DT the) (NN up-regulation)) (PP (IN of) (NP (NN HB-EGF) (NN mRNA)))) (CC and) (NP (NN kappa) (NN B) (NN binding) (NN activity))) (VP (VBN induced) (PP (IN by) (NP (NN PAF))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS antagonists) (, ,)) (ADVP (RB however)) (, ,) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN phorbol) (JJ ester-induced) (NN up-regulation)) (PP (IN of) (NP (NP (NN HB-EGF) (NN mRNA)) (CC and) (NP (NN kappa) (NN B) (NN binding) (NN activity))))))) (. .))))
(S1 (S (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NNS monocytes))) (PP (IN with) (NP (NN pertussis) (NN toxin)))) (VP (VBD inhibited) (NP (NP (DT these) (NNS functions)) (PP (IN of) (NP (NN PAF)))) (, ,) (SBAR (IN whereas) (S (NP (NN cholera) (NN toxin)) (VP (VBD had) (NP (DT no) (JJ inhibitory) (NN effect)))))) (. .))))
(S1 (S (S (NP (NP (NN Pyrrolidine) (NN dithiocarbamate)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN for) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))) (, ,)) (ADVP (RB markedly)) (VP (VBD reduced) (NP (NP (JJ PAF-stimulated) (NN kappa) (NN B) (NN binding) (NN activity)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN up-regulation)) (PP (IN of) (NP (NN HB-EGF) (NN mRNA)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP suggest) (NP (NP (DT a) (JJ potential) (NN role)) (PP (IN of) (NP (NN PAF))) (PP (IN in) (NP (NP (NN HB-EGF)) (NN expression))))) (CC and) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (DT this) (NN stimulation)) (VP (MD may) (VP (VB occur) (PP (IN through) (NP (VBN increased) (NN kappa) (NN B) (NN binding) (NN activity)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (NN IL-1) (NN receptor))) (CC and) (NP (NP (NN TCR))) (NP (NNS signals))) (VP (VBP synergize) (S (VP (TO to) (VP (VB activate) (NP (NN NF-kappa) (JJ B-mediated) (NN gene) (NN transcription)))))) (. .)))))
(S1 (S (S (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NP (NP (NN IL-1) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN IL-1R)) (-RRB- -RRB-))) (: -)) (CC and) (NP (JJ TCR-initiated) (NNS signals))) (VP (MD can) (VP (VB interact) (ADVP (RB synergistically))) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN transcription)) (PP (IN of) (NP (JJ several) (NP (NN lymphokine)) (CC and) (NP (NN lymphokine) (NN receptor)) (NP (NNS genes))))))) (PP (IN during) (NP (NP (DT the) (NN competence) (NN phase)) (PP (IN of) (NP (DT the) (NN activation) (NN program))) (PP (IN in) (NP (NN T) (NN helper) (NNS lymphocytes))))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (NP (PRP we)) (VP (VBP describe) (SBAR (WHADVP (WRB how)) (S (NP (NP (NNS signals)) (VP (VBN initiated) (PP (IN through) (NP (DT the) (NP (NN type) (CD I) (NN IL-1R)))))) (VP (VBP interact) (PP (IN with) (NP (NP (NNS signals)) (PP (IN from) (NP (DT the) (NN antigen) (NN receptor))))) (S (VP (TO to) (ADVP (RB synergistically)) (VP (VB augment) (NP (NP (DT the) (NN transactivating) (NNS properties)) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ synergistic) (NP (NN antigen) (NN receptor)) (JJ initiated) (NNS signals)) (VP (VP (VBP are) (VP (VBN mediated) (PP (IN through) (NP (NN protein) (NN kinase) (NN C)))) (SBAR (IN because) (S (NP (PRP they)) (VP (MD can) (VP (VB be) (VP (VBN mimicked) (PP (PP (IN by) (NP (NP (DT the) (NN phorbol) (NN ester)) (, ,) (NP (NN 12-O-tetradecanoylphorbol-13-acetate)))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NN calcium) (NNS ionophores)))))))))) (: ;) (CC and) (VP (VBP are) (ADJP (ADJP (NN staurosporine) (JJ sensitive)) (CC but) (ADJP (NN cyclosporine) (JJ resistant))))) (. .))))
(S1 (S (S (NP (NN Gel) (NN shift) (NNS analyses)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN NF-kappa) (NN B)) (JJ nuclear) (NN translocation)) (VP (VBZ is) (VP (VBN stimulated) (ADVP (RB primarily)) (PP (PP (IN by) (NP (NN IL-1))) (CONJP (RB rather) (IN than)) (PP (IN by) (NP (NP (NN antigen) (NN receptor)) (NNS signals))))))))) (. .))))
(S1 (S (S (NP (NP (NN Western) (NN blot)) (CC and) (NP (NN phosphorylation)) (NP (NNS analyses))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (JJ synergistic) (NN effect)) (PP (IN on) (NP (NP (NN NF-kappa) (NN B)) (JJ functional) (NN activity)))) (VP (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NP (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN MAD3)) (-RRB- -RRB-))) (NN -NF-kappa) (NN B) (NN dissociation)) (PP (IN in) (NP (DT the) (NN cytosol))))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NN I) (NN kappa) (NN B)) (JJ nuclear) (NN translocation))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ IL-1-induced) (NP (NN NF-kappa) (NN B)) (NN DNA) (JJ nuclear) (NN localization)) (VP (VP (VBZ is) (ADJP (JJ transient))) (CC and) (VP (MD can) (VP (VB be) (ADJP (JJ prolonged) (PP (CC either) (PP (IN by) (NP (DT an) (NN antigen) (JJ receptor-initiated) (NN signal))) (CC or) (PP (IN by) (S (VP (VBG inhibiting) (NP (NN protein) (NN synthesis)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN IL-1)) (VP (VBZ induces) (NP (CC both) (NP (NP (NN NF-kappa) (NN B)) (JJ nuclear) (NN translocation)) (CC and) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (DT a) (NN protein) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (ADJP (JJ responsible) (PP (IN for) (S (VP (VBG terminating) (NP (NP (NN NF-kappa) (NN B-DNA) (NN interaction)) (PP (IN in) (NP (DT the) (NN nucleus)))))))))))))))) (. .))))
(S1 (S (S (NP (NN Antigen) (NN receptor) (NNS signals)) (VP (VP (VBP prolong) (NP (NN NF-kappa) (NN B-DNA) (NN interaction)) (, ,) (ADVP (RB probably)) (PP (IN by) (S (ADVP (RB functionally)) (VP (VBG antagonizing) (NP (NP (DT the) (JJ IL-1-induced) (NN synthesis)) (PP (IN of) (NP (NP (DT a) (NN protein) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (JJ transient) (NN NF-kappa) (NN B-DNA) (NN interaction))))))))))) (CC and) (ADVP (RB consequently)) (ADVP (RB synergistically)) (VP (VBP enhance) (NP (JJ IL-1-induced) (NN NF-kappa) (JJ B-dependent) (NN gene) (NN transcription)))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Identification)) (CC and) (NP (NN purification))) (PP (IN of) (NP (NP (JJ human) (NN Stat) (NNS proteins)) (VP (VBN activated) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN interleukin-2)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (JJ key) (NP (NN cytokine))) (VP (VBN induced) (PP (IN during) (NP (DT the) (JJ immune) (NN response))))) (VP (VBZ is) (NP (NN IL-2))) (. .)))))
(S1 (S (S (PP (VBG Following) (NP (NN T) (NN cell) (NN activation))) (, ,) (NP (NP (DT the) (NNS genes)) (VP (VBG encoding) (NP (NP (NN IL-2)) (CC and) (NP (NP (DT the) (JJ various) (NNS chains)) (PP (IN of) (NP (PRP$ its) (NN receptor))))))) (VP (VBP are) (ADVP (RB transcriptionally)) (VP (VBN induced))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN turn))) (, ,) (NP (VBN secreted) (NP (NN IL-2))) (VP (VBZ serves) (S (VP (TO to) (VP (VB stimulate) (NP (NP (DT the) (NP (NN proliferation)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NN T) (NNS lymphocytes)))))))) (. .))))
(S1 (S (S (NP (JJ Several) (JJ recent) (NNS studies)) (VP (VBP have) (VP (VBN implicated) (NP (NP (NN Jak) (NNS kinases)) (PP (IN in) (NP (NP (DT the) (NN signaling) (NN pathway)) (VP (VBN induced) (PP (IN by) (NP (NN IL-2))))))))) (. .))))
(S1 (S (S (S (VP (VBG Following) (NP (DT this) (NN lead)))) (, ,) (S (NP (PRP we)) (VP (VBD set) (PRT (RP out)) (S (VP (TO to) (VP (VB identify) (NP (NP (NN transcription) (NNS factors)) (VP (VBN induced) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN IL-2)))))))))))) (. .))))
(S1 (S (S (NP (JJ Human) (JJ peripheral) (NN blood) (NNS lymphocytes)) (VP (VBD were) (VP (VBN observed) (S (VP (TO to) (VP (VB contain) (NP (JJ several) (JJ IL-2-inducible) (NN DNA) (NN binding) (NNS activities))))))) (. .))))
(S1 (S (S (NP (JJ Similar) (NNS activities)) (VP (VBD were) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NP (DT a) (NP (VBN transformed) (JJ human) (NN lymphocyte) (NN line))) (, ,) (VP (VBN termed) (S (NP (NN YT)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VP (VBN purified) (NP (DT these) (NNS activities))) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP (DT the) (JJ principal) (NP (JJ IL-2-inducible) (NN component))) (VP (VBZ bears) (NP (NP (JJ significant) (NN relatedness)) (PP (TO to) (NP (NP (DT a) (NP (JJ prolactin-induced) (NN transcription) (NN factor))) (VP (ADVP (RB first)) (VBN identified) (PP (IN in) (NP (NN sheep) (JJ mammary) (NN gland) (NN tissue))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT this) (NN protein)) (, ,) (VP (VBN designated) (S (NP (NN hStat5)))))) (, ,)) (VP (VBZ helps) (S (VP (VB govern) (NP (NP (DT the) (JJ biological) (NNS effects)) (PP (IN of) (NP (NN IL-2)))) (PP (IN during) (NP (DT the) (JJ immune) (NN response))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Induction)) (PP (IN of) (NP (NN transcription) (NNS factors))) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))) (PP (IN by) (NP (JJ aspirin-like) (NNS drugs))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Aspirin-like) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NN ALD)) (-RRB- -RRB-))) (VP (VP (VBP induce) (NP (NP (NN calcium) (NN mobilization)) (, ,) (NP (NP (DT an) (JJ essential) (NN component)) (PP (IN of) (NP (NN T) (NN cell) (NN activation)))))) (, ,) (CC but) (VP (VBP do) (RB not) (VP (VB induce) (NP (NP (DT the) (NN biosynthesis)) (PP (IN of) (NP (NN IL-2))))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB understand) (NP (NP (DT the) (NN extent)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (NN ALD)) (VP (MD may) (VP (VB mimic) (NP (JJ mitogenic) (NN stimulation)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (NP (ADJP (JJ cytoplasmic))) (CC and) (NP (ADJP (JJ nuclear))) (NP (NN signaling) (NNS steps))) (PP (IN in) (NP (JJ ALD-treated) (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN ALD)) (VP (VP (VBP induce) (NP (NP (DT a) (JJ transient) (NN activation)) (PP (IN of) (NP (NP (NN protein) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-)))))) (CC but) (VP (VBP have) (NP (DT no) (NN effect)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (JJ anti-CD3) (NNS antibodies))))) (-RRB- -RRB-)) (PP (PP (IN on) (NP (NN protein) (NN tyrosine) (NN phosphorylation))) (CC nor) (PP (IN on) (NP (NN PCL) (NN gamma) (CD 1) (NN tyrosine) (NN phosphorylation))))))))) (. .))))
(S1 (S (S (NP (JJ ALD-induced) (NP (NN calcium) (NN mobilization)) (CC and) (NP (NP (NN PKC)) (NN activation))) (VP (VBP are) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN tyrosine) (NN protein) (NN kinase)) (NN activity)))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN effect)) (PP (IN of) (NP (NP (NN herbimycin)) (, ,) (NP (DT a) (JJ tyrosine-protein) (JJ kinase-specific) (NN inhibitor)))))))))))) (. .))))
(S1 (S (S (S (SBAR (IN Although) (S (NP (PRP we)) (VP (VBD detected) (NP (DT no) (NP (NN IL-2) (NN mRNA))) (PP (IN in) (NP (JJ ALD-treated) (NNS cells)))))) (, ,) (S (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (DT these) (NNS cells)))) (VP (VBP contain) (NP (NP (NNS proteins)) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG binding) (PP (TO to) (NP (NP (CD three) (NP (JJ regulatory) (NNS sequences))) (PP (IN in) (NP (DT the) (NP (NN IL-2) (NN promoter) (NN region)))))))))))))) (: :) (NP (NP (NN NFAT)) (, ,) (NP (NN NF) (NN kappa) (NN B)) (, ,) (CC and) (NP (NN AP-1))) (. .))))
(S1 (S (S (NP (DT These) (NN binding) (NNS activities)) (VP (VBP are) (VP (VBN expressed) (ADVP (RB only)) (PP (IN in) (NP (VBN activated) (NN T) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NN AP-1)))) (VP (VBD depended) (PP (IN on) (NP (NP (NN calcium) (NN mobilization)) (CC and) (NP (NP (NN PKC)) (NN activation))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN ALD)) (VP (VBP cause) (NP (ADJP (ADJP (JJ transient)) (CC but) (ADJP (JJ significant))) (NNS changes)) (PP (IN in) (NP (NN T) (NN cell) (NN transmembrane) (NN signaling))) (, ,) (SBAR (IN although) (S (NP (NP (DT some) (NNS events)) (VP (VBN induced) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN with) (NP (JJ anti-CD3) (NNS antibodies))))))) (VP (VBP are) (RB not) (VP (VBN induced) (PP (IN by) (NP (NN ALD))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN signal)) (VP (VP (VBZ is) (VP (VBN transmitted) (PP (TO to) (NP (DT the) (NN nucleus))))) (CC and) (VP (VBZ induces) (NP (JJ DNA-binding) (NN activity)) (PP (IN by) (NP (JJ several) (NP (NN transcription) (NNS factors)))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT the) (NN ALD) (NN stimulus)) (VP (VBZ is) (RB not) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG causing) (NP (JJ complete) (NN T) (NN cell) (NN activation))))))) (. .))))
(S1 (S (S (S (NP (NN Interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -10)) (VP (VBZ inhibits) (NP (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF) (NN kappa) (NN B)) (-RRB- -RRB-))) (NN activation)) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .)))))
(S1 (S (S (NP (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (VP (VBP suppress) (NP (NP (NN cytokine)) (NN synthesis)) (PP (IN by) (NP (JJ different) (NNS mechanisms)))) (. .))))
(S1 (S (S (S (NP (NP (PRP$ Our) (JJ previous) (NNS studies)) (PP (IN in) (NP (JJ human) (NNS monocytes)))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -10)) (VP (VBZ inhibits) (NP (NP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -stimulated) (NN production)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cytokines)) (, ,) (NP (NP (NN IL-1) (NN beta)) (, ,) (NP (NN IL-6)) (, ,) (NP (NN IL-8)) (, ,) (CC and) (NP (NN tumor) (NN necrosis) (NN factor) (-LRB- -LRB-) (NN TNF) (-RRB- -RRB-) (NN -alpha)))))) (PP (IN by) (S (VP (VBG blocking) (NP (NN gene) (NN transcription)))))))))) (. .)))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NN EMSA)) (-RRB- -RRB-))))) (, ,) (S (NP (PRP we)) (ADVP (RB now)) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NP (NNS monocytes)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN LPS)) (CC or) (NP (NN TNF) (NN alpha))))))) (, ,) (NP (NN IL-10)) (VP (VBZ inhibits) (NP (NP (JJ nuclear) (NN stimulation)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF) (NN kappa) (NN B)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NN transcription) (NN factor))) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ inflammatory) (NN cytokine) (NNS genes))))))))))))))) (. .))))
(S1 (S (S (NP (NP (ADJP (JJ Several) (JJ other)) (NP (NN transcription) (NNS factors))) (PP (VBG including) (NP (NP (NN NF-IL-6)) (, ,) (NP (NN AP-1)) (, ,) (NP (NN AP-2)) (, ,) (NP (NN GR)) (, ,) (NP (NN CREB)) (, ,) (NP (NN Oct-1)) (, ,) (CC and) (NP (NN Sp-1))))) (VP (VBP are) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN IL-10))))) (. .))))
(S1 (S (S (NP (NP (DT This) (JJ selective) (NN inhibition)) (PP (IN by) (NP (NN IL-10))) (PP (IN of) (NP (NP (NN NF) (NN kappa) (NN B)) (NN activation)))) (VP (VP (VBZ occurs) (UCP (ADVP (RB rapidly)) (CC and) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))) (CC and) (VP (VBZ correlates) (ADVP (RB well)) (PP (IN with) (NP (NP (NN IL-10)) (POS 's) (NP (NN cytokine)) (NN synthesis) (JJ inhibitory) (NN activity))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (CC both) (NP (NNS kinetics)) (CC and) (NP (NN dose) (NN responsiveness)))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NNS compounds)) (PP (JJ such) (IN as) (NP (NP (NP (NN tosylphenylalanyl) (NN chloromethyl) (NN ketone)) (CC and) (NP (NN pyrrolidinedithiocarbamate))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (ADVP (RB selectively)) (VP (VB inhibit) (NP (NP (NN NF) (NN kappa) (NN B)) (NN activation)))))))))))) (VP (VBP block) (NP (NP (NN cytokine) (NN gene) (NN transcription)) (PP (IN in) (NP (JJ LPS-stimulated) (NNS monocytes))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN NF) (NN kappa) (NN B)) (NN activation)))) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (NN mechanism)) (PP (IN for) (NP (NP (NP (NN IL-10)) (NN suppression)) (PP (IN of) (NP (NP (NN cytokine) (NN gene) (NN transcription)) (PP (IN in) (NP (JJ human) (NNS monocytes)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN IL-4)) (, ,) (NP (NP (DT another) (NP (NN cytokine))) (SBAR (WHNP (WDT that)) (S (VP (VBZ inhibits) (NP (NP (NP (NN cytokine) (NN mRNA)) (NN accumulation)) (PP (IN in) (NP (NNS monocytes)))))))) (, ,)) (VP (VBZ shows) (NP (JJ little) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (JJ LPS-induced) (NP (NN NF) (NN kappa) (NN B)) (NN activation)))) (. .))))
(S1 (S (S (NP (RB Further) (NN examination)) (VP (VBZ reveals) (SBAR (IN that) (S (, ,) (PP (IN unlike) (NP (NN IL-10))) (, ,) (NP (NN IL-4)) (VP (VP (VBZ enhances) (NP (NP (NN mRNA)) (NN degradation))) (CC and) (VP (VBZ does) (RB not) (VP (VB suppress) (NP (NN cytokine) (NN gene) (NN transcription)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (VP (VBP inhibit) (NP (NP (NP (NN cytokine)) (NN production)) (PP (IN by) (NP (JJ different) (NNS mechanisms)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Coupling)) (PP (IN of) (NP (NP (DT a) (NP (NN signal) (NN response) (NN domain))) (PP (IN in) (NP (NN I) (NN kappa) (NN B) (NN alpha))))) (PP (TO to) (NP (NP (JJ multiple) (NNS pathways)) (PP (IN for) (NP (NP (NN NF-kappa) (NN B)) (NN activation))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ eukaryotic) (NN transcription) (NN factor)) (NP (NN NF-kappa) (NN B)))) (VP (VBZ plays) (NP (DT a) (JJ central) (NN role)) (PP (PP (IN in) (NP (NP (DT the) (VBN induced) (NN expression)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))))) (CC and) (PP (IN in) (NP (NP (JJ many) (NNS aspects)) (PP (IN of) (NP (NP (DT the) (JJ genetic) (NN program)) (VP (VBG mediating) (NP (JJ normal) (NN T-cell) (NP (NN activation)) (CC and) (NP (NN growth)))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (JJ nuclear) (NN activity)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBZ is) (ADVP (RB tightly)) (VP (VBN regulated) (PP (IN from) (NP (DT the) (JJ cytoplasmic) (NN compartment))) (PP (IN by) (NP (NP (DT an) (NP (JJ inhibitory) (NN subunit))) (VP (VBN called) (S (NP (NN I) (NN kappa) (NN B) (NN alpha)))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ cytoplasmic) (NN inhibitor)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VP (VBN phosphorylated)) (CC and) (VP (VBN degraded))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (DT a) (JJ diverse) (NN set)) (PP (IN of) (NP (NN NF-kappa) (JJ B-inducing) (NNS agents))) (, ,) (PP (VBG including) (NP (NP (NN T-cell) (NNS mitogens) (, ,)) (NP (JJ proinflammatory) (NNS cytokines)) (, ,) (CC and) (NP (NP (JJ viral) (NNS transactivators)) (PP (JJ such) (IN as) (NP (NP (DT the) (NP (NN Tax) (NN protein))) (PP (IN of) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1))))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB explore) (NP (NP (DT these) (NN I) (NN kappa) (NN B) (JJ alpha-dependent) (NNS mechanisms)) (PP (IN for) (NP (NP (NN NF-kappa) (NN B)) (NN induction))))))) (, ,) (S (NP (PRP we)) (VP (VBD identified) (NP (NP (NP (JJ novel) (NNS mutants)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (SBAR (WHNP (WDT that)) (S (VP (VBP uncouple) (NP (PRP$ its) (ADJP (ADJP (JJ inhibitory)) (CC and) (NP (JJ signal-transducing))) (NNS functions)) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes))))))))) (. .))))
(S1 (S (S (ADVP (RB Specifically)) (, ,) (NP (NP (NN removal)) (PP (IN of) (NP (NP (DT the) (NP (JJ N-terminal) (CD 36) (NN amino) (NNS acids))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (VP (VBD failed) (S (VP (TO to) (VP (VB disrupt) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB form) (NP (NP (JJ latent) (NNS complexes)) (PP (IN with) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (DT the) (NN cytoplasm)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN deletion) (NN mutation)) (VP (VBD prevented) (NP (NP (NP (DT the) (VBN induced) (NN phosphorylation)) (, ,) (NP (JJ degradative) (NN loss)) (, ,) (CC and) (NP (NP (JJ functional) (NN release)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (PP (IN from) (NP (NN NF-kappa) (NN B))))) (PP (IN in) (NP (JJ Tax-expressing) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (NN Alanine) (NNS substitutions)) (VP (VBN introduced) (PP (IN at) (NP (NP (CD two) (NN serine) (NNS residues)) (ADJP (JJ positioned) (PP (IN within) (NP (NP (DT this) (NP (JJ N-terminal) (JJ regulatory) (NN region))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))))))) (ADVP (RB also)) (VP (VBD yielded) (NP (NP (JJ constitutive) (NNS repressors)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBD escaped) (PP (IN from) (NP (JJ Tax-induced) (NN turnover)))))) (CC and) (SBAR (WHNP (WDT that)) (S (ADVP (RB potently)) (VP (VBD inhibited) (NP (NP (NP (JJ immune) (NN activation) (NNS pathways)) (PP (IN for) (NP (NP (NN NF-kappa) (NN B)) (NN induction)))) (, ,) (PP (VBG including) (NP (NP (DT those)) (VP (VBN initiated) (PP (IN from) (NP (NP (NN antigen)) (CC and) (NP (NN cytokine)) (NP (NNS receptors)))))))))))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN introduction)) (PP (IN of) (NP (NP (DT a) (NN phosphoserine)) (ADJP (JJ mimetic) (PP (IN at) (NP (DT these) (NNS sites))))))) (VP (VBD rectified) (NP (DT this) (JJ functional) (NN defect)))) (, ,) (NP (NP (DT a) (NN finding)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (JJ causal) (NN linkage)) (PP (IN between) (NP (NP (NP (DT the) (NN phosphorylation) (NN status)) (CC and) (NP (JJ proteolytic) (NN stability))) (PP (IN of) (NP (DT this) (NP (JJ cytoplasmic) (NN inhibitor)))))))))) (. .))))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (DT these) (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBP define) (NP (NP (DT a) (JJ critical) (NN signal) (NN response) (NN domain)) (PP (IN in) (NP (NN I) (NN kappa) (NN B) (NN alpha))) (SBAR (WHNP (WDT that)) (S (ADVP (RB coordinately)) (VP (VBZ controls) (NP (NP (DT the) (JJ biologic) (NNS activities)) (PP (IN of) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC and) (NP (NN NF-kappa) (NN B))))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (ADJP (JJ viral))) (CC and) (NP (ADJP (JJ immune))) (NP (NNS stimuli))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN HIV) (NN type) (CD 1) (NP (NN protease)) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN within) (NP (NN T) (JJ lymphoid) (NNS cells))) (. .)))))
(S1 (S (S (S (NP (NN NF-kappa) (NN B)) (VP (VBZ is) (NP (NP (DT a) (NP (JJ nuclear) (NN protein))) (PP (IN of) (NP (NP (DT the) (NP (NN rel) (NN oncogene) (NN family))) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG enhancing) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (JJ several) (JJ cellular) (NNS genes)) (, ,) (PP (VBG including) (NP (NP (NP (NN IL-2)) (CC and) (NP (DT the) (NP (NN IL-2) (NN receptor)))) (, ,) (CC and) (NP (NP (JJ viral) (NNS genes)) (VP (VBN transcribed) (PP (IN from) (NP (DT the) (NP (NN HIV-1) (NN LTR))))))))))))))))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NN HIV-1) (NN protease)) (VP (MD may) (VP (VB cleave) (NP (DT the) (NP (NN NF-kappa) (NN B)) (NN precursor)) (PP (TO to) (NP (PRP$ its) (JJ active) (NN form))) (ADVP (FW in) (FW vitro))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN HIV) (NN protease))) (PP (IN on) (NP (NP (NN NF-kappa) (NN B)) (NN precursor) (NN activation)))) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (NN Jurkat) (NP (NN T) (NNS cells)))) (PP (IN by) (S (VP (VBG introducing) (NP (DT a) (NP (NN protease) (NN expression) (NN vector))) (PP (IN into) (NP (DT the) (NNS cells)))))))) (. .))))
(S1 (S (S (S (NP (VBN Increased) (NP (NN NF-kappa) (NN B)) (NN activity)) (VP (VBD was) (VP (VBN observed)))) (CC and) (S (NP (DT this) (VBN increased) (NN activity)) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NP (DT a) (JJ specific) (NN inhibitor)) (PP (IN of) (NP (DT the) (NP (JJ viral) (NN protease))))))))) (. .))))
(S1 (S (S (NP (JJ Viral) (NN transcription) (, ,)) (SBAR (IN as) (S (VP (VBN measured) (S (VP (VBG using) (NP (JJ LTR-CAT) (NNS assays))))))) (, ,) (VP (VBD was) (ADVP (RB only) (RB slightly)) (VP (VBN enhanced) (PP (IN in) (NP (DT the) (NP (NN HIV-protease) (JJ expressing) (NNS cells))))) (, ,) (SBAR (IN while) (S (NP (NP (NP (NN secretion)) (PP (IN of) (NP (NN IL-2)))) (CC and) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NN IL-2)) (NN receptor))))) (VP (VBD were) (RB not) (VP (VBN affected)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ limited) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN by) (NP (NN HIV) (NN protease)))) (VP (VBZ appears) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (NN virus) (NN expression)) (CC or) (NP (NN T) (NN cell) (NN function))))))))) (. .))))
(S1 (S (S (S (NP (NN Erythropoietin)) (VP (VBZ stimulates) (NP (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NP (NN TAL1/SCL) (NN gene))))) (CC and) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (PRP$ its) (NP (NN protein) (NNS products))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (DT the) (NP (NN TAL1) (-LRB- -LRB-) (CC or) (NN SCL) (-RRB- -RRB-) (NN gene))) (, ,) (ADVP (RB originally)) (VP (VBN identified) (PP (IN through) (NP (NP (PRP$ its) (NN involvement)) (PP (IN by) (NP (DT a) (JJ recurrent) (JJ chromosomal) (NN translocation)))))))) (, ,)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ frequent) (JJ molecular)) (NN lesion)) (VP (VBN recognized) (PP (IN in) (NP (NN T-cell) (JJ acute) (JJ lymphoblastic) (NN leukemia)))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NP (NN protein) (NNS products))) (PP (IN of) (NP (DT this) (NN gene)))) (VP (VBP contain) (NP (NP (DT the) (NP (JJ basic-helix-loop-helix) (NN motif))) (ADJP (JJ characteristic) (PP (IN of) (NP (NP (DT a) (JJ large) (NN family)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (PP (TO to) (NP (DT the) (NP (JJ canonical) (NN DNA) (NN sequence) (NN CANNTG)))) (PP (IN as) (NP (NN protein) (NNS heterodimers))))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN TAL1)) (NN expression)) (PP (PP (IN by) (NP (NP (JJ erythroid) (NNS cells)) (ADJP (FW in) (FW vivo)))) (CC and) (PP (IN in) (NP (NP (JJ chemical-induced) (NN erythroleukemia) (NN cell) (NNS lines)) (ADJP (FW in) (FW vivo)))))) (VP (VBD suggested) (NP (DT the) (NN gene)) (VP (MD might) (VP (VB regulate) (NP (NP (NNS aspects)) (PP (IN of) (NP (JJ erythroid) (NN differentiation))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ terminal) (NNS events)) (PP (IN of) (NP (NN erythropoiesis)))) (VP (VBP are) (VP (VBN controlled) (PP (IN by) (NP (DT the) (NP (NP (NN glycoprotein) (NN hormone) (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NN Epo)) (-RRB- -RRB-))))))))) (, ,) (S (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (DT the) (NP (NN expression)) (CC or) (NP (NN activity))) (PP (IN of) (NP (NP (DT the) (NP (NN TAL1) (NN gene))) (CC and) (NP (PRP$ its) (NP (NN protein) (NNS products)))))) (VP (VBD were) (VP (VBN affected) (PP (IN by) (NP (NP (NN Epo)) (PP (IN in) (NP (NP (JJ splenic) (NNS erythroblasts)) (PP (IN from) (NP (NP (NNS mice)) (VP (VBN infected) (PP (IN with) (NP (NP (DT an) (JJ anemia-inducing) (NN strain)) (PP (IN of) (NP (NP (NN Friend) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN FVA) (NNS cells)) (-RRB- -RRB-))))))))))))))))))) (. .))))
(S1 (S (S (NP (NN Epo)) (VP (VBD elicited) (NP (NP (DT a) (ADJP (ADJP (JJ rapid)) (, ,) (ADJP (JJ dose-related))) (NN increase)) (PP (IN in) (NP (NN TAL1) (NN mRNA)))) (PP (IN by) (S (VP (VP (VBG increasing) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN gene))))) (CC and) (VP (VBG stabilizing) (NP (NP (CD one)) (PP (IN of) (NP (PRP$ its) (NP (NNS mRNAs)))))))))) (. .))))
(S1 (S (S (NP (DT An) (JJ Epo-inducible) (NP (NN TAL1)) (NN DNA) (NN binding) (NN activity)) (VP (VBD was) (VP (VBN identified) (PP (IN in) (NP (NP (NN FVA) (NN cell) (JJ nuclear) (NNS extracts)) (SBAR (WHNP (WDT that)) (S (ADVP (RB subsequently)) (VP (VBD decayed) (PP (IN despite) (S (VP (VBG accumulating) (NP (NP (NN mRNA)) (CC and) (NP (NN protein))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (NN DNA) (NN binding) (NN activity)))) (VP (VBD was) (VP (VBN associated) (ADVP (RB temporally)) (PP (IN with) (NP (NP (JJ Epo-induced) (NN phosphorylation)) (PP (IN of) (NP (JJ nuclear) (NN TAL1) (NN protein))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Epo)) (VP (VBZ acts) (PP (IN at) (NP (NP (CC both) (NP (ADJP (JJ transcriptional))) (CC and) (NP (ADJP (JJ posttranscriptional))) (NP (NNS levels))) (PP (IN on) (NP (DT the) (NP (NN TAL1)) (NN locus))))) (PP (IN in) (NP (NN Friend) (JJ virus-induced) (NNS erythroblasts))))))) (CC and) (VP (VBP establish) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (NP (NN Epo)) (NN signaling) (NNS mechanisms)) (CC and) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN differentiation)) (PP (IN of) (NP (JJ diverse) (NN cell) (NNS lineages)))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Abnormal) (NN regulation)) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN promoter)))) (PP (IN in) (NP (NN lpr) (NP (JJ CD4-CD8-) (NN T) (NNS lymphocytes))))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ constitutive) (NN expression)) (PP (IN of) (NP (DT a) (NP (JJ novel) (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (JJ cells-binding) (NN factor))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ inert) (NN quality)) (PP (IN of) (NP (NN MRL-Ipr/Ipr) (-LRB- -LRB-) (NN Ipr) (-RRB- -RRB-) (JJ peripheral) (JJ CD4-CD8-) (-LRB- -LRB-) (JJ CD4-8-) (-RRB- -RRB-) (NN T) (NNS cells)))) (VP (VBZ manifests) (ADVP (RB primarily)) (PP (IN as) (NP (DT an) (NN inability) (S (VP (TO to) (VP (VP (VB proliferate)) (CC or) (VP (VB produce)) (NP (NN IL-2))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN TCR)) (CC or) (NP (JJ mitogenic)) (NP (NN stimulation))))))))))) (. .)))))
(S1 (S (S (ADVP (RB Yet)) (NP (DT these) (JJ same) (NNS cells)) (VP (VBP do) (VP (VB initiate) (NP (NP (JJ early) (JJ TCR-mediated) (NN signaling) (NNS events)) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN generation)) (PP (IN of) (NP (JJ inositol) (NNS phosphates)))) (CC and) (NP (VBN increased) (JJ intracellular) (NN calcium))))))) (. .))))
(S1 (S (S (NP (PRP They)) (ADVP (RB also)) (VP (VBP display) (ADVP (RB constitutively)) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NP (NN p59fyn))) (CC and) (NP (NP (NN CD3) (NN zeta)) (NN tyrosine)) (NP (NN phosphorylation)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN generation)) (PP (IN of) (NP (JJ second) (NNS messengers))) (PP (IN in) (NP (NN T) (NNS cells)))) (ADVP (RB normally)) (VP (VBZ leads) (PP (TO to) (NP (NP (JJ downstream) (NN signaling)) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN in) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN gene)))))))))))) (. .))))
(S1 (S (S (NP (PRP We) (, ,)) (ADVP (RB therefore)) (, ,) (VP (VBD compared) (NP (NP (DT the) (NN activation) (NN state)) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN gene) (NN promoter) (NN region)))) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated))) (CC and) (NP (VBN stimulated)) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells))))) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ normal) (NN T) (NNS lymphocytes)))))) (. .))))
(S1 (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NP (DT the) (NN octamer)) (, ,) (NP (NN NF-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN p50-p65) (NN heterodimer)) (-RRB- -RRB-)) (, ,) (CC and) (NP (NN AP-1) (JJ transcriptional) (NNS factors))))) (VP (VBP are) (ADVP (RB constitutively)) (VP (VBN elevated) (PP (IN in) (NP (ADJP (RB freshly) (VBN isolated)) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells))))) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (VBN activated) (NN phenotype)) (PP (IN of) (NP (DT these) (NNS cells))))))) (. .))))
(S1 (S (S (PP (IN Upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NNS mitogens))))) (, ,) (NP (NP (NN formation)) (PP (IN of) (NP (NP (DT the) (VBG transactivating) (NN complex)) (, ,) (NP (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-))))) (, ,)) (VP (VBZ occurs) (PP (IN with) (NP (JJ normal) (NNS kinetics))) (PP (IN in) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells)))) (. .))))
(S1 (S (S (ADVP (RB Yet)) (, ,) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT the) (VBG activating) (NP (NN NF-AT) (NN complex))))) (ADVP (RB never)) (VP (VBP reach) (NP (NP (DT those)) (VP (VBN observed) (PP (IN in) (NP (ADJP (RB similarly) (VBN stimulated)) (JJ normal) (NP (NN T) (NNS cells))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells)))) (VP (VBP display) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (DT a) (ADJP (ADJP (JJ novel)) (ADJP (JJ specific))) (NN binding) (NN activity)))) (PP (IN at) (NP (NP (DT the) (NP (NN NF-AT) (NN site))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ present) (PP (IN at) (NP (NP (ADJP (JJ much) (JJR lower)) (NNS levels)) (PP (IN in) (NP (ADJP (RB freshly) (VBN isolated)) (NP (JJ normal) (NN T) (NNS lymphocytes))))))))))))) (. .))))
(S1 (S (S (PP (IN Upon) (NP (JJ mitogenic) (NN stimulation))) (, ,) (NP (NP (DT the) (NN binding) (NN activity)) (PP (IN of) (NP (DT the) (JJ novel) (NP (JJ NF-AT-binding) (NN factor))))) (VP (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN down-regulated) (PP (IN in) (NP (JJ normal) (NP (NN T) (NNS cells)))))) (, ,) (CC but) (VP (VBZ persists) (PP (IN at) (NP (JJ high) (NNS levels))) (PP (IN in) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells))))) (. .))))
(S1 (S (S (NP (NP (DT These) (CD two) (NNS abnormalities)) (PP (IN at) (NP (DT the) (NP (NN NF-AT) (NN site))))) (VP (VBP provide) (NP (NP (DT a) (JJ potential) (NN mechanism)) (SBAR (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN defect)) (PP (IN in) (NP (NP (NP (NN IL-2)) (NN production)) (PP (IN from) (NP (NN Ipr) (JJ CD4-8-) (NN T) (NNS cells))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN GM-CSF)) (CC and) (NP (NN IL-2))) (VP (VBP share) (NP (JJ common) (NN control) (NNS mechanisms)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (JJ costimulatory) (NNS signals)) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Antigen)) (VP (VBN complexed) (PP (IN with) (NP (JJ major) (NN histocompatibility) (NN complex) (NN class) (NP (CD I)) (CC or) (NP (CD II)) (NP (NNS molecules)))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN antigen) (NN presenting) (NNS cells))))))) (VP (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NP (NP (NN T) (NN cell) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN T) (NNS cells)))))) (CC and) (VP (VBZ initiates) (NP (DT an) (NN activation) (NN cascade)))) (. .)))))
(S1 (S (S (NP (NP (ADJP (RB So) (VBN called)) (JJ costimulatory) (NNS signals)) (, ,) (VP (VBN mediated) (PP (IN by) (NP (NP (JJ other) (NN cell) (NN surface) (NNS interactions)) (CC or) (NP (NP (JJ soluble) (NNS cytokines)) (VP (VBN produced) (PP (IN by) (NP (NN antigen) (NN presenting) (NNS cells)))))))) (, ,)) (VP (VBP are) (ADVP (RB also)) (VP (VBN required) (PP (IN for) (NP (JJ complete) (NN T) (NN cell) (NN activation))))) (. .))))
(S1 (S (S (NP (NP (JJ High) (NNS levels)) (PP (IN of) (NP (NP (NN cytokine)) (NN gene) (NN expression))) (PP (IN in) (NP (NN T) (NNS cells)))) (ADVP (RB also)) (VP (VBD required) (NP (CC both) (NP (NN TCR)) (CC and) (NP (JJ costimulatory)) (NP (NNS signals)))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor))) (VP (VBZ requires) (NP (NP (NP (NNS sequences)) (PP (IN in) (NP (DT the) (NP (NN promoter))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (JJ powerful) (NP (NN enhancer))) (ADJP (JJ located) (ADVP (NP (RB 3kb)) (RB upstream))))) (S (VP (TO to) (VP (VB respond) (PP (TO to) (JJ TCR-like) (NNS signals)))))) (. .))))
(S1 (S (S (NP (DT These) (NP (NN promoter) (CC and) (NN enhancer) (NNS regions))) (VP (VBP are) (ADVP (RB mainly)) (VP (VBN activated) (PP (IN by) (NP (DT the) (NP (NP (NN transcription) (NN factor) (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN NFAT)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NN NFAT))) (PP (IN by) (NP (NP (NN TCR)) (NNS signals)))) (VP (VBZ has) (VP (VBN been) (ADVP (RB well)) (VP (VBN described) (PP (IN for) (NP (NP (NP (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-)))) (CC and) (NP (NN IL-4)) (NP (NN gene) (NN transcription))) (PP (IN in) (NP (NN T) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Costimulatory) (NNS signals)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN CD28) (NN cell) (NN surface) (NN molecule)))) (PP (IN on) (NP (NN T) (NNS cells))))) (, ,)) (VP (VBP lead) (PP (TO to) (NP (NN activation))) (PP (IN through) (NP (NP (DT a) (JJ distinct) (NN region)) (PP (IN of) (NP (DT the) (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor) (-LRB- -LRB-) (NN GM-CSF) (-RRB- -RRB-) (NN promoter))))))) (. .))))
(S1 (S (S (NP (DT This) (NN region)) (VP (VP (VBZ is) (VP (VBN termed) (S (NP (DT the) (NP (NN CK-1)) (CC or) (NP (NN CD28RE)))))) (CC and) (VP (VBZ appears) (S (VP (TO to) (VP (VB bind) (NP (NP (JJ specific) (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappa) (NN B) (NN family))) (PP (IN of) (NP (NN transcription) (NNS factors))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Human) (NN T) (NN leukemia) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HTLV-1)) (-RRB- -RRB-))) (VP (VP (VBZ infects) (NP (NN T) (NNS cells))) (CC and) (VP (MD can) (VP (VB lead) (S (VP (TO to) (VP (VB increase) (NP (NP (NN GM-CSF)) (NN expression)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN HTLV-1) (NN transactivator) (NN protein))) (, ,) (NP (NN tax)) (, ,)) (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ costimulatory) (NN signal)) (PP (IN for) (NP (NP (NN GM-CSF)) (CC and) (NP (NN IL-2)) (NP (NN gene) (NN transcription)))))) (, ,) (PP (IN in) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VB cooperate) (PP (IN with) (NP (NP (NN TCR)) (NNS signals)))) (S (VP (TO to) (VP (VB mediate) (NP (JJ high) (NN level) (NN gene) (NN expression)))))))))))))) (. .))))
(S1 (S (S (NP (NN Tax)) (VP (VP (VBZ activates) (NP (DT the) (NP (NN GM-CSF) (NN promoter))) (PP (IN through) (NP (DT the) (NN CK-1/CD28RE) (NN region)))) (CC and) (ADVP (RB also)) (VP (VBZ activates) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (VP (VBG binding) (PP (TO to) (NP (DT this) (NN region))))))) (. .))))
(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ other) (NP (NN transcription) (NNS factors)) (CC or) (NP (NNS coactivators))) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (NN tax)) (NN activation)))))) (CC but) (S (NP (DT these)) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (VP (VBN identified))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN CK-1/CD28RE)) (PP (IN of) (NP (NN GM-CSF)))) (VP (VBZ shows) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NP (NN similarity)) (PP (TO to) (NP (DT the) (NP (NN IL-2)) (NP (NN CD28RE))))))))) (CC and) (S (NP (DT the) (NP (NN IL-3) (NN gene))) (ADVP (RB also)) (VP (VBZ contains) (NP (DT a) (JJ related) (NN region)))) (. .))))
(S1 (S (S (NP (DT This) (NN observation) (, ,)) (ADVP (RB together)) (PP (IN with) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP (CC both) (NP (NN GM-CSF)) (CC and) (NP (NN IL-2))) (VP (VBP respond) (PP (TO to) (NP (NP (NN TCR)) (NNS signals))) (PP (IN via) (NP (NN NFAT)))))))) (, ,) (VP (VBZ implies) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NN conservation)))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN cytokine)) (NN gene) (NN expression))) (PP (IN in) (NP (NN T) (NNS cells)))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN MIP1) (NN alpha) (JJ nuclear) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN MNP)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ novel) (NP (NN transcription) (NN factor))) (VP (VBN expressed) (PP (IN in) (NP (JJ hematopoietic) (NNS cells)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ crucial) (PP (IN for) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN MIP-1) (NN alpha) (NN gene))))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Murine) (NN macrophage) (JJ inflammatory) (NN protein) (CD 1) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN MIP-1) (NN alpha)) (-RRB- -RRB-))) (CC and) (NP (NP (PRP$ its) (NP (JJ human) (NN equivalent))) (PRN (-LRB- -LRB-) (NP (NP (NN GOS19)) (, ,) (NP (NN LD78)) (, ,) (CC or) (NP (NN AT464))) (-RRB- -RRB-)))) (VP (VBP are) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN -C-C) (NN family))) (PP (IN of) (NP (JJ low-molecular-weight) (NNS chemokines))))))) (. .)))))
(S1 (S (S (S (VP (VBN Secreted) (PP (IN from) (NP (NP (VBN activated) (NN T) (NNS cells)) (CC and) (NP (NNS macrophages)))))) (, ,) (S (NP (NN bone) (NP (JJ marrow-derived) (NN MIP-1) (NN alpha/GOS19))) (VP (VP (VBZ inhibits) (NP (JJ primitive) (JJ hematopoietic) (NN stem) (NNS cells))) (CC and) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ homeostatic) (NN control)) (PP (IN of) (NP (NP (NN stem) (NN cell)) (NN proliferation)))))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (ADVP (RB also)) (VP (VBZ induces) (NP (NP (NN chemotaxis)) (CC and) (NP (JJ inflammatory) (NNS responses))) (PP (IN in) (NP (JJ mature) (NN cell) (NNS types)))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ important)) (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHNP (WDT which)) (S (VP (VBP control) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN MIP-1) (NN alpha/GOS19)))))))))))) (. .))))
(S1 (S (S (NP (JJ Previous) (NN work)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells))) (, ,) (NP (NP (NP (DT a) (NN set)) (PP (IN of) (NP (ADJP (RB widely) (VBN expressed)) (NP (NN transcription) (NNS factors))))) (PRN (-LRB- -LRB-) (NP (DT the) (NP (NN ICK-1) (NN family))) (-RRB- -RRB-))) (VP (VBP affect) (NP (DT the) (NP (NN GOS19) (NN promoter)))))))) (. .))))
(S1 (S (S (NP (NP (CD One) (NN member)) (, ,) (NP (NN ICK-1A)) (, ,)) (VP (VBZ behaves) (PP (IN as) (NP (DT a) (NP (JJ strong) (JJ negative) (NN regulator))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN communication))) (, ,) (NP (PRP we)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NN pathway)) (PP (IN of) (NP (NN induction))) (PP (IN in) (NP (DT the) (NP (NP (NN macrophage) (NN cell) (NN line)) (NP (NN U937)))))) (VP (VBZ is) (ADJP (JJ different) (PP (IN from) (NP (NP (DT that)) (PP (IN in) (NP (NN Jurkat) (NNS cells))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NP (NN ICK-1) (NN binding) (NN site))) (VP (VBZ does) (RB not) (VP (VB confer) (NP (NP (JJ negative) (NN regulation)) (PP (IN in) (NP (NN U937) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP provide) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (DT an) (JJ additional) (NP (VBG binding) (NN site))) (, ,) (NP (NP (DT the) (NP (NN MIP-1) (NN alpha) (JJ nuclear) (NN protein) (-LRB- -LRB-) (NN MNP) (-RRB- -RRB-) (NN site))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ overlaps) (NP (DT the) (NP (NN ICK-1) (NN site))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Interaction)) (PP (IN of) (NP (NP (JJ nuclear) (NNS extracts)) (PP (IN from) (NP (NP (JJ various) (NN cell) (NNS lines)) (CC and) (NP (NN tissue)))))) (PP (IN with) (NP (DT the) (NP (NN MNP) (NN site))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (JJ fast-migrating) (JJ protein-DNA) (NNS complexes))) (PP (IN with) (NP (ADJP (ADJP (JJ similar)) (CC but) (ADJP (JJ distinct))) (JJ electrophoretic) (NNS mobilities)))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN mutation)) (PP (IN of) (NP (NP (DT the) (NP (NN MNP) (NN site))) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB abrogate) (NP (NN ICK-1) (NN binding))))))))) (VP (VP (VBZ inactivates) (NP (NP (DT the) (NP (NN GOS19.1) (NN promoter))) (PP (IN in) (NP (NN U937) (NNS cells))))) (CC and) (VP (VBZ reduces) (NP (PRP$ its) (NN activity)) (PP (IN by) (NP (RB fourfold))) (PP (IN in) (NP (NN Jurkat) (NNS cells))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN MNP) (NN protein)) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VBG binding) (PP (IN at) (NP (DT the) (NP (NN MNP) (NN site)))))) (VP (VBZ constitutes) (NP (NP (DT a) (JJ novel) (NP (NN transcription) (NN factor)) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VBN expressed) (PP (IN in) (NP (JJ hematopoietic) (NNS cells))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Ligand-dependent) (NN repression)) (PP (IN of) (NP (DT the) (NP (NP (JJ erythroid) (NN transcription) (NN factor)) (NP (NN GATA-1))))) (PP (IN by) (NP (DT the) (NP (NN estrogen) (NN receptor)))) (. .)))))
(S1 (S (S (S (NP (JJ High-dose) (NN estrogen) (NN administration)) (VP (VBZ induces) (NP (NN anemia)) (PP (IN in) (NP (NNS mammals)))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NNS chickens))) (, ,) (NP (NNS estrogens)) (VP (VP (VBP stimulate) (NP (NP (NN outgrowth)) (PP (IN of) (NP (NN bone) (JJ marrow-derived) (JJ erythroid) (NN progenitor) (NNS cells))))) (CC and) (VP (VBP delay) (NP (PRP$ their) (NN maturation)))) (. .))))
(S1 (S (S (NP (DT This) (NN delay)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN down-regulation)) (PP (IN of) (NP (NP (JJ many) (NP (JJ erythroid) (JJ cell-specific) (NNS genes))) (, ,) (PP (VBG including) (NP (NP (NP (NN alpha-)) (CC and) (NP (NN beta-globin))) (, ,) (NP (NN band) (CD 3)) (, ,) (NP (NN band) (CD 4.1)) (, ,) (CC and) (NP (DT the) (NP (NP (JJ erythroid) (JJ cell-specific) (NN histone)) (NP (NN H5)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NNS estrogens)) (ADVP (RB also)) (VP (VBP reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ erythroid) (NN progenitor) (NNS cells)))) (PP (IN in) (NP (JJ primary) (JJ human) (NN bone) (NN marrow) (NNS cultures))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB address) (NP (NP (JJ potential) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NNS estrogens)) (VP (VBP suppress) (NP (NN erythropoiesis))))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (NP (NN GATA-1)) (, ,) (NP (NP (DT an) (NP (JJ erythroid) (NN transcription) (NN factor))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ participates) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ erythroid) (JJ cell-specific) (NNS genes)))))))) (CC and) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN for) (NP (NP (JJ full) (NN maturation)) (PP (IN of) (NP (NNS erythrocytes))))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN GATA-1)))) (VP (VBZ is) (ADVP (RB strongly)) (VP (VBN repressed) (PP (IN by) (NP (DT the) (NP (NP (NN estrogen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN ER)) (-RRB- -RRB-))))) (PP (IN in) (NP (DT a) (JJ ligand-dependent) (NN manner))))))) (CC and) (SBAR (IN that) (S (NP (DT this) (NN repression)) (VP (VBZ is) (ADJP (JJ reversible) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN 4-hydroxytamoxifen))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ ER-mediated) (NN repression)) (PP (IN of) (NP (NP (NN GATA-1)) (NN activity)))) (VP (VBZ occurs) (PP (PP (IN on) (NP (NP (DT an) (NP (JJ artificial) (NN promoter))) (VP (VBG containing) (NP (DT a) (JJ single) (NP (JJ GATA-binding) (NN site)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (DT an) (NP (JJ intact) (NN promoter))) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB normally)) (VP (VBN regulated) (PP (IN by) (NP (NN GATA-1))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN GATA-1)) (CC and) (NP (NN ER))) (VP (VBP bind) (PP (TO to) (NP (DT each) (JJ other))) (ADVP (FW in) (FW vitro)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN DNA)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN coimmunoprecipitation) (NNS experiments)) (VP (VBG using) (NP (VBN transfected) (NP (NN COS) (NNS cells)))))) (, ,) (NP (NP (NN GATA-1)) (CC and) (NP (NN ER))) (VP (VBP associate) (PP (IN in) (NP (DT a) (JJ ligand-dependent) (NN manner)))) (. .))))
(S1 (S (S (NP (NN Mapping) (NNS experiments)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN GATA-1)) (CC and) (NP (DT the) (NP (NN ER)))) (VP (VBP form) (NP (NP (QP (IN at) (JJS least) (CD two)) (NNS contacts)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP involve) (NP (NP (NP (DT the) (NN finger) (NN region)) (CC and) (NP (DT the) (NP (JJ N-terminal) (NN activation) (NN domain)))) (PP (IN of) (NP (NN GATA-1)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP speculate) (SBAR (IN that) (S (NP (NNS estrogens)) (VP (VBP exert) (NP (NNS effects)) (PP (IN on) (NP (NN erythropoiesis))) (PP (IN by) (S (VP (VBG modulating) (NP (NP (NN GATA-1)) (NN activity)) (PP (IN through) (NP (NP (JJ protein-protein) (NN interaction)) (PP (IN with) (NP (DT the) (NP (NN ER))))))))))))) (. .))))
(S1 (S (PRN (-LRB- -LRB-) (NP (NP (NN ABSTRACT)) (VP (VBN TRUNCATED) (PP (IN AT) (NP (CD 250) (NNS WORDS))))) (-RRB- -RRB-))))
(S1 (S (NP (NP (NP (NP (VBN Reduced) (JJ mitogenic) (NN stimulation)) (PP (IN of) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))) (PP (IN as) (NP (NP (DT a) (JJ prognostic) (NN parameter)) (PP (IN for) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NN breast) (NN cancer))))))) (: :)) (NP (DT a) (ADJP (ADJP (JJ prospective)) (ADJP (JJ longitudinal))) (NN study)) (. .)))))
(S1 (S (S (S (NP (NN Immunosuppression)) (VP (VBZ has) (VP (VBN been) (ADVP (RB often)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ malignant) (NNS diseases)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNS PBMCs)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (JJ mitogenic) (NN stimulation)) (PP (IN with) (NP (NP (NN phytohaemagglutinin)) (PRN (-LRB- -LRB-) (NP (NN PHA)) (-RRB- -RRB-))))))))) (VP (VBD was) (VP (VBN assessed) (ADVP (RB prospectively)) (PP (IN in) (NP (NP (CD 90) (NNS patients)) (PP (IN with) (NP (NN stage) (CD I-III) (NN breast) (NN cancer))))))) (. .))))
(S1 (S (S (SBAR (IN Whereas) (S (NP (NP (JJ PHA-induced) (NN proliferation)) (PP (IN of) (NP (NP (NNS PBMCs)) (VP (VBN derived) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN breast) (NN cancer))))) (ADVP (RB preoperatively)))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased)) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (NNS data)) (VP (VBN obtained) (PP (IN in) (NP (NP (JJ healthy) (JJ control) (NNS individuals)) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJR &lt;) (NP (CD 0.001)))) (-RRB- -RRB-))))))))))))) (, ,) (S (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (DT the) (NN defect)) (PP (IN in) (NP (NP (JJ PHA-induced) (NN proliferation)) (PP (IN of) (NP (NNS PBMCs)))))))) (VP (VBD depended) (PP (IN upon) (NP (DT the) (NN tumour) (NN burden))) (SBAR (IN as) (S (VP (VBN manifested) (PP (IN by) (NP (NP (NP (NN tumour) (NN size)) (CC and) (NP (NN axillary) (NN lymph) (NN node) (NN involvement))) (PRN (-LRB- -LRB-) (NP (NP (NP (NN P)) (ADJP (JJR &lt;) (NP (CD 0.003)))) (PP (IN in) (NP (DT each) (NN case)))) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (NP (NP (JJ PHA-induced) (NN proliferation)) (PP (IN of) (NP (NNS PBMCs)))) (VP (VBD dropped) (ADVP (RB significantly)) (PP (PP (IN in) (NP (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (JJ adjuvant) (NN chemotherapy)) (VP (VBG consisting) (PP (IN of) (NP (NP (NP (NN cyclophosphamide)) (, ,) (NP (NN methotrexate)) (CC and) (NP (NN fluorouracil))) (PRN (-LRB- -LRB-) (NP (NN CMF)) (-RRB- -RRB-)))))) (PP (IN after) (NP (NP (DT an) (NN observation) (NN period)) (PP (IN of) (NP (CD 6) (NNS months))))))))) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJR &lt;) (NP (CD 0.01)))) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (NNS patients)) (PP (IN under) (NP (NP (JJ adjuvant) (NN treatment)) (PP (IN with) (NP (NP (NN tamoxifen)) (ADVP (RB only)))))))))) (. .))))
(S1 (S (S (PP (PP (IN After) (NP (DT an) (JJ additional) (CD 6) (NNS months))) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (PP (NP (CD 12) (NNS months)) (IN after) (NP (NN surgery))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ PHA-induced) (NN proliferation)) (PP (IN of) (NP (NNS PBMCs)))) (VP (VP (VBD was) (ADJP (JJ similar) (PP (PP (IN in) (NP (NP (NNS patients)) (PP (IN after) (NP (NP (JJ adjuvant) (NN chemotherapy)) (PP (IN with) (NP (NN CMF))))))) (CC and) (PP (IN in) (NP (NP (NP (DT those)) (VP (VBG receiving) (NP (JJ continued) (JJ adjuvant) (NN tamoxifen) (NN treatment)))) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJR &gt;) (NP (CD 0.1)))) (-RRB- -RRB-))))))) (, ,) (CC but) (PP (IN in) (NP (DT all) (NNS patients))) (ADVP (RB still) (RB significantly)) (VP (VBD decreased) (SBAR (IN as) (S (VP (VBN compared) (PP (IN with) (NP (NP (JJ healthy) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (NN P)) (ADJP (JJR &lt;) (NP (CD 0.001)))) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NNS data)) (VP (VBN obtained) (UCP (ADVP (RB preoperatively)) (CC and) (PP (IN after) (NP (CD 12) (NNS months)))))) (VP (VBD were) (VP (VBN compared))))) (, ,) (S (NP (PRP it)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (PP (RB out) (PP (IN of) (NP (NP (CD 23) (NNS patients)) (SBAR (WHNP (WP$ whose) (NP (NNS PBMCs))) (S (VP (VBD had) (VP (VBN experienced) (NP (DT a) (NN drop)) (PP (IN in) (NP (PRP$ their) (JJ PHA-induced) (NN proliferation)))))))))) (, ,) (NP (NP (CD 14)) (PRN (-LRB- -LRB-) (NP (CD 61) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (VP (VBN developed) (NP (JJ metastatic) (NN disease)) (PP (PP (IN within) (NP (DT the) (JJ subsequent) (CD 24) (NNS months))) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (NP (NP (CD 36) (NNS months)) (PP (IN after) (NP (NN surgery)))) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (PP (RB out) (PP (IN of) (NP (NP (CD 59) (NNS patients)) (SBAR (WHNP (WP$ whose) (NP (NNS PBMCs))) (S (VP (VBD showed) (NP (DT an) (NN increase)) (PP (IN in) (NP (PRP$ their) (JJ PHA-induced) (NN proliferation))) (PP (IN within) (NP (NP (DT the) (JJ first) (CD 12) (NNS months)) (PP (IN after) (NP (NN surgery))))))))))) (, ,) (NP (NP (QP (RB only) (CD one))) (PRN (-LRB- -LRB-) (NP (CD 2) (NN %)) (-RRB- -RRB-))) (VP (VBD presented) (PP (IN with) (NP (NN disease) (NN progression)))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB thus)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (JJ PHA-induced) (NN proliferation)) (PP (IN of) (NP (NP (NNS PBMCs)) (VP (VBN derived) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN breast) (NN cancer))))))))) (VP (VP (VBZ depends) (PP (IN upon) (NP (DT the) (NN tumour) (NN load)))) (CC and) (VP (VBZ is) (NP (DT a) (ADJP (ADJP (JJ good)) (ADJP (JJ clinical))) (NN predictor)) (PP (IN for) (NP (NP (DT the) (JJ further) (NN course)) (PP (IN of) (NP (DT the) (NN disease)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (NP (NN CD48) (NN gene))))) (VP (VBZ demonstrates) (NP (NP (DT a) (JJ positive) (NN element)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADJP (JJ specific) (PP (TO to) (NP (JJ Epstein-Barr) (JJ virus-immortalized) (NN B-cell) (NNS lines))))) (CC and) (VP (VBZ contains) (NP (DT an) (JJ essential) (NP (NN NF-kappa) (NN B) (NN site))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (NN infection)) (PP (IN of) (NP (ADJP (JJ mature)) (, ,) (NP (VBG resting) (NN B) (NNS cells))))) (VP (VBZ drives) (NP (PRP them)) (S (VP (TO to) (VP (VB become) (NP (NP (NNS lymphoblasts)) (VP (VBG expressing) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN cell) (NN surface) (NNS molecules)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN CD48)) (, ,) (ADVP (RB characteristically)) (VP (VBN expressed) (PP (IN on) (NP (JJ normal) (VBN activated) (NN B) (NNS cells))))))))))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP report) (PP (IN on) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (NP (DT an) (NP (NN enhancer) (NN element))) (PP (IN in) (NP (DT the) (NP (NN CD48) (NN gene))))) (SBAR (WHNP (WDT which)) (S (ADVP (RB reproducibly)) (VP (VBZ confers) (NP (JJ strong) (JJ transcriptional) (NN activity)) (PP (ADVP (RB only)) (IN in) (NP (JJ EBV-positive) (JJ B-lymphoblastoid) (NN cell) (NNS lines))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NN element)) (VP (VBZ is) (RB not) (VP (VBN activated) (PP (IN upon) (NP (NP (NN infection)) (PP (IN of) (NP (JJ established) (NP (JJ EBV-negative) (NN B-cell) (NNS lines))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN EBV)) (VP (VBZ fails) (S (VP (TO to) (VP (VB drive) (NP (DT these) (NNS cells)) (PP (TO to) (NP (DT a) (ADVP (RB fully)) (NP (JJ lymphoblastoid) (NN phenotype))))))))))))) (. .))))
(S1 (S (S (NP (DT An) (NP (NN NF-kappa) (NN B)) (NN binding) (NN site)) (VP (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN component)) (PP (IN of) (NP (DT the) (NN element))))) (CC but) (ADVP (RB alone)) (VP (VBZ is) (RB not) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (DT the) (NN activity)) (CC or) (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (DT the) (NN element))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VP (VBP have) (VP (VBN detected) (NP (NP (DT a) (JJ specific) (NP (JJ nuclear) (NN protein) (NN complex))) (SBAR (WHNP (WDT that)) (S (VP (VBZ binds) (PP (TO to) (NP (DT the) (NN element))))))))) (CC and) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN NF-kappa) (NN B1)) (PRN (-LRB- -LRB-) (NP (NN p50)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (DT this) (NN complex))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (JJ EBV-encoded) (JJ latent) (NN membrane) (NN protein) (CD 1))) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG transactivating) (NP (NP (DT the) (VBN isolated) (NP (NN CD48)) (NP (NN NF-kappa) (NN B) (NN site))) (CONJP (CC but) (RB not)) (NP (DT the) (NP (JJ intact) (NN element)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (JJ latent) (NN membrane) (NN protein) (JJ 1-driven) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B/Rel)))) (VP (MD must) (VP (VB interact) (PP (IN with) (NP (JJ other) (JJ regulatory) (NNS pathways)))) (S (VP (TO to) (VP (VB control) (NP (NP (NN expression)) (PP (IN of) (NP (JJ cellular) (NNS genes))))))) (SBAR (IN as) (S (NP (NN EBV)) (VP (VBZ drives) (NP (VBG resting) (NN B) (NNS cells)) (PP (IN into) (NP (DT the) (NN cell) (NN cycle)))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Distinct) (NNS roles)) (PP (IN of) (NP (DT the) (JJ molecular) (NP (NN chaperone) (NN hsp90)))) (PP (IN in) (S (VP (VBG modulating) (NP (NN dioxin) (NN receptor) (NN function)) (PP (IN via) (NP (NP (DT the) (JJ basic) (NP (JJ helix-loop-helix))) (CC and) (NP (NN PAS) (NNS domains))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ intracellular) (NN dioxin) (NN receptor))) (VP (VP (VBZ mediates) (NP (NN signal) (NN transduction)) (PP (IN by) (NP (NN dioxin)))) (CC and) (VP (VBZ functions) (PP (IN as) (NP (DT a) (NP (JJ ligand-activated) (NN transcription) (NN factor)))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ contains) (NP (NP (DT a) (NP (JJ basic) (JJ helix-loop-helix) (-LRB- -LRB-) (JJ bHLH) (-RRB- -RRB-) (NN motif))) (ADJP (JJ contiguous) (PP (IN with) (NP (DT a) (NP (NN Per-Arnt-Sim) (-LRB- -LRB-) (NN PAS) (-RRB- -RRB-) (NN homology) (NN region))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NNS extracts)) (PP (IN from) (NP (JJ nonstimulated) (NNS cells))))) (NP (DT the) (NN receptor)) (VP (VBZ is) (VP (VBN recovered) (PP (IN in) (NP (NP (DT an) (ADJP (ADJP (JJ inducible)) (ADJP (JJ cytoplasmic))) (NN form)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT the) (NP (JJ 90-kDa) (NN heat) (NN shock) (NN protein))) (PRN (-LRB- -LRB-) (NP (NN hsp90)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NP (JJ molecular) (NN chaperone)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN reconstituted) (NP (NP (JJ ligand-dependent) (NN activation)) (PP (IN of) (NP (DT the) (NN receptor)))) (PP (TO to) (NP (DT a) (NP (JJ DNA-binding) (NN form)))) (PP (IN by) (S (VP (VBG using) (NP (NP (DT the) (NP (NN dioxin) (NN receptor))) (CC and) (NP (NP (NP (PRP$ its) (NP (JJ bHLH-PAS) (NN partner) (NN factor))) (NP (NN Arnt))) (VP (VBN expressed) (PP (IN by) (NP (NP (ADJP (FW in) (FW vitro)) (NN translation)) (PP (IN in) (NP (JJ reticulocyte) (NN lysate))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Deletion)) (PP (IN of) (NP (NP (DT the) (NP (NN PAS) (NN domain))) (PP (IN of) (NP (DT the) (NN receptor)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ constitutive) (NN dimerization)) (PP (IN with) (NP (NN Arnt)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT this) (NN receptor) (NN mutant)) (VP (VBD showed) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (JJ xenobiotic) (NN response) (JJ element-binding) (NN activity)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (NP (NN PAS) (NN domain))) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN for) (NP (NP (JJ DNA-binding) (NP (NN affinity)) (CC and/or) (NP (NN specificity))) (PP (IN of) (NP (DT the) (NN receptor))))))))))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBD was) (RB not) (ADJP (JJ possible) (S (VP (TO to) (VP (VB reconstitute) (NP (NP (NN dioxin) (NN receptor)) (NN function)) (PP (IN with) (NP (NP (NNS proteins)) (VP (VBN expressed) (PP (IN in) (NP (NN wheat) (NN germ) (NN lysate))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN line)) (PP (IN with) (NP (DT these) (NNS observations))))) (, ,) (NP (NP (NN reticulocyte) (NN lysate)) (CONJP (CC but) (RB not)) (NP (NN wheat) (NN germ) (NN lysate))) (VP (VBD promoted) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (ADJP (FW de) (FW novo)) (VBN synthesized) (NP (NN dioxin) (NN receptor)))) (PP (IN with) (NP (NN hsp90))))) (. .))))
(S1 (S (S (S (NP (NP (QP (IN At) (JJS least) (CD two)) (JJ distinct) (NNS domains)) (PP (IN of) (NP (DT the) (NN receptor)))) (VP (VBD mediated) (NP (NP (NN interaction)) (PP (IN with) (NP (NN hsp90)))))) (: :) (NP (NP (NP (DT the) (NP (JJ ligand-binding) (NN domain))) (ADJP (JJ located) (PP (IN within) (NP (DT the) (NP (NN PAS) (NN region)))))) (CC and) (, ,) (ADVP (RB surprisingly)) (, ,) (NP (DT the) (NP (JJ bHLH) (NN domain)))) (. .))))
(S1 (S (S (SBAR (IN Whereas) (S (NP (JJ ligand-binding) (NN activity)) (VP (VBD correlated) (PP (IN with) (NP (NP (NN association)) (PP (IN with) (NP (NN hsp90)))))))) (, ,) (S (NP (JJ bHLH-hsp90) (NN interaction)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (PP (IN for) (NP (JJ DNA-binding) (NN activity))) (CC but) (PP (RB not) (IN for) (NP (NP (NN dimerization) (PP (IN of) (NP (DT the) (NN receptor))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (ADJP (JJ Several) (JJ distinct)) (NNS roles)) (PP (IN for) (NP (NN hsp90))) (PP (IN in) (S (VP (VBG modulating) (NP (NP (NN dioxin) (NN receptor)) (NN function)))))) (VP (VBP are) (ADVP (RB therefore)) (ADJP (JJ likely)))) (: :) (NP (NP (NP (JJ correct) (NN folding)) (PP (IN of) (NP (DT the) (JJ ligand-binding) (NN domain)))) (, ,) (NP (NP (NN interference)) (PP (IN with) (NP (NP (NN Arnt)) (NN heterodimerization)))) (, ,) (CC and) (NP (NP (NN folding)) (PP (IN of) (NP (NP (DT a) (JJ DNA-binding) (NN conformation)) (PP (IN of) (NP (DT the) (NP (JJ bHLH) (NN domain)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (DT the) (NP (NN dioxin) (NN receptor)) (NN system)) (VP (VBZ provides) (NP (NP (DT a) (ADJP (ADJP (JJ complex)) (CC and) (ADJP (JJ interesting))) (NN model)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN transcription) (NNS factors))) (PP (IN by) (NP (NN hsp90))))))) (. .))))
(S1 (S (NP (NP (NP (NN T-cell) (JJ functional) (NNS regions)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN IL-3) (JJ proximal) (NN promoter)))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ human) (NN interleukin-3) (-LRB- -LRB-) (NN IL-3) (-RRB- -RRB-) (NN gene))) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB almost) (RB exclusively)) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS cells)))))) (. .)))))
(S1 (S (S (NP (PRP$ Its) (NN expression)) (VP (VBZ is) (VP (VBN regulated) (PP (IN at) (NP (CC both) (DT the) (NP (ADJP (JJ transcriptional))) (CC and) (NP (ADJP (JJ post-transcriptional))) (NP (NN level)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN treatment)) (PP (IN of) (NP (NN Jurkat) (NN T) (NNS cells))) (PP (IN with) (NP (NP (NP (NN phytohemaglutinin)) (PRN (-LRB- -LRB-) (NP (NN PHA)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN phorbol) (NN ester)) (, ,) (NP (NN PMA)) (, ,))))) (VP (VBD activated) (NP (NP (NN transcription) (NN initiation)) (PP (IN from) (NP (DT the) (NP (NN IL-3) (NN gene)))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB define) (NP (NP (DT the) (NNS regions)) (PP (IN of) (NP (NP (DT the) (NN gene)) (VP (VBN required) (PP (IN for) (NP (NN transcription) (NN activation)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD generated) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NN reporter) (NNS constructs)) (VP (VBG containing) (NP (NP (JJ different) (NNS regions)) (PP (IN of) (NP (DT the) (NP (NN IL-3) (NN gene) (JJ 5') (CC and) (JJ 3') (JJ flanking) (NNS sequences))))))))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (ADJP (JJ positive))) (CC and) (NP (ADJP (JJ negative))) (NP (JJ regulatory) (NNS elements))) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (NP (DT the) (NP (JJ proximal) (JJ 5') (JJ flanking) (NN region))) (PP (IN of) (NP (DT the) (NP (NN IL-3) (NN gene)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN promoter) (NN region))) (PP (IN between) (NP (CD -173) (CC and) (CD -60)))) (VP (VBD contained) (NP (DT the) (JJS strongest) (NP (VBG activating) (NNS elements)))) (. .))))
(S1 (S (S (NP (DT The) (NP (NP (NN transcription) (NN factor)) (NP (NN AP-1)))) (VP (MD could) (VP (VB bind) (PP (TO to) (NP (NP (DT this) (JJ positive) (NN activator) (NN region)) (PP (IN of) (NP (DT the) (NN promoter))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VP (VBD examined) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (DT the) (NP (NN IL-3) (NN CK-1/CK-2) (NNS elements))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (JJ many) (NP (NN cytokine) (NNS genes)))))))))))) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP (PRP they)) (VP (VP (VBD acted) (PP (IN as) (NP (NP (DT a) (NN repressor)) (PP (IN of) (NP (JJ basal) (NN level) (NN expression))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN cloned) (ADVP (RB upstream) (PP (IN of) (NP (DT a) (NP (JJ heterologous) (NN promoter))))))))) (CC but) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ inducible) (PP (IN by) (NP (NN PMA/PHA)))))))))) (. .))))
(S1 (S (S (S (NP (CD Two) (JJ distinct) (NN signalling) (NNS pathways)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (DT the) (JJ biphasic) (NP (NN junB)) (NN transcription)) (VP (VBN induced) (PP (IN by) (NP (NN interleukin-6))) (PP (IN in) (NP (DT the) (NP (NN B) (NN cell) (NN hybridoma) (NN 7TD1))))))))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN measured) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN junB) (NN mRNA)) (PP (IN in) (NP (DT the) (NP (NN B) (NN hybridoma) (NN cell) (NN line) (NN 7TD1))))))) (, ,) (PP (IN under) (NP (NP (NP (NN interleukin-6)) (PRN (-LRB- -LRB-) (NP (NN IL-6)) (-RRB- -RRB-))) (NN stimulation))))) (. .)))))
(S1 (S (S (NP (NN IL-6)) (VP (VBZ increases) (NP (NN junB) (NN mRNA)) (PP (IN in) (NP (DT a) (JJ biphasic) (NN fashion)))) (. .))))
(S1 (S (S (NP (DT The) (ADJP (ADJP (JJ first)) (ADJP (JJ early-induced))) (NN peak)) (VP (VP (VBD was) (ADJP (JJ transient))) (CC and) (ADVP (RB likely)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT the) (ADJP (ADJP (RB well) (VBN documented)) (ADJP (JJ typical))) (NP (NN junB) (NN mRNA))) (, ,) (VP (VBN stimulated) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (JJ numerous) (NP (NN growth) (NNS factors))) (, ,) (PP (VBG including) (NP (NN IL-6)))))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (NN variance))) (, ,) (NP (NP (DT the) (JJ second) (NN peak)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN reported) (ADVP (RB previously))))))) (, ,)) (VP (VBD lasted) (NP (JJ several) (NNS hours))) (. .))))
(S1 (S (S (PP (IN As) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (PRP$ its) (NN effect)) (PP (IN on) (NP (NN junB) (NN mRNA))))))) (, ,) (NP (NN IL-6)) (VP (VBD stimulated) (, ,) (PP (IN in) (NP (DT a) (JJ biphasic) (NN fashion))) (, ,) (NP (NP (DT the) (JJ nuclear) (NN accumulation)) (PP (IN of) (NP (DT the) (NP (NN JunB) (NN protein)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (SBAR (IN that) (S (NP (NP (NN IL-6)) (NN regulation)) (VP (VBD occurred) (ADVP (RB exclusively)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level)))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (JJ bimodal) (NN increase)) (PP (IN of) (NP (NP (NN junB) (NN mRNA)) (CC and) (NP (NN JunB) (NN protein))))) (VP (MD can) (VP (VB be) (VP (VBN accounted) (PP (IN for) (PP (IN by) (NP (NP (DT a) (JJ biphasic) (NN stimulation)) (PP (IN of) (NP (NP (NN junB)) (NN transcription))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP point) (PP (TO to) (NP (NP (CD two) (JJ major) (NNS differences)) (PP (IN between) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN control)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ early))) (CC and) (NP (DT the) (ADJP (JJ late))) (NP (JJ IL-6-induced) (NP (NN junB)) (NN transcription) (NNS waves))))))))))) (. .))))
(S1 (S (S (ADVP (RB First)) (, ,) (NP (NN cycloheximide)) (ADVP (RB strongly)) (VP (VBD potentiated) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (DT the) (JJ second) (NN wave)))) (, ,) (SBAR (IN whereas) (S (NP (PRP it)) (VP (VBD failed) (S (VP (TO to) (VP (VB affect) (NP (DT the) (JJ early-induced) (NN burst))))))))) (. .))))
(S1 (S (S (ADVP (RB Second)) (, ,) (NP (NP (NN tyrphostin)) (, ,) (NP (DT a) (NN tyrosine) (NN kinase) (NN inhibitor)) (, ,)) (VP (VBD impaired) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ first))) (CONJP (CC but) (RB not)) (NP (DT the) (ADJP (JJ second))) (NP (NP (NN junB) (NN mRNA)) (NN peak)))))) (. .))))
(S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (NP (NN genistein)) (, ,) (NP (DT another) (NN tyrosine) (NN kinase) (NN inhibitor)) (, ,)) (ADVP (RB totally)) (VP (VBD abolished) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ second) (NN peak)) (PP (IN of) (NP (NN junB) (NN mRNA)))))) (SBAR (IN whereas) (S (NP (PRP it)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (JJ first) (NN peak))))))))) (. .))))
(S1 (S (S (ADVP (RB Altogether)) (NP (DT these) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NN 7TD1) (NNS cells))) (, ,) (NP (NN IL-6)) (VP (VBZ controls) (NP (NP (NN junB)) (NN transcription)) (PP (IN in) (NP (DT a) (JJ biphasic) (NN fashion))) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (CD two) (JJ separate) (NN transduction) (NNS pathways))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Posttranscriptional) (NN regulation)) (PP (IN of) (NP (NN macrophage) (NP (NN tissue) (NN factor)) (NN expression))) (PP (IN by) (NP (NNS antioxidants))) (. .)))))
(S1 (S (S (S (NP (NP (NP (NP (NN Tissue) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TF)) (-RRB- -RRB-))) (NN expression)) (PP (IN by) (NP (NP (NNS cells)) (PP (IN of) (NP (NN monocyte/macrophage) (NN lineage)))))) (VP (VBZ represents) (NP (NP (DT an) (JJ important) (NN mechanism)) (VP (VBG underlying) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (NN fibrin)) (NN deposition))) (PP (IN at) (NP (NP (NNS sites)) (PP (IN of) (NP (JJ extravascular) (NN inflammation))))))))) (. .)))))
(S1 (S (S (NP (JJ Recent) (NN evidence)) (VP (VBZ suggests) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (JJ oxidant) (NN stress)) (PP (IN in) (NP (NP (DT the) (NN signalling) (NN pathway)) (PP (IN of) (NP (JJ various) (NN cell) (NNS types)))))))) (PP (IN by) (NP (NP (NN virtue)) (PP (IN of) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB induce) (NP (NP (NN DNA) (NN binding)) (PP (IN of) (NP (NP (JJ various) (NP (NN transcription) (NNS factors))) (, ,) (PP (VBG including) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (CC and) (NP (NN AP-1))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ antioxidant) (NN treatment))) (PP (IN on) (NP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -induced) (NP (NN TF)) (NN expression)))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NP (NN murine) (JJ peritoneal) (NNS macrophages)) (CC and) (NP (JJ human) (NNS monocytes)))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (, ,) (NP (DT an) (JJ oxidant) (NN scavenger))) (, ,) (CC and) (NP (NP (NN N-acetyl-cysteine)) (, ,) (NP (NP (DT a) (NN precursor)) (PP (IN of) (NP (NP (DT the) (JJ endogenous) (JJ antioxidant)) (NP (NN glutathione)))))) (, ,)) (VP (VBD inhibited) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN macrophage) (NN procoagulant) (NN activity))) (PP (IN by) (NP (NN LPS))))) (. .))))
(S1 (S (S (NP (NN Northern) (NN blot) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS agents)))) (VP (VBD reduced) (NP (JJ LPS-stimulated) (NP (NN TF)) (NN mRNA) (NN accumulation))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suggesting) (NP (NP (DT a) (JJ posttranscriptional) (NN mechanism)) (PP (IN for) (NP (DT the) (NN effect))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunofluorescence) (NNS studies)) (PP (IN of) (NP (JJ human) (NNS monocytes))) (VP (VBG using) (NP (JJ polyclonal) (NP (JJ anti-TF) (NN antibody))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN N-acetyl-cysteine) (NN treatment)) (VP (VBD prevented) (NP (NP (DT the) (JJ characteristic) (JJ plasmalemmal) (NN localization)) (PP (IN of) (NP (NN TF) (NN antigen))) (SBAR (WHNP (WDT that)) (S (VP (VBZ occurs) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN LPS))))))))))))) (. .))))
(S1 (S (S (S (NP (NN Western) (NN blot) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN N-acetyl-cysteine)) (VP (VBD reduced) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (DT the) (NP (JJ 47-kD) (JJ mature) (NN glycoprotein)))) (PP (IN in) (NP (JJ LPS-treated) (NNS cells))))))))) (, ,) (NP (NP (DT a) (NN finding)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT the) (NN immunofluorescence) (NNS studies))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (DT these) (NNS conditions)) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN accumulation)) (PP (IN of) (NP (NP (DT the) (ADJP (RBR less) (JJ mature)) (NNS forms)) (PP (IN of) (NP (NN TF))))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN considered) (ADVP (RB together))))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS antioxidants)) (VP (VBP exert) (NP (PRP$ their) (NNS effects)) (PP (PP (IN by) (S (VP (VBG impairing) (NP (NN translation))))) (CC and/or) (PP (IN by) (S (VP (VBG causing) (NP (NP (NN degradation)) (PP (IN of) (NP (RB newly) (NP (VBN translated) (NN protein)))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS antioxidants))) (PP (IN on) (NP (NN tumor) (NN necrosis) (NN factor)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (NNS species) (JJ specific) (, ,) (PP (PP (IN with) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (JJ LPS-induced) (NN tumor) (NN necrosis) (NN factor)) (PP (IN in) (NP (NN murine) (NNS cells))))))) (, ,) (CC but) (PP (IN with) (NP (NP (NN inhibition)) (PP (IN in) (NP (JJ human) (NNS monocytes))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ posttranscriptional) (NN effect)) (PP (IN of) (NP (NNS antioxidants))) (PP (IN on) (NP (NP (NN TF)) (NN expression) (NNS data)))) (VP (VBZ suggests) (NP (NP (DT a) (JJ novel) (NN mechanism)) (SBAR (WHADVP (WRB whereby)) (S (NP (DT these) (NNS agents)) (VP (MD might) (VP (VB modulate) (NP (NN monocyte/macrophage) (NN activation)))))))) (. .))))
(S1 (S (NP (NP (NP (NN 1,25-Dihydroxyvitamin) (NN D3) (NNS receptors)) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (ADJP (JJ primary))) (CC and) (NP (ADJP (JJ secondary))) (NP (NN hyperparathyroidism)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (VBN decreased) (NN number)) (PP (IN of) (NP (NN calcitriol) (-LRB- -LRB-) (NN 1,25-LRB-OH-RRB-2D3) (-RRB- -RRB-) (NNS receptors)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (JJ parathyroid) (NNS glands)) (PP (IN of) (NP (JJ uremic) (NNS animals)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NNS humans))) (, ,) (NP (NP (NNS studies)) (VP (VBN carried) (PRT (RP out)) (PP (IN in) (NP (ADJP (RB surgically) (VBN removed)) (JJ parathyroid) (NNS glands))))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN calcitriol) (NN binding)) (VP (VBZ is) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (ADJP (JJ primary)))) (PP (IN than) (PP (IN in) (NP (ADJP (JJ secondary)) (NP (NN hyperparathyroidism))))))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (JJ specific) (NNS receptors)) (PP (IN for) (NP (NN calcitriol)))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN investigated) (NP (NP (DT the) (JJ specific) (NN uptake)) (PP (IN of) (NP (JJ 3H-labelled) (NN 1,25-LRB-OH-RRB-2D3))) (PP (IN in) (NP (NP (NN PBMC)) (PP (IN of) (NP (NP (NP (CD 12) (NNS women)) (PP (IN with) (NP (NP (JJ primary) (NN hyperparathyroidism)) (PRN (-LRB- -LRB-) (NP (NN PHP)) (-RRB- -RRB-))))) (, ,) (NP (NP (CD 8) (NNS women)) (PP (IN with) (NP (NP (NN hyperparathyroidism) (ADJP (JJ secondary) (PP (TO to) (NP (ADJP (JJ chronic) (JJ renal)) (NN failure))))) (PRN (-LRB- -LRB-) (NP (NN SH)) (-RRB- -RRB-))))) (, ,) (NP (NP (CD 9) (NNS women)) (PP (IN with) (NP (NP (JJ renal) (NN transplant)) (PRN (-LRB- -LRB-) (NP (NN RT)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (CD 23) (JJ healthy) (NNS women)))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (JJ median) (NP (NP (NN dissociation) (NN constant)) (PRN (-LRB- -LRB-) (NP (NN Kd)) (-RRB- -RRB-)))) (VP (VBD was) (ADJP (JJ similar) (PP (PP (IN in) (NP (NP (DT all) (CD three) (NNS groups)) (PP (IN of) (NP (NNS patients))))) (CC and) (PP (IN in) (NP (JJ healthy) (NNS women))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN mean) (CC +/-) (NN S.D.)) (PRN (-LRB- -LRB-) (NP (NN range)) (-RRB- -RRB-))) (: :)) (NP (NP (NP (NN PHP)) (, ,) (NP (NP (NP (CD 1.2) (CC +/-) (CD 1.0)) (PRN (-LRB- -LRB-) (NP (CD 0.2-4)) (-RRB- -RRB-))) (CC x) (NP (CD 10-LRB--10-RRB-) (NN M)))) (: ;) (NP (NP (NN SH)) (, ,) (NP (NP (NP (CD 0.6) (CC +/-) (CD 0.4)) (PRN (-LRB- -LRB-) (NP (CD 0.2-1.2)) (-RRB- -RRB-))) (CC x) (NP (CD 10-LRB--10-RRB-) (NN M)))) (: ;) (NP (NP (NN RT)) (, ,) (NP (NP (NP (CD 1.1) (CC +/-) (CD 0.5)) (PRN (-LRB- -LRB-) (NP (CD 0.4-1.9)) (-RRB- -RRB-))) (CC x) (NP (CD 10-LRB--10-RRB-) (NN M))))) (: ;) (NP (NP (NNS controls)) (, ,) (NP (NP (NP (CD 1.0) (CC +/-) (CD 0.6)) (PRN (-LRB- -LRB-) (NP (CD 0.3-2.6)) (-RRB- -RRB-))) (CC x) (NP (CD 10-LRB--10-RRB-) (NN M))))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ maximal) (NN binding) (NN capacity)) (PRN (-LRB- -LRB-) (NP (NN Nmax)) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB significantly)) (VP (VP (VP (VBN enhanced) (PP (IN in) (NP (NN PHP)))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NP (NP (CD 3.9) (CC +/-) (CD 1.9)) (PRN (-LRB- -LRB-) (NP (CD 1.3-7.6)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells)) (CC vs.) (NP (NP (NP (CD 2.3) (CC +/-) (CD 0.9)) (PRN (-LRB- -LRB-) (NP (CD 1.1-4.4)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells))) (PP (IN in) (NP (NNS controls)))) (: ;) (NP (NP (NN P)) (ADJP (JJ =) (NP (CD 0.0006))))) (-RRB- -RRB-))) (CC and) (VP (VP (VBN decreased) (PP (IN in) (NP (NN SH))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NP (NP (CD 0.8) (CC +/-) (CD 0.5)) (PRN (-LRB- -LRB-) (NP (CD 0.2-1.6)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells)) (CC vs.) (NP (NP (NP (CD 2.3) (CC +/-) (CD 0.9)) (PRN (-LRB- -LRB-) (NP (CD 1.1-4.4)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells))) (PP (IN in) (NP (NNS controls)))) (: ;) (NP (NP (NN P)) (ADJP (JJ =) (NP (CD 0.0001))))) (-RRB- -RRB-))))) (, ,) (SBAR (IN whereas) (S (NP (DT no) (NNS changes)) (VP (VBD were) (VP (VBN seen) (PP (IN in) (NP (NP (NN RT)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NP (CD 2.3) (CC +/-) (CD 0.7)) (PRN (-LRB- -LRB-) (NP (CD 1.2-3.3)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells)) (CC vs.) (NP (NP (NP (CD 2.3) (CC +/-) (CD 0.9)) (PRN (-LRB- -LRB-) (NP (CD 1.1-4.4)) (-RRB- -RRB-))) (NN fmol/10-LRB-7-RRB-) (NNS cells))) (PP (IN in) (NP (NNS controls)))) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (CD three) (NNS patients)) (PP (IN with) (NP (NN PHP))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NN parathyroidectomy))))))))) (, ,) (NP (DT the) (NN calcitriol) (NN number)) (VP (VBD came) (PRT (RB down)) (PP (TO to) (ADJP (JJ normal)))) (. .))))
(S1 (S (S (NP (NP (NNS Changes)) (PP (IN of) (NP (NN calcitriol) (NNS receptors))) (PP (IN in) (NP (NP (ADJP (JJ primary))) (CC and) (NP (ADJP (JJ secondary))) (NP (NN hyperparathyroidism))))) (VP (VP (MD could) (VP (VB magnify) (NP (NP (DT the) (NNS consequences)) (PP (IN of) (NP (NP (NNS disturbances)) (PP (IN in) (NP (NP (NN serum) (NN concentration)) (PP (IN of) (NP (NN calcitriol) (PRP itself)))))))))) (CC and) (VP (MD might) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ secondary) (NN hyperparathyroidism)) (PP (IN in) (NP (NN uremia)))))))))) (. .))))
(S1 (S (NP (NP (NP (NNS Effects)) (PP (IN of) (NP (DT the) (JJ antisense) (NN myb) (NN expression))) (PP (IN on) (NP (NP (NP (NN hemin-)) (CC and) (NP (JJ erythropoietin-induced) (JJ erythroid) (NN differentiation))) (PP (IN of) (NP (NN K562) (NNS cells))))) (. .)))))
(S1 (S (S (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN c-myb) (NN gene))) (PP (IN in) (NP (NP (JJ erythroid) (NN differentiation)) (PP (IN of) (NP (NN K562) (NN cell))) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NN hemin)) (PRN (-LRB- -LRB-) (NP (NN Hm)) (-RRB- -RRB-))) (CC and) (NP (NP (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NN Epo)) (-RRB- -RRB-))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD constructed) (NP (NP (JJ recombinant) (NN plasmid)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB produce) (NP (JJ antisense) (NN myb) (NN RNA)) (PP (IN after) (NP (NP (NN induction)) (PP (IN with) (NP (NN dexamethasone)))))))))))) (. .)))))
(S1 (S (S (PP (IN During) (NP (NP (NN treatment)) (PP (IN with) (NP (NN Hm))))) (, ,) (S (S (NP (NN K562) (NNS cells)) (ADVP (RB constitutively)) (VP (VBD expressed) (NP (NN c-myb) (NN mRNA)))) (, ,) (CC and) (S (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (PRP them)))) (VP (VBD began) (S (VP (TO to) (VP (VB synthesize) (NP (NP (NN hemoglobin)) (PRN (-LRB- -LRB-) (NP (NN Hb)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (JJ antisense) (NN myb) (NN RNA)))) (VP (VBD reduced) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN c-myb) (NN mRNA)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ Hb-synthesizing) (NNS cells)))) (VP (VBD was) (VP (VBN decreased) (PP (TO to) (NP (CD 20) (NN %)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Epo))))) (, ,) (S (S (NP (NN c-myb) (NN mRNA)) (VP (VBD declined))) (CC and) (S (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (NN K562) (NNS cells)))) (VP (VBD synthesized) (NP (NN Hb)) (ADVP (JJ regardless) (PP (IN of) (NP (NP (JJ antisense) (NN myb) (NN RNA)) (NN expression))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (SBAR (IN that) (S (NP (NP (JJ constitutive) (NN expression)) (PP (IN of) (NP (NN c-myb) (NN mRNA)))) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN for) (JJ Hm-induced) (NN differentiation)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN c-myb) (NN mRNA)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ antisense) (NN myb) (NN RNA)) (NN expression))))))))) (VP (VBZ suppresses) (NP (JJ Hm-induced) (NN differentiation)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN amount)) (PP (IN of) (NP (NP (NN c-myb) (NN mRNA)) (PP (IN in) (NP (NN K562) (NNS cells)))))) (VP (VBD was) (VP (VBN reduced) (PP (IN during) (NP (NP (DT the) (NN differentiation)) (VP (VBN induced) (PP (IN by) (NP (NN Epo)))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN GATA-1) (NN mRNA)))) (VP (VP (VBD was) (ADJP (RB almost) (JJ constant) (PP (IN during) (NP (JJ Hm-induced) (NN differentiation))))) (, ,) (CC but) (VP (VBD increased) (PP (IN during) (NP (NP (NN Epo)) (NN treatment))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN supposed) (SBAR (IN that) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (JJ Hm-induced) (NN differentiation)))) (VP (VBZ is) (VP (VBN distinguished) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ Epo-induced) (NN differentiation)) (PP (IN in) (NP (NN K562) (NNS cells))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (CC and) (NP (NN p105))) (PP (IN in) (NP (NP (NP (NNS monocytes)) (CC and) (NP (NNS macrophages))) (VP (ADVP (RB persistently)) (VBN infected) (PP (IN with) (NP (JJ human) (NN immunodeficiency) (NN virus)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NNS mechanisms)) (VP (VBG regulating) (NP (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NN persistence)) (PP (IN in) (NP (JJ human) (NNS monocytes/macrophages)))))) (VP (VBP are) (ADVP (RB partially)) (VP (VBN understood))) (. .)))))
(S1 (S (S (NP (NP (JJ Persistent) (NN HIV) (NN infection)) (PP (IN of) (NP (NN U937) (JJ monocytic) (NNS cells)))) (VP (VBZ results) (PP (IN in) (NP (NP (NN NF-kappa) (NN B)) (NN activation)))) (. .))))
(S1 (S (S (SBAR (IN Whether) (S (NP (JJ virus-induced) (NP (NN NF-kappa) (NN B)) (NN activation)) (VP (VBZ is) (NP (NP (DT a) (NN mechanism)) (SBAR (WHNP (WDT that)) (S (VP (VBZ favors) (NP (NP (JJ continuous) (JJ viral) (NN replication)) (PP (IN in) (NP (NNS macrophages))))))))))) (VP (VBZ remains) (ADJP (JJ unknown))) (. .))))
(S1 (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB delineate) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (JJ HIV-infected) (NP (NNS monocytes)) (CC and) (NP (NNS macrophages))))))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NN I) (NN kappa) (NN B) (NNS molecules)))))))) (. .))))
(S1 (S (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ persistent) (NN HIV) (NN infection)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (JJ monocytic) (NNS cells))) (CONJP (CC but) (RB also)) (PP (IN in) (NP (NNS macrophages)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ HIV-infected) (NNS cells))) (, ,) (NP (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN protein) (NNS levels)) (VP (VBP are) (VP (VBN decreased) (ADJP (JJ secondary) (PP (TO to) (NP (VBN enhanced) (NN protein) (NN degradation)))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ parallels) (NP (NP (DT the) (VBN increased) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN synthesis)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (VBN increased) (NP (NN I) (NN kappa) (NN B) (NN alpha)) (NN gene) (NN transcription)) (, ,) (PP (FW i.e.)) (, ,) (NP (NP (VBN increased) (NP (NN RNA)) (CC and) (NP (ADJP (JJ transcriptional))) (NP (NN activity))) (PP (IN of) (NP (PRP$ its) (NN promoter-enhancer))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (DT Another) (NN protein)) (PP (IN with) (NP (NN I) (NN kappa) (NN B) (NN function)))) (, ,) (NP (NN p105)) (, ,)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN modified) (PP (IN in) (NP (JJ HIV-infected) (NNS cells)))))) (: :) (S (NP (NP (NP (NN p105))) (CC and) (NP (NP (NN p50))) (NP (JJ steady-state) (NN protein) (NNS levels))) (VP (VBP are) (VP (VBN increased) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NP (VBN increased) (NN synthesis)) (CC and) (NP (JJ proteolytic) (NN processing))) (PP (IN of) (NP (NN p105)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Transcriptional) (NN activity)) (PP (IN of) (NP (NN p105)))) (VP (VP (VBZ is) (ADVP (RB also)) (VP (VBN increased) (PP (IN in) (NP (JJ infected) (NNS cells))))) (CC and) (VP (VBZ is) (ADVP (RB also)) (VP (VBN mediated) (PP (IN by) (NP (NN NF-kappa) (NN B))) (PP (IN through) (NP (DT a) (JJ specific) (NP (NN kappa) (NN B) (NN motif))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (NP (DT a) (JJ triple) (JJ autoregulatory) (NN loop)) (PP (IN in) (NP (NP (NNS monocytes)) (CC and) (NP (NNS macrophages)))) (VP (VBG involving) (NP (NP (NN HIV)) (, ,) (NP (NP (NN p105)) (CC and) (NP (NN p50))) (, ,) (CC and) (NP (NN MAD3)))))) (, ,) (PP (IN with) (NP (NP (DT the) (NN end) (NN result)) (PP (IN of) (NP (NP (JJ persistent) (NN NF-kappa) (NN B) (NN activation)) (CC and) (NP (JJ viral) (NN persistence)))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ persistent) (NN HIV) (NN infection)) (PP (IN of) (NP (NP (NNS monocytes)) (CC and) (NP (NNS macrophages))))) (VP (VBZ provides) (NP (NP (DT a) (JJ useful) (NN model)) (SBAR (WHPP (IN with) (WHNP (WDT which))) (S (VP (TO to) (VP (VB study) (NP (NP (JJ concomitant) (NNS modifications)) (PP (IN of) (NP (JJ different) (NP (NN I) (NN kappa) (NN B) (NNS molecules))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Detection)) (PP (IN of) (NP (DT the) (NP (NN chromosome) (CD 16) (NN CBF) (NN beta-MYH11) (NN fusion) (NN transcript)))) (PP (IN in) (NP (JJ myelomonocytic) (NNS leukemias))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Karyotypic) (NN detection)) (PP (IN of) (NP (NP (JJ chromosomal) (CD 16) (NNS abnormalities)) (VP (ADVP (RB classically)) (VBN associated) (PP (IN with) (NP (NN AML) (NN M4Eo))))))) (VP (MD can) (VP (VB be) (ADJP (JJ difficult)))) (. .)))))
(S1 (S (S (NP (NP (NN Characterization)) (PP (IN of) (NP (NP (NP (DT the) (CD two) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (DT the) (NN inv-LRB-16-RRB--LRB-p13q22-RRB-))))) (, ,) (NP (NP (NN CBF) (NN beta)) (CC and) (NP (NN MYH11))))) (, ,)) (VP (VBZ has) (VP (VBN allowed) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN fusion) (NNS transcripts))) (PP (IN by) (NP (NP (NN reverse-transcriptase) (NN polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN analyzed) (NP (NN CBF) (NN beta-MYH11) (NN fusion) (NNS transcripts)) (PP (IN by) (NP (NN RT-PCR))) (PP (IN in) (NP (JJ myelomonocytic) (NNS leukemias))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without)) (NP (NN eosinophilia)))) (, ,) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (PRP$ their) (NN presence)) (VP (VBZ correlates) (PP (IN with) (NP (NN morphology)))))))))) (. .))))
(S1 (S (S (NP (NP (CD Fifty-three) (NP (NNS cases))) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 11))) (NP (NN AML) (NN M4Eo))) (: ;) (NP (NP (QP (CD 1)) (NP (NP (NN AML) (NN M4)) (PP (IN with) (NP (JJ atypical) (JJ abnormal) (NNS eosinophils)))) (PRN (-LRB- -LRB-) (NP (NN AML) (NN M4) (`` ``) (NN Eo)) (-RRB- -RRB-)))) (: ;) (NP (NP (QP (CD 29))) (NP (NN AML) (NN M4))) (: ;) (NP (NP (QP (CD 8))) (NP (NN AML) (NN M5))) (: ;) (NP (NP (QP (CD 3))) (NP (NN CMML))) (: ;) (CC and) (NP (NP (QP (CD 1))) (NP (NP (NN AML) (NN M2)) (PP (IN with) (NP (NN eosinophilia)))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN analyzed))) (. .))))
(S1 (S (S (NP (DT All) (CD 11) (JJ typical) (NN AML) (NN M4Eo)) (VP (VBD were) (ADJP (NN CBF) (NN beta-MYH11) (JJ positive))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ single) (NN case)) (PP (IN of) (NP (NP (NN AML) (NN M4)) (PP (IN with) (NP (JJ distinctive) (NN eosinophil) (NNS abnormalities)))))) (VP (VBD was) (ADJP (JJ negative) (PP (IN by) (NP (NP (NN karyotype)) (, ,) (NP (NN RT-PCR)) (CC and) (NP (NP (JJ fluorescent) (ADJP (FW in) (FW situ)) (NN hybridization)) (PRN (-LRB- -LRB-) (NP (NN FISH)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (S (NP (NP (CD Three)) (PP (IN of) (NP (NP (NP (CD 29)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN %)) (-RRB- -RRB-))) (NP (NP (NN AML) (NN M4)) (PP (IN without) (NP (JJ abnormal) (NNS eosinophils))))))) (VP (VBD were) (ADJP (NN CBF) (NN beta-MYH11) (JJ positive))) (, ,) (SBAR (WHNP (NP (CD 1)) (WHPP (IN of)) (WDT which)) (S (VP (VBD did) (RB not) (VP (VB show) (NP (DT any) (JJ apparent) (NP (NN chromosome) (CD 16)) (NNS abnormalities)) (PP (IN by) (NP (JJ classical) (NN metaphase) (NN analysis)))))))) (PRN (-LRB- -LRB-) (NP (NP (CD 2)) (VP (RB not) (VBN tested))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (NP (NP (DT Both) (NNS cases)) (VP (VBN tested))) (ADVP (RB also)) (VP (VBD showed) (NP (NP (NN MYH11)) (JJ genomic) (NN rearrangement))) (. .))))
(S1 (S (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (JJ other) (NNS leukemias)))) (VP (VBD were) (ADJP (NN RT-PCR) (JJ positive))) (. .))))
(S1 (S (S (NP (NP (NN Follow-up)) (PP (IN of) (NP (CD three) (NN patient)))) (VP (VBD showed) (NP (NP (JJ residual) (NN positivity)) (PP (IN in) (NP (ADJP (ADJP (JJ apparent)) (ADJP (JJ complete))) (NN remission))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NN CBF) (NN beta-MYH11) (NN fusion) (NNS transcripts)) (VP (VBP occur) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (NP (DT the) (JJ vast) (NN majority)) (PP (IN of) (NP (JJ typical) (NN AML) (NN M4Eo))))) (, ,) (CONJP (CC but) (RB also)) (PP (IN in) (NP (NP (NP (QP (RB approximately) (CD 10)) (NN %)) (PP (IN of) (NP (NP (NN AML) (NN M4)) (PP (IN without) (NP (JJ eosinophilic) (NNS abnormalities)))))) (, ,) (NP (NP (DT a) (ADJP (RB much) (JJR higher)) (NN incidence)) (SBAR (IN than) (S (NP (NP (DT the) (JJ sporadic) (NNS reports)) (PP (IN of) (NP (NP (NP (NN chromosome) (CD 16)) (NNS abnormalities)) (PP (IN in) (NP (NN AML) (NN M4)))))) (VP (MD would) (VP (VB suggest))))))))))))) (. .))))
(S1 (S (S (S (VP (VBN Taken) (ADVP (RB together)) (PP (IN with) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NN CBF) (NN beta-MYH11) (NNS transcripts))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ apparent) (NP (NN chromosome) (CD 16)) (NNS abnormalities))))) (PP (IN by) (NP (JJ classical) (NN banding) (NNS techniques))))))) (, ,) (S (NP (DT these) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ additional) (NN screening)) (PP (IN by) (NP (CC either) (NP (NN RT-PCR)) (CC or) (NP (NN FISH))))) (VP (MD should) (VP (VB be) (VP (VBN performed) (PP (IN in) (NP (DT all) (NN AML) (NN M4))) (, ,) (ADVP (RB regardless) (PP (IN of) (NP (JJ morphologic) (NNS features)))))) (, ,) (S (VP (TO to) (VP (VB allow) (NP (NP (JJ accurate) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (JJ prognostic) (NN importance)) (PP (IN of) (NP (DT this) (NP (NN fusion) (NN transcript))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN OBF-1)) (, ,) (NP (NP (DT a) (NP (JJ novel) (NN B) (JJ cell-specific) (NN coactivator))) (SBAR (WHNP (WDT that)) (S (VP (VBZ stimulates) (NP (NP (NN immunoglobulin) (NN promoter)) (NN activity)) (PP (IN through) (NP (NP (NN association)) (PP (IN with) (NP (JJ octamer-binding) (NNS proteins))))))))) (. .)))))
(S1 (S (S (S (NP (ADJP (JJ Recent)) (NP (ADJP (JJ biochemical))) (CC and) (NP (ADJP (JJ genetic))) (NP (NNS studies))) (VP (VBP indicate) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (NP (DT the) (NP (JJ octamer-binding) (NNS proteins))) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2))))))) (, ,) (NP (JJ other) (NP (NN B) (NN cell) (NNS components))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (ADJP (ADJP (JJ lymphoid-restricted)) (, ,) (ADJP (NN octamer) (JJ site-mediated))) (NP (NN immunoglobulin) (NN gene) (NN promoter)) (NN activity)))))))) (. .)))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (DT a) (JJ genetic) (NN screen)) (PP (IN in) (NP (NN yeast)))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN isolated) (NP (NP (NN B) (JJ cell-derived) (NNS cDNAs)) (VP (JJ encoding) (NP (NP (NP (JJ Oct-binding) (NN factor) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN OBF-1)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ novel) (NN protein)) (SBAR (WHNP (WDT that)) (S (ADVP (RB specifically)) (VP (VBZ associates) (PP (IN with) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2)))))))))))))) (. .))))
(S1 (S (S (NP (JJ Biochemical) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN OBF-1)) (VP (VP (VBZ has) (NP (DT no) (JJ intrinsic) (JJ DNA-binding) (NN activity))) (CC and) (VP (VBZ recognizes) (NP (NP (NP (DT the) (NP (NN POU) (NNS domains))) (PP (IN of) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2))))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT those)) (PP (IN of) (NP (NP (NN Oct-4)) (CC and) (NP (NN Oct-6))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN OBF-1) (NN mRNA))) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT a) (ADJP (RB highly) (JJ cell-specific)) (NN manner)))) (, ,) (S (VP (VBG being) (ADJP (ADJP (ADJP (RBS most) (JJ abundant)) (PP (IN in) (NP (NN B) (NNS cells)))) (CC and) (ADVP (RB essentially)) (ADJP (JJ absent) (PP (IN in) (NP (NP (JJS most)) (PP (IN of) (NP (NP (DT the) (JJ other) (NP (NNS cells)) (CC or) (NP (NNS tissues))) (VP (VBN tested))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (NN OBF-1))) (PP (IN in) (NP (NN HeLa) (NNS cells)))) (ADVP (RB selectively)) (VP (VBZ stimulates) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT a) (JJ natural) (NP (NN immunoglobulin) (NN promoter))))) (PP (IN in) (NP (DT an) (NN octamer) (JJ site-dependent) (NN manner)))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN OBF-1)) (VP (VBZ has) (NP (NP (PDT all) (DT the) (NNS properties)) (VP (VBN expected) (PP (IN for) (NP (DT a) (NP (NN B) (JJ cell-specific) (JJ transcriptional) (NN coactivator) (NN protein))))))) (. .))))
(S1 (S (S (S (NP (NN HIV-1) (NN Tat)) (VP (VBZ potentiates) (NP (JJ TNF-induced) (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (CC and) (NP (NN cytotoxicity))) (PP (IN by) (S (VP (VBG altering) (NP (DT the) (JJ cellular) (NN redox) (NN state)))))) (. .)))))
(S1 (S (S (S (NP (DT This) (NN study)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (-LRB- -LRB-) (NN HIV-1) (-RRB- -RRB-) (NN Tat) (NN protein)) (VP (VBZ amplifies) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (NN tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN cytokine)) (SBAR (WHNP (WDT that)) (S (VP (VBZ stimulates) (NP (NN HIV-1) (NN replication)) (PP (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))))))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NP (NP (NN HeLa) (NNS cells)) (VP (ADVP (RB stably)) (VBN transfected) (PP (IN with) (NP (DT the) (NP (NN HIV-1) (NN tat) (NN gene)))))) (PRN (-LRB- -LRB-) (NP (JJ HeLa-tat) (NNS cells)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NN Tat) (NN protein))))) (VP (VBD enhanced) (NP (CC both) (NP (NP (JJ TNF-induced) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (CC and) (NP (JJ TNF-mediated) (NN cytotoxicity)))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ similar) (NN potentiation)) (PP (IN of) (NP (NP (NN TNF)) (NNS effects)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NP (NN Jurkat) (NN T) (NNS cells)) (CC and) (NP (NN HeLa) (NNS cells))) (VP (VBN treated) (PP (IN with) (NP (JJ soluble) (NP (NN Tat) (NN protein))))))))) (. .))))
(S1 (S (S (NP (JJ TNF-mediated) (NP (NP (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (CC and) (NP (NN cytotoxicity))) (VP (VBZ involves) (NP (NP (DT the) (JJ intracellular) (NN formation)) (PP (IN of) (NP (JJ reactive) (NN oxygen) (NNS intermediates))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ Tat-mediated) (NNS effects)) (PP (IN on) (NP (DT the) (JJ cellular) (NN redox) (NN state)))) (VP (VBD were) (VP (VBN analyzed))) (. .))))
(S1 (S (S (PP (IN In) (NP (CC both) (NP (NN T) (NNS cells)) (CC and) (NP (NN HeLa) (NNS cells)))) (NP (NN HIV-1) (NN Tat)) (VP (VBD suppressed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (JJ Mn-dependent) (NN superoxide) (NN dismutase)) (PRN (-LRB- -LRB-) (NP (NN Mn-SOD)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (JJ mitochondrial) (NN enzyme))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (JJ cellular) (NN defense) (NN system)) (PP (IN against) (NP (JJ oxidative) (NN stress)))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN Mn-SOD)) (NN RNA) (NN protein) (NP (NNS levels)) (CC and) (NP (NN activity))) (VP (VBD were) (ADVP (RB markedly)) (VP (VBN reduced) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Tat))))))) (. .))))
(S1 (S (S (NP (VBN Decreased) (NP (NN Mn-SOD)) (NN expression)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NN glutathione)))) (CC and) (NP (NP (DT a) (JJR lower) (NN ratio)) (PP (IN of) (NP (ADJP (ADJP (VBN reduced)) (: :) (ADJP (VBN oxidized))) (NN glutathione)))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT A) (VBN truncated) (NP (NN Tat) (NN protein))) (PRN (-LRB- -LRB-) (NP (CD Tat1-72)) (-RRB- -RRB-))) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB transactivate) (NP (DT the) (NP (NP (NN HIV-1) (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-)))))))) (, ,)) (ADVP (RB no) (RBR longer)) (VP (VBD affected) (NP (NP (NP (NN Mn-SOD)) (NN expression)) (, ,) (NP (DT the) (JJ cellular) (NN redox) (NN state)) (CC or) (NP (JJ TNF-mediated) (NN cytotoxicity)))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NNS experiments)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ C-terminal) (NN region))) (PP (IN of) (NP (NN HIV-1) (NN Tat)))) (VP (VBZ is) (VP (VBN required)) (S (VP (VP (TO to) (VP (VB suppress) (NP (NP (NN Mn-SOD)) (NN expression)))) (CC and) (VP (TO to) (VP (VB induce) (NP (NP (JJ pro-oxidative) (NNS conditions)) (VP (VBN reflected) (PP (IN by) (NP (NP (DT a) (NN drop)) (PP (IN in) (NP (NP (VBN reduced) (NP (NP (NN glutathione)) (PRN (-LRB- -LRB-) (NP (NN GSH)) (-RRB- -RRB-)))) (CC and) (NP (DT the) (NP (NP (NN GSH)) (: :) (NP (NP (VBN oxidized) (NN GSH)) (PRN (-LRB- -LRB-) (NP (NN GSSG)) (-RRB- -RRB-)))) (NN ratio)))))))))))))))) (. .))))
(S1 (S (PRN (-LRB- -LRB-) (NP (NP (NN ABSTRACT)) (VP (VBN TRUNCATED) (PP (IN AT) (NP (CD 250) (NNS WORDS))))) (-RRB- -RRB-))))
(S1 (S (S (S (NP (JJ Calcium/calmodulin-dependent) (NN protein) (NN kinase) (CD II)) (VP (VBZ downregulates) (NP (NP (CC both) (NP (NN calcineurin)) (CC and) (NP (NN protein) (NN kinase) (JJ C-mediated)) (NP (NNS pathways))) (PP (IN for) (NP (NP (NP (NN cytokine) (NN gene)) (NN transcription)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Engagement)) (PP (IN of) (NP (NP (DT the) (NP (NN T) (NN cell) (NN receptor))) (PP (IN for) (NP (NN antigen)))))) (VP (VBZ activates) (NP (NN phospholipase) (NN C)) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ intracellular) (JJ free) (NN calcium) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NN -LSB-Ca2+-RSB-i)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-)))))))))) (. .)))))
(S1 (S (S (NP (VBN Increased) (NN -LSB-Ca2+-RSB-i)) (VP (VBZ activates) (NP (NP (JJ Ca2+/calmodulin-dependent) (NNS kinases)) (PP (VBG including) (NP (NP (DT the) (JJ multifunctional) (NP (NP (JJ Ca2+/calmodulin-dependent) (NN protein) (NN kinase) (CD II)) (PRN (-LRB- -LRB-) (NP (NN CaM-K) (CD II)) (-RRB- -RRB-)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN calcineurin)) (, ,) (NP (DT a) (NP (NN type) (NN 2B) (NN protein) (NN phosphatase)))))))) (. .))))
(S1 (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP have) (VP (VBN identified) (NP (NN calcineurin)) (PP (IN as) (NP (NP (DT a) (JJ key) (NN enzyme)) (PP (IN for) (NP (NP (NP (NP (NN interleukin)) (PRN (-LRB- -LRB-) (NP (NN IL)) (-RRB- -RRB-))) (CD -2)) (CC and) (NP (NN IL-4)) (NP (NN promoter) (NN activation)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN CaM-K) (CD II)))) (VP (VBZ remains) (ADJP (JJ unknown))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (NNS mutants)) (PP (IN of) (NP (NP (DT these) (NP (NNS kinases)) (CC and) (NP (NNS phosphatases))) (PRN (-LRB- -LRB-) (NP (NP (NP (NN gamma) (NN B*CaM-K)) (CC and) (NP (NN delta) (NN CaM-AI))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))))) (S (VP (TO to) (VP (VB explore) (NP (NP (PRP$ their) (JJ relative) (NN role)) (PP (IN in) (NP (NP (NP (NN cytokine) (NN gene)) (NN transcription)) (CC and) (NP (NP (PRP$ their) (NNS interactions)) (PP (IN with) (NP (JJ PKC-dependent) (NN signaling) (NNS systems))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN gamma) (NN B*CaM-K)) (CC and) (NP (NN delta) (NN CaM-AI))) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB exhibit) (NP (ADJP (JJ constitutive) (JJ Ca-LRB-2+-RRB--independent)) (NN activity)))))) (, ,)) (VP (VBD were) (VP (VBN cotransfected) (PRN (-LRB- -LRB-) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NN combination)))) (-RRB- -RRB-)) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells))) (PP (IN with) (NP (NP (DT a) (NN plasmid)) (VP (VBG containing) (NP (DT the) (JJ intact) (NP (NN IL-2) (NN promoter)) (VP (VBG driving) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN chloramphenicol) (NN acetyltransferase) (NN reporter) (NN gene)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN of) (NP (NN gamma) (NN B*CaM-K))) (PP (IN with) (NP (DT the) (NP (NN IL-2) (NN promoter) (NN construct))))) (VP (VBD downregulated) (NP (PRP$ its) (NN transcription)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN ionomycin)) (CC and) (NP (NP (NN phorbol) (NN myristate) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN CaM-K) (CD II))) (PP (IN on) (NP (NN IL-2) (NN promoter)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN decreased) (NN transcription)) (PP (IN of) (NP (PRP$ its) (NP (NN AP-1)) (CC and) (NP (NN NF-AT)) (NP (NN transactivating) (NNS pathways)))))))) (. .))))
(S1 (S (S (PP (IN Under) (NP (DT the) (JJ same) (NNS conditions))) (, ,) (NP (NN delta) (NN CaM-AI)) (VP (VBD superinduced) (NP (NP (NP (NN IL-2) (NN promoter)) (NN activity)) (PRN (-LRB- -LRB-) (NP (ADJP (RB approximately) (JJ twofold)) (NN increase)) (-RRB- -RRB-)))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT both) (NNS mutants)) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (NN combination))))))) (, ,) (S (NP (NN gamma) (NN B*CaM-K)) (VP (VBD inhibited) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN promoter)))) (PP (IN by) (NP (NN delta) (NN CaM-AI)))))) (. .))))
(S1 (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (NN construct)) (VP (VBG containing) (NP (DT the) (NP (NN IL-4) (NN promoter))))) (ADVP (RB also)) (VP (VBD was) (VP (VBN used)))))) (. .))))
(S1 (S (S (NP (NN gamma) (NN B*CaM-K)) (ADVP (RB also)) (VP (VBD downregulated) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN AP-1)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (NN transfection)) (PP (IN with) (NP (DT a) (ADJP (RB constitutively) (JJ active)) (NN mutant)) (PP (IN of) (NP (NN PKC))))) (CC or) (NP (NP (NN stimulation)) (PP (IN with) (NP (NN PMA))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN CaM-K) (CD II)) (VP (MD may) (VP (VB exert) (NP (JJ negative) (NNS influences)) (PP (IN on) (NP (NP (NP (NN cytokine) (NN gene)) (NN transcription)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells)))))))))) (, ,) (CC and) (VP (VBP provide) (NP (NP (JJ preliminary) (NN evidence)) (PP (IN for) (NP (NP (JJ negative) (NN cross-talk)) (PP (IN with) (NP (DT the) (NP (NN calcineurin-)) (CC and) (NP (NN PKC-)) (NP (JJ dependent) (NN signaling) (NNS systems))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Regulation)) (CC and) (NP (NN specificity))) (PP (IN of) (NP (NP (NP (NN MNDA)) (NN expression)) (PP (IN in) (NP (NP (NNS monocytes)) (, ,) (NP (NNS macrophages)) (, ,) (CC and) (NP (NN leukemia/B) (NN lymphoma) (NN cell) (NNS lines)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (JJ myeloid) (NN cell) (JJ nuclear) (NN differentiation) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN MNDA)) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN observed) (ADVP (RB specifically)) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (JJ granulocyte-macrophage) (NN lineage))))) (PP (IN in) (NP (PRP$ our) (JJR earlier) (NNS reports))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN specificity)) (PP (IN of) (NP (NP (NP (NN MNDA)) (NN expression)) (PP (IN for) (NP (NP (NNS cells)) (PP (IN in) (NP (DT the) (NN granulocyte-macrophage) (NN lineage)))))))) (VP (VBD was) (VP (VBN reexamined) (PP (IN in) (NP (NP (NN cell) (NNS lines)) (VP (VBN established) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Philadelphia) (JJ chromosome-positive) (JJ chronic) (JJ myeloid) (NN leukemia)))))))))) (. .))))
(S1 (S (S (S (S (NP (NP (NN Cell) (NNS lines)) (SBAR (WHNP (WDT that)) (S (VP (VBD expressed) (NP (NN MNDA)))))) (VP (VBD exhibited) (NP (JJ myeloid) (NN cell) (NNS features)))) (CC and) (S (NP (NP (NN granulocyte)) (CC or) (NP (NN monocyte)) (NP (NN differentiation))) (VP (MD could) (VP (VB be) (VP (VBN induced) (ADVP (FW in) (FW vitro)))))) (, ,) (SBAR (IN while) (S (NP (NP (NN cell) (NNS lines)) (VP (VBG exhibiting) (NP (NP (NNS properties)) (PP (IN of) (NP (NP (RB very) (JJ early) (NN stage) (NNS cells)) (CC or) (NP (JJ multipotential) (NNS cells))))))) (VP (VBD did) (RB not) (VP (VB express) (NP (NN MNDA))))))) (. .))))
(S1 (S (S (NP (NP (NNS Cells)) (VP (VBG originating) (PP (IN from) (NP (NP (NNS cases)) (PP (IN of) (NP (NN Burkitt) (POS 's) (NN lymphoma))))))) (VP (VBD were) (ADJP (JJ negative))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (S (S (NP (NP (CD three) (NP (JJ lymphoblastoid) (NN cell) (NNS lines))) (PRN (-LRB- -LRB-) (VP (VBN immortalized) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (JJ Epstein-Barr) (NN virus)))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (RB weakly) (JJ positive)))) (CC and) (S (NP (NN MNDA)) (VP (VBD was) (VP (VBN up-regulated) (PP (IN by) (NP (NP (NP (NN interferon-alpha)) (PRN (-LRB- -LRB-) (NP (NN IFN-alpha)) (-RRB- -RRB-))) (NN treatment))))))) (. .))))
(S1 (S (S (S (SBAR (IN As) (S (NP (PRP we)) (VP (VBD reported) (ADVP (RB previously))))) (, ,) (S (NP (NP (NP (NN MNDA) (NN mRNA)) (NN level)) (PP (IN in) (NP (JJ adherent) (NP (NNS monocytes))))) (VP (VBZ is) (VP (VBN elevated) (PP (IN by) (NP (NN IFN-alpha))))))) (: ;) (S (PP (IN in) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (ADVP (RB further)) (VP (VBD assessed) (NP (NP (NP (NN MNDA)) (NN expression)) (PP (IN in) (NP (ADJP (FW in) (FW vitro)) (JJ monocyte-derived) (NP (NNS macrophages))))))) (. .))))
(S1 (S (S (NP (NP (NP (CD Three) (JJ additional) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN endotoxin)) (, ,) (NP (NN phytohemagglutinin)) (, ,) (CC and) (NP (NN phorbol) (NN ester))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ other) (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (NN function)) (, ,) (NP (NP (NP (NN cytokine)) (NP (NN production)) (, ,) (NP (NN differentiation))) (, ,) (CC and/or) (NP (NP (NN growth)) (PP (IN of) (NP (NNS monocytes))))))))))) (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB alter) (NP (NP (NN MNDA)) (NN expression))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS results)) (VP (VBD varied) (PP (IN with) (NP (NP (DT the) (NN agent)) (, ,) (NP (NN cell) (NN type)) (, ,) (CC and) (NP (NP (NN stage)) (PP (IN of) (NP (NN differentiation))))))) (. .))))
(S1 (S (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NN MNDA)) (NN expression)))) (VP (VBD occurred) (ADVP (ADVP (RB slowly)) (PRN (-LRB- -LRB-) (NP (NP (NNS hours)) (PP (TO to) (NP (NNS days)))) (-RRB- -RRB-))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN MNDA)) (VP (MD could) (VP (VB mediate) (NP (NP (NNS changes)) (VP (VBN realized) (PP (IN over) (NP (DT a) (JJ long) (NN period)))))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS results)) (ADVP (RB also)) (VP (VBP reveal) (NP (NP (DT a) (NN discordance)) (PP (IN in) (NP (JJ certain) (NP (NN MNDA) (JJ positive) (NNS cells)))) (PP (IN between) (NP (NP (JJ steady-state) (NNS levels)) (CC or) (NP (NP (NP (NNS changes)) (PP (IN in) (NP (NNS levels))) (PP (IN of) (NP (NP (NN protein)) (CC and) (NP (NN mRNA))))) (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NN MNDA)) (NN expression)))) (VP (VBZ occurs) (PP (IN at) (NP (QP (JJR more) (IN than) (CD one)) (NN point)))))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NN MNDA)) (NN expression)))) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG opposing) (NP (NP (NN macrophage) (NN differentiation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NNS monocytes/macrophages)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NNS Differences)) (PP (IN in) (NP (NP (NN binding)) (PP (IN of) (NP (NN glucocorticoid) (NN receptor))) (PP (TO to) (NP (NN DNA))))) (PP (IN in) (NP (JJ steroid-resistant) (NN asthma))) (. .)))))
(S1 (S (S (S (SBAR (IN Although) (S (NP (NNS glucocorticosteroids)) (VP (VBP are) (NP (NP (DT a) (ADJP (RB very) (JJ effective)) (NN treatment)) (PP (IN for) (NP (NP (NN asthma)) (CC and) (NP (JJ other) (ADJP (ADJP (JJ chronic)) (ADJP (JJ inflammatory))) (NNS diseases)))))))) (, ,) (S (NP (NP (DT a) (JJ small) (NN proportion)) (PP (IN of) (NP (NNS patients)))) (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (PRP$ their) (JJ therapeutic) (NNS effects)))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (JJ molecular) (NN mechanism)) (PP (IN for) (NP (DT this) (NN steroid) (NN resistance)))) (VP (VBZ is) (ADJP (JJ unclear))) (. .))))
(S1 (S (S (NP (NN Steroid) (NN resistance)) (VP (MD can) (RB not) (VP (VB be) (VP (VBN explained) (PP (PP (IN by) (NP (JJ pharmacokinetic) (NNS mechanisms))) (, ,) (PP (IN by) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NNS steroids))) (PP (TO to) (NP (NN glucocorticoid) (NNS receptors))))))) (, ,) (CC nor) (PP (IN by) (NP (NP (JJ defective) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (DT this) (NN receptor)))))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (JJ molecular) (NN abnormality)) (VP (VBZ lies) (ADJP (JJ distal) (PP (TO to) (NP (JJ nuclear) (NN translocation)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ nuclear) (VBN translocated) (NP (NN glucocorticoid) (NNS receptors)))) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (PRP$ their) (NP (NP (NN DNA) (NN binding) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NN GRE)) (-RRB- -RRB-))))))))) (S (VP (VBG using) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PP (IN in) (NP (NP (NN PBMC)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (ADJP (JJ steroid-sensitive))) (CC and) (NP (ADJP (JJ steroid-resistant))) (NP (NN asthma)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN binding)) (PP (IN of) (NP (DT the) (NP (NN glucocorticoid) (NN receptor)))) (PP (TO to) (NP (NP (NN DNA)) (PP (IN in) (NP (DT these) (NNS patients)))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN studied)) (S (VP (VBG using) (NP (NN Scatchard) (NN analysis))))) (. .))))
(S1 (S (S (S (NP (NN Dexamethasone)) (VP (VBD induced) (NP (NP (DT a) (ADJP (ADJP (JJ significant)) (ADJP (ADJP (JJ rapid)) (CC and) (ADJP (JJ sustained))) (JJ twofold)) (NN increase)) (PP (IN in) (NP (NP (NP (NN GRE)) (NN binding)) (PP (IN in) (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (JJ steroid-sensitive) (JJ asthmatic) (NNS patients)) (CC and) (NP (JJ nonasthmatic) (NNS individuals))))))))))) (, ,) (CC but) (S (NP (DT this)) (VP (VBD was) (ADVP (RB markedly)) (VP (VBN reduced) (PP (IN in) (NP (JJ steroid-resistant) (JJ asthmatic) (NNS patients)))))) (. .))))
(S1 (S (S (NP (NP (NN Scatchard) (NN analysis)) (PP (IN of) (NP (NN glucocorticoid) (NN receptor-GRE) (NN binding)))) (VP (VP (VBD showed) (NP (DT no) (NN change)) (PP (IN in) (NP (NN binding) (NN affinity)))) (CC but) (VP (VBD did) (VP (VB show) (NP (NP (DT a) (VBN reduced) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (ADJP (JJ available) (PP (IN for) (NP (NP (NN DNA) (NN binding)) (PP (IN in) (NP (DT the) (JJ steroid-resistant) (NNS patients)))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT the) (NP (NN glucocorticoid) (NN receptor)))) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NN GRE))))))) (VP (VBZ is) (ADJP (JJ impaired) (PP (IN in) (NP (JJ steroid-resistant) (NNS patients))) (PP (IN because) (PP (IN of) (NP (NP (DT a) (VBN reduced) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (ADJP (JJ available) (PP (IN for) (S (VP (VBG binding) (PP (TO to) (NP (NN DNA))))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT A) (NN family)) (PP (IN of) (NP (NP (NN serine) (NNS proteases)) (VP (VBN expressed) (ADVP (RB exclusively)) (PP (IN in) (NP (JJ myelo-monocytic) (NNS cells))))))) (ADVP (RB specifically)) (VP (VP (VBZ processes) (NP (DT the) (NP (JJ nuclear) (NN factor-kappa) (NN B) (NN subunit) (NN p65))) (ADVP (FW in) (FW vitro))) (CC and) (VP (MD may) (VP (VB impair) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN replication)) (PP (IN in) (NP (DT these) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (NP (CD Two) (NNS groups)) (PP (IN of) (NP (NN U937) (JJ promonocytic) (NNS cells)))) (VP (VBD were) (VP (VBN obtained) (PP (IN by) (S (VP (VBG limiting) (NP (NP (NN dilution) (NN cloning)) (SBAR (WHNP (WDT which)) (S (VP (VBD differed) (ADVP (RB strikingly)) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB support) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN replication)))))))))))))))) (. .)))))
(S1 (S (S (NP (`` ``) (JJ Plus) (NNS clones)) (VP (VBD replicated) (NP (DT the) (NN virus)) (ADVP (RB efficiently)) (, ,) (SBAR (IN whereas) (S (NP (`` ``) (JJ minus) (NNS clones)) (VP (VBD did) (RB not))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (NP (DT these) (NNS clones)) (PP (IN for) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B)) (NN activity)) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB account) (PP (IN for) (NP (DT the) (VBN observed) (NN phenomenon)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (CC plus) (NNS clones)))) (VP (VBD liberated) (NP (DT the) (JJ classical) (NP (NN p50-p65) (NN complex))) (PP (IN from) (NP (JJ cytoplasmic) (NNS pools))) (, ,) (SBAR (IN whereas) (S (NP (JJ minus) (NNS clones)) (VP (VBD produced) (NP (DT an) (ADJP (RB apparently) (JJ novel)) (, ,) (NP (JJ faster-migrating) (NN complex)))))) (, ,) (SBAR (IN as) (S (VP (VBN judged) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ surprising)) (SBAR (IN that) (S (NP (DT the) (NP (JJ faster-migrating) (NN complex))) (VP (VBD was) (VP (VBN composed) (ADVP (RB also)) (PP (IN of) (NP (NP (NN p50)) (CC and) (NP (NN p65))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT the) (NP (NN p65) (NN subunit))) (VP (VBD was) (ADVP (RB COOH-terminally)) (VP (VBN truncated)) (, ,) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NN immunoprecipitation))))))) (. .))))
(S1 (S (S (NP (DT The) (NN truncation)) (VP (VBD resulted) (PP (IN from) (NP (NP (JJ limited) (NN proteolysis)) (PP (IN of) (NP (NN p65))))) (PP (IN during) (NP (NP (JJ cellular) (NN extraction)) (SBAR (WHNP (WDT which)) (S (VP (VBD released) (NP (NP (JJ particular) (NP (JJ lysosomal) (NN serine) (NNS proteases))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN elastase)) (, ,) (NP (NN cathepsin) (NN G)) (, ,) (CC and) (NP (NN proteinase) (CD 3))))))))))) (. .))))
(S1 (S (S (NP (DT These) (JJ specific) (NNS proteases)) (VP (VP (VBP are) (ADVP (RB coordinately)) (VP (VBN expressed))) (CC and) (VP (VBD were) (ADJP (JJ present) (PP (ADVP (RB exclusively)) (PP (IN in) (NP (DT the) (NP (JJ minus) (NN U937) (NNS clones)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (DT the) (NP (JJ plus) (NNS clones)))))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN cathepsin) (NN G)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT these) (NNS proteases)) (VP (VBD were) (VP (VBN detected) (PP (PP (IN in) (NP (NP (JJ certain) (NNS subclones)) (PP (IN of) (NP (NP (NN THP-1)) (CC and) (NP (NN HL-60) (NNS cells)))))) (CC and) (PP (IN in) (NP (JJ primary) (NP (NNS monocytes)))))) (, ,) (S (PP (IN in) (NP (DT each) (NN case))) (VP (VBG correlating) (PP (IN with) (NP (NP (DT the) (VBN truncated) (IN from)) (PP (IN of) (NP (NN p65)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (NP (NP (ADJP (FW in) (FW vitro)) (NN cleavage)) (PP (IN of) (NP (NN p65)))) (PP (IN by) (NP (VBN purified) (NP (NN elastase)) (CC and) (NP (NN cathepsin) (NN G))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (JJ particular) (NP (NN serine) (NNS proteases))) (VP (MD may) (VP (VB have) (NP (NN inhibiting) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (NN HIV-1))) (PP (IN in) (NP (JJ myelo-monocytic) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB also)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ special) (NNS precautions)) (VP (MD must) (VP (VB be) (VP (VBN taken))) (SBAR (WHADVP (WRB when)) (S (VP (VBG making) (NP (NNS extracts)) (PP (IN from) (NP (JJ myelo-monocytic) (NNS cells)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (ADJP (JJ Positive))) (CC and) (NP (ADJP (JJ negative))) (NP (NN regulation))) (PP (IN of) (NP (NP (DT the) (NP (JJ composite) (NN octamer) (NN motif))) (PP (IN of) (NP (DT the) (NP (NN interleukin) (CD 2) (NN enhancer)))))) (PP (IN by) (NP (NP (NN AP-1)) (, ,) (NP (NN Oct-2)) (, ,) (CC and) (NP (JJ retinoic) (NN acid) (NN receptor)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (VBG differentiating) (NN agent) (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (ADVP (RB previously)) (VP (VBN reported) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (NP (NN 12-O-tetradecanoyl-phorbol-13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-))) (JJ /Ca-LRB-2+-RRB--induced) (NNS signals))) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (DT the) (NP (CD -96) (TO to) (JJ -66-bp) (NN octamer) (NN motif))) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NN enhancer)) (PP (IN for) (NP (NP (DT the) (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -2) (NN gene))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encodes) (NP (DT a) (JJ major) (NP (NN T) (NN lymphocyte) (NN growth) (NN factor))))))))))))))))))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (NN IL-2) (NN octamer) (NN motif))) (VP (VBZ is) (NP (NP (DT a) (JJ composite) (NP (NN cis-element))) (SBAR (WHNP (WDT which)) (S (VP (VBZ binds) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NP (JJ TPA/Ca-LRB-2+-RRB--inducible) (JJ nuclear) (NN factor))) (, ,) (ADVP (RB previously)) (VP (VBN termed) (S (NP (NP (JJ octamer-associated) (NN protein)) (PRN (-LRB- -LRB-) (NP (CD OAP40)) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (NN Oct-2) (, ,)) (PP (IN despite) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT an) (ADJP (ADJP (JJ active)) (ADJP (JJ transcriptional))) (NN activation) (NN domain))))) (, ,) (VP (VBZ requires) (NP (JJ TPA/Ca-LRB-2+-RRB--induced) (NNS signals)) (S (VP (TO to) (ADVP (RB strongly)) (VP (VB transactivate) (NP (DT the) (NP (NN IL-2) (NN octamer) (NN motif))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ Oct-2-dependent) (NN transactivation)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NN RA))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NP (DT an) (NP (JJ intact) (JJ COOH-terminal) (NN domain))) (PP (IN of) (NP (NN Oct-2)))))) (VP (VBZ contributes) (PP (TO to) (NP (CC both) (NP (JJ TPA/Ca-LRB-2+-RRB--induced) (NN transactivation)) (CC and) (NP (DT the) (JJ RA-mediated) (NN repression))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (CC both) (NP (NP (NN Fos))) (CC and) (NP (NP (NN Jun))) (NP (NNS components))) (PP (IN of) (NP (DT the) (NP (NN AP-1)) (NNS factors)))) (VP (VBP participate) (PP (IN in) (NP (DT the) (NP (NN OAP40) (NN complex)))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (VBN transfected) (NP (NN c-jun)) (, ,) (NP (NN jun-B)) (, ,) (NP (NN jun-D)) (, ,) (NP (NN c-fos)) (, ,) (CC or) (NP (NN Fos-B)) (NP (NN expression) (NNS vectors))) (ADVP (RB partially)) (VP (VP (VBP substitute) (PP (IN for) (NP (NP (NN TPA)) (CC and) (NP (NN Ca2+))))) (CC and) (VP (VBP cooperate) (PP (IN with) (NP (NN Oct-2))) (PP (IN for) (NP (NP (DT the) (NN transactivation)) (PP (IN of) (NP (DT the) (JJ combined) (NP (NN OAP/octamer) (NN cis-element)))))))) (. .))))
(S1 (S (S (NP (NP (NNS Mutations)) (PP (IN of) (NP (DT the) (NP (JJ genuine) (JJ octamer-binding) (NN site))))) (VP (VBP abrogate) (NP (CC both) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2))))) (CC and) (NP (NP (DT the) (JJ TPA/Ca-LRB-2+-RRB--induced) (NN transactivation)) (PP (IN of) (NP (DT the) (NP (NN OAP/octamer) (NN motif))))))) (. .))))
(S1 (S (S (NP (NN OAP)) (VP (VBZ confers) (PP (TO to) (NP (NP (NP (NN Oct-2)) (NN responsivity)) (PP (TO to) (NP (CC both) (NP (NN TPA/Ca2+)) (CC and) (NP (NN RA)))))) (, ,) (SBAR (IN since) (S (NP (NP (JJ specific) (NNS mutations)) (PP (IN of) (NP (DT the) (NP (JJ AP-1/OAP-binding) (NN site))))) (ADVP (RB significantly)) (VP (VP (VBP reduce) (NP (NP (DT the) (NN transactivation)) (PP (IN by) (NP (NN Oct-2)))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN TPA)) (CC and) (NP (NN Ca2+))))))) (CC and) (VP (VBP abolish) (NP (NP (DT the) (NN inhibition)) (PP (IN by) (NP (NN RA))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (JJ retinoic) (NN acid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN RAR)) (-RRB- -RRB-))) (NN alpha)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB inhibit) (ADVP (FW in) (FW vitro)) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT the) (NN complex)) (PP (IN between) (NP (NP (DT the) (JJ nuclear) (NN AP-1/OAP)) (CC and) (NP (PRP$ its) (JJ specific) (VBG binding) (NN site))))))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN interference)) (PP (IN with) (NP (NP (JJ Oct-2-dependent) (JJ cis-regulatory) (NN function)) (PP (IN of) (NP (DT this) (NP (NN AP-1)) (NN element)))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT the) (JJ TPA/calcium-activated) (NN AP-1/OAP) (NN element)) (VP (VBZ is) (NP (NP (DT the) (JJ main) (NN target)) (PP (IN of) (NP (NP (NP (ADJP (JJ positive))) (CC or) (NP (ADJP (JJ negative))) (NP (JJ regulatory) (NNS signals))) (VP (VBG influencing) (NP (DT the) (NP (NN IL-2) (NN octamer) (NN motif))) (, ,) (PP (IN through) (NP (NP (NP (NN synergism)) (PP (IN with) (NP (NN Oct-2)))) (CC and) (NP (NP (NN antagonism)) (PP (IN by) (NP (NN RAR)))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I) (NP (NN Tax)) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B/Rel)))) (VP (VBZ involves) (NP (NP (NP (NP (NN phosphorylation)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))) (CC and) (NP (NP (NP (NP (NN RelA)) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-))) (JJ -mediated) (NN induction)) (PP (IN of) (NP (DT the) (NP (JJ c-rel) (NN gene))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN tax) (NN gene) (NN product)) (PP (IN of) (NP (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-I)) (-RRB- -RRB-))))) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NP (JJ transcriptional) (NN activator))) (SBAR (WHNP (WDT that)) (S (VP (CC both) (VP (VBZ stimulates) (NP (JJ viral) (NN gene) (NN expression))) (CC and) (VP (VBZ activates) (NP (NP (DT an) (NN array)) (PP (IN of) (NP (NP (JJ cellular) (NNS genes)) (VP (VBN involved) (PP (IN in) (NP (NP (NN T-cell)) (NN growth))))))))))))) (. .)))))
(S1 (S (S (NP (NN Tax)) (VP (VBZ acts) (ADVP (RB indirectly)) (PP (IN by) (S (VP (VP (VBG inducing)) (CC or) (VP (VBG modifying)) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (JJ various) (NN host) (NP (NN transcription) (NNS factors))) (, ,) (PP (VBG including) (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappa) (NN B/Rel) (NN family))) (PP (IN of) (NP (JJ enhancer-binding) (NNS proteins)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (VBG resting) (NN T) (NNS cells))) (, ,) (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (NP (NN NF-kappa) (NN B/Rel) (NNS factors))))) (VP (VBP are) (VP (VBN sequestered) (PP (IN in) (NP (DT the) (NN cytoplasm))) (PP (IN by) (NP (NP (JJ various) (NP (JJ ankyrin-rich) (JJ inhibitory) (NNS proteins))) (, ,) (PP (VBG including) (NP (NN I) (NN kappa) (NN B) (NN alpha))))))) (. .))))
(S1 (S (S (S (NP (NP (NN HTLV-I) (NN Tax)) (NN expression)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (JJ constitutive) (JJ nuclear) (NN expression)) (PP (IN of) (NP (NP (ADJP (RB biologically) (JJ active)) (NP (NN NF-kappa) (NN B))) (CC and) (NP (NN c-Rel) (NNS complexes)))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (JJ biochemical) (NN mechanism) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (VP (VBG underlying) (NP (DT this) (NN response)))) (VP (VBZ remains) (VP (ADVP (RB poorly)) (VBN understood)))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (JJ Tax-stimulated) (JJ nuclear) (NN expression)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (CC both) (NP (JJ HTLV-I-infected) (CC and) (JJ Tax-transfected) (JJ human) (NN T) (NNS cells))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NP (NN phosphorylation)) (CC and) (NP (ADJP (ADJP (JJ rapid)) (ADJP (JJ proteolytic))) (NN degradation))) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (ADJP (ADJP (JJ prior)) (ADJP (FW in) (FW vitro))) (NNS studies))))) (, ,) (NP (NP (ADVP (IN at) (JJS least)) (NP (DT a) (NN fraction))) (PP (IN of) (NP (NP (DT the) (JJ phosphorylated) (NN form)) (PP (IN of) (NP (NN I) (NN kappa) (NN B) (NN alpha)))))) (VP (VP (VBZ remains) (ADVP (RB physically)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NP (NN NF-kappa) (NN B) (NN complex)))) (ADVP (FW in) (FW vivo)))) (CC but) (VP (VBZ is) (ADJP (JJ subject) (PP (TO to) (NP (JJ rapid) (NN degradation)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG promoting) (NP (NP (DT the) (JJ nuclear) (NN translocation)) (PP (IN of) (NP (DT the) (JJ active) (NP (NN NF-kappa) (NN B) (NN complex))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NP (NN Tax)) (NN induction)) (PP (IN of) (NP (JJ nuclear) (NP (NN c-Rel)) (NN expression)))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NP (NP (NP (NP (DT the) (NP (NN RelA))) (PRN (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-))) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ activates) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NP (JJ c-rel) (NN gene))))) (PP (IN through) (NP (DT an) (JJ intrinsic) (NP (NN kappa) (NN B) (NN enhancer) (NN element)))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ normal) (NNS cells))) (, ,) (NP (NP (DT the) (JJ subsequent) (NN accumulation)) (PP (IN of) (NP (JJ nuclear) (NN c-Rel)))) (VP (VBZ acts) (S (VP (TO to) (VP (VB inhibit) (NP (PRP$ its) (JJ own) (JJ continued) (NN production))))) (, ,) (S (VP (VBG indicating) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT an) (JJ autoregulatory) (NN loop))))))) (. .))))
(S1 (S (PRN (-LRB- -LRB-) (NP (NP (NN ABSTRACT)) (VP (VBN TRUNCATED) (PP (IN AT) (NP (CD 250) (NNS WORDS))))) (-RRB- -RRB-))))
(S1 (S (S (S (NP (JJ Distinct) (NP (NN DNase-I) (JJ hypersensitive) (NNS sites))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NN TAL-1)) (NN transcription)) (PP (IN in) (NP (NP (ADJP (JJ erythroid))) (CC and) (NP (NN T-cell)) (NP (NNS lines)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN tal-1) (NN gene))) (, ,) (ADVP (RB frequently)) (VP (VBN activated) (PP (IN in) (NP (JJ human) (NP (NP (NN T-cell) (JJ acute) (JJ lymphoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN T-ALL)) (-RRB- -RRB-)))))) (, ,)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (DT the) (NP (ADJP (JJ erythroid))) (, ,) (NP (ADJP (JJ megakaryocytic))) (, ,) (CC and) (NP (NN mast)) (NP (NN cell) (NNS lineages)))) (PP (IN during) (NP (JJ normal) (NN hematopoiesis))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB gain) (NP (NP (JJ further) (NN insight)) (PP (IN into) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (VBP control) (NP (NP (NN tal-1)) (NN expression))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD investigated) (NP (NP (NP (NN tal-1)) (NN chromatin) (NN structure)) (PP (PP (IN in) (NP (JJ erythroid/megakaryocytic) (NN cell) (NNS lines))) (CC and) (PP (IN in) (NP (NP (NN T-cell) (NNS lines)) (PP (CC either) (PP (IN with)) (CC or) (PP (IN without)) (NP (NN tal-1) (NNS rearrangements))))))))) (. .))))
(S1 (S (S (NP (NN Tal-1) (NN transcription)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ monoallelic) (PP (IN in) (NP (NP (NN Jurkat)) (, ,) (NP (NP (DT a) (NN T-cell) (NN line)) (SBAR (WHNP (WDT that)) (S (VP (VBZ expresses) (NP (NN tal-1)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ apparent)) (ADJP (JJ genomic)) (NN alteration))) (PP (IN of) (NP (DT the) (NN locus))))))))))))))))))) (. .))))
(S1 (S (S (NP (NN Methylation) (NNS studies)) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT the) (NP (NN tal-15) (POS ') (JJ GC-rich) (NN region))) (VP (VBZ behaves) (PP (IN like) (NP (NP (DT a) (NP (NN CpG) (NN island))) (, ,) (VP (VP (VBN hypomethylated) (PP (IN in) (NP (JJ normal) (NNS cells)))) (, ,) (CC and) (VP (VBN methylated) (ADVP (FW de) (FW novo)) (PP (IN on) (NP (NP (RB transcriptionally) (JJ inactive) (NNS alleles)) (PP (IN in) (NP (JJ established) (NN cell) (NNS lines))))))))))))) (. .))))
(S1 (S (S (NP (CD Five) (JJ major) (NP (NP (NN DNase-I) (JJ hypersensitive) (NNS sites)) (PRN (-LRB- -LRB-) (NP (NN HS)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN mapped) (PP (IN in) (NP (DT the) (NP (NN tal-1)) (NN locus))))) (. .))))
(S1 (S (S (NP (NN HS) (NP (CD I)) (, ,) (NP (CD IV)) (, ,) (CC and) (NP (CD V))) (VP (VBD were) (ADVP (RB exclusively)) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NP (JJ erythroid/megakaryocytic) (NN cell) (NNS lines))) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (NN tal-1)) (PP (IN from) (NP (NP (DT the) (NNS promoters)) (NP (NP (NN 1a)) (CC and) (NP (NN 1b)))))))))))) (. .))))
(S1 (S (S (NP (NN HS) (CD II)) (VP (VBD was) (UCP (ADJP (JJ weak) (PP (IN in) (NP (JJ hematopoietic) (NN cell) (NNS lines)))) (, ,) (ADJP (JJ absent) (PP (IN in) (NP (NN Hela)))) (, ,) (CC and) (ADVP (RB greatly)) (VP (VBN enhanced) (PP (IN in) (NP (NN Jurkat))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT this) (NN region)) (VP (MD might) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN cis-activation)) (PP (IN of) (NP (NP (NN tal-1) (NN promoter) (NN 1b)) (PP (IN in) (NP (DT this) (NN cell) (NN line))))))))))))))) (. .))))
(S1 (S (S (NP (NN HS) (CD III)) (VP (VBD was) (UCP (ADJP (JJ weak) (PP (IN in) (NP (NP (NN HEL)) (CC and) (NP (NN Jurkat))))) (, ,) (CC and) (ADVP (RB greatly)) (VP (VBN enhanced) (PP (IN in) (NP (NP (NN DU528)) (, ,) (NP (NP (DT a) (NP (NN T-cell) (NN line))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ bears) (NP (DT a) (NN t-LRB-1;14-RRB-))) (CC and) (VP (VBZ initiates) (NP (NP (NN tal-1)) (NN transcription)) (PP (IN within) (NP (NN exon) (CD 4))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ distinct) (NP (JJ regulatory) (NNS elements))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (JJ different) (NP (NN tal-1) (NNS promoters))))))))))) (. .))))
(S1 (S (NP (NP (NP (NNS Functions)) (PP (IN of) (NP (NP (NN glutathione)) (CC and) (NP (NN glutathione) (NN disulfide)))) (PP (IN in) (NP (NP (NN immunology)) (CC and) (NP (NN immunopathology)))) (. .)))))
(S1 (S (S (S (NP (ADVP (RB Even)) (NP (DT a) (JJ moderate) (NN increase)) (PP (IN in) (NP (DT the) (JJ cellular) (NN cysteine) (NN supply)))) (VP (VP (VBZ elevates) (NP (DT the) (ADJP (JJ intracellular)) (NP (NP (NN glutathione)) (PRN (-LRB- -LRB-) (NP (NN GSH)) (-RRB- -RRB-))) (CC and) (NP (NP (NN glutathione) (NN disulfide)) (PRN (-LRB- -LRB-) (NP (NN GSSG)) (-RRB- -RRB-))) (NP (NNS levels)))) (CC and) (VP (VBZ potentiates) (NP (NP (JJ immunological) (NNS functions)) (PP (IN of) (NP (NNS lymphocytes)))) (ADVP (FW in) (FW vitro)))) (. .)))))
(S1 (S (S (PP (IN At) (NP (JJ low) (NN GSSG) (NNS levels))) (, ,) (NP (NN T) (NNS cells)) (VP (MD can) (RB not) (ADVP (RB optimally)) (VP (VB activate) (NP (DT the) (ADJP (RB immunologically) (JJ important)) (NP (NP (NN transcription) (NN factor)) (NP (NN NF) (NN kappa) (NN B))))) (, ,) (SBAR (IN whereas) (S (NP (JJ high) (NN GSSG) (NNS levels)) (VP (VBP inhibit) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN GSSG)))) (VP (VBP are) (VP (VBN antagonized) (PP (IN by) (NP (VBN reduced) (NP (NP (NN thioredoxin)) (PRN (-LRB- -LRB-) (NP (NN TRX)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (SBAR (IN As) (S (NP (NP (DT the) (NP (NN protein) (NN tyrosine) (NN kinase)) (NNS activities)) (NP (NP (NN p56lck)) (CC and) (NP (NN p59fyn)))) (VP (VBP are) (VP (VBN activated) (PP (IN in) (NP (JJ intact) (NNS cells))) (PP (IN by) (NP (NN hydrogen) (NN peroxide))))))) (, ,) (S (NP (PRP they)) (VP (VBP are) (NP (NP (JJ likely) (NNS targets)) (PP (IN for) (NP (NN GSSG) (NN action)))))) (. .))))
(S1 (S (S (NP (DT These) (NP (JJ redox-regulated) (NNS enzymes))) (VP (VP (VBP trigger) (NP (NN signal) (NNS cascades)) (PP (IN for) (NP (NP (NN NF) (NN kappa) (NN B)) (NN activation)))) (CC and) (VP (VBP transduce) (NP (NNS signals)) (PP (PP (IN from) (NP (DT the) (NP (NN T) (NN cell) (NN antigen) (NN receptor)))) (, ,) (PP (IN from) (NP (NP (NP (NN CD4))) (CC and) (NP (NN CD8) (NNS molecules)))) (, ,) (CC and) (PP (IN from) (NP (DT the) (NP (NN IL-2) (NN receptor) (NN beta-chain))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT The) (NN effector) (NN phase)) (PP (IN of) (NP (NP (JJ cytotoxic) (NN T) (NN cell)) (NNS responses)))) (CC and) (NP (JJ IL-2-dependent) (NNS functions))) (VP (VBP are) (VP (VBN inhibited) (PP (ADVP (RB even)) (IN by) (NP (NP (DT a) (JJ partial) (NN depletion)) (PP (IN of) (NP (DT the) (JJ intracellular) (NN GSH) (NN pool))))))) (. .))))
(S1 (S (S (SBAR (IN As) (S (NP (NN signal) (NN transduction)) (VP (VBZ is) (VP (VBN facilitated) (PP (IN by) (NP (JJ prooxidant) (NNS conditions))))))) (, ,) (S (NP (PRP we)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (ADJP (JJ well-known)) (ADJP (JJ immunological))) (NNS consequences)) (PP (IN of) (NP (NN GSH) (NN depletion)))) (ADVP (RB ultimately)) (VP (MD may) (VP (VB be) (NP (NP (NNS results)) (PP (IN of) (NP (DT the) (VBG accompanying) (NN GSSG) (NN deficiency)))))))))) (. .))))
(S1 (S (S (SBAR (IN As) (S (NP (NP (JJ HIV-infected) (NNS patients)) (CC and) (NP (JJ SIV-infected) (NN rhesus) (NNS macaques))) (VP (VBP have) (, ,) (PP (IN on) (NP (DT the) (NN average))) (, ,) (ADVP (RB significantly)) (NP (VBN decreased) (NP (NN plasma) (NN cyst) (-LRB- -LRB-) (NN e) (-RRB- -RRB-) (NN ine)) (CC and) (NP (JJ intracellular) (NN GSH)) (NP (NNS levels)))))) (, ,) (S (NP (PRP we)) (ADVP (RB also)) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (NN AIDS)) (VP (MD may) (VP (VB be) (NP (NP (DT the) (NN consequence)) (PP (IN of) (NP (DT a) (NN GSSG) (NN deficiency)))) (ADVP (RB as) (RB well)))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Erythropoietin-dependent) (NN induction)) (PP (IN of) (NP (NP (NN hemoglobin)) (NN synthesis))) (PP (IN in) (NP (DT a) (NP (NP (JJ cytokine-dependent) (NN cell) (NN line)) (NP (NN M-TAT))))) (. .)))))
(S1 (S (S (S (NP (NN M-TAT)) (VP (VBZ is) (NP (NP (DT a) (NP (JJ cytokine-dependent) (NN cell) (NN line))) (PP (IN with) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB differentiate) (PP (IN along) (NP (DT the) (NP (ADJP (JJ erythroid))) (CC and) (NP (ADJP (JJ megakaryocytic))) (NP (NNS lineages))))))))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD cultured) (NP (NN M-TAT) (NNS cells)) (NP (NP (JJ long) (NN term)) (PRN (-LRB- -LRB-) (ADJP (JJR &gt;) (NP (CD 1) (NN year))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ continuous) (NN presence)) (PP (IN of) (NP (NP (NP (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NN EPO)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NN stem) (NN cell) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SCF)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (DT These) (JJ long) (NN term) (NNS cultures)) (VP (VBP are) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (NN M-TAT/EPO)) (, ,) (NP (NN M-TAT/GM-CSF)) (, ,) (CC and) (NP (NN M-TAT/SCF)) (NP (NNS cells)))) (, ,) (ADVP (RB respectively)))) (. .))))
(S1 (S (S (NP (NP (NP (NN Hemoglobin)) (NN concentration)) (CC and) (NP (NP (NP (NN gamma-globin))) (CC and) (NP (NP (JJ erythroid) (JJ delta-aminolevulinate) (NN synthase) (NN mRNA))) (NP (NNS levels)))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN in) (NP (NN M-TAT/EPO) (NNS cells))) (PP (IN than) (PP (IN in) (NP (NN M-TAT/GM-CSF) (NNS cells)))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (VBN supplemented) (NP (NN cytokine))) (VP (VBD was) (VP (VBN switched) (PP (IN from) (NP (NN GM-CSF))) (PP (TO to) (NP (NN EPO))))))) (, ,) (S (S (NP (NP (NP (NN hemoglobin)) (NN synthesis)) (PP (IN in) (NP (NN M-TAT/GM-CSF) (NNS cells)))) (VP (VBD increased) (ADVP (ADVP (RB rapidly)) (PRN (-LRB- -LRB-) (PP (IN within) (NP (CD 5) (NN h))) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN GATA-1) (NN mRNA)))) (VP (VBD increased)))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN GM-CSF))) (PP (TO to) (NP (DT the) (NP (NN M-TAT/EPO) (NN cell) (NN culture))))) (VP (VBD decreased) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN hemoglobin)))) (, ,) (PP (ADVP (RB even)) (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN EPO))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN EPO)) (NN signal)) (PP (IN for) (NP (JJ erythroid) (NN differentiation)))) (VP (VBZ is) (VP (VBN suppressed) (PP (IN by) (NP (NN GM-CSF)))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ erythroid) (NN development)) (PP (IN of) (NP (NN M-TAT) (NNS cells)))) (VP (VBZ is) (VP (VP (VBN promoted) (PP (IN by) (NP (NN EPO)))) (CC and) (VP (VBN suppressed) (PP (IN by) (NP (NN GM-CSF)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN EPO)) (ADVP (RB actively)) (VP (VBZ influences) (NP (NP (DT the) (NN programming)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (VP (VBN required) (PP (IN for) (NP (NP (JJ erythroid) (NN progenitor) (NN cell)) (NN differentiation)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ DNA-binding) (NNS studies)) (PP (IN of) (NP (DT the) (NP (NP (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN antigen) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN EBNA-2)) (-RRB- -RRB-))))) (: :)) (NP (NP (NN evidence)) (PP (IN for) (NP (NP (JJ complex) (NN formation)) (PP (IN by) (NP (NP (JJ latent) (NN membrane) (NN protein) (NN gene) (JJ promoter-binding) (NNS proteins)) (PP (IN in) (NP (JJ EBNA-2-positive) (NN cell) (NNS lines)))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ Epstein-Barr) (NN virus) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ nuclear) (NN antigen) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN EBNA-2)) (-RRB- -RRB-))) (NN protein)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN immortalization)) (PP (IN of) (ADJP (NP (JJ human) (JJ primary) (NN B) (NNS cells)))) (PP (IN by) (NP (NN EBV))))))) (. .)))))
(S1 (S (S (NP (NN EBNA-2)) (VP (VBZ trans-activates) (NP (NP (NP (ADJP (JJ cellular))) (CC and) (NP (ADJP (JJ viral))) (NP (NNS genes))) (PP (IN like) (NP (NP (NN CD23)) (, ,) (NP (NN c-fgr)) (, ,) (NP (NP (JJ latent) (NN membrane) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN LMP1)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ terminal) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN TP1)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NP (NN Trans-activation)) (PP (PP (IN of) (NP (DT the) (NP (NN TP1) (NN promoter)))) (CC and) (PP (IN of) (NP (DT the) (NP (NN BamHI) (NN C) (NN promoter)))))) (VP (VP (VBZ has) (ADVP (RB already)) (VP (VBN been) (VP (VBN investigated) (PP (IN in) (NP (NN detail)))))) (CC and) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (PP (IN via) (NP (JJ protein-protein) (NNS interactions))) (CC and) (RB not) (PP (IN by) (NP (NP (JJ direct) (NN binding)) (PP (IN of) (NP (NP (NN EBNA-2) (NN type) (NN A)) (PRN (-LRB- -LRB-) (PP (IN of) (NP (NN EBV) (NN type) (CD 1))) (-RRB- -RRB-)))) (PP (TO to) (NP (DT the) (NN DNA)))))))))))) (. .))))
(S1 (S (S (NP (NN EBNA-2)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB trans-activate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN LMP) (NN gene)))) (PP (IN in) (NP (JJ several) (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (NP (JJ Various) (NNS reports)) (VP (VBP have) (VP (VBN delineated) (NP (NP (DT the) (NP (JJ cis-acting) (NNS elements))) (PP (IN of) (NP (DT the) (NP (NN LMP) (NN promoter)))) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NN EBNA-2)) (VP (VBZ mediates) (NP (NN trans-activation)))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NN EBNA-2)) (ADVP (RB also)) (VP (VBZ trans-activates) (NP (DT the) (NP (NN LMP) (NN promoter))) (PP (IN by) (NP (JJ protein-protein) (NNS interactions))))))))) (, ,) (S (NP (PRP we)) (VP (VBD performed) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NP (NN gel) (NN retardation) (NNS assays)) (CC and) (NP (NN competition) (NNS experiments))) (PP (IN with) (NP (NP (NN LMP) (NN promoter) (NNS fragments)) (PP (IN of) (NP (JJ different) (NNS sizes)))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD determined) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ protein-binding) (NN region))) (PP (IN on) (NP (DT the) (NP (NN LMP) (NN promoter))))) (VP (VBD was) (PP (IN within) (NP (NP (DT a) (NP (CD 42) (NN bp) (NN fragment))) (VP (VBG encompassing) (NP (NP (NNS nucleotides) (CD -135) (TO to) (CD -176)) (ADJP (JJ relative) (PP (TO to) (NP (DT the) (NP (NN LMP) (JJ transcriptional) (NN start) (NN site))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN None)) (PP (IN of) (NP (NP (DT the) (NN DNA) (NNS fragments)) (VP (VBN investigated))))) (VP (VBD indicated) (NP (NP (NN interaction)) (PP (IN of) (NP (NN EBNA-2))) (PP (IN with) (NP (DT the) (NN DNA))) (PP (IN via) (NP (JJ protein-protein) (NNS interactions))))) (. .))))
(S1 (S (S (NP (NP (DT No) (JJ significant) (NNS differences)) (PP (IN between) (NP (NP (ADJP (JJ EBNA-2-positive))) (CC and) (NP (ADJP (JJ EBNA-2-negative))) (NP (JJ nuclear) (NNS extracts))))) (VP (MD could) (VP (VB be) (VP (VBN seen) (PP (IN in) (NP (DT the) (NN gel) (NN retardation) (NN assay))) (PP (IN under) (NP (NP (NNS conditions)) (SBAR (WHNP (WDT that)) (S (ADVP (RB clearly)) (VP (VBD showed) (NP (NP (NN binding)) (PP (IN of) (NP (NN EBNA-2A))) (PP (TO to) (NP (DT the) (NP (NN TP1) (NN promoter))))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NN sucrose) (NN gradient) (NNS fractions)) (PP (IN in) (NP (DT the) (NN gel) (NN retardation) (NN assay)))))) (VP (VBD provided) (NP (NN evidence) (SBAR (IN that) (S (NP (DT the) (NP (NN LMP) (JJ promoter-binding) (NNS proteins))) (VP (VBP form) (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (JJR higher) (NN M-LRB-r-RRB-)))) (PP (IN in) (NP (NP (JJ EBNA-2-positive) (NN cell)) (NNS extracts)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS complexes)) (VP (VBD were) (VP (VBN destroyed) (PP (IN by) (NP (NN detergent))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP deduce) (PP (IN from) (NP (DT these) (NNS results))) (SBAR (IN that) (S (NP (JJ EBNA-2-positive) (NNS cells)) (VP (MD might) (ADVP (RB indeed)) (VP (VB contain) (NP (NP (JJ specific) (NNS complexes)) (VP (VBN bound) (PP (TO to) (NP (NP (DT the) (NP (NN LMP) (NN promoter)))))) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (, ,) (ADVP (RB however)) (, ,) (ADJP (RB too) (JJ labile) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (DT a) (JJ standard) (NN gel) (NN retardation) (NN assay)))))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (VBN Enhanced) (NN responsiveness)) (PP (TO to) (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)))) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (JJ unique) (NN phenotype)) (PP (IN of) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus) (NN variant)) (NP (NN SIVsmmPBj14))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Infection)) (PP (IN with) (NP (NP (NP (DT a) (NN variant)) (PP (IN of) (NP (JJ simian) (NN immunodeficiency) (NN virus)))) (, ,) (NP (NN SIVsmmPBj14)))) (, ,)) (VP (VBZ leads) (PP (TO to) (NP (NP (ADJP (ADJP (JJ severe)) (ADJP (JJ acute))) (NN disease)) (PP (IN in) (NP (NNS macaques)))))) (. .)))))
(S1 (S (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed)) (S (VP (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ functional) (NN significance)) (PP (IN of) (NP (NP (ADJP (RB previously) (VBN described)) (NNS mutations)) (PP (IN in) (NP (NP (DT the) (NP (JJ viral) (JJ long) (JJ terminal) (NN repeat))) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))))))))) (CC and) (VP (TO to) (VP (VB elucidate) (NP (NP (PRP$ their) (NN contribution)) (PP (TO to) (NP (NP (DT the) (JJ unique) (NN phenotype)) (PP (IN of) (NP (NN SIVsmmPBj14))))))))))) (. .))))
(S1 (S (S (NP (JJ LTR-directed) (NN transcription)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (S (VP (VBG using) (NP (NP (NN luciferase) (NN reporter) (NNS constructs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADVP (RB transiently)) (VP (VBN transfected) (PP (IN into) (NP (VBN cultured) (NNS cells))))))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN cell) (NNS types))))) (, ,) (NP (NP (DT the) (ADJP (ADJP (JJ basal)) (ADJP (JJ transcriptional))) (NN activity)) (PP (IN of) (NP (NP (DT the) (NP (NN LTR))) (PP (IN from) (NP (NN SIVsmmPBj14)))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (NP (CD 2-) (TO to) (RB 4.5-fold)) (JJR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (DT an) (NP (NN LTR))) (PP (IN from) (NP (DT a) (ADJP (RB non-acutely) (JJ pathogenic)) (NN strain))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NP (NNS LTRs))) (VP (VBP differ) (PP (IN by) (NP (NP (CD five) (NN point) (NNS mutations)) (CC and) (NP (NP (DT a) (NP (JJ 22-bp) (NN duplication))) (PP (IN in) (NP (NN SIVsmmPBj14))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ includes) (NP (DT a) (NP (JJ nuclear) (NN factor) (NN kappa) (NN B) (-LRB- -LRB-) (NN NF) (NN kappa) (NN B) (-RRB- -RRB-) (NN site)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Transcriptional) (NNS differences)) (PP (IN between) (NP (DT these) (NP (NNS LTRs))))) (VP (VBD were) (ADVP (RB further)) (VP (VBN enhanced) (PP (IN by) (NP (CD two-) (TO to) (RB threefold))) (PP (PP (IN upon) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NP (NN phorbol) (NN ester)) (CC or) (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)))))) (CC or) (PP (IN by) (NP (NP (NN cotransfection)) (PP (IN with) (NP (NP (NNS plasmids)) (VP (VBG expressing) (NP (NP (NN NF) (NN kappa) (NN B)) (NNS subunits)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutagenesis) (NNS studies)) (, ,) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT a) (NN reporter) (NN construct)) (VP (VBG containing) (NP (DT an) (JJ enhancerless) (NN promoter)))))) (, ,)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT these) (JJ transcriptional) (NNS effects)) (VP (VBP are) (ADJP (JJ due) (PP (ADVP (RB principally)) (TO to) (NP (NP (DT the) (NP (JJ 22-bp) (NN sequence) (NN duplication))) (CC and) (NP (NP (DT the) (NP (NN NF) (NN kappa) (NN B) (NN site))) (VP (VBN contained) (PP (IN within) (NP (PRP it)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (JJ infectious) (NN virus) (NNS stocks)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ isogenic) (PP (IN except) (PP (IN for) (NP (DT the) (NP (NN LTR)))))))))) (VP (VBD were) (VP (VBN generated))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (NN LTR))) (PP (IN from) (NP (NN SIVsmmPBj14)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB confer) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NNS kinetics)) (PP (IN of) (NP (NN virus) (NN replication)))))) (PP (IN in) (NP (VBN cultured) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (NN Inclusion)) (PP (IN of) (NP (DT this) (NP (NN LTR)))) (PP (IN in) (NP (JJ recombinant) (NNS SIVs)))) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD two-) (TO to) (JJ threefold)) (NN rise)) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (JJ cellular) (NN proliferation)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (JJ quiescent) (JJ simian) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS studies)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NP (NN LTR)) (NNS mutations)) (VP (VP (VBP assist) (NP (NN SIVsmmPBj14)) (PP (IN in) (S (VP (VBG responding) (ADVP (RB efficiently)) (PP (TO to) (NP (JJ cellular) (NN stimulation))))))) (CC and) (VP (VBP allow) (S (NP (PRP it)) (VP (TO to) (VP (VB replicate) (PP (TO to) (NP (JJ high) (NNS titers))) (PP (IN during) (NP (NP (DT the) (JJ acute) (NN phase)) (PP (IN of) (NP (JJ viral) (NN infection)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Identification)) (PP (IN of) (NP (NP (DT a) (NN region)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ directs) (NP (NP (DT the) (JJ monocytic) (NN activity)) (PP (IN of) (NP (DT the) (NP (JJ colony-stimulating) (NN factor) (CD 1) (-LRB- -LRB-) (NN macrophage) (JJ colony-stimulating) (NN factor) (-RRB- -RRB-) (NN receptor) (NN promoter)))))) (CC and) (VP (VBZ binds) (NP (NP (NN PEBP2/CBF)) (PRN (-LRB- -LRB-) (NP (NN AML1)) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN receptor)) (PP (IN for) (NP (DT the) (NP (NP (NN macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (CC or) (NP (NP (JJ colony-stimulating) (NN factor) (CD 1)) (PRN (-LRB- -LSB-) (NP (NN CSF-1)) (-RRB- -RSB-))) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN expressed) (PP (IN from) (NP (NP (JJ different) (NNS promoters)) (PP (IN in) (NP (NP (JJ monocytic) (NNS cells)) (CC and) (NP (JJ placental) (NNS trophoblasts)))))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (JJ monocyte-specific) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN CSF-1) (NN receptor))))) (VP (VBZ is) (VP (VBN regulated) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (NN transcription)))))) (PP (IN by) (NP (NP (DT a) (NP (JJ tissue-specific) (NN promoter))) (SBAR (WHNP (WP$ whose) (NN activity)) (S (VP (VBZ is) (VP (VBN stimulated) (PP (IN by) (NP (DT the) (NP (NP (JJ monocyte/B-cell-specific) (NN transcription) (NN factor)) (NP (NN PU.1)))))))))))))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP D.-E.Zhang)) (, ,) (NP (NNP C.J.Hetherington)) (, ,) (NP (NNP H.-M.Chen)) (, ,) (CC and) (NP (NNP D.G.Tenen))) (, ,) (NP (NNP Mol) (NNP .Cell.) (NNP Biol.) (CD 14)) (: :) (NP (CD 373-381)) (, ,) (NP (CD 1994))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (DT the) (NN tissue) (NN specificity)) (PP (IN of) (NP (DT this) (NP (NN promoter))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN mediated) (PP (IN by) (NP (NP (NNS sequences)) (PP (IN in) (NP (NP (DT a) (NP (NN region) (CD II))) (PRN (-LRB- -LRB-) (NP (NN bp) (QP (CD -88) (TO to) (CD -59))) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ lies) (NP (NP (CD 10) (NN bp) (RB upstream)) (PP (IN from) (NP (DT the) (NP (JJ PU.1-binding) (NN site))))))))))))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN analyzed) (PP (IN by) (NP (NP (NN DNase)) (NN footprinting)))))) (, ,) (S (NP (NN region) (CD II)) (VP (VBD was) (VP (VBN protected) (ADVP (RB preferentially)) (PP (IN in) (NP (JJ monocytic) (NNS cells)))))) (. .))))
(S1 (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (VP (VBD confirmed) (SBAR (IN that) (S (NP (NN region) (CD II)) (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NP (JJ nuclear) (NNS proteins)) (PP (IN from) (NP (JJ monocytic) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (NP (CD Two) (NP (NN gel) (NN shift) (NNS complexes))) (PRN (-LRB- -LRB-) (NP (NP (NN Mono) (NN A)) (CC and) (NP (NN Mono) (NN B))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN formed) (PP (IN with) (NP (NP (JJ separate) (NN sequence) (NNS elements)) (PP (IN within) (NP (DT this) (NN region))))))) (. .))))
(S1 (S (S (NP (NP (NN Competition)) (CC and) (NP (NN supershift)) (NP (NNS experiments))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Mono) (NN B)) (VP (VBZ contains) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN polyomavirus) (JJ enhancer-binding) (NN protein) (JJ 2/core-binding) (NN factor) (-LRB- -LRB-) (NN PEBP2/CBF) (-RRB- -RRB-) (NN family) (, ,)))) (SBAR (WHNP (WDT which)) (S (VP (VBZ includes) (NP (DT the) (NN AML1) (NN gene) (NN product)))))) (, ,) (SBAR (IN while) (S (NP (NN Mono) (NN A)) (VP (VBZ is) (NP (NP (DT a) (JJ distinct) (NN complex)) (VP (ADVP (RB preferentially)) (VBN expressed) (PP (IN in) (NP (JJ monocytic) (NNS cells)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Promoter) (NNS constructs)) (PP (IN with) (NP (NP (NNS mutations)) (PP (IN in) (NP (DT these) (NN sequence) (NNS elements)))))) (VP (VBD were) (ADVP (RB no) (RBR longer)) (VP (VBN expressed) (ADVP (RB specifically)) (PP (IN in) (NP (NNS monocytes))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (JJ multimerized) (NN region) (CD II) (NN sequence) (NNS elements)) (VP (VBD enhanced) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT a) (JJ heterologous) (NN thymidine) (NN kinase) (NN promoter))) (PP (IN in) (NP (NP (JJ monocytic) (NNS cells)) (CONJP (CC but) (RB not)) (NP (NP (JJ other) (NN cell) (NNS types)) (VP (VBN tested))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NP (DT the) (NP (JJ monocyte/B-cell-specific) (NN transcription) (NN factor))) (NP (NN PU.1))) (CC and) (NP (DT the) (NP (NN Mono) (NN A)) (CC and) (NP (NN Mono) (NN B)) (NP (NN protein) (NNS complexes)))) (VP (VBP act) (PP (IN in) (NP (NN concert))) (S (VP (TO to) (VP (VB regulate) (NP (NP (JJ monocyte-specific) (NN transcription)) (PP (IN of) (NP (DT the) (NP (NN CSF-1) (NN receptor)))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Epstein-Barr) (NN virus) (NN SM) (NN protein)) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN protein) (NNS products)) (PP (IN of) (NP (DT the) (NP (NP (JJ Epstein-Barr) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN EBV)) (-RRB- -RRB-))) (NN BMLF1) (JJ open) (NN reading) (NN frame)))) (VP (VBP have) (VP (VBN been) (VP (VBN characterized) (PP (IN in) (NP (NP (DT the) (ADJP (ADJP (JJ early)) (ADJP (JJ productive))) (NN cycle)) (PP (IN in) (NP (NP (NN B95-8)) (CC and) (NP (NN Akata) (NNS cells))))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NP (NN SM) (NN protein))) (VP (VBN derived) (PP (IN from) (NP (NP (DT the) (VBN spliced) (NN RNA)) (VP (VBG joining) (NP (NN BSLF2)) (PP (TO to) (NP (NN BMLF1)))))))) (VP (VBZ is) (NP (ADJP (RB much) (DT the) (RBS most) (JJ abundant)) (NN protein))) (. .))))
(S1 (S (S (NP (NN SM)) (VP (VP (VBZ is) (NP (NP (DT a) (NP (NN phosphoprotein))) (PP (IN in) (NP (JJ EBV-infected) (NNS cells))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN phosphorylated) (ADVP (FW in) (FW vitro)) (PP (IN with) (NP (NP (NN casein) (NN kinase) (CD II)) (PRN (-LRB- -LRB-) (NP (NN CKII)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (NP (NP (NN Computer) (NN analysis)) (PP (IN of) (NP (DT the) (NP (NN SM) (NN protein)) (NN sequence)))) (VP (VP (VBD showed) (S (NP (NP (DT a) (NP (NN C) (JJ terminal) (NN section))) (PP (IN of) (NP (NN SM)))) (VP (TO to) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (NP (NN genome) (JJ positional) (NNS homologues)) (PP (IN of) (NP (CD four) (JJ other) (NNS herpesviruses)))))))))) (CC and) (VP (VBD revealed) (NP (NP (NN consensus) (NN CKII) (NNS sites)) (PP (JJ near) (NP (NP (DT the) (NP (NN N) (NNS termini))) (PP (IN of) (NP (NP (DT the) (NP (NN EBV) (NN SM) (NN protein))) (, ,) (NP (DT the) (NP (NN herpes) (JJ simplex) (NN virus) (-LRB- -LRB-) (NN HSV) (-RRB- -RRB-) (NN ICP27) (NN protein))) (CC and) (NP (DT the) (NP (NN herpesvirus) (NNS saimiri) (-LRB- -LRB-) (NNS HVS) (-RRB- -RRB-) (JJ open) (NN reading) (NN frame) (CD 57) (NN protein)))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Site-directed) (NN mutagenesis)) (PP (IN of) (NP (NP (DT the) (NP (NN consensus) (NN CKII) (NN site))) (PP (IN in) (NP (NN EBV) (NP (NN SM))))))) (ADVP (RB greatly)) (VP (VBD reduced) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN phosphorylation)) (PP (IN of) (NP (NN SM))) (PP (IN by) (NP (NN CKII))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NP (NN transactivation)) (PP (IN by) (NP (NN BMLF1) (NNS proteins)))))) (VP (VBZ has) (VP (VBN been) (ADJP (JJ controversial))))) (CC but) (S (NP (NN SM)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB transactivate) (NP (NP (NN gene) (NN expression)) (PP (IN from) (NP (DT a) (NP (NN CAT) (NN reporter) (NN construct))))) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ cytoplasmic) (NN CAT) (NN mRNA))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutagenesis)) (PP (IN of) (NP (NP (DT the) (NP (NN CKII)) (NN site)) (PP (IN in) (NP (NN SM)))))) (VP (VBD made) (NP (DT no) (NN difference)) (PP (TO to) (NP (DT the) (NN transactivation))) (PP (IN in) (NP (DT this) (JJ transient) (NN transfection) (NN assay)))) (. .))))
(S1 (S (NP (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NN NFATp))) (PP (IN in) (NP (NP (NN cyclosporin) (JJ A-sensitive) (NN tumor) (NN necrosis) (NN factor-alpha) (NN gene)) (NN transcription))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN tumor) (NN necrosis) (NN factor-alpha) (-LRB- -LRB-) (NN TNF) (NN alpha) (-RRB- -RRB-) (NN gene))) (VP (VBZ is) (NP (NP (DT an) (JJ immediate) (JJ early) (NN gene)) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS cells))))) (, ,) (PP (IN in) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VBN induced) (PP (IN without) (NP (NP (DT a) (NN requirement)) (PP (IN for) (NP (NN protein) (NN synthesis))))))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Maximal) (NN induction)) (PP (IN of) (NP (NN TNF) (NN alpha) (NN mRNA)))) (VP (MD can) (VP (VB be) (VP (VBN induced) (PP (IN by) (NP (NP (NN treatment)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN with) (NP (NP (NN calcium) (NNS ionophores)) (ADVP (RB alone)))))) (, ,) (PP (IN via) (NP (NP (DT a) (JJ calcineurin-dependent) (NN process)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN blocked) (PP (IN by) (NP (NN cyclosporin) (NN A)))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN identified) (NP (NP (NP (DT a) (NP (NN promoter) (NN element))) (, ,) (NP (NN kappa) (CD 3))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (ADJP (ADJP (JJ calcium-stimulated)) (, ,) (ADJP (NN cyclosporin) (JJ A-sensitive))) (NN induction)) (PP (IN of) (NP (DT the) (NP (NN TNF) (NN alpha) (NN gene)))) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS cells))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT the) (NP (NN kappa) (CD 3) (NN binding) (NN factor))) (VP (VBZ contains) (NP (NP (NN NFATp)) (, ,) (NP (NP (DT a) (NP (JJ cyclosporin-sensitive) (JJ DNA-binding) (NN protein))) (VP (VBN required) (PP (IN for) (NP (NP (NN interleukin-2) (NN gene)) (NN transcription)))))))))) (. .))))
(S1 (S (S (S (NP (NN NFATp)) (VP (VBZ binds) (PP (TO to) (NP (NP (CD two) (NNS sites)) (PP (IN within) (NP (DT the) (NP (NN kappa) (CD 3) (NN element)))))))) (, ,) (CC and) (S (NP (NP (NN occupancy)) (PP (IN of) (NP (DT both) (NNS sites)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NN TNF)) (NN alpha) (NN gene) (NN induction)))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (IN although) (S (NP (DT the) (NP (NN kappa) (CD 3) (NN element))) (VP (VBZ has) (NP (NP (JJ little) (NN sequence) (NN similarity)) (PP (TO to) (NP (JJ other) (NP (JJ NFATp-binding) (NNS sites)))))))) (, ,) (S (NP (PRP it)) (VP (VBZ appears) (S (VP (TO to) (VP (VB function) (PP (IN as) (NP (DT a) (NP (JJ cyclosporin-sensitive) (NN promoter) (NN element))) (PP (IN in) (NP (NN T) (NNS cells))) (PP (IN by) (NP (NP (NN virtue)) (PP (IN of) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB bind) (NP (NN NFATp))))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN involvement)) (PP (IN of) (NP (NN NFATp))) (PP (IN in) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (DT both) (DT the) (NP (NN interleukin-2))) (CC and) (NP (NN TNF) (NN alpha) (NNS genes))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (NN factor)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ coordinate) (NN induction)) (PP (IN of) (NP (JJ multiple) (NP (NN cytokine) (NNS genes)))))) (, ,) (S (VP (VBG starting) (PP (IN at) (NP (NP (DT the) (JJS earliest) (NNS stages)) (PP (IN of) (NP (NN T) (NN cell) (NN activation))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN replication))) (PP (IN by) (NP (DT a) (NP (JJ Tat-activated) (, ,) (VBN transduced) (NN interferon) (NN gene)))) (: :)) (NP (NP (VBN targeted) (NN expression)) (PP (TO to) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (JJ 1-infected) (NNS cells)))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (NN feasibility)) (PP (IN of) (S (VP (VBG using) (NP (NP (NP (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN IFN)) (-RRB- -RRB-))) (NN gene) (NN transfer)) (PP (IN as) (NP (NP (DT a) (JJ novel) (NN approach)) (PP (TO to) (NP (NP (NP (JJ anti-human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN therapy))))))))) (PP (IN in) (NP (DT this) (NN study))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB limit) (NP (NP (NN expression)) (PP (IN of) (NP (NP (DT a) (VBN transduced) (NP (NN HIV-1) (JJ long) (JJ terminal) (NN repeat) (-LRB- -LRB-) (NN LTR) (-RRB- -RRB-) (NN -IFNA2))) (PRN (-LRB- -LRB-) (S (NP (NP (DT the) (ADJP (JJ new) (JJ approved)) (NN nomenclature)) (PP (IN for) (NP (NN IFN) (NNS genes)))) (VP (VBZ is) (VP (VBN used) (PP (IN throughout) (NP (DT this) (NN article)))))) (-RRB- -RRB-)))))))) (S (NP (NP (NP (NN hybrid) (NN gene)) (PP (TO to) (NP (DT the) (NP (JJ HIV-1-infected) (NNS cells))))) (, ,) (NP (NN HIV-1) (NN LTR))) (VP (VBD was) (VP (VBN modified)))) (. .))))
(S1 (S (S (NP (NP (NN Deletion)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappa) (NN B) (NNS elements))) (PP (IN of) (NP (DT the) (NP (NN HIV-1) (NN LTR))))))) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (JJ Tat-mediated) (NN transactivation)) (PP (PP (IN in) (NP (NN T-cell) (NNS lines))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (DT a) (NP (NN monocyte) (NN line))) (, ,) (NP (NN U937)))))) (. .))))
(S1 (S (S (NP (NP (NN Replacement)) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappa) (NN B) (NNS elements))) (PP (IN in) (NP (DT the) (NP (NN HIV-1) (NN LTR)))))) (PP (IN by) (NP (NP (DT a) (NP (NN DNA) (NN fragment))) (VP (VBN derived) (PP (IN from) (NP (NP (DT the) (NP (JJ 5'-flanking) (NN region))) (PP (IN of) (NP (NP (NP (JJ IFN-stimulated) (NN gene) (CD 15)) (PRN (-LRB- -LRB-) (NP (NN ISG15)) (-RRB- -RRB-))) (, ,) (VP (VBG containing) (NP (DT the) (NP (JJ IFN-stimulated) (NN response) (NN element))))))))))) (, ,)) (ADVP (RB partially)) (VP (VBD restored) (NP (NP (JJ Tat-mediated) (NN activation)) (PP (IN of) (NP (NN LTR))) (PP (PP (IN in) (NP (NN T) (NNS cells))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NNS monocytes)))))) (. .))))
(S1 (S (S (NP (NP (NN Insertion)) (PP (IN of) (NP (DT this) (NP (NP (JJ chimeric) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN ISG15) (NN LTR)) (-RRB- -RRB-))))) (ADVP (JJ upstream) (PP (IN of) (NP (DT the) (NP (JJ human) (NN IFNA2) (NN gene)))))) (VP (VBD directed) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN IFN)) (NN synthesis)))) (PP (IN in) (NP (JJ Tat-expressing) (NNS cells))) (, ,) (SBAR (IN while) (S (NP (DT this) (NN promoter)) (VP (VBD was) (RB not) (ADJP (JJ responsive) (PP (TO to) (NP (NN tumor) (NN necrosis) (NN factor) (JJ alpha-mediated) (NN activation)))))))) (. .))))
(S1 (S (S (NP (NP (JJ ISG15-LTR-IFN) (NN hybrid) (NN gene)) (VP (VBN inserted) (PP (IN into) (NP (DT the) (NP (NN retrovirus) (NN vector)))))) (VP (VBD was) (VP (VBN transduced) (PP (IN into) (NP (NP (NN Jurkat)) (CC and) (NP (NN U937) (NNS cells)))))) (. .))))
(S1 (S (S (S (NP (VBN Selected) (NP (VBN transfected) (NNS clones))) (VP (VBD produced) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NP (NN IFN) (NN A)) (PRN (-LRB- -LRB-) (NP (NN IFNA)) (-RRB- -RRB-))))) (ADVP (RB constitutively)))) (, ,) (CC and) (S (NP (PRP$ their) (NNS abilities) (S (VP (TO to) (VP (VB express) (NP (NP (NN interleukin-2)) (CC and) (NP (NN interleukin-2) (NN receptor))) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN with) (NP (NP (NN phytohemagglutinin)) (CC and) (NP (NN phorbol) (NN myristate) (NN acetate)))))))))) (VP (VBD were) (VP (VBN retained)))) (. .))))
(S1 (S (S (NP (NP (NN Enhancement)) (PP (IN of) (NP (NP (NN IFNA)) (NN synthesis))) (VP (VBN observed) (PP (IN upon) (NP (NN HIV-1) (NN infection))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ significant) (NN inhibition)) (PP (IN of) (NP (NN HIV-1) (NN replication))))) (PP (IN for) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 30)) (NNS days)))))) (. .))))
(S1 (S (S (NP (NP (NN Virus)) (VP (VBN isolated) (PP (IN from) (NP (JJ IFNA-producing) (NNS cells))))) (VP (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB replicate) (PP (IN in) (NP (DT the) (NP (NN U937) (NNS cells))))))))) (CC but) (VP (VBD did) (RB not) (VP (VB replicate) (ADVP (RB efficiently)) (PP (IN in) (NP (NP (NN U937) (NNS cells)) (VP (VBN transduced) (PP (IN with) (NP (DT the) (NP (NN IFNA) (NN gene)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (S (VP (VBG targeting) (NP (NP (NN IFN)) (NN synthesis)) (PP (TO to) (NP (JJ HIV-1-infected) (NNS cells))))) (VP (VBZ is) (NP (DT an) (JJ attainable) (NN goal))))) (CC and) (SBAR (IN that) (S (NP (NN autocrine) (NP (NN IFN)) (NN synthesis)) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (JJ long-lasting)) (CC and) (NP (JJ permanent))) (NN suppression)) (PP (IN of) (NP (NN HIV-1) (NN replication)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN protein) (CD 2)) (NN transactivation)) (PP (IN of) (NP (DT the) (NP (JJ latent) (NN membrane) (NN protein) (CD 1) (NN promoter))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NN J) (NN kappa)) (CC and) (NP (NN PU.1)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (DT the) (NP (JJ Epstein-Barr) (NN virus) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ latent) (NN membrane) (NN protein) (CD 1) (-LRB- -LRB-) (NN LMP-1) (-RRB- -RRB-) (NN oncogene))))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (DT the) (NP (NN EBV) (JJ nuclear) (NN protein) (CD 2) (-LRB- -LRB-) (NN EBNA-2) (-RRB- -RRB-) (NN transactivator)))))) (. .)))))
(S1 (S (S (NP (NN EBNA-2)) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (DT the) (NP (NP (JJ cellular) (JJ DNA-binding) (NN protein)) (NP (NN J) (NN kappa)))))))))) (CC and) (VP (VBZ is) (VP (VBN recruited) (PP (TO to) (NP (NP (NNS promoters)) (VP (VBG containing) (NP (DT the) (NN GTGGGAA) (NP (NN J) (NN kappa) (NN recognition) (NN sequence))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (JJ minimal) (JJ EBNA-2-responsive) (NN LMP-1) (NN promoter))) (VP (VBZ includes) (NP (CD one) (NP (NN J) (JJ kappa-binding) (NN site))))) (, ,) (CC and) (S (NP (PRP we)) (ADVP (RB now)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (NN mutation)) (PP (IN of) (NP (DT that) (NN site)))) (, ,) (NP (NP (JJ such)) (SBAR (WHNP (IN that)) (S (NP (NN J) (NN kappa)) (VP (MD can) (RB not) (VP (VB bind)))))) (, ,)) (VP (VBZ reduces) (NP (NP (NN EBNA-2)) (NN responsiveness)) (PP (IN by) (NP (CD 60) (NN %)))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB identify) (NP (NP (JJ other) (NNS factors)) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (DT the) (NP (NP (NN LMP-1) (NN EBNA-2) (NN response) (NN element)) (PRN (-LRB- -LRB-) (NP (NN E2RE)) (-RRB- -RRB-)))))))))))) (, ,) (S (NP (DT a) (NP (JJ -236/-145) (JJ minimal) (NN E2RE))) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN probe))) (PP (IN in) (NP (DT an) (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (ADJP (RB previously) (VBN characterized)) (NNS factors)) (NP (NP (NN J) (NN kappa)) (, ,) (NP (NN PU.1)) (, ,) (CC and) (NP (NN AML1)))) (VP (VBP bind) (PP (TO to) (NP (DT the) (NP (NN LMP-1) (NN E2RE)))) (, ,) (PP (IN along) (PP (IN with) (NP (NP (CD six) (ADJP (JJ other) (JJ unidentified)) (NNS factors)) (PRN (-LRB- -LRB-) (NP (NP (NN LBF2)) (PP (TO to) (NP (NN LBF7)))) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (VBG Binding) (NNS sites)) (VP (VBD were) (VP (VBN mapped) (PP (IN for) (NP (DT each) (NN factor))))) (. .))))
(S1 (S (S (NP (NN LBF4)) (VP (VP (VBZ is) (ADJP (NN B-) (CC and) (NN T-cell) (JJ specific))) (CC and) (VP (VBZ recognizes) (NP (DT the) (NP (NN PU.1) (NN GGAA) (NN core) (NN sequence))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NN methylation) (NN interference)))))))) (. .))))
(S1 (S (S (NP (NN LBF4)) (VP (VP (VBZ has) (NP (NP (DT a) (JJ molecular) (NN mass)) (PP (IN of) (NP (CD 105) (NN kDa))))) (CC and) (VP (VBZ is) (ADVP (RB probably)) (ADJP (JJ unrelated) (PP (TO to) (NP (NN PU.1)))))) (. .))))
(S1 (S (S (NP (NN LBF2)) (VP (VBD was) (VP (VBN found) (PP (RB only) (IN in) (NP (JJ epithelial) (NN cell) (NNS lines)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN LBF3)) (, ,) (NP (NN LBF5)) (, ,) (NP (NN LBF6)) (, ,) (CC and) (NP (NN LBF7))) (VP (VBD were) (RB not) (ADJP (NN cell) (NN type) (JJ specific)))))) (. .))))
(S1 (S (S (NP (NP (NNS Mutations)) (PP (IN of) (NP (DT the) (NP (NN AML1-)) (CC or) (NP (ADJP (JJ LBF4-binding))) (NP (NNS sites))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN EBNA-2)) (NN transactivation))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN mutation)) (PP (IN of) (NP (DT the) (NP (JJ PU.1-binding) (NN site))))) (ADVP (RB completely)) (VP (VBD eliminated) (NP (NP (NN EBNA-2)) (NNS responses)))))) (. .))))
(S1 (S (S (NP (DT A) (NP (NN gst-EBNA-2) (NN fusion) (NN protein))) (ADVP (RB specifically)) (VP (VP (VBD depleted) (NP (NN PU.1)) (PP (IN from) (NP (JJ nuclear) (NNS extracts)))) (CC and) (VP (VBD bound) (ADVP (FW in) (FW vitro)) (NP (VBN translated) (NP (NN PU.1)))) (, ,) (S (VP (VBG providing) (NP (NP (JJ biochemical) (NN evidence)) (PP (IN for) (NP (DT a) (JJ direct) (JJ EBNA-2-PU.1) (NN interaction))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (NN EBNA-2)) (NN transactivation)) (PP (IN of) (NP (DT the) (NP (NN LMP-1) (NN promoter))))) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (QP (IN at) (JJS least) (CD two)) (ADJP (ADJP (JJ distinct)) (ADJP (JJ sequence-specific))) (NP (JJ DNA-binding) (NNS proteins))) (, ,) (NP (NP (NN J) (NN kappa)) (CC and) (NP (NN PU.1))))))))) (. .))))
(S1 (S (S (NP (NP (NN LBF3)) (, ,) (NP (NN LBF5)) (, ,) (NP (NN LBF6)) (, ,) (CC or) (NP (NN LBF7))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN involved))) (, ,) (SBAR (IN since) (S (NP (PRP$ their) (VBG binding) (NNS sites)) (ADVP (RB also)) (VP (VBP contribute) (PP (TO to) (NP (NP (NN EBNA-2)) (NN responsiveness))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Pyrrolidine) (NN dithiocarbamate)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-))) (NN activation)))) (, ,)) (VP (VBZ prevents) (NP (NP (NN apoptosis)) (PP (IN in) (NP (JJ human) (NP (JJ promyelocytic) (NN leukemia) (NN HL-60) (NNS cells)) (CC and) (NP (NNS thymocytes)))))) (. .)))))
(S1 (S (S (S (NP (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB potently)) (VP (VBZ blocks) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B)) (-RRB- -RRB-)))))))))) (, ,) (PP (IN on) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NN apoptosis)) (PP (IN by) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS agents))))))))))) (. .)))))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (DT a) (NP (NP (JJ human) (JJ promyelocytic) (NN leukemia) (NN cell) (NN line)) (, ,) (NP (NN HL-60))))) (, ,) (PP (IN with) (NP (NP (CD 10) (NNS micrograms/mL) (NN etoposide)) (CC or) (NP (CD 2) (NN microM) (NN 1-beta-D-arabinofuranosylcytosine))))) (VP (VP (VBD induced) (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN within) (NP (CD 1) (NN hr)))) (CC and) (ADVP (RB subsequently)) (VP (VBD caused) (NP (NN apoptosis)) (PP (IN within) (NP (QP (JJ 3-4)) (NN hr))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ simultaneous) (NN addition)) (PP (IN of) (NP (ADJP (QP (CD 50-500)) (NN microM)) (NN PDTC))) (PP (IN with) (NP (DT these) (NNS agents)))) (VP (VP (VBD blocked) (NP (NP (NN NF-kappa) (NN B)) (NN activation))) (CC and) (ADVP (RB completely)) (VP (VBD abrogated) (NP (CC both) (ADVP (RB morphologically)) (NP (JJ apoptotic) (NNS changes)) (CC and) (NP (JJ internucleosomal) (NN DNA) (NN fragmentation))) (PP (IN for) (NP (QP (RB up) (TO to) (CD 6)) (NN hr))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN PDTC)) (VP (VBD failed) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NP (NN endonuclease)) (NN activity)) (VP (VBN contained) (PP (IN in) (NP (DT the) (JJ whole) (NN cell) (NNS lysates))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN PDTC)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (PP (IN in) (NP (NP (NP (NN etoposide-)) (CC and) (NP (JJ dexamethasone-induced)) (NP (NN apoptosis))) (PP (IN in) (NP (JJ human) (NNS thymocytes))) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (QP (CD 1-10)) (NN microM))))))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NN PDTC)) (VP (VBZ has) (NP (CC both) (NP (ADJP (NN antioxidant))) (CC and) (NP (JJ metal-ion)) (NP (NN chelating) (NNS activities)))))) (, ,) (S (NP (PRP we)) (VP (VBD tested) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NP (NN N-acetyl-L-cysteine)) (PRN (-LRB- -LRB-) (NP (NN NAC)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (ADJP (JJ antioxidant)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (NN o-phenanthroline)) (PRN (-LRB- -LRB-) (NP (NN OP)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (JJ metal-ion) (NN chelator)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN apoptosis)))))))) (. .))))
(S1 (S (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (NP (NN HL-60) (NNS cells)) (CC or) (NP (NNS thymocytes)))) (PP (IN with) (NP (NP (ADJP (QP (CD 100-500)) (NN microM)) (NN OP)) (PP (IN for) (NP (CD 2) (NN hr))) (, ,) (CONJP (CC but) (RB not)) (NP (ADJP (QP (CD 10-60)) (NN mM)) (NN NAC)))) (, ,)) (VP (VBD suppressed) (NP (NP (JJ subsequent) (NN occurrence)) (PP (IN of) (NP (NP (NN apoptosis)) (VP (VBN induced) (PP (IN by) (NP (NN etoposide)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ apoptotic) (NN process)) (PP (IN of) (NP (JJ human) (JJ hematopoietic) (NNS cells))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Differential) (NN regulation)) (PP (IN of) (NP (NP (NNS proto-oncogenes)) (NP (NP (NN c-jun)) (CC and) (NP (NN c-fos))))) (PP (IN in) (NP (NP (NN T) (NNS lymphocytes)) (VP (VBN activated) (PP (IN through) (NP (NN CD28)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN T) (NN cell) (NN surface) (NN molecule))) (NP (NN CD28))) (VP (VBZ binds) (PP (TO to) (NP (NP (NNS ligands)) (PP (IN on) (NP (NP (JJ accessory) (NNS cells)) (CC and) (NP (NNS APCs)))))) (, ,) (S (VP (VBG playing) (NP (DT an) (ADJP (ADJP (JJ important)) (ADJP (JJ costimulatory))) (NN role)) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (TO to) (NP (NN Ags)))))))) (. .)))))
(S1 (S (S (NP (NP (PRP$ Our) (NN knowledge)) (PP (IN of) (NP (NP (DT the) (JJ intracellular) (NN signaling) (NNS pathways)) (VP (VBN coupled) (PP (TO to) (NP (DT this) (NN receptor))))))) (VP (VBZ is) (ADJP (JJ incomplete))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NN phospholipase) (NN C) (NN gamma) (CD 1))))))) (, ,) (NP (NP (NN ligation)) (PP (IN of) (NP (DT this) (NN receptor)))) (ADVP (RB also)) (VP (VBZ seems) (S (VP (TO to) (VP (VB activate) (NP (DT a) (ADJP (ADJP (JJ calcium-independent)) (, ,) (ADJP (JJ CD28-specific))) (NN pathway)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NN cross-linking)) (PP (IN of) (NP (NP (NN CD28)) (PRN (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (NP (NN CD2)) (, ,) (NP (NN CD5)) (, ,) (NP (NN LFA-1)) (, ,) (CC or) (NP (NN CD7))) (-RRB- -RRB-))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NN c-jun) (NN mRNA))))) (, ,) (PP (IN with) (NP (NP (RB only) (JJ minimal) (NN activation)) (PP (IN of) (NP (NP (NN c-fos)) (NN expression))))))))) (. .))))
(S1 (S (S (NP (NP (JJ CD28-dependent) (NN induction)) (PP (IN of) (NP (NP (NN c-jun)) (NN expression)))) (VP (VP (VBZ requires) (NP (NP (NN protein) (NN tyrosine) (NN kinase)) (NN activity))) (, ,) (CC but) (VP (VBZ does) (RB not) (VP (VB depend) (PP (IN on) (NP (NP (NP (NN activation)) (PP (IN of) (NP (DT a) (NP (NN phorbol) (JJ ester-responsive) (NN protein) (NN kinase) (NN C))))) (CC or) (NP (NP (NN elevation)) (PP (IN of) (NP (JJ cytosolic) (NN calcium))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (JJ CD28-dependent) (NN elevation)) (PP (IN of) (NP (NN c-jun) (NN mRNA)))) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN mRNA) (NN stability))))))))))) (. .))))
(S1 (S (S (NP (DT A) (NN mechanism)) (VP (VBZ is) (VP (VBN suggested))) (WHADVP (WRB whereby)) (S (NP (NP (NN expression)) (PP (IN of) (NP (NP (NN c-jun)) (CC and) (NP (NN junB)))) (, ,)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NP (NN fos) (NN family)))))))) (, ,) (VP (MD can) (VP (VB prevent) (NP (NP (JJ inappropriate) (NN activation)) (PP (IN of) (NP (NN T) (NNS cells))) (VP (VBN caused) (PP (IN by) (NP (NP (NN ligation)) (PP (IN of) (NP (NN CD28))))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT a) (ADJP (ADJP (JJ specific)) (ADJP (JJ antigenic))) (NN stimulus)))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Constitutive) (NP (JJ nuclear) (NN NF-kappa) (NN B))) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NN monocyte) (NN lineage))))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (NNS monocytes))) (, ,) (NP (DT the) (NP (JJ nuclear) (NN factor) (NN NF-kappa) (NN B))) (VP (VBZ has) (VP (VBN been) (VP (VBN invoked) (PP (IN as) (NP (NP (DT an) (JJ important) (NP (NN transcription) (NN factor))) (PP (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (PP (IN of) (NP (NN cytokine) (NNS genes))) (, ,) (PP (IN of) (NP (JJ cell-surface) (NNS receptors)))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (JJ such) (NNS cells))) (, ,) (NP (NP (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF-kappa) (NN B)))) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN without) (NP (JJ intentional) (NN stimulation)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (PRP$ our) (NNS studies))) (, ,) (NP (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (JJ monocytic) (NN line)) (NP (NN Mono) (NN Mac) (CD 6)))))) (, ,) (VP (VBN cultured) (PP (IN in) (NP (NP (NN medium)) (VP (VBG containing) (NP (NP (JJ fetal-calf) (NN serum)) (CC and) (NP (NP (JJ low) (NNS levels)) (PP (IN of) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))))))) (, ,)) (ADVP (RB also)) (VP (VBP exhibit) (NP (ADJP (JJ such) (`` ') (JJ constitutive) ('' ')) (NP (NN NF-kappa) (NN B))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (JJ mobility-shift) (NN analysis)) (PP (IN of) (NP (JJ nuclear) (NNS extracts))))))))) (. .))))
(S1 (S (S (NP (DT This) (NP (JJ nuclear) (NN NF-kappa) (NN B))) (VP (VBD was) (ADVP (RB still)) (ADJP (JJ present)) (SBAR (SBAR (WHADVP (WRB when)) (S (NP (JJ contaminant) (NN LPS)) (VP (VBD was) (VP (VBN removed) (PP (IN by) (NP (NN ultrafiltration))))))) (CC and) (SBAR (WHADVP (WRB when)) (S (NP (NN serum)) (VP (VBD was) (VP (VBN omitted))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Protein-DNA) (NNS complexes)) (PP (IN of) (NP (JJ constitutive) (NP (NN NF-kappa) (NN B))))) (VP (VBP are) (ADJP (JJ similar) (PP (IN in) (NP (NN mobility))) (PP (TO to) (NP (DT the) (NP (JJ LPS-induced) (NN NF-kappa) (NN B))))))) (CC and) (S (NP (DT both)) (VP (VBP are) (VP (VBN recognized) (PP (IN by) (NP (NP (DT an) (NN antibody)) (ADJP (JJ specific) (PP (TO to) (NP (NP (DT the) (NP (NN p50) (NN subunit))) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))))) (. .))))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))))) (VP (MD will) (ADVP (RB only)) (VP (VB block) (NP (NP (JJ LPS-induced) (NN NF-kappa) (NN B)) (, ,) (CONJP (CC but) (RB not)) (NP (DT the) (NP (JJ constitutive) (VBG binding) (NN protein)))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (ADJP (JJ LPS-free))) (CC and) (NP (ADJP (JJ serum-free))) (NP (NNS conditions))))) (, ,) (S (NP (JJ constitutive) (NP (NN NF-kappa) (NN B))) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (PP (IN in) (NP (NP (JJ different) (NP (NN cell) (NNS lines))) (PP (IN of) (NP (DT the) (NP (JJ monocytic) (NN lineage)))) (PRN (-LRB- -LRB-) (NP (NP (NN HL60)) (, ,) (NP (NN U937)) (, ,) (NP (NN THP-1)) (, ,) (NP (NN Mono) (NN Mac) (CD 1)) (CC and) (NP (NN Mono) (NN Mac) (CD 6))) (-RRB- -RRB-)))) (, ,) (CC but) (PP (RB not) (IN in) (NP (NP (NN Molt) (CD 4) (NN T) (NNS cells)) (CC or) (NP (NN K562) (NN stem) (NNS cells))))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN ordered) (PP (VBG according) (PP (TO to) (NP (NP (NN stage)) (PP (IN of) (NP (NN maturation))))))))) (, ,) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ constitutive) (NP (NN NF-kappa) (NN B))))) (VP (VBD was) (RB not) (VP (VBN increased) (PP (IN in) (NP (RBR more) (NP (JJ mature) (NN cell) (NNS lines))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBG inducing) (NP (NP (NN differentiation)) (PP (IN in) (NP (NN Mono) (NN Mac) (CD 6) (NNS cells)))) (, ,) (PP (IN with) (NP (NN vitamin) (NN D3)))))) (, ,) (S (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (ADJP (JJ constitutive))) (CC or) (NP (ADJP (JJ inducible))) (NP (NN NF-kappa) (NN B))))) (VP (MD can) (VP (VB be) (VP (VBN detected))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (JJ primary) (NNS cells)))) (VP (VBD revealed) (NP (NP (ADJP (ADJP (JJ substantial)) (ADJP (JJ constitutive))) (NN NF-kappa) (JJ B-binding) (NN activity)) (PP (IN in) (NP (NP (NN blood) (NNS monocytes)) (, ,) (NP (JJ pleural) (NNS macrophages)) (CC and) (NP (JJ alveolar) (NNS macrophages)))))) (. .))))
(S1 (S (S (S (NP (DT The) (JJ constitutive) (NP (NN NF-kappa) (NN B))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RB functionally) (JJ active))))) (, ,) (SBAR (IN since) (S (NP (NP (DT a) (JJ low) (NN level)) (PP (IN of) (NP (NN tumour) (NN necrosis) (NN factor) (-LRB- -LRB-) (NN TNF) (-RRB- -RRB-) (NN transcript)))) (VP (VBZ is) (ADJP (JJ detectable) (PP (IN in) (NP (NNS monocytes))))))))) (, ,) (CC and) (S (NP (DT this) (NN level)) (VP (MD can) (VP (VB be) (VP (VBN increased) (PP (IN by) (S (VP (VBG blocking) (NP (NN transcript) (NN degradation)) (S (VP (VBG using) (NP (NN cycloheximide))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (JJ constitutive) (NP (NN NF-kappa) (NN B)))) (PP (IN in) (NP (DT these) (NNS cells)))) (VP (VP (VBZ is) (ADJP (JJ variable))) (CC and) (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJR lower) (PP (IN in) (NP (DT the) (RBR more) (NP (JJ mature) (NNS macrophages))))))))))) (. .))))
(S1 (S (S (NP (JJ Constitutive) (NP (NN NF-kappa) (NN B))) (VP (VBD was) (RB not) (VP (VBN maintained) (PP (IN by) (NP (NP (JJ autocrine) (NN action)) (PP (IN of) (NP (NP (NNS cytokines)) (NP (NP (NN TNF)) (, ,) (NP (NN interleukin) (CD 6)) (, ,) (NP (NP (NN interleukin)) (CD 10)) (, ,) (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (CC or) (NP (NN macrophage) (JJ colony-stimulating) (NN factor)))))))) (, ,) (SBAR (IN since) (S (NP (VBG neutralizing) (NNS antibodies)) (VP (VBD did) (RB not) (VP (VB reduce) (NP (ADJP (ADJP (JJ constitutive)) (ADJP (JJ DNA-binding))) (NN activity))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NN blockade)) (PP (IN of) (NP (NN prostaglandin)))) (CC or) (NP (NN leukotriene) (NN biosynthesis))) (VP (VBD did) (RB not) (VP (VB affect) (NP (JJ constitutive) (NP (NN NF-kappa) (NN B))))) (. .))))
(S1 (S (PRN (-LRB- -LRB-) (NP (NP (NN ABSTRACT)) (VP (VBN TRUNCATED) (PP (IN AT) (NP (CD 400) (NNS WORDS))))) (-RRB- -RRB-))))
(S1 (S (S (S (NP (NN Protein) (NN kinase) (NN C-zeta)) (VP (VBZ mediates) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (JJ human) (NN immunodeficiency) (JJ virus-infected) (NNS monocytes))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN molecular) (NNS mechanisms)) (VP (VBG regulating) (NP (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NN persistence)) (PP (IN in) (NP (NP (DT a) (JJ major) (NN cell) (NN reservoir)) (PP (JJ such) (IN as) (NP (DT the) (NP (NN macrophage))))))))) (VP (VBP remain) (ADJP (JJ unknown))) (. .)))))
(S1 (S (S (NP (NN NF-kappa) (NN B)) (VP (VP (VBZ is) (NP (NP (DT a) (NP (NN transcription) (NN factor))) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NP (NN HIV) (JJ long) (JJ terminal) (NN repeat))))))))) (CC and) (VP (VBZ is) (ADVP (RB selectively)) (VP (VBN activated) (PP (VBG following) (NP (NP (NN HIV) (NN infection)) (PP (IN of) (NP (JJ human) (NNS macrophages)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ little) (NN information)) (PP (IN as) (PP (TO to) (SBAR (WHNP (WP what) (NN signal) (NN transduction) (NNS pathways)) (S (VP (VBP mediate) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (NNS monocytes-macrophages)))))))))) (VP (VBZ is) (ADJP (JJ available))))) (, ,) (S (NP (PRP$ our) (JJ previous) (NN work)) (VP (VBD indicated) (SBAR (IN that) (S (NP (JJ classical) (NP (NN protein) (NN kinase) (NN C) (-LRB- -LRB-) (NN PKC) (-RRB- -RRB-) (NNS isoenzymes))) (VP (VBD were) (RB not) (VP (VBN involved) (PP (IN in) (NP (DT the) (JJ HIV-mediated) (NP (NN NF-kappa) (NN B)) (NN activation))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (JJ atypical) (NP (NN PKC) (NNS isoenzymes)))))) (. .))))
(S1 (S (S (NP (NN PKC-zeta)) (VP (VP (VBZ belongs) (PP (TO to) (NP (DT this) (NN family)))) (CC and) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ important) (NN step)) (PP (IN in) (NP (NP (NP (NN NF-kappa) (NN B)) (NN activation)) (PP (IN in) (NP (JJ other) (NN cell) (NNS systems)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunoblotting) (NNS experiments)) (PP (IN with) (NP (NN U937) (NNS cells)))) (VP (VBP demonstrate) (UCP (SBAR (IN that) (S (NP (NN PKC-zeta)) (VP (VBZ is) (ADJP (JJ present) (PP (IN in) (NP (DT these) (NNS cells))))))) (, ,) (CC and) (NP (PRP$ its) (NN expression)) (VP (MD can) (VP (VB be) (VP (VBN downmodulated) (PP (IN by) (NP (NP (JJ antisense) (NNS oligonucleotides)) (PRN (-LRB- -LRB-) (NP (NN AO)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ HIV-mediated) (NP (NN NF-kappa) (NN B)) (NN activation)) (VP (VBZ is) (ADVP (RB selectively)) (VP (VBN reduced) (PP (IN by) (NP (NN AO))) (PP (TO to) (NP (NN PKC-zeta))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN cotransfection)) (PP (IN of) (NP (NP (NP (DT a) (JJ negative) (JJ dominant) (NN molecule)) (PP (IN of) (NP (NN PKC-zeta)))) (PRN (-LRB- -LRB-) (NP (NN PKC-zeta) (NN mut)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN NF-kappa) (JJ B-dependent) (NN reporter) (NNS genes)))) (ADVP (RB selectively)) (VP (VBZ inhibits) (NP (NP (DT the) (NP (NN HIV-)) (CC but) (NP (RB not) (NP (NN phorbol) (NN myristate) (NN acetate-)) (CC or) (NP (JJ lipopolysaccharide-mediated)) (NP (NN activation)))) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (. .))))
(S1 (S (S (SBAR (IN That) (S (NP (NN PKC-zeta)) (VP (VBZ is) (ADJP (JJ specific) (PP (IN in) (S (VP (VBG regulating) (NP (NN NF-kappa) (NN B))))))))) (VP (VBZ is) (VP (VBN concluded) (PP (IN from) (NP (NP (DT the) (NN inability)) (PP (IN of) (NP (NN PKC-zeta) (-LRB- -LRB-) (NN mut) (-RRB- -RRB-))) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (DT the) (NP (ADJP (JJ basal))) (CC or) (NP (NN phorbol) (NN myristate) (JJ acetate-inducible)) (NP (NP (NN CREB-)) (CC or) (NP (JJ AP1-dependent)) (NP (JJ transcriptional) (NN activity)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Lastly)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (NP (DT a) (JJ selective) (NN inhibition)) (PP (IN of) (NP (NP (NN p24)) (NN production))) (PP (IN by) (NP (JJ HIV-infected) (JJ human) (NNS macrophages)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN treated) (PP (IN with) (NP (NN AO))) (PP (TO to) (NP (NN PKC-zeta)))))))) (. .))))
(S1 (S (S (ADVP (RB Altogether)) (, ,) (NP (DT these) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ atypical) (NN PKC) (NNS isoenzymes)) (, ,) (PP (VBG including) (NP (NN PKC-zeta))) (, ,)) (VP (VBP participate) (PP (IN in) (NP (NP (DT the) (NN signal) (NN transduction) (NNS pathways)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN HIV) (NN infection)) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN NF-kappa) (NN B))) (PP (IN in) (NP (NP (JJ human) (JJ monocytic) (NNS cells)) (CC and) (NP (NNS macrophages))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ NF-AT-dependent) (NN transcription))) (PP (IN by) (NP (NN NF-kappa) (NN B))) (: :)) (NP (NP (NNS implications)) (PP (IN for) (NP (NP (JJ differential) (NN gene) (NN expression)) (PP (IN in) (NP (NN T) (NN helper) (NN cell) (NNS subsets)))))) (. .)))))
(S1 (S (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (JJ individual) (NP (JJ CD4+) (NN T) (NNS cells))))) (VP (VBZ results) (PP (IN in) (NP (JJ differential) (NP (NN lymphokine)) (NN expression))))) (: :) (S (NP (NP (NN interleukin) (CD 2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB preferentially)) (VP (VBN produced) (PP (IN by) (NP (NP (NN T) (NN helper) (NN type) (CD 1) (-LRB- -LRB-) (NN TH1) (-RRB- -RRB-) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (JJ cell-mediated) (JJ immune) (NNS responses)))))))))) (, ,) (SBAR (IN whereas) (S (NP (NN IL-4)) (VP (VBZ is) (VP (VBN synthesized) (PP (IN by) (NP (NP (NN TH2) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (JJ humoral) (NN immunity))))))))))))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (JJ Ca-LRB-2+-RRB--dependent) (NN factor)) (NP (NN NF-ATp))) (VP (VBZ plays) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ inducible) (NN transcription)) (PP (IN of) (NP (DT both) (DT these) (NP (NN lymphokine) (NNS genes))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (SBAR (IN while) (S (NP (NP (NN IL2)) (NN expression)) (VP (VBZ requires) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (NP (NN Ca-LRB-2+-RRB--)) (CC and) (NP (NN protein) (NN kinase) (JJ C-dependent) (NNS signals)))))))) (, ,) (S (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NP (JJ human) (NN IL4)) (NN transcription))) (PP (IN through) (NP (DT the) (JJ Ca-LRB-2+-RRB--dependent) (NN pathway)))) (VP (VBZ is) (VP (VBN diminished) (PP (IN by) (NP (NP (NP (NN protein) (NN kinase) (NN C)) (NN stimulation)) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN phenomenon)) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (ADJP (RB mutually) (JJ exclusive)) (NN binding)) (PP (IN of) (NP (NP (NN NF-ATp)) (CC and) (NP (NN NF-kappa) (NN B)))) (PP (TO to) (NP (NP (DT the) (NP (NN P) (NN sequence))) (, ,) (NP (NP (DT an) (NN element)) (ADJP (JJ located) (PP (NP (CD 69) (NN bp) (RB upstream)) (IN of) (NP (DT the) (NP (NN IL4) (NN transcription) (NN initiation) (NN site)))))))))))) (. .))))
(S1 (S (S (NP (JJ Human) (NN IL4) (JJ promoter-mediated) (NN transcription)) (VP (VBZ is) (VP (VP (VBN downregulated) (PP (IN in) (NP (NP (NN Jurkat) (NNS cells)) (VP (VBN stimulated) (PP (IN with) (NP (DT the) (NP (NP (NN NF-kappa) (JJ B-activating) (NN cytokine)) (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha))))))))) (CC and) (VP (VBN suppressed) (PP (IN in) (NP (JJ RelA-overexpressing) (NNS cells)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (NN protein) (NN kinase) (NN C)) (NN stimulation)) (CC or) (NP (NP (NN RelA)) (NN overexpression))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (DT a) (NP (JJ human) (NN IL4) (NN promoter))) (VP (VBG containing) (NP (NP (DT a) (NP (NN mouse) (NN P) (NN sequence))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (NP (DT a) (NP (JJ higher-affinity) (NN site))) (PP (IN for) (NP (NN NF-ATp)))) (CC and) (NP (NP (DT a) (NP (JJ lower-affinity) (NN site))) (PP (IN for) (NP (NN RelA))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN competition)) (PP (IN between) (NP (NP (CD two) (JJ general) (NP (JJ transcriptional) (NNS activators))) (, ,) (NP (NP (NN RelA)) (CC and) (NP (NN NF-ATp))))) (, ,)) (VP (VP (VBZ mediates) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (NN stimulation))) (PP (IN on) (NP (NP (NN IL4)) (NN expression))))) (CC and) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (JJ differential) (NN gene) (NN expression)) (PP (IN in) (NP (NN TH) (NNS cells)))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Functional) (NN characterization)) (PP (IN of) (NP (NP (DT the) (NP (JJ murine) (NN homolog))) (PP (IN of) (NP (DT the) (NP (NP (NN B) (JJ cell-specific) (NN coactivator)) (NP (NN BOB.1/OBF.1))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN B) (JJ cell-specific) (JJ transcriptional) (NN promoter) (NN activity)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NP (NN octamer) (NN motif)))))) (VP (VBZ requires) (NP (NP (DT the) (NP (NP (NN Oct1))) (CC or) (NP (NN Oct2) (NN protein))) (CC and) (NP (JJ additional) (NP (NN B) (JJ cell-restricted) (NNS cofactors))))) (. .)))))
(S1 (S (S (NP (NP (CD One) (JJ such) (NP (NN cofactor))) (, ,) (NP (NN BOB.1/OBF.1)) (, ,)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN isolated) (PP (IN from) (NP (JJ human) (NN B) (NNS cells))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (NP (DT the) (NN isolation)) (CC and) (NP (JJ detailed) (NN characterization))) (PP (IN of) (NP (DT the) (NP (JJ murine) (NN homolog)))))) (. .))))
(S1 (S (S (S (NP (JJ Full-length) (NP (NNS cDNAs)) (CC and) (NP (JJ genomic) (NNS clones))) (VP (VBD were) (VP (VBN isolated)))) (, ,) (CC and) (S (NP (DT the) (NN gene) (NN structure)) (VP (VBD was) (VP (VBN determined)))) (. .))))
(S1 (S (S (NP (NP (NN Comparison)) (PP (IN of) (NP (DT the) (VBN deduced) (NN amino) (NNS acids)))) (VP (VBZ shows) (NP (NP (ADJP (CD 88) (NN %)) (NN sequence) (NN identity)) (PP (IN between) (NP (NP (NN mouse)) (CC and) (NP (ADJP (JJ human))) (NP (NN BOB.1/OBF.1)))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NP (JJ NH2-terminal) (CD 126) (NN amino) (NNS acids))) (PP (IN of) (NP (NN BOB.1/OBF.1)))) (VP (VBP are) (ADJP (CC both) (ADJP (JJ essential)) (CC and) (ADJP (JJ sufficient)) (PP (IN for) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (DT the) (NP (NN POU) (NNS domains))) (PP (IN of) (NP (CC either) (NP (NN Oct1)) (CC or) (NP (NN Oct2)))))))))) (. .))))
(S1 (S (S (S (NP (DT This) (JJ protein-protein) (NN interaction)) (VP (VBZ does) (RB not) (VP (VB require) (NP (NP (DT the) (JJ simultaneous) (NN binding)) (PP (IN of) (NP (NN Oct) (NNS proteins))) (PP (TO to) (NP (NN DNA))))))) (, ,) (CC and) (S (NP (NP (JJ high) (NN resolution) (NN footprinting)) (PP (IN of) (NP (DT the) (NN Oct-DNA) (NN interaction)))) (VP (VBZ reveals) (SBAR (IN that) (S (NP (NP (NN binding)) (PP (IN of) (NP (NN BOB.1/OBF.1))) (PP (TO to) (NP (NP (NN Oct1)) (CC or) (NP (NN Oct2))))) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (DT the) (NN interaction)) (PP (IN with) (NP (NN DNA)))))))))) (. .))))
(S1 (S (S (S (NP (NN BOB.1/OBF.1)) (VP (MD can) (ADVP (RB efficiently)) (VP (VB activate) (NP (NP (JJ octamer-dependent) (NNS promoters)) (PP (IN in) (NP (NNS fibroblasts))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP it)) (VP (VBZ fails) (S (VP (TO to) (VP (VB stimulate) (NP (NP (JJ octamer-dependent) (NN enhancer)) (NN activity))))))) (. .))))
(S1 (S (S (NP (NP (NN Fusion)) (PP (IN of) (NP (NP (NNS subdomains)) (PP (IN of) (NP (NN BOB.1/OBF.1))))) (PP (IN with) (NP (DT the) (NP (NN GAL4) (NN DNA) (NN binding) (NN domain))))) (VP (VBZ reveals) (UCP (SBAR (IN that) (S (NP (NP (CC both) (NP (NN NH2-)) (CC and) (NP (JJ COOH-terminal) (NNS domains))) (PP (IN of) (NP (NN BOB.1/OBF.1)))) (VP (VBP contribute) (PP (TO to) (NP (JJ full) (NN transactivation) (NN function)))))) (, ,) (NP (DT the) (NP (JJ COOH-terminal) (NN domain))) (VP (VBZ is) (ADJP (RBR more) (JJ efficient) (PP (IN in) (NP (DT this) (NN transactivation) (NN assay))))))) (. .))))
(S1 (S (S (ADVP (JJ Consistent) (PP (IN with) (NP (NP (DT the) (NN failure)) (PP (IN of) (NP (JJ full-length) (NN BOB.1/OBF.1))) (S (VP (TO to) (VP (VB stimulate) (NP (NP (JJ octamer-dependent) (NN enhancer) (NNS elements)) (PP (IN in) (NP (JJ non) (NN B) (NNS cells)))))))))) (, ,) (S (NP (DT the) (NP (NN GAL4) (NNS fusions))) (ADVP (RB likewise)) (ADVP (RB only)) (VP (VBP stimulate) (PP (IN from) (NP (DT a) (JJ promoter-proximal) (NN position))))) (. .))))
(S1 (S (S (S (NP (NN IL-10)) (VP (VBZ cooperates) (PP (IN with) (NP (NN TNF-alpha))) (S (VP (TO to) (VP (VB activate) (NP (NN HIV-1)) (PP (IN from) (NP (NP (NP (ADVP (RB latently))) (CC and) (NP (ADVP (RB acutely))) (NP (JJ infected) (NNS cells))) (PP (IN of) (NP (NN monocyte/macrophage) (NN lineage))))))))) (. .)))))
(S1 (S (S (S (NP (NN IL-10)) (VP (VP (VBZ is) (ADJP (JJ elevated) (PP (IN in) (NP (JJ HIV-1-infected) (NNS individuals))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NN disease) (NN progression))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN IL-10))) (PP (IN on) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN HIV-1)) (PP (IN from) (NP (NP (JJ infected) (NNS monocytes)) (CC and) (NP (NNS macrophages)))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (NN IL-10)) (ADVP (RB alone))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NN HIV-1) (NN replication)))))) (, ,) (S (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN TNF-alpha))))) (, ,) (NP (NN IL-10)) (VP (ADVP (RB markedly)) (VBD enhanced) (NP (NP (NN virion) (NN production)) (PP (PP (IN from) (NP (DT a) (ADJP (RB chronically) (JJ infected)) (NP (NP (JJ promonocytic) (NN cell) (NN line)) (PRN (-LRB- -LRB-) (NP (NN U1)) (-RRB- -RRB-))))) (CC and) (PP (IN in) (NP (ADJP (RB acutely) (JJ infected)) (NP (JJ monocyte-derived) (NNS macrophages)))))))) (. .))))
(S1 (S (S (S (VP (VBG Neutralizing) (NP (NNS mAbs)) (PP (TO to) (NP (NP (NN IL-10)) (CC and) (NP (NN TNF-alpha)))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (DT both) (NP (NNS cytokines))) (VP (VP (VBD were) (ADJP (JJ essential) (PP (IN for) (NP (DT the) (NN induction))))) (CC and) (VP (VBD were) (VP (VBN required)) (S (VP (TO to) (VP (VB generate) (NP (NP (DT a) (JJ synergistic) (NN increase)) (PP (IN in) (NP (NN virus) (NN expression)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (DT the) (CD two) (NP (NNS cytokines))))) (VP (VBD were) (ADJP (JJ distinguishable) (ADVP (RB functionally))) (SBAR (IN since) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN TNF-alpha)))) (VP (VBD attenuated) (NP (DT the) (NP (NN cytokine)) (NN cooperativity)) (, ,) (SBAR (IN while) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN IL-10)))) (VP (VBD potentiated) (NP (PRP$ their) (NN cooperativity))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN IL-10)) (CC and) (NP (NN TNF-alpha))) (VP (VBP play) (NP (JJ different) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN virus)))))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Northern) (NN blot) (NN analysis)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN Ab) (NN blocking)) (CC and) (NP (NP (NN cytokine)) (NN secretion)) (NP (NNS studies)))) (VP (VBD indicated) (SBAR (IN that) (S (S (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (CC either) (NP (JJ endogenous) (NN TNF-alpha)) (CC or) (NP (NN IL-10))))) (VP (VBD was) (RB not) (VP (VBN involved) (PP (IN in) (NP (DT the) (NN cooperativity)))))) (, ,) (CC nor) (SINV (VBD was) (NP (NP (DT an) (NN up-regulation)) (PP (IN of) (NP (NN TNF-alpha) (NNS receptors)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN combination)) (PP (IN with) (NP (NN TNF-alpha))))) (, ,) (NP (NN IL-10)) (VP (VP (VBD stimulated) (NP (NP (NP (VBG activating) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappa) (NN B)) (NN binding) (NNS activities)))) (CC and) (VP (VBD cooperated) (S (VP (TO to) (VP (VP (VB increase) (NP (NN HIV-1) (JJ steady-state) (NN mRNA) (NNS levels))) (CC and) (VP (VB enhance) (NP (JJ long) (JJ terminal) (JJ repeat-directed) (NN transcription)) (PP (IN through) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN NF-kappa) (NN B) (NN binding) (NNS sites))))))))))) (, ,) (S (VP (VBG suggesting) (NP (DT the) (NP (NN IL-10)) (NN effect)) (VP (VBZ occurs) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-10) (, ,)) (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (S (VP (VBG down-regulating) (NP (NP (DT the) (JJ cellular) (JJ immune) (NN response)) (PP (TO to) (NP (NN HIV-1))))))))) (, ,) (VP (MD may) (ADVP (RB also)) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (JJ TNF-alpha-mediated) (NN activation)) (PP (IN of) (NP (NP (NN HIV-1) (NN replication)) (PP (IN in) (NP (DT the) (NP (JJ monocyte/macrophage) (NN lineage))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Inhibition)) (PP (IN of) (NP (JJ lipopolysaccharide-induced) (NP (NN monocyte) (NN interleukin-1) (NN receptor)) (NN antagonist) (NN synthesis))) (PP (IN by) (NP (NN cortisol))) (: :)) (NP (NP (NN involvement)) (PP (IN of) (NP (DT the) (NP (NN mineralocorticoid) (NN receptor))))) (. .)))))
(S1 (S (S (S (NP (NNS Glucocorticoids) (, ,)) (PP (IN as) (NP (NP (DT a) (NN part)) (PP (IN of) (NP (NP (PRP$ their) (JJ physiological) (NN role)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (ADJP (JJ inflammatory))) (CC and) (NP (ADJP (JJ immune))) (NP (NNS processes)))))))))) (, ,) (VP (VBP suppress) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NN interleukin-1)) (PRN (-LRB- -LRB-) (NP (NN IL-1)) (-RRB- -RRB-))) (CC and) (NP (JJ other) (NP (NNS cytokines))))))) (. .)))))
(S1 (S (S (NP (NP (NP (NP (JJ Human) (NN monocyte) (NN IL-1) (NN receptor) (NN antagonist) (-LRB- -LRB-) (NN IL-1ra) (-RRB- -RRB-) (NN messenger) (NN ribonucleic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN mRNA)) (-RRB- -RRB-))) (NN expression)) (CC and) (NP (NN protein) (NN secretion))) (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (NN dexamethasone))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB now)) (ADVP (RB further)) (VP (VBN studied) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN IL-1ra))) (PP (IN by) (NP (NP (DT the) (ADJP (ADJP (JJ major)) (ADJP (JJ physiological))) (JJ human) (NN glucocorticoid)) (, ,) (NP (NN cortisol))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NN cortisol) (NN incubation)) (VP (VBD induced) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN IL-1ra) (NN mRNA)) (NN expression)))) (CC and) (NP (NP (DT a) (JJ significant) (NN inhibition)) (PP (IN of) (NP (NP (NN IL-1ra) (NN protein)) (NN secretion))))) (PP (IN in) (NP (NP (NN cell) (NNS cultures)) (PP (IN of) (NP (NP (JJ human) (JJ peripheral) (NNS monocytes)) (VP (VBN stimulated) (PP (IN with) (NP (DT the) (JJ bacterial) (NN endotoxin) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (ADJP (CD 276) (NN mumol)) (NN cortisol))) (PP (TO to) (NP (JJ normal) (NNS subjects)))) (ADVP (RB also)) (VP (VBD decreased) (NP (NP (JJ LPS-induced) (NP (NN IL-1ra)) (NN synthesis)) (PP (IN in) (NP (VBN cultured) (NNS monocytes))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG coincubating) (NP (DT the) (NP (NNS monocytes))) (PP (IN with) (NP (CC either) (NP (DT the) (NN mineralocorticoid) (NN antagonist) (NN spironolactone)) (CC or) (NP (DT the) (NP (NN glucocorticoid) (NN receptor)) (NN antagonist) (NN RU) (CD 38486))))))) (, ,) (NP (NP (DT the) (ADJP (ADJP (FW in) (FW vitro)) (ADJP (JJ cortisol-induced))) (NN inhibition)) (PP (IN of) (NP (JJ LPS-stimulated) (NP (NN IL-1ra)) (NN secretion)))) (VP (VBD was) (ADVP (RB partially)) (VP (VBN reversed))) (. .))))
(S1 (S (S (NP (DT The) (NN mineralocorticoid) (NN aldosterone)) (VP (VBD exerted) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ LPS-induced) (NN monocyte) (NP (NN IL-1ra)) (NN secretion)))) (ADVP (FW in) (FW vitro)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NP (NN coincubation)) (PP (IN with) (NP (NN spironolactone)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN mineralocorticoid) (NN receptor) (NN mRNA))) (PP (IN in) (NP (JJ human) (NP (NNS monocytes))))) (VP (VBD was) (VP (VBN observed) (PP (IN by) (NP (NP (NN PCR)) (PP (IN of) (NP (VBN reversed) (VBN transcribed) (NN RNA))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (ADVP (RB further)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS corticosteroids)) (ADVP (RB physiologically)) (VP (VBP control) (NP (DT the) (JJ IL-1/IL-1ra) (NN system)) (PP (IN during) (NP (NP (ADJP (JJ inflammatory))) (CC or) (NP (ADJP (JJ immune))) (NP (NNS processes)))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (PRP we)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (, ,) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (NP (DT a) (NN glucocorticoid) (JJ receptor-mediated) (NN effect))))) (, ,) (NP (DT the) (NP (NN mineralocorticoid) (NN receptor))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN monocyte) (NP (NN IL-1ra)) (NN secretion))) (PP (IN by) (NP (NN cortisol))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Distinctive) (NN expression) (NN pattern)) (PP (IN of) (NP (DT the) (NP (NN BCL-6) (NN protein)))) (PP (IN in) (NP (JJ nodular) (NN lymphocyte) (NN predominance) (NN Hodgkin) (POS 's) (NN disease))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NN BCL-6) (NN gene))) (VP (VBG encoding) (NP (DT a) (NP (JJ nuclear-located) (JJ Kruppel-type) (NN zinc) (NN finger) (NN protein))))) (VP (VP (VBZ is) (VP (VBN rearranged) (PP (IN in) (NP (ADJP (QP (RB about) (CD 30)) (NN %)) (JJ diffuse) (JJ large) (NP (NN B-cell) (NNS lymphomas)))))) (CC and) (VP (VBZ is) (VP (VBN expressed) (ADVP (RB predominantly)) (PP (IN in) (NP (NP (JJ normal) (NP (JJ germinal) (NN center) (NN B) (NNS cells))) (CC and) (NP (JJ related) (NNS lymphomas))))))) (. .)))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NN BCL-6)) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (S (VP (VBG regulating) (NP (NP (NN differentiation)) (PP (IN of) (NP (JJ normal) (NP (JJ germinal) (NN center) (NN B) (NNS cells)))))))))))) (CC and) (SBAR (IN that) (S (NP (NP (PRP$ its) (VBN deregulated) (NN expression)) (VP (VBN caused) (PP (IN by) (NP (NNS rearrangements))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NN lymphomagenesis))))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (NN BCL-6) (NN protein))) (PP (IN in) (NP (NP (NN Hodgkin) (POS 's) (NN disease)) (PRN (-LRB- -LRB-) (NP (NN HD)) (-RRB- -RRB-)))))))) (, ,) (S (VP (VBG focusing) (PP (IN on) (NP (NP (DT the) (NP (NP (JJ nodular) (NN lymphocyte) (NN predominance) (NN subtype)) (PRN (-LRB- -LRB-) (NP (NN NLPHD)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ differs) (PP (IN from) (NP (JJ classical) (NN HD))) (PP (IN by) (NP (NP (NN virtue)) (PP (IN of) (NP (NP (NP (DT the) (NN B-cell) (NN nature)) (PP (IN of) (NP (NP (DT the) (NP (JJ malignant) (NN cell) (NN population))) (PRN (-LRB- -LRB-) (NP (JJ so-called) (NP (NN L) (CC &amp;) (NN H) (NNS cells))) (-RRB- -RRB-))))) (CC and) (NP (NP (PRP$ its) (NN relationship)) (PP (IN with) (NP (JJ germinal) (NNS centers)))))))))))))))))) (. .))))
(S1 (S (S (NP (NP (CD Forty-one) (NN HD) (NNS samples)) (PRN (-LRB- -LRB-) (NP (NP (CD 19) (NN NLPHD)) (, ,) (NP (CD 12) (JJ nodular) (NN sclerosis)) (, ,) (CC and) (NP (CD 10) (JJ mixed) (NN cellularity))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN immunostained) (PP (IN with) (NP (NP (NP (DT the) (NP (JJ monoclonal) (NNS antibodies))) (NP (NP (NN PG-B6)) (CC and) (NP (NN PG-B6p)))) (SBAR (WHNP (WDT that)) (S (VP (VBP react) (PP (IN with) (NP (NP (NP (DT a) (JJ fixative-sensitive)) (CC and) (NP (DT a) (NP (JJ formalin-resistant) (NN epitope)))) (PP (IN on) (NP (NP (DT the) (NP (JJ aminoterminal) (NN region))) (PP (IN of) (NP (DT the) (NP (NN BCL-6) (NN gene) (NN product)))))))) (, ,) (ADVP (RB respectively))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Strong) (JJ nuclear) (NN positivity)) (PP (IN for) (NP (DT the) (NP (NN BCL-6) (NN protein))))) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (NN tumor) (-LRB- -LRB-) (NN L) (CC &amp;) (NN H) (-RRB- -RRB-) (NNS cells)) (PP (IN in) (NP (NP (DT all) (NNS cases)) (PP (IN of) (NP (NN NLPHD))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN BCL-6)) (VP (VBD was) (VP (VBN expressed) (PP (ADVP (RB only)) (IN in) (NP (NP (DT a) (JJ small) (NN percentage)) (PP (IN of) (NP (NP (NN Hodgkin) (CC and) (NN Reed-Sternberg) (NNS cells)) (PP (IN in) (NP (NP (QP (RB about) (CD 30)) (NN %)) (PP (IN of) (NP (JJ classical) (NN HD) (NNS cases))))))))))) (. .))))
(S1 (S (S (ADVP (RB Notably)) (, ,) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (NP (JJ reactive) (JJ CD3+/CD4+) (NN T) (NNS cells)) (UCP (ADJP (JJ nearby) (PP (TO to))) (CC and) (VP (VBG rosetting) (PP (IN around))) (NP (NP (NN L) (CC &amp;) (NN H) (NNS cells)) (PP (IN in) (NP (NN NLPHD)))))))) (VP (VP (VBD were) (ADVP (RB also)) (ADJP (RB strongly) (JJ BCL-6+))) (, ,) (CC but) (VP (VBD lacked) (NP (NP (NP (NN CD40) (NN ligand)) (PRN (-LRB- -LRB-) (NP (NN CD40L)) (-RRB- -RRB-))) (NN expression)))) (. .))))
(S1 (S (S (NP (DT This) (NN staining) (NN pattern)) (ADVP (RB clearly)) (VP (VBD differed) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ classical) (NN HD)) (, ,) (SBAR (WHNP (WP$ whose) (JJ cellular) (NN background)) (S (VP (VBD was) (VP (VBN made) (PRT (IN up)) (PP (IN of) (NP (NP (JJ CD3+/CD4+) (NN T) (NNS cells)) (VP (VBG showing) (NP (DT the) (JJ BCL-6-/CD40L+) (NN phenotype)))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (ADVP (RBR further)) (VP (VP (VBP support) (NP (DT the) (NN concept) (SBAR (IN that) (S (NP (NN NLPHD)) (VP (VBZ is) (NP (NP (DT an) (ADJP (ADJP (RB histogenetically) (JJ distinct)) (, ,) (ADJP (JJ B-cell-derived))) (NN subtype)) (PP (IN of) (NP (NN HD))))))))) (CC and) (VP (VBP suggest) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN BCL-6))) (PP (IN in) (NP (PRP$ its) (NN development)))))) (. .))))
(S1 (S (S (S (NP (NP (NN MEK1)) (CC and) (NP (DT the) (NP (JJ extracellular) (JJ signal-regulated) (NNS kinases)))) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NP (NP (NN IL-2) (NN gene)) (NN transcription)) (PP (IN in) (NP (NN T) (NNS cells))))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN TCR)) (NN engagement)) (VP (VBZ stimulates) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN protein) (NN kinase)) (NP (NN Raf-1)))))) (. .)))))
(S1 (S (S (NP (JJ Active) (NP (NN Raf-1))) (VP (VP (VBZ phosphorylates)) (CC and) (VP (VBZ activates)) (NP (DT the) (NP (NP (JJ mitogen-activated) (NN protein) (-LRB- -LRB-) (NN MAP) (-RRB- -RRB-) (JJ kinase/extracellular) (JJ signal-regulated) (NN kinase) (NN kinase) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN MEK1)) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (NN turn))) (VP (VP (VBZ phosphorylates)) (CC and) (VP (VBZ activates)) (NP (NP (DT the) (NP (NN MAP) (JJ kinases/extracellular) (NN signal) (JJ regulated) (NNS kinases))) (, ,) (NP (NP (NN ERK1)) (CC and) (NP (NN ERK2))))))) (. .))))
(S1 (S (S (NP (NP (NN Raf-1)) (NN activity)) (VP (VBZ promotes) (NP (NP (NN IL-2) (NN production)) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS lymphocytes)))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NP (NN MEK1))) (CC and) (NP (NP (NN ERK))) (NP (NNS activities))) (ADVP (RB also)) (VP (VBP stimulate) (NP (NP (NN IL-2) (NN gene)) (NN transcription))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (ADJP (RB constitutively) (JJ active)) (NP (NN Raf-1)) (CC or) (NP (NN MEK1)))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))) (VP (VBD enhanced) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NP (NN IL-2) (JJ promoter-driven) (NN transcription)) (VP (VBN stimulated) (PP (IN by) (NP (NP (DT a) (NN calcium) (NN ionophore)) (CC and) (NP (NN PMA)))))))))) (, ,) (CC and) (S (PP (ADVP (RB together)) (IN with) (NP (DT a) (NN calcium) (NN ionophore))) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT each) (NN protein)))) (VP (VBD was) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB stimulate) (NP (NP (NN NF-AT)) (NN activity))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (JJ MEK1-interfering) (NNS mutants)))) (VP (VP (VBD inhibited) (NP (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NN IL-2) (JJ promoter-driven) (NN transcription))))) (CC and) (VP (VBD blocked) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (ADJP (RB constitutively) (JJ active)) (NP (NN Ras)) (CC and) (NP (NN Raf-1)))) (S (VP (TO to) (VP (VB costimulate) (NP (NP (NN NF-AT)) (NN activity)) (PP (IN with) (NP (DT a) (NN calcium) (NN ionophore))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN MAP) (JJ kinase-specific) (NN phosphatase)) (, ,) (NP (NN MKP-1)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ blocks) (NP (NP (NN ERK)) (NN activation))))))) (, ,)) (VP (VBD inhibited) (NP (NP (NP (NP (NN IL-2) (NN promoter))) (CC and) (NP (JJ NF-AT-driven) (NN transcription))) (VP (VBN stimulated) (PP (IN by) (NP (NP (DT a) (NN calcium) (NN ionophore)) (CC and) (NP (NN PMA)))))))) (, ,) (CC and) (S (PP (IN in) (NP (NN addition))) (, ,) (NP (NN MKP-1)) (VP (VBD neutralized) (NP (NP (DT the) (JJ transcriptional) (NN enhancement)) (VP (VBN caused) (PP (IN by) (NP (JJ active) (NP (NN Raf-1)) (CC and) (NP (NN MEK1)) (NP (NN expression)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN MAP) (NN kinase)) (NN signal) (NN transduction) (NN pathway)) (VP (VBG consisting) (PP (IN of) (NP (NP (NP (NN Raf-1)) (, ,) (NP (NN MEK1))) (, ,) (CC and) (NP (NP (NN ERK1)) (CC and) (NP (NN ERK2))))))) (VP (VBZ functions) (PP (IN in) (NP (NP (DT the) (NN stimulation) (NP (NN IL-2) (NN gene)) (NN transcription)) (PP (IN in) (NP (VBN activated) (NP (NN T) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (S (NP (NN HIV) (NN glycoprotein) (CD 120)) (VP (VBZ enhances) (NP (NP (NP (JJ intercellular) (NN adhesion) (NN molecule-1)) (NN gene) (NN expression)) (PP (IN in) (NP (JJ glial) (NNS cells))))) (. .)))))
(S1 (S (NP (NP (NP (NN Involvement)) (PP (IN of) (NP (NN Janus) (JJ kinase/signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription)))) (CC and) (NP (NP (NN protein) (NN kinase) (NN C)) (NN signaling) (NNS pathways)) (. .))))
(S1 (S (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB well)) (VP (VBN established) (SBAR (IN that) (S (NP (NP (NP (DT the) (CD two) (JJ major) (NP (JJ glial) (NNS cells))) (PP (IN in) (NP (DT the) (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-)))))) (, ,) (NP (NP (NNS astrocytes)) (CC and) (NP (NN microglia))) (, ,)) (VP (VBP are) (NP (NP (JJ key) (NNS participants)) (PP (IN in) (S (VP (VBG mediating) (NP (NP (DT the) (JJ neurologic) (NN dysfunction)) (VP (VBN associated) (PP (IN with) (NP (NP (NN HIV) (NN infection)) (PP (IN of) (NP (DT the) (NN CNS)))))))))))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NP (DT the) (NP (JJ major) (NN envelope) (NN glycoprotein))) (PP (IN of) (NP (NN HIV))))) (, ,) (NP (NP (NN glycoprotein) (CD 120)) (PRN (-LRB- -LRB-) (NP (NN gp120)) (-RRB- -RRB-)))) (, ,) (S (VP (TO to) (VP (VB regulate) (NP (NP (NP (NP (JJ intercellular) (NN adhesion) (NN molecule-1)) (PRN (-LRB- -LRB-) (NP (NN ICAM-1)) (-RRB- -RRB-))) (NN expression)) (PP (IN in) (NP (JJ glial) (NNS cells)))))))) (, ,) (SBAR (IN because) (S (NP (NN ICAM-1)) (VP (VBZ is) (ADJP (JJ important) (PP (IN in) (S (VP (VP (VBG mediating) (NP (NP (JJ immune) (NN responsiveness)) (PP (IN in) (NP (DT the) (NN CNS))))) (, ,) (VP (VBG facilitating) (NP (NP (NN entry)) (PP (IN of) (NP (JJ HIV-infected) (NNS cells))) (PP (IN into) (NP (DT the) (NN CNS))))) (, ,) (CC and) (VP (VBG promoting) (NP (NN syncytia) (NN formation))))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN gp120)) (VP (VBZ enhances) (NP (NP (NP (NN ICAM-1)) (NN gene) (NN expression)) (PP (IN in) (NP (NP (JJ primary) (NN rat) (NNS astrocytes)) (, ,) (NP (JJ primary) (JJ human) (NNS astrocytes)) (, ,) (NP (DT a) (NP (JJ human) (NN astroglioma) (NN cell) (NN line) (NN CRT))) (, ,) (CC and) (NP (JJ primary) (NN rat) (NNS microglia))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN signal) (NN transduction) (NNS events)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ gp120-mediated) (NN enhancement)) (PP (IN of) (NP (NN ICAM-1))))))) (VP (VBP appear) (S (VP (TO to) (VP (VB involve) (NP (NP (NN activation)) (PP (IN of) (NP (CC both) (NP (NN protein) (NN kinase) (NN C)) (CC and) (NP (NN tyrosine) (NN kinase)))))))) (, ,) (SBAR (IN because) (S (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN C)) (CC and) (NP (NN tyrosine) (NN kinase))))) (VP (VBP abrogate) (NP (NP (JJ gp120-mediated) (NP (NN ICAM-1)) (NN expression)) (PP (IN in) (NP (CC both) (NP (NNS astrocytes)) (CC and) (NP (NNS microglia))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NN gp120)) (VP (VBZ induces) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (NP (NN signal) (NN transducer) (CC and) (NN activator) (IN of) (NN transcription)) (PRN (-LRB- -LRB-) (NP (NN STAT-1) (NN alpha)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NP (NP (NN Janus) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN JAK2)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ glial) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (JJ gp120-mediated) (NP (NN ICAM-1)) (NN expression)) (VP (VBZ has) (NP (JJ functional) (NN significance)) (, ,) (SBAR (IN as) (NP (PRP it)) (VP (VBZ enhances) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ monocytic) (NNS cells))) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (JJ gp120-stimulated) (JJ human) (NNS astrocytes))) (PP (IN in) (NP (DT an) (NN ICAM-1/beta) (CD 2) (JJ integrin-dependent) (NN fashion))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (NP (JJ new) (NNS insights)) (PP (IN into) (SBAR (WHADVP (WRB how)) (S (NP (NN gp120)) (VP (MD can) (VP (VB influence) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (JJ glial) (NNS cells))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN AIDS) (JJ dementia) (NN complex))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (NN NF-AT)) (NN signal) (NN transduction) (NNS events))) (PP (IN by) (NP (NP (DT a) (JJ dominant-negative) (NN form)) (PP (IN of) (NP (NN calcineurin))))) (. .)))))
(S1 (S (S (S (NP (NP (DT An) (ADJP (ADJP (JJ inhibitory)) (, ,) (`` ``) (ADJP (JJ dominant-negative)) (, ,)) (NN form)) (PP (IN of) (NP (DT the) (NP (NN calcineurin) (JJ catalytic) (-LRB- -LRB-) (NN A) (-RRB- -RRB-) (NN subunit))))) (VP (VBD was) (VP (VBN prepared))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ lacks) (NP (NP (DT the) (NP (JJ calmodulin-binding) (NN domain))) (, ,) (NP (JJ autoinhibitory) (NN domain)) (CC and) (NP (NP (JJS most)) (PP (IN of) (NP (PRP$ its) (JJ catalytic) (NN core)))))) (CC but) (VP (VBZ possesses) (NP (DT the) (NP (JJ regulatory) (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (NN subunit)) (NN binding) (NN domain)))))) (. .)))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN tested) (PP (IN for) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB block) (NP (NP (JJ calcineurin-dependent) (NN signaling)) (PP (IN in) (NP (NN Jurkat) (NNS cells)))))))))))) (, ,) (S (NP (NP (NN expression)) (PP (IN of) (NP (DT this) (NP (`` ``) (JJ B-subunit) (JJ knock-out) (-LRB- -LRB-) (NN BKO) (-RRB- -RRB-) (NN construct))))) (VP (VBD suppressed) (NP (NP (NP (NN reporter) (NN gene)) (NN activity)) (VP (VBN driven) (PP (IN by) (NP (NP (NN NF-AT)) (, ,) (NP (NP (DT the) (JJ pivotal) (NP (NN promoter) (NN element))) (PP (IN for) (NP (NP (NN interleukin) (-LRB- -LRB-) (NN IL) (-RRB- -RRB-) (CD -2) (NN gene)) (NN induction)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Immunoprecipitation)) (PP (IN of) (NP (JJ epitope-labeled) (NN BKO)))) (VP (VBD demonstrated) (PP (IN for) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT a) (JJ tight) (NN complex)) (PP (IN with) (NP (NP (JJ endogenous) (NN B) (NN subunit)) (PP (IN in) (NP (NN Jurkat) (NNS cells))))))))) (, ,) (ADVP (JJ consistent) (PP (IN with) (NP (NP (DT an) (JJ inhibitory) (NN mechanism)) (SBAR (WHNP (WDT that)) (S (VP (VBZ involves) (NP (NP (DT the) (NN sequestration)) (PP (IN of) (NP (DT the) (NP (NN B) (NN subunit)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (ADJP (RB sharply) (VBN reduced)) (NP (NN NF-AT)) (NN activity)) (VP (VBN produced) (PP (IN by) (NP (VBG co-transfecting) (NN BKO))))) (VP (MD could) (VP (VB be) (`` ``) (VP (VBN rescued) (PP (IN by) (NP (NP (NN overexpression)) (PP (IN of) (NP (VBN transfected) (NP (NN B) (NN subunit)))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN depletion)) (PP (IN of) (NP (DT this) (NN subunit)))) (VP (VBD was) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (NN inhibition)))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (DT the) (JJ potential) (NN utility)) (PP (IN of) (NP (NP (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP disrupt) (NP (JJ calcineurin-mediated) (NN signal) (NN transduction) (NNS pathways)) (PP (IN by) (S (VP (VBG blocking) (NP (NP (NN formation)) (PP (IN of) (NP (NP (DT the) (NP (RB catalytically) (JJ active) (NN dimer))) (PP (IN of) (NP (NN calcineurin) (NP (NN A)) (CC and) (NP (NN B)) (NP (NNS subunits))))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Cross-linking)) (PP (IN of) (NP (NN Fc) (NN gamma) (NNS receptors)))) (VP (VBZ activates) (NP (NP (NN HIV-1) (JJ long) (JJ terminal) (JJ repeat-driven) (NN transcription)) (PP (IN in) (NP (JJ human) (NNS monocytes))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Elevation)) (PP (IN of) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (VBG circulating) (JJ immune) (NNS complexes)))))) (VP (VP (ADVP (RB frequently)) (VBZ accompanies) (NP (NN HIV-1) (NN infection))) (CC and) (VP (VBZ is) (NP (NP (DT a) (JJ prognostic) (NN indicator)) (PP (IN of) (NP (NP (JJ clinical) (NN progression)) (PP (IN from) (NP (JJ asymptomatic) (NN infection))) (PP (TO to) (NP (NN AIDS)))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NN cross-linking)) (PP (IN of) (NP (NP (NN Fc) (NN gamma) (NN RI)) (CC or) (NP (NN Fc) (NN gamma) (NN RII)))) (PP (PP (IN by) (NP (JJ adherent) (JJ human) (NN IgG))) (CC or) (PP (IN by) (NP (JJ specific) (NP (JJ anti-Fc) (NN gamma) (NN R) (NN mAb)))))) (VP (VP (VBZ activates) (NP (NP (NN HIV-1) (NN gene) (NN expression)) (PP (IN in) (NP (DT the) (NP (NP (JJ human) (JJ monocytic) (NN cell) (NN line)) (NP (NN BF24))))))) (CC and) (VP (VBN increased) (NP (NP (NP (NN HIV) (NN RNA)) (NN expression)) (PP (IN in) (NP (NP (NNS monocytes)) (PP (IN from) (NP (NN HIV) (JJ infected) (NNS patients))))))) (SBAR (IN as) (S (VP (VBN assayed) (PP (IN by) (NP (JJ reverse) (NN transcription-PCR)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN THP-1) (NNS cells))) (, ,) (NP (NP (NN Fc) (NN gamma) (NN R)) (NN cross-linking)) (VP (VBD induced) (NP (NP (NN NF-kappa) (NN B)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN known) (S (VP (VP (TO to) (VP (VB bind) (PP (TO to) (NP (NP (DT the) (NP (JJ regulatory) (NN region))) (PP (IN of) (NP (DT the) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))) (PP (IN of) (NP (NN HIV-1))))))))) (CC and) (VP (TO to) (VP (VB activate) (NP (NN HIV-1) (NN transcription)))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Anti-TNF-alpha) (NN antibody)) (CONJP (CC but) (RB not)) (NP (JJ anti-IL-1) (NN beta) (NN antibody))) (ADVP (RB strongly)) (VP (VBD inhibited) (NP (NP (CC both) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ HIV-1-LTR-driven) (NN transcription)))) (CC and) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN NF-kappa) (NN B))))) (PP (IN by) (NP (NP (NN Fc) (NN gamma) (NN R)) (NN cross-linking))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Fc) (NN gamma) (NN R)) (VP (MD can) (VP (VB mediate) (NP (NP (DT a) (JJ TNF-alpha-dependent) (NN induction)) (PP (IN of) (NP (NP (NN HIV-1) (NN gene)) (NN transcription))))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ immune) (NNS complexes)) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NN HIV-1) (NN infection))))) (PP (IN by) (S (VP (VBG augmenting) (NP (NP (JJ viral) (NN replication)) (PP (IN in) (NP (NNS monocytes))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Identification)) (PP (IN of) (NP (NP (DT an) (NP (NN ionomycin/cyclosporin) (JJ A-responsive) (NN element))) (PP (IN within) (NP (DT the) (NP (JJ human) (NN T) (NN cell) (NN receptor) (NN gamma) (NN enhancer)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN through) (NP (DT the) (NN Ca2+/calcineurin) (NN pathway)))) (VP (VBZ is) (ADJP (JJ essential) (PP (TO to) (NP (NP (DT the) (NN transcription)) (PP (IN of) (NP (JJ many) (NP (NN cytokine) (NNS genes)))))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NP (NP (VBN conserved) (NN cis-acting) (NN sequence)) (, ,) (NP (NN GGAAAA)))) (, ,) (CC and) (NP (NP (NN transcription) (NNS factors)) (VP (VBG binding) (PP (TO to) (NP (DT this) (NN sequence)))))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (VBN increased) (JJ intracellular) (NN Ca2+) (NNS concentrations))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NP (NN identification)) (CC and) (NP (NN importance))) (PP (IN of) (NP (NP (NP (DT the) (JJ same) (NN sequence)) (PP (IN in) (NP (DT a) (NP (JJ non-cytokine) (NN gene))))) (, ,) (NP (DT the) (NP (JJ human) (NN T) (NN cell) (NN receptor) (NN gamma) (-LRB- -LRB-) (NN TCRG) (-RRB- -RRB-) (NN enhancer))))))) (. .))))
(S1 (S (S (NP (NP (NP (NNS Results)) (PP (IN from) (NP (JJ site-directed) (NNS mutations)))) (CC and) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays))) (ADVP (RB strongly)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT this) (NN sequence)) (VP (VBZ mediates) (NP (NP (DT the) (JJ ionomycin-induced) (NN activation)) (PP (IN of) (NP (DT the) (NP (NN TCRG) (NN enhancer))))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS studies)) (VP (VBP provide) (NP (NP (DT an) (NN explanation)) (PP (IN for) (NP (DT a) (JJ previous) (NN observation) (SBAR (IN that) (S (NP (NP (NP (NP (NN TCRG) (NN mRNA)) (NNS levels)) (, ,) (CONJP (CC but) (RB not)) (NP (NN mRNA) (NNS levels))) (PP (IN for) (NP (NN T) (NN cell) (NN receptor) (NP (NN alpha)) (CC and) (NP (NN -beta)))) (, ,)) (VP (VBP are) (VP (VBN increased) (PP (IN by) (NP (NN ionomycin) (NN treatment))))))))))) (. .))))
(S1 (S (S (S (S (NP (JJ Aspirin-like) (NNS drugs)) (VP (MD can) (VP (VB protect) (NP (JJ human) (NN T) (NNS lymphocytes)) (PP (IN against) (NP (NN benzoquinone) (NN cytotoxicity)))))) (: :) (NP (NP (NN evidence)) (PP (IN for) (NP (DT a) (NN NAD-LRB-P-RRB-H:quinone) (JJ reductase-dependent) (NN mechanism)))) (. .)))))
(S1 (S (S (S (NP (NP (NN Benzene) (NN toxicity)) (PP (IN towards) (NP (NNS lymphocytes)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (NP (NNS metabolites)) (PP (IN of) (NP (NN benzene)))) (PP (VBG including) (NP (NP (NN benzoquinone)) (PRN (-LRB- -LRB-) (NP (NN BQ)) (-RRB- -RRB-)))))))))))) (. .)))))
(S1 (S (S (NP (NP (NN NAD-LRB-P-RRB-H:quinone) (NN reductase)) (PRN (-LRB- -LRB-) (NP (NN QR)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB protect) (PP (IN against) (NP (NN BQ) (NN toxicity)))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN QR) (NN gene))))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (DT the) (NP (NP (NN transcription) (NN factor)) (NP (NN AP-1))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD had) (ADVP (RB previously)) (VP (VBN found) (SBAR (IN that) (S (NP (NP (JJ aspirin-like) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NN ALD)) (-RRB- -RRB-))) (VP (VBP induce) (NP (NN AP-1)) (PP (IN in) (NP (JJ human) (NN T) (NNS lymphocytes)))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (ADVP (RB therefore)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NN ALD)) (VP (MD would) (VP (VB protect) (NP (NNS lymphocytes)) (PP (IN against) (NP (NN BQ) (NN toxicity))) (PP (IN by) (S (VP (VBG inducing) (NP (NN QR))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Molt-4) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN M4)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NP (JJ human) (NN T) (NN lymphocyte) (NN cell) (NN line))) (, ,)) (VP (VBD were) (VP (VP (VBN incubated) (PP (IN with) (NP (NP (JJ different) (NNS concentrations)) (PP (IN of) (NP (NP (CD two) (NN ALD)) (, ,) (NP (NP (NN flurbiprofen)) (CC and) (NP (NN sodium) (NN diclofenac)))))))) (, ,) (CC and) (ADVP (RB then)) (VP (VBN exposed) (PP (TO to) (NP (NN BQ)))))) (. .))))
(S1 (S (S (NP (NN Toxicity)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (NN viability)) (PRN (-LRB- -LRB-) (NP (NN trypan) (JJ blue) (NN exclusion)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (S (NP (DT Both) (NNS drugs)) (VP (VBD protected) (NP (DT the) (NNS cells)) (PP (IN against) (NP (NN BQ) (NN cytotoxicity))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))))) (, ,) (PP (FW e.g.)) (, ,) (S (NP (NP (NN sodium) (NN diclofenac)) (PP (IN at) (NP (CD 15) (NN microM)))) (VP (VBD reduced) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (JJ BQ-treated) (JJ dead) (NNS cells)))) (PP (IN by) (NP (CD 70) (NN %))))) (. .))))
(S1 (S (S (NP (NNS ALDs)) (VP (VBD induced) (NP (NP (NP (NN QR)) (NN activity)) (PP (IN in) (NP (DT the) (NN M4) (NNS cells)))) (PP (IN in) (NP (NP (NP (DT the) (JJ same) (NN range)) (PP (IN of) (NP (NNS concentrations)))) (SBAR (WHNP (WDT that)) (S (VP (VBD protected) (NP (DT the) (NNS cells)) (PP (IN against) (NP (NN BQ) (NN toxicity))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ protective) (NN effect)) (PP (IN of) (NP (NN ALD)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN by) (NP (NP (NN dicoumarol)) (, ,) (NP (DT a) (JJ QR-specific) (NN inhibitor)))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (JJ human) (NN T) (NNS cells)) (CC and) (NP (NN T) (NN cell) (NNS lines))) (VP (VBP do) (RB not) (VP (VB metabolize) (NP (JJ arachidonic) (NN acid)))))) (, ,) (S (NP (PRP$ our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN ALD)) (VP (MD can) (VP (VB protect) (NP (JJ human) (NN T) (NNS lymphocytes)) (PP (IN against) (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NN benzene))))) (PP (IN by) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN QR)) (NN activity))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Human) (NN herpesvirus) (CD 6) (NP (NN variant) (NN A)) (, ,) (CONJP (CC but) (RB not)) (NP (NN variant) (NN B)) (, ,)) (VP (VBZ infects) (NP (JJ EBV-positive) (NN B) (JJ lymphoid) (NNS cells)) (, ,) (S (VP (VBG activating) (NP (DT the) (NP (JJ latent) (NN EBV) (NN genome))) (PP (IN through) (NP (DT a) (JJ BZLF-1-dependent) (NN mechanism)))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Human) (NN herpesvirus) (CD 6)) (, ,) (NP (DT a) (ADJP (RB predominantly) (NN T) (JJ lymphotropic)) (NN virus)) (, ,)) (VP (VBZ has) (VP (VBN been) (ADVP (RB recently)) (VP (VBN shown) (S (VP (VP (TO to) (VP (VB infect) (NP (DT some) (NP (JJ EBV) (JJ -positive) (NN B) (NN cell) (NNS lines))))) (, ,) (CC and) (VP (TO to) (VP (VB induce) (PP (IN in) (NP (PRP them))) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NN EBV) (JJ lytic) (NN cycle))))))))))) (. .)))))
(S1 (S (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP have) (VP (VP (VBN confirmed)) (CC and) (VP (VBN extended)) (NP (JJ such) (NNS observations))) (, ,) (S (VP (VBG showing) (SBAR (IN that) (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (DT this) (NN phenomenon)) (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (NP (DT the) (NN variant) (NN A)) (PP (IN of) (NP (NN HHV-6))))))))))))) (: :) (S (PP (IN in) (NP (NN fact))) (NP (NP (CD two) (NNS isolates)) (VP (VBG belonging) (PP (TO to) (NP (NP (DT the) (NN HHV-6) (NN variant) (NN B)) (PRN (-LRB- -LRB-) (NP (NP (NN BA92)) (CC and) (NP (NN Z29))) (-RRB- -RRB-)))))) (VP (VBD were) (CC neither) (ADJP (JJ able) (VP (VP (TO to) (S (VP (VB infect) (NP (DT any) (NP (NN B) (NN cell) (NN line))) (, ,) (ADVP (ADVP (RB independently)) (PP (IN of) (NP (DT the) (NN EBV) (NN status))))))) (, ,) (CC nor) (VP (TO to) (S (VP (VB induce) (NP (DT the) (NN EBV) (NN genome) (NN expression))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (JJ only) (NN exception)) (VP (VBZ is) (VP (VBN represented) (PP (IN by) (NP (NP (DT the) (NP (NN P3HR1) (NNS cells))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (, ,) (ADVP (RB however)) (, ,) (S (NP (NP (DT the) (NN infection)) (PP (IN by) (NP (DT the) (NN variant) (NN B)))) (VP (VBZ does) (RB not) (VP (VB determine) (NP (NP (NN induction)) (PP (IN of) (NP (NN EBV) (NNS antigens))))))))))))) (: ;) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (NP (NN EBV) (NN genome))))) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (NN susceptibility)) (PP (IN of) (NP (DT the) (NP (NN B) (NN cell) (NNS lines)))) (PP (TO to) (NP (NN HHV-6) (NN infection))))) (, ,) (S (VP (VBG increasing) (NP (NP (DT the) (VBG binding) (NNS sites)) (CC and) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (JJ infectable) (NNS cells))))) (, ,) (SBAR (IN as) (VP (VBN detected) (PP (IN by) (NP (NN immunoelectron) (NN microscopy))))))))) (: ;) (CC and) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (NP (NN HHV-6) (JJ infected) (NN T) (NNS cells)) (, ,) (VP (VBN transfected) (PP (IN with) (NP (NP (NNS plasmids)) (VP (VBG bearing) (NP (NP (DT the) (NP (NN promoter) (NNS regions))) (PP (IN of) (NP (NP (DT the) (NN EBV) (RB early) (NNS genes)) (NP (NP (NN BZLF1)) (CC and) (NP (NN BMRF1)))))))))) (, ,)) (VP (VBP show) (NP (NP (DT a) (JJ strong) (NN transactivation)) (PP (IN of) (NP (DT these) (NP (NNS promoters))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (NN JAK3)) (, ,) (CONJP (CC but) (RB not)) (NP (NN JAK1)))) (, ,)) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (NP (JJ IL-2-induced) (NN proliferation)) (CC and) (NP (NP (NP (NN STAT5)) (NN recruitment)) (PP (IN by) (NP (NP (DT a) (NP (JJ COOH-terminal) (NN region))) (PP (IN of) (NP (DT the) (NP (NN IL-2) (NN receptor) (NN beta-chain))))))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NP (NNS cytokines)) (CC and) (NP (NN growth) (NNS factors))))) (VP (VBP use) (NP (DT the) (NN JAK-STAT) (NN pathway)) (S (VP (TO to) (VP (VB signal) (PP (IN from) (NP (DT the) (NN cell) (NN membrane))) (PP (TO to) (NP (DT the) (NN nucleus))))))) (. .)))))
(S1 (S (S (SBAR (IN While) (S (NP (VBG homodimerizing) (NN cytokine) (NNS receptors)) (VP (MD may) (VP (VB transmit) (NP (NN signal)) (PP (IN via) (NP (NP (DT a) (JJ single) (NN form)) (PP (IN of) (NP (NP (NN JAK)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (NP (NN growth) (NN hormone) (NNS receptors)) (-RRB- -RRB-)))))))))) (, ,) (S (NP (JJ several) (NP (JJ multicomponent) (NN cytokine) (NNS receptors))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB require) (NP (NP (JJ simultaneous) (NN activation)) (PP (IN of) (NP (NP (NNS pairs)) (PP (IN of) (NP (NP (JJ different) (NP (NN JAK) (NNS kinases))) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (NP (NN interferon) (NNS receptors)) (-RRB- -RRB-)))))))))))))) (. .))))
(S1 (S (S (NP (NP (JJ Recent) (NN evidence)) (PP (IN for) (NP (NP (DT a) (JJ preferential) (NN coupling)) (PP (PP (IN of) (NP (NN JAK3))) (PP (TO to) (NP (NP (NN interleukin-2) (NN receptor-gamma)) (PRN (-LRB- -LRB-) (NP (NN IL-2R) (NN gamma)) (-RRB- -RRB-)))) (CC and) (PP (NP (NN JAK1)) (PP (TO to) (NP (NN IL-2R) (NN beta)))))))) (VP (VBZ supports) (NP (NP (DT the) (NN concept)) (PP (IN of) (NP (NP (NN heterotrans-activation)) (PP (IN of) (NP (NP (NN JAK1)) (CC and) (NP (NN JAK3)))) (VP (VBN caused) (PP (IN by) (NP (NP (JJ IL-2-induced) (NN heterodimerization)) (PP (IN of) (NP (PRP$ their) (NN receptor) (NNS partners)))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VP (VBD verified) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN IL-2))) (S (VP (TO to) (VP (VB cause) (NP (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN JAK1)) (CC and) (NP (NN JAK3))))))))))) (, ,) (CC but) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN IL-2)) (VP (VBD stimulated) (NP (NN JAK3)) (PP (TO to) (NP (NP (DT a) (ADJP (RB significantly) (JJR larger)) (NN extent)) (SBAR (IN than) (S (NP (NP (NN JAK1)) (PP (IN in) (NP (NP (JJ human) (NN T) (NNS lymphocytes)) (CC and) (NP (DT the) (NP (NN YT) (NN cell) (NN line))))))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN conclusion)) (VP (VBD was) (VP (VBN based) (PP (IN upon) (NP (NP (JJ several) (JJ independent) (NNS criteria)) (, ,) (PP (VBG including) (NP (NP (NP (NP (ADJP (RBR more) (JJ vigorous)) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN JAK3)))) (, ,) (NP (NP (ADJP (RBR more) (JJ marked) (JJ enzymatic)) (NN activation)) (PP (IN of) (NP (NN JAK3)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJR higher) (NN abundance)) (PP (IN of) (NP (NN JAK3))))) (PP (IN in) (NP (VBN activated) (NP (NN IL-2) (NN receptor) (NNS complexes)))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (JJ human) (NN IL-2R) (NN beta)) (VP (VBD was) (ADVP (RB stably)) (VP (VBN expressed) (PP (IN in) (NP (JJ murine) (NN BA/F3) (NNS cells))))))) (, ,) (S (NP (ADJP (JJ robust)) (NP (JJ IL-2-induced) (NN proliferation)) (CC and) (NP (NP (NN JAK3)) (NN activation))) (VP (VBD occurred) (PP (IN without) (NP (NP (JJ detectable) (NN involvement)) (PP (IN of) (NP (CC either) (NP (NN JAK1)) (, ,) (NP (NN JAK2)) (CC or) (NP (NN TYK2)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NN IL-2) (NN receptor)) (NN signal) (NN transduction)) (VP (VBZ does) (RB not) (VP (VB depend) (PP (IN on) (NP (NP (JJ equimolar) (NN heterodimerization)) (PP (IN of) (NP (NP (NN JAK1)) (CC and) (NP (NN JAK3)))))) (PP (VBG following) (NP (NP (JJ IL-2-induced) (NN heterodimerization)) (PP (IN of) (NP (NP (NN IL-2R) (NN beta)) (CC and) (NP (NN IL-2R) (NN gamma))))))))))) (. .))))
(S1 (S (S (ADVP (RB Nonetheless)) (, ,) (S (S (NP (NP (NP (DT a) (NP (JJ membrane-proximal) (NN region))) (PP (IN of) (NP (JJ human) (NP (NN IL-2R) (NN beta))))) (PRN (-LRB- -LRB-) (NP (NN Asn240-Leu335)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJ critical) (PP (IN for) (NP (NP (NN JAK3)) (NN activation)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN JAK3)) (ADJP (JJ present) (PP (IN in) (NP (VBN activated) (NP (NN IL-2) (NN receptor) (NNS complexes)))))))) (VP (VBD increased) (PP (IN with) (NP (NN time))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN stabilization)) (PP (IN of) (NP (NP (NP (NN JAK3)) (NN binding)) (PP (TO to) (NP (DT the) (NP (NN receptor) (NN complex))))))) (VP (VBZ relies) (PP (IN on) (NP (CC both) (NP (NN IL-2R) (NN beta)) (CC and) (NP (NN IL-2R) (NN gamma)))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NN STAT5)) (VP (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ predominant) (NP (NN STAT) (NN transcription) (NN factor))) (VP (VBN used) (PP (IN by) (NP (NP (NN IL-2)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells)))))))))))) (, ,) (CC and) (ADVP (RB specifically)) (VP (VBD required) (NP (NP (NP (DT a) (NP (JJ COOH-terminal) (NN region))) (PP (IN of) (NP (NN IL-2R) (NN beta)))) (PRN (-LRB- -LRB-) (NP (NN Ser386-Val525)) (-RRB- -RRB-))) (, ,) (SBAR (IN while) (S (NP (NP (NN STAT5)) (NN recruitment)) (VP (VBD was) (RB not) (VP (VBN correlated) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN IL-2R) (NN gamma)) (CC or) (NP (NN JAK3)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Transactivation)) (PP (IN of) (NP (DT the) (NP (NN interleukin-1alpha) (NN promoter)))) (PP (IN by) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II)) (NP (NN Tax) (NNS proteins)))) (. .)))))
(S1 (S (S (S (NP (JJ Human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I) (-LRB- -LRB-) (NN HTLV-I) (-RRB- -RRB-) (JJ -infected) (NN T-cell) (NNS lines)) (ADVP (RB constitutively)) (VP (VBP produce) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN interleukin-1alpha)) (PRN (-LRB- -LRB-) (NP (NN IL-1alpha)) (-RRB- -RRB-)))))) (. .)))))
(S1 (S (S (S (VP (TO To) (VP (VB analyze) (NP (NP (DT the) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (VBP lead) (PP (TO to) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN IL-1alpha))) (PP (IN in) (NP (JJ HTLV-I-infected) (NN cell) (NNS lines)))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD studied) (NP (NP (JJ regulatory) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ human) (NP (NN IL-1alpha) (NN promoter))) (VP (VBN involved) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NN IL-1alpha) (NN gene)))))))))))) (. .))))
(S1 (S (S (NP (NN IL-1alpha) (NN promoter) (NNS constructs)) (VP (VBP drive) (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NP (NN chloramphenicol) (NN acetyltransferase) (-LRB- -LRB-) (NN CAT) (-RRB- -RRB-) (NN reporter) (NN gene)))) (PP (IN in) (NP (NP (JJ HTLV-I-positive) (NN MT-2) (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB constitutively)) (VP (VBP produce) (NP (NN IL-1alpha))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT a) (NN cotransfection) (NN assay))) (, ,) (NP (NP (DT the) (NP (NN Tax) (NN protein))) (PP (IN of) (NP (CC both) (NP (NN HTLV-I)) (CC and) (NP (NN HTLV-II))))) (ADVP (RB specifically)) (VP (VBD activated) (NP (NP (NN transcription)) (PP (IN from) (NP (NP (DT the) (NP (NN IL-1alpha) (NN promoter))) (PP (IN in) (NP (DT an) (NP (JJ uninfected) (NN Jurkat) (NN cell) (NN line)))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (JJ mutant) (NP (NN Tax) (NN protein))) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NN transactivation)) (PP (IN of) (NP (NNS genes))) (PP (IN by) (NP (DT the) (NP (JJ nuclear) (NN factor) (-LRB- -LRB-) (NN NF) (-RRB- -RRB-) (NN -kappaB)) (NN pathway))))))) (VP (VP (VBD was) (ADJP (JJ unable) (S (VP (TO to) (VP (VB induce) (NP (NP (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN IL-1alpha) (JJ promoter-CAT) (NNS constructs))))))))) (, ,) (CC but) (VP (VBD was) (VP (VBN rescued) (PP (IN by) (NP (NP (JJ exogenous) (NN provision)) (PP (IN of) (NP (NP (NN p65/p50)) (NP (NN NF-kappaB))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (SBAR (IN that) (S (NP (NP (CD two) (NP (NN IL-1alpha) (JJ kappaB-like) (NNS sites))) (PRN (-LRB- -LRB-) (NP (NNS positions) (NP (NP (CD -1,065) (TO to) (CD -1,056)) (CC and) (NP (CD +646) (TO to) (CD +655)))) (-RRB- -RRB-))) (ADVP (RB specifically)) (VP (VBD formed) (NP (DT a) (JJ complex)) (PP (IN with) (NP (NP (JJ NF-kappaB-containing) (JJ nuclear) (NN extract)) (PP (IN from) (NP (NN MT-2) (NNS cells)))))))) (CC and) (SBAR (IN that) (S (NP (NN NF-kappaB)) (VP (VBD bound) (PP (IN with) (NP (NP (JJR higher) (NN affinity)) (PP (TO to) (NP (DT the) (NP (JJ 3') (NN NF-kappaB) (NN binding) (NN site)))) (PP (IN than) (PP (TO to) (NP (DT the) (NP (JJ 5') (NN NF-kappaB) (NN site)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN deletion)) (PP (IN of) (NP (CC either) (NP (ADJP (JJ 5'))) (CC or) (NP (ADJP (JJ 3'))) (NP (NN NF-kappaB) (NNS sites))))) (VP (VBD reduced) (NP (NP (NP (NP (NN IL-1alpha) (NN promoter)) (NN activity)) (PP (IN in) (NP (NN MT-2) (NNS cells)))) (CC and) (NP (NP (NN transactivation)) (PP (IN of) (NP (DT the) (NP (NN IL-1alpha) (NN promoter)))) (PP (IN by) (NP (NP (NP (JJ exogenous) (NP (NN NF-kappaB))) (CC and) (NP (NN Tax))) (PP (IN in) (NP (NN Jurkat) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ general) (NN role)) (PP (IN for) (NP (NP (NP (NN Tax)) (NN induction)) (PP (IN of) (NP (NP (NN IL-1alpha) (NN gene)) (NN transcription))) (PP (IN by) (NP (DT the) (NP (NN NF-kappaB)) (NN pathway))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN IL-1alpha))) (PP (IN by) (NP (NN HTLV-I) (RB productively) (NP (JJ infected) (NNS cells))))) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (NP (DT the) (NN hypercalcemia)) (, ,) (NP (JJ osteolytic) (NN bone) (NNS lesions)) (, ,) (NP (NN neutrophilia)) (, ,) (NP (NP (NN elevation)) (PP (IN of) (NP (JJ C-reactive) (NN protein)))) (, ,) (CC and) (NP (NN fever))) (VP (ADVP (RB frequently)) (VBN seen) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ HTLV-I-induced) (JJ adult) (NN T-cell) (NN leukemia/lymphoma))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Activation)) (PP (IN of) (NP (NN c-Jun) (JJ N-terminal) (NN kinase))) (PP (IN in) (NP (JJ bacterial) (JJ lipopolysaccharide-stimulated) (NNS macrophages))) (. .)))))
(S1 (S (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NNS macrophages))) (PP (IN by) (NP (JJ bacterial) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))))) (VP (VBZ induces) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBP encode) (PP (IN for) (NP (NP (JJ proinflammatory) (NNS regulators)) (PP (IN of) (NP (DT the) (JJ immune) (NN response)))))))))))) (. .)))))
(S1 (S (S (NP (JJ Previous) (NN work)) (VP (VBZ has) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NP (NP (NN transcription) (NN factor) (NN activator) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-)))))) (VP (VBZ is) (NP (NP (CD one) (JJ LPS-induced) (NN event)) (SBAR (WHNP (WDT that)) (S (VP (VBZ mediates) (NP (DT this) (NN response))))))))))) (. .))))
(S1 (S (S (ADVP (JJ Consistent) (PP (IN with) (NP (DT this) (NN notion)))) (, ,) (S (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NN LPS)) (VP (VBD stimulated) (NP (NP (JJ AP-1-mediated) (NN transcription)) (PP (IN of) (NP (DT a) (NP (VBN transfected) (NN reporter) (NN gene)))) (PP (IN in) (NP (DT the) (NP (JJ murine) (NN macrophage) (NN cell) (NN line) (NN RAW) (CD 264.7)))))))))) (. .))))
(S1 (S (S (SBAR (IN As) (S (NP (NP (NN AP-1)) (NN activity)) (VP (VBZ is) (VP (VBN regulated) (PP (IN in) (NP (NN part))) (PP (IN by) (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NP (NP (NN c-Jun) (JJ N-terminal) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN JNK)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ phosphorylates)) (CC and) (ADVP (RB subsequently)) (VP (VBZ increases) (NP (NP (DT the) (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN c-Jun)))))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD examined) (SBAR (IN whether) (S (NP (NP (NN LPS) (NN treatment)) (PP (IN of) (NP (NNS macrophages)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (DT this) (NP (NN kinase))))))))))) (. .))))
(S1 (S (S (NP (NP (NN LPS) (NN treatment)) (PP (IN of) (NP (NP (NP (NN RAW) (CD 264.7) (NNS cells)) (, ,) (NP (JJ murine) (NN bone) (JJ marrow-derived) (NNS macrophages))) (, ,) (CC and) (NP (DT the) (NP (JJ human) (NN monocyte) (NN cell) (NN line) (NN THP-1)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ rapid) (NN activation)) (PP (IN of) (NP (NP (DT the) (NP (NN p46)) (CC and) (NP (NN p54)) (NP (NNS isoforms))) (PP (IN of) (NP (NN JNK)))))))) (. .))))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NP (NP (ADJP (JJ wild-type))) (CC and) (NP (ADJP (JJ rough))) (NP (JJ mutant) (NNS forms))) (PP (IN of) (NP (NP (NN LPS)) (CC and) (NP (JJ synthetic) (NN lipid) (NN A))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN JNK)) (NN activation))) (, ,) (SBAR (IN while) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (DT the) (NP (NN tyrosine) (NN kinase)) (NN inhibitor) (NN herbimycin) (NN A)))) (VP (VBD inhibited) (NP (DT this) (NN response)))))) (. .))))
(S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN LPS-LPS) (NN binding) (NN protein) (-LRB- -LRB-) (NN LBP) (-RRB- -RRB-) (NNS complexes))) (PP (TO to) (NP (NP (NN CD14)) (, ,) (NP (NP (DT a) (NP (NN surface) (NN receptor))) (SBAR (WHNP (WDT that)) (S (VP (VBZ mediates) (NP (JJ many) (NN LPS) (NNS responses)))))))) (, ,)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ crucial)))))) (, ,) (SBAR (IN as) (S (NP (NP (NN pretreatment)) (PP (IN of) (NP (NN THP-1) (NNS cells))) (PP (IN with) (NP (NP (DT the) (NP (JJ monoclonal) (NN antibody) (NN 60b))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ blocks) (NP (DT this) (NN binding))))))) (, ,)) (VP (VBD inhibited) (NP (NP (NN JNK)) (NN activation)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN LPS) (NN activation)) (PP (IN of) (NP (NN JNK))) (PP (IN in) (NP (JJ monocyte/macrophage) (NNS cells)))) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (NN CD14-)) (CC and) (ADJP (NN protein) (NN tyrosine) (JJ phosphorylation-dependent))) (NN event)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB mediate) (NP (NP (DT the) (JJ early) (NN activation)) (PP (IN of) (NP (NN AP-1)))) (PP (IN in) (S (VP (VBG regulating) (NP (JJ LPS-triggered) (NN gene) (NN induction)))))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Transcriptional) (NN basis)) (PP (IN for) (NP (NP (NN hyporesponsiveness)) (PP (IN of) (NP (DT the) (NP (JJ human) (JJ inducible) (JJ nitric) (NN oxide) (NN synthase) (NN gene)))) (PP (TO to) (NP (NN lipopolysaccharide/interferon-gamma))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN work)) (VP (VBN reported) (ADVP (RB here)))) (VP (VBZ resolves) (, ,) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN gene) (NN regulation))))) (, ,) (NP (NP (DT the) (NN controversy)) (PP (IN as) (PP (TO to) (SBAR (IN whether) (CC or) (RB not) (S (NP (JJ human) (NNS monocytes/macrophages)) (VP (MD can) (VP (VB produce) (NP (NP (JJ nitric) (NN oxide)) (PRN (-LRB- -LRB-) (NP (NN NO)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN stimulated) (PP (IN with) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-)))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without)) (NP (NP (NN co-stimulation)) (PP (IN by) (NP (NP (NN interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-)))))))))))))))) (. .)))))
(S1 (S (S (NP (NNS Studies)) (VP (VBD included) (NP (NP (NP (JJ structural) (NN comparison)) (PP (IN of) (NP (NP (DT the) (NNS promoters)) (PP (IN for) (NP (NP (ADJP (JJ human))) (CC and) (NP (NN mouse)) (NP (JJ inducible) (NN NO) (NN synthase) (-LRB- -LRB-) (NN iNOS) (-RRB- -RRB-) (NNS genes))))))) (, ,) (NP (NP (NP (NP (NN transfection)) (CC and) (NP (NN assay))) (PP (IN of) (NP (NP (ADJP (JJ human))) (CC and) (NP (NN mouse)) (NP (NN iNOS) (NN promoter) (NNS regions))))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN LPS) (CC +/-) (NP (NN IFN-gamma))))))) (, ,) (CC and) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PP (IN of) (NP (NN kappa) (NN B) (NN response) (NNS elements)))))) (. .))))
(S1 (S (S (S (NP (NP (CD Two) (NNS explanations)) (PP (IN for) (NP (NP (NN hyporesponsiveness)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN iNOS) (NN promoter)))) (PP (TO to) (NP (NN LPS) (CC +/-) (NP (NN IFN-gamma))))))) (VP (VBD were) (VP (VBN found)))) (: :) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (ADJP (ADJP (JJ multiple)) (ADJP (VBG inactivating))) (JJ nucleotide) (NNS substitutions)) (PP (IN in) (NP (NP (NP (DT the) (JJ human) (NN counterpart)) (PP (IN of) (NP (DT the) (NP (NN enhancer) (NN element))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB regulate) (NP (NP (NN LPS/IFN-gamma) (JJ induced) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN mouse) (NN iNOS) (NN gene)))))))))))))))) (: ;) (CC and) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (CC and) (NN absence)) (PP (IN of) (NP (NP (NP (NP (QP (CD one) (CC or) (JJR more)) (NP (JJ nuclear) (NNS factors))) (PP (IN in) (NP (NP (JJ human) (NNS macrophages))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (DT an) (NP (JJ LPS-inducible) (JJ nuclear) (NN factor-kappa) (NN B/Rel) (NN complex))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is)) (PRN (-LRB- -LRB-) (VP (VBP are)) (-RRB- -RRB-))) (VP (VBN required) (PP (IN for) (NP (NP (JJ maximal) (NN expression)) (PP (IN of) (NP (DT the) (NN gene)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN importance)) (PP (IN of) (NP (NP (NN resolution)) (PP (IN of) (NP (DT this) (NN controversy)))))) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (JJ future) (NN research)) (PP (IN in) (NP (DT this) (NN area)))) (VP (MD should) (VP (VB be) (VP (VBN directed) (PP (IN toward) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (JJ alternative) (NNS mechanisms)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (DT the) (JJ successful) (NN production)) (PP (IN of) (NP (NN NO))))))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (NN Ubiquitinylation)) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (NP (NP (NN c-Jun)) (CC and) (NP (NN c-Fos))))) (S (VP (VBG using) (NP (VBN reconstituted) (VBG ubiquitinylating) (NNS enzymes)))) (. .)))))
(S1 (S (S (S (NP (JJ Recombinant) (NP (NN c-Jun)) (CC and) (NP (NN c-Fos))) (VP (VBD were) (VP (VBN ubiquitinylated) (PP (IN by) (NP (NP (DT the) (NP (NN ubiquitin) (NN carrier) (NNS enzymes))) (NP (NP (NN E214K)) (, ,) (NP (NN E220K)) (, ,) (CC or) (NP (NN E232K))))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT the) (NP (JJ ubiquitin-activating) (NN enzyme))) (, ,) (NP (NN E1)))))))) (. .)))))
(S1 (S (S (NP (NP (NN Addition)) (PP (IN of) (NP (NN ubiquitin) (NN protein) (NN ligase) (NN E3)))) (ADVP (RB substantially)) (VP (VBD enhanced) (NP (NP (DT the) (JJ E214K-mediated) (NN ubiquitinylation)) (PP (IN of) (NP (NP (NN c-Jun)) (CC and) (NP (NN c-Fos)))))) (. .))))
(S1 (S (S (NP (NP (VBN Truncated) (NP (NN c-Jun)) (CC and) (NP (NN c-Fos)) (NP (JJ mutant) (NNS proteins))) (PP (VBG including) (NP (NP (NN wbJun)) (CC and) (NP (NN wbFos))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN ubiquitinylated) (PP (IN under) (NP (DT the) (JJ same) (NNS conditions)))) (, ,) (S (VP (VBG suggesting) (S (NP (NP (DT the) (NNS sites)) (PP (IN of) (NP (NN ubiquitinylation)))) (VP (VBP are) (ADJP (JJ located) (PP (IN within) (NP (NP (DT the) (NP (NN dimerization)) (CC and) (NP (NN DNA) (NN binding)) (NP (NNS domains))) (PP (IN of) (NP (NP (NN c-Jun)) (CC and) (NP (NN c-Fos)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ E3-dependent) (NN ubiquitinylation)) (PP (IN of) (NP (NN c-Jun)))) (VP (VBD was) (VP (VBN inhibited) (PP (IN upon) (NP (NP (DT the) (NN heterodimerization)) (PP (IN of) (NP (NN c-Jun))) (PP (IN with) (NP (NN c-Fos))))))) (. .))))
(S1 (S (S (NP (NP (IN Further) (NN addition)) (PP (IN of) (NP (NN E220K)))) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (NN ubiquitinylation)) (PP (IN of) (NP (NN c-Jun))) (PP (IN in) (NP (DT the) (NN heterodimer)))) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ regulatory) (NN role)) (PP (IN of) (NP (NN E220K))))))) (. .))))
(S1 (S (S (NP (NP (VBN Polyubiquitinylated) (NP (NN c-Jun)) (, ,) (NP (NN wbFos)) (, ,) (CC and) (NP (NN wbJun))) (, ,) (CONJP (CC but) (RB not)) (NP (JJ E220K-ubiquitinylated) (NN c-Jun)) (, ,)) (VP (VBD were) (ADVP (RB readily)) (VP (VBN degraded) (PP (IN by) (NP (DT the) (NP (JJ ATP-dependent) (CD 26) (NN S) (JJ multicatalytic) (NNS proteases)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (UCP (SBAR (IN that) (S (NP (NP (DT the) (JJ temporal) (NN control)) (PP (IN of) (NP (NP (NN c-Jun)) (CC and) (NP (NN c-Fos))))) (VP (MD may) (VP (VB be) (VP (VBN regulated) (PP (IN through) (NP (DT the) (NN ubiquitinylation) (NNS pathways)))))))) (, ,) (CC and) (NP (NP (DT the) (NN ubiquitinylation)) (PP (IN of) (NP (NP (NN c-Jun)) (CC and) (NP (NN c-Fos))))) (VP (MD may) (PP (IN in) (NP (NN turn))) (VP (VB be) (VP (VBN regulated) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (DT the) (NN heterodimerization)) (PP (IN between) (NP (PRP them)))) (CC and) (NP (NP (DT the) (NN cooperation)) (PP (IN between) (NP (NP (NN E220K)) (CC and) (NP (NN E3)) (NP (JJ mediated) (NN polyubiquitinylation)))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Modulation)) (PP (IN of) (NP (JJ endogenous) (NP (NN IL-1) (NN beta)) (CC and) (NP (NP (NN IL-1) (NN receptor)) (NN antagonist))))) (VP (VBZ results) (PP (IN in) (NP (NP (JJ opposing) (NNS effects)) (PP (IN on) (NP (NP (NN HIV) (NN expression)) (PP (IN in) (NP (RB chronically) (JJ infected) (JJ monocytic) (NNS cells)))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (NN proportion)) (PP (IN of) (NP (JJ HIV-infected) (NNS individuals)))) (VP (VBP experience) (NP (NP (NNS episodes)) (PP (IN of) (NP (NP (NP (ADJP (JJ localized))) (CC or) (NP (ADJP (JJ systemic))) (NP (JJ bacterial) (NNS infections))) (VP (VBN caused) (PP (IN by) (NP (JJ Gram-negative) (NNS bacteria)))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Many)) (PP (IN of) (NP (NP (DT the) (JJ clinical) (JJ side) (NNS effects)) (PP (IN of) (NP (DT these) (NNS infections)))))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (JJ proinflammatory) (NNS cytokines)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN induced) (PP (ADVP (RB primarily)) (IN by) (NP (NP (NN LPS)) (, ,) (NP (NP (DT a) (NN constituent)) (PP (IN of) (NP (NP (DT the) (JJ bacterial) (NN cell) (NN wall)) (PP (IN of) (NP (JJ Gram-negative) (NNS bacteria)))))))))))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ examines) (NP (NP (DT the) (NNS mechanisms)) (VP (VBN involved) (PP (IN in) (NP (NP (JJ LPS-mediated) (NN induction)) (PP (IN of) (NP (NP (NN HIV) (NN expression)) (PP (IN in) (NP (NP (NN U1) (NNS cells)) (, ,) (NP (NP (DT a) (NP (JJ promonocytic) (NN cell) (NN line))) (VP (ADVP (RB chronically)) (VBN infected) (PP (IN with) (NP (NN HIV)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NN U1) (NNS cells))) (PP (IN by) (NP (NP (NN LPS)) (ADVP (RB alone))))) (VP (VBD induced) (NP (NP (JJ minimal) (NNS levels)) (PP (IN of) (NP (NP (NN HIV) (NN expression)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB significantly)) (VP (VBN enhanced) (PP (IN by) (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Costimulation)) (PP (IN of) (NP (NN U1) (NNS cells))) (PP (IN with) (NP (NP (NN LPS)) (CC plus) (NP (NN GM-CSF))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NP (JJ steady-state) (NNS levels)) (PP (IN of) (NP (NN HIV) (NN RNA))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (ADJP (QP (RB only) (DT a)) (JJ weak)) (NN induction)) (PP (IN of) (NP (NP (NN HIV) (JJ long) (JJ terminal) (JJ repeat-driven) (NN transcription)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (DT the) (NP (JJ cellular) (NN transcription) (NN factor)) (NP (JJ nuclear) (NN factor-kappa) (NN B)))))))))))) (, ,)) (VP (VBD was) (VP (VBN noted)))) (. .))))
(S1 (S (S (NP (NP (NN Costimulation)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NP (NN LPS)) (CC plus) (NP (NN GM-CSF))))) (VP (VBD induced) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NP (JJ proinflammatory) (NNS cytokines)) (, ,) (NP (NN IL-8)) (, ,) (NP (NN IL-1) (NN beta)) (CC and) (NP (NN IL-6))) (, ,) (CONJP (CC but) (RB not)) (NP (NN TNF-alpha)))))) (. .))))
(S1 (S (S (NP (NP (NP (NN IL-1) (NN receptor)) (NN antagonist)) (PRN (-LRB- -LRB-) (NP (NN ra)) (-RRB- -RRB-))) (VP (VBD inhibited) (NP (NP (NN LPS) (NN enhancement)) (PP (IN of) (NP (NP (NN HIV) (NN expression)) (PP (IN in) (NP (JJ GM-CSF-stimulated) (NNS cells)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ endogenous) (NN IL-1)) (VP (VBD was) (VP (VBN involved) (PP (IN in) (NP (JJ LPS-mediated) (JJ viral) (NN production)))))))))) (. .))))
(S1 (S (S (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP (JJ anti-inflammatory) (NNS cytokines)) (VP (VBD inhibited) (NP (ADJP (ADJP (NN LPS)) (CC plus) (ADJP (JJ GM-CSF-stimulated))) (NN HIV) (NN expression)))) (, ,) (CC and) (S (NP (DT this) (NN effect)) (ADVP (RB closely)) (VP (VBD correlated) (PP (PP (IN with) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN IL-1) (NN beta)) (NN release))))) (CC and) (, ,) (PP (IN in) (NP (JJ particular))) (, ,) (PP (IN with) (NP (NP (NN up-regulation)) (PP (IN of) (NP (JJ endogenous) (NN IL-1ra) (NN production)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN balance)) (PP (IN between) (NP (NP (NP (DT an) (NP (RB endogenously) (VBN produced) (JJ viral) (NN inducer))) (PRN (-LRB- -LRB-) (NP (NN IL-1) (NN beta)) (-RRB- -RRB-))) (CC and) (NP (NP (DT an) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN IL-1ra)) (-RRB- -RRB-)))))) (VP (MD may) (VP (VB represent) (NP (NP (DT an) (JJ important) (NN pathway)) (VP (VBG leading) (PP (TO to) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (NN HIV) (NN expression)) (PP (IN from) (NP (JJ monocytic) (NNS cells))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Transcriptional) (NN regulation)) (PP (IN of) (NP (DT the) (NP (NN interleukin-2) (NN gene)))) (PP (IN in) (NP (JJ normal) (NP (JJ human) (JJ peripheral) (NN blood) (NN T) (NNS cells)))) (. .)))))
(S1 (S (NP (NP (NP (NN Convergence)) (PP (IN of) (NP (JJ costimulatory) (NNS signals)))) (CC and) (NP (NP (NNS differences)) (PP (IN from) (NP (VBN transformed) (NN T) (NNS cells)))) (. .))))
(S1 (S (S (S (S (VP (TO To) (VP (VB study) (NP (NP (JJ transcriptional) (NN regulation)) (PP (IN in) (NP (JJ normal) (JJ human) (NN T) (NNS cells))))))) (, ,) (S (NP (PRP we)) (VP (VBP have) (VP (VBN optimized) (NP (NP (NNS conditions)) (PP (IN for) (NP (JJ transient) (NN transfection))))))) (. .)))))
(S1 (S (S (NP (NN Interleukin-2) (-LRB- -LRB-) (NN IL-2) (-RRB- -RRB-) (JJ promoter-reporter) (NN gene) (NN behavior)) (ADVP (RB closely)) (VP (VBZ parallels) (NP (DT the) (NP (JJ endogenous) (NN gene))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NN T) (NN cell) (NN receptor)) (CC and) (NP (JJ costimulatory) (NNS signals))))))) (. .))))
(S1 (S (S (SBAR (IN As) (S (VP (VBN assessed) (PP (IN with) (NP (VBN mutagenized) (NNS promoters)))))) (, ,) (S (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (NP (NN IL-2) (JJ cis-regulatory) (NNS elements))) (PP (IN in) (NP (JJ normal) (NN T) (NNS cells)))) (VP (VBP are) (NP (NP (DT the) (NP (JJ proximal) (NN AP-1) (NN site))) (CC and) (NP (DT the) (NP (NN NF-kappaB) (NN site)))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NP (JJ primary) (NN activation)) (, ,) (PP (IN with) (NP (NP (NN phytohemagglutinin)) (CC or) (NP (NNS antibodies) (TO to) (NN CD3))))) (, ,) (CC and) (NP (NP (NN costimulation)) (, ,) (VP (VBN provided) (PP (IN by) (NP (NP (NP (NNS pairs)) (PP (IN of) (NP (NN CD2) (NNS antibodies)))) (CC or) (NP (NP (JJ B7-positive) (-LRB- -LRB-) (NN B) (NNS cells) (-RRB- -RRB-)) (CC or) (NP (JJ B7-negative) (-LRB- -LRB-) (NN endothelial) (-RRB- -RRB-) (JJ accessory) (NNS cells) (, ,)))))))) (VP (VBP are) (VP (VBN mediated) (PP (IN through) (NP (DT the) (JJ same) (NP (NNS cis-elements)))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (DT the) (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NN cell) (NNS sites))) (VP (VBP are) (ADJP (ADJP (ADVP (RB much) (RBR less)) (JJ important)) (PP (IN in) (NP (JJ normal) (NN T) (NNS cells))) (PP (IN than) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NP (NN IL-2)) (JJ transcriptional) (NN regulation)) (VP (VBZ differs) (PP (IN in) (NP (NN tumor) (NN cell) (NNS lines))) (PP (VBN compared) (PP (IN with) (NP (JJ normal) (NN T) (NNS cells))))))) (CC and) (SBAR (IN that) (S (NP (JJ different) (JJ costimulatory) (NNS signals)) (VP (VBP converge) (PP (IN on) (NP (NP (DT the) (JJ same) (NP (NNS cis-elements))) (PP (IN in) (NP (DT the) (NP (NN IL-2) (NN promoter))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Monocytic) (NN cell) (JJ type-specific) (JJ transcriptional) (NN induction)) (PP (IN of) (NP (NN collagenase))) (. .)))))
(S1 (S (S (S (NP (NP (NP (JJ Interstitial) (NP (NN collagenase))) (PRN (-LRB- -LRB-) (NP (NN MMP-1)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NP (NN metalloproteinase))) (VP (VBN produced) (PP (IN by) (NP (NP (ADJP (JJ resident))) (CC and) (NP (ADJP (JJ inflammatory))) (NP (NNS cells)))) (PP (IN during) (NP (JJ connective) (NN tissue) (NN turnover))))) (, ,)) (VP (VBZ cleaves) (NP (NN type) (CD I) (NN collagen) (NNS fibrils))) (. .)))))
(S1 (S (S (NP (DT This) (JJ catalytic) (NN event)) (VP (VBZ is) (ADJP (NN rate) (VBG limiting) (PP (IN in) (NP (NP (NN remodeling)) (PP (IN of) (NP (NP (NNS tissues)) (ADJP (JJ rich) (PP (IN in) (NP (NP (JJ fibrillar) (NN collagen)) (PP (JJ such) (IN as) (NP (NP (DT the) (NN skin)) (CC and) (NP (NNS lungs))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN regulation)) (PP (IN of) (NP (NP (NN collagenase)) (NN expression)))) (VP (VBZ is) (ADJP (NN cell-type) (JJ specific)))) (: ;) (S (NP (NP (JJ bacterial) (NN LPS)) (CC and) (NP (NP (NN zymosan)) (, ,) (NP (DT a) (NN yeast) (NN cell) (NN wall) (NN derivative))) (, ,)) (VP (VP (VBP are) (NP (NP (JJ potent) (NNS inducers)) (PP (IN of) (NP (NP (NP (NN collagenase)) (NN expression)) (PP (IN in) (NP (NNS macrophages))))))) (, ,) (CC but) (VP (VBP do) (RB not) (VP (VB alter) (NP (NP (NN fibroblast)) (NP (NN collagenase)) (NN expression)))))) (. .))))
(S1 (S (S (SBAR (IN Since) (S (NP (NP (NN promoter) (NNS elements)) (VP (VBG controlling) (NP (NP (NP (NN collagenase)) (NN transcription)) (PP (IN in) (NP (JJ monocytic) (NNS cells)))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB previously)) (VP (VBN defined)))))) (, ,) (S (NP (PRP we)) (VP (VBD sought) (S (VP (TO to) (VP (VB delineate) (NP (NP (JJ responsive) (NP (JJ cis-acting) (NNS elements))) (PP (IN of) (NP (NP (DT the) (NP (NN collagenase) (NN promoter))) (PP (IN in) (NP (ADJP (RB transiently) (VBN transfected)) (NP (NP (NP (ADJP (JJ human))) (PRN (-LRB- -LRB-) (NP (NN U937)) (-RRB- -RRB-)))) (CC and) (NP (NP (NP (ADJP (JJ murine))) (PRN (-LRB- -LRB-) (NP (NN J774)) (-RRB- -RRB-)))) (NP (JJ monocytic) (NN cell) (NNS lines)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Deletion) (NNS constructs)) (VP (VBG containing) (NP (NP (QP (RB as) (JJ little) (IN as) (CD 72)) (NN bp)) (PP (IN of) (NP (NP (JJ 5'-flanking) (NN sequence)) (PP (IN of) (NP (DT the) (NP (NN collagenase) (NN promoter))))))))) (VP (VBD were) (ADJP (JJ sufficient) (PP (IN for) (NP (NP (NN LPS-)) (CC or) (NP (ADJP (JJ zymosan-mediated))) (NP (JJ transcriptional) (NN induction))))) (, ,) (SBAR (IN whereas) (S (NP (NN phorbol) (NN inducibility)) (VP (VBD exhibited) (NP (NP (DT an) (JJ absolute) (NN requirement)) (PP (IN for) (NP (NP (JJ upstream) (NNS elements)) (PP (VBG including) (NP (NP (NP (DT the) (NP (NN polyoma) (NN enhancer) (JJ A-binding) (NN protein-3) (NN site))) (PRN (-LRB- -LRB-) (NP (CD -83) (TO to) (CD -91)) (-RRB- -RRB-))) (CC and) (NP (NP (NN TTCA) (NN sequence)) (PRN (-LRB- -LRB-) (NP (CD -102) (TO to) (CD -105)) (-RRB- -RRB-)))))))) (PP (IN in) (NP (CC both) (NP (JJ monocytic) (NNS cells)) (CC and) (NP (NNS fibroblasts)))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutagenesis)) (PP (IN of) (NP (NP (DT the) (NP (NN activator) (NN protein-1) (-LRB- -LSB-) (NN AP-1) (-RRB- -RSB-) (NN site))) (PP (IN at) (NP (CD -72)))))) (VP (VBD abolished) (NP (NP (NP (JJ basal) (NN promoter)) (NN activity)) (CC and) (NP (NN LPS/zymosan) (NN inducibility))) (, ,) (SBAR (IN while) (S (NP (NP (NN mutagenesis)) (PP (IN of) (NP (NP (DT an) (NP (JJ NF-kappaB-like) (NN site))) (PP (IN at) (NP (QP (CD -20) (TO to) (CD -10))))))) (VP (VBD had) (NP (DT no) (NN effect)))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Nuclear) (NNS extracts)) (PP (IN from) (NP (NP (NN LPS-)) (CC and) (NP (JJ zymosan-treated) (NNS cells))))) (VP (VBD showed) (NP (JJ strong) (NP (NN AP-1)) (NN activity)) (PP (IN by) (NP (JJ gel-shift) (NN analysis))))) (, ,) (CC and) (S (NP (NN supershift) (NN analysis)) (VP (VBD showed) (NP (DT the) (NP (NN AP-1) (NNS complexes))) (VP (VBD contained) (NP (NP (JJ specific) (NNS members)) (PP (IN of) (NP (CC both) (DT the) (NP (NN jun)) (CC and) (NP (NN fos)) (NP (NN gene) (NNS families)))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (TO to) (NP (JJS most) (NN LPS) (NNS effects))))) (, ,) (NP (NP (NN AP-1)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ nuclear) (NN factor-kappaB)) (, ,)) (VP (VBZ mediates) (NP (NP (NN LPS) (NN induction)) (PP (IN of) (NP (NP (NP (NN collagenase)) (NN transcription)) (PP (IN in) (NP (JJ macrophagelike) (NNS cells)))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (SBAR (IN as) (VP (VBN compared) (PP (TO to) (NP (NP (NN regulation)) (PP (IN by) (NP (NN phorbol) (NN ester))))))) (, ,) (S (NP (NP (NP (NN collagenase)) (NN induction)) (PP (IN in) (NP (JJ monocytic) (NNS cells))) (PP (IN by) (NP (NP (NN cell) (NN wall) (NNS derivatives)) (PP (IN of) (NP (NP (NNS bacteria)) (CC or) (NP (NN yeast))))))) (VP (VBZ is) (ADJP (RB largely) (JJ independent) (PP (IN of) (NP (JJ upstream) (NN promoter) (NNS sequences)))))) (. .))))
(S1 (S (NP (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NN p16))) (PP (IN in) (NP (DT the) (NP (JJ E2F-dependent) (NN thymidine) (NN kinase)) (NN regulation))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (NNS alterations)) (PP (IN of) (NP (NP (DT the) (NP (NN MTS1) (NN tumor) (NN suppressor) (NN gene))) (PP (IN on) (NP (NN chromosome) (NN 9p21))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ encodes) (NP (NP (NN p16)) (, ,) (NP (NP (DT the) (NN inhibitor)) (PP (IN of) (NP (NP (NN cyclin-dependent-kinase-4)) (CC and) (NP (CD 6))))))))))) (, ,) (PP (IN in) (NP (NN tumorigenesis)))))) (VP (VBZ is) (ADVP (RB not) (RB yet)) (ADJP (JJ clear))) (. .)))))
(S1 (S (S (NP (NP (NN Phosphorylation)) (PP (IN of) (NP (DT the) (NP (NN retinoblastoma) (NN protein)))) (PP (IN by) (NP (JJ cyclin-dependent) (NNS kinases) (NP (CD 4)) (CC and) (NP (CD 6))))) (VP (VBZ prevents) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NP (DT the) (NP (NP (NN transcription) (NN factor)) (NP (NN E2F)))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB subsequently)) (VP (VBZ promotes) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN S) (NN phase) (JJ regulated) (NNS genes)) (, ,) (PP (JJ such) (IN as) (NP (NN thymidine) (NN kinase))))))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (DT a) (NN role)) (PP (IN of) (NP (NN p16))) (PP (IN in) (NP (DT this) (NN regulation)))) (VP (VBZ has) (VP (VBN been) (VP (VBN presumed)))))) (, ,) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN proof)) (ADVP (RB so) (RB far)) (SBAR (IN that) (S (NP (NP (NN loss)) (PP (IN of) (NP (DT this) (NP (NN tumor) (NN suppressor) (NN gene))))) (ADVP (RB really)) (VP (VBZ affects) (NP (JJ E2F-mediated) (NNS regulations)))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN thymidine) (NN kinase))) (PP (PP (IN in) (NP (JJ phytohemagglutinin-stimulated) (JJ normal) (JJ human) (NNS lymphocytes))) (CC and) (PP (IN in) (NP (NP (DT the) (NP (JJ p16-negative) (JJ human) (JJ acute) (JJ lymphoblastic) (NN leukemia) (NN cell) (NNS lines))) (, ,) (NP (NP (NN MOLT-4)) (CC and) (NP (NN CEM)))))))) (. .))))
(S1 (S (S (PP (VBN Compared) (PP (TO to) (NP (JJ normal) (NNS lymphocytes)))) (, ,) (NP (NP (NN MOLT-4)) (CC and) (NP (NN CEM)) (NP (NNS cells))) (VP (VBD exhibited) (NP (NP (NP (DT an) (JJ altered) (NN cell) (NN cycle) (NN regulation)) (PP (IN of) (NP (NN thymidine) (NN kinase)))) (, ,) (NP (NP (DT a) (ADJP (RB much) (JJR higher) (JJ intracellular)) (NN activity)) (PP (IN of) (NP (DT this) (NP (NN enzyme))))) (, ,) (CC and) (NP (JJR higher) (NP (NN thymidine) (NN kinase) (NN mRNA)) (NN expression)))) (. .))))
(S1 (S (S (NP (NP (JJ Transient) (NN expression)) (PP (IN of) (NP (NN p16))) (PP (IN in) (NP (JJ normal) (JJ human) (NNS lymphocytes)))) (VP (VP (VBD caused) (NP (NP (NN arrest)) (PP (IN in) (NP (NN G1))))) (, ,) (CC but) (VP (VBD was) (PP (IN without) (NP (NP (NN effect)) (PP (IN on) (NP (NP (DT the) (NN cell) (NN growth)) (PP (IN of) (NP (NP (NN MOLT-4)) (CC and) (NP (NN CEM)) (NP (NNS cells))))))))) (, ,) (SBAR (IN although) (S (NP (NP (DT all)) (PP (IN of) (NP (PRP them)))) (VP (VBP express) (NP (JJ functional) (NP (NN retinoblastoma) (NN protein))))))) (. .))))
(S1 (S (S (ADVP (RB Nevertheless)) (, ,) (PP (IN in) (NP (DT the) (CD two) (NP (NN leukemia) (NN cell) (NNS lines)))) (NP (NP (JJ transient) (NN overexpression)) (PP (IN of) (NP (NN p16)))) (VP (VBD reestablished) (NP (NP (NP (DT the) (JJ normal) (NN regulation)) (PP (IN of) (NP (NN thymidine) (NN kinase)))) (, ,) (VP (VBN paralleled) (PP (IN by) (NP (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (DT the) (JJ underphosphorylated) (NN form)) (PP (IN of) (NP (NN retinoblastoma) (NN protein)))))) (CC and) (NP (NP (NN decrease)) (PP (IN of) (NP (NP (JJ free) (NP (NN E2F))) (VP (VBD bound) (PP (TO to) (NP (NP (PRP$ its) (NN motif)) (PP (IN in) (NP (DT the) (NP (NN thymidine) (NN kinase) (NN promoter))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN loss)) (PP (IN of) (NP (NN p16)))) (VP (VBZ causes) (NP (NP (NN upregulation)) (PP (IN of) (NP (DT this) (NN DNA) (NN precursor) (NN pathway) (NP (NN enzyme)))) (PP (IN via) (NP (NP (NN activation)) (PP (IN of) (NP (NN E2F))) (PP (IN by) (NP (NP (DT a) (NN mechanism)) (VP (VBG involving) (NP (NN retinoblastoma) (NN protein)))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN cAMP) (NN inducibility)) (PP (IN of) (NP (NP (JJ transcriptional) (NN repressor)) (NP (NN ICER)))) (PP (IN in) (NP (NP (VBG developing)) (CC and) (NP (JJ mature) (JJ human) (NN T) (NNS lymphocytes))))) (S (-LRB- -LSB-) (NP (VBN published) (NN erratum)) (VP (VBZ appears) (PP (IN in) (NP (NP (NNP Proc) (NNP Natl) (NNP Acad) (NNP Sci) (NNP U) (NNP S) (NNP A)) (NP (CD 1996) (NNP Jul) (CD 23)) (: ;) (NP (CD 93) (-LRB- -LRB-) (CD 15) (-RRB- -RRB-)) (: :) (NP (CD 8154))))) (-RRB- -RSB-))))))
(S1 (S (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (DT the) (JJ cAMP-dependent) (NN signaling) (NN pathway)))) (VP (VBZ exerts) (NP (DT an) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NP (DT the) (NP (NN proliferation)) (CC and) (NP (NN effector) (NNS functions))) (PP (IN of) (NP (NN T) (NNS cells)))))) (. .)))))
(S1 (S (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN T) (NNS cells))) (S (VP (TO to) (VP (VB form) (NP (NP (JJ high) (JJ intracellular) (NNS levels)) (PP (IN of) (NP (NN cAMP)))))))) (VP (VP (VBZ is) (VP (VBN acquired) (PP (IN during) (NP (NP (NN development)) (PP (IN in) (NP (DT the) (JJ human) (NN thymus))))))) (CC and) (VP (VBZ is) (VP (VBN retained) (PP (IN by) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ mature) (NP (JJ peripheral) (NN T) (NNS lymphocytes))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ elevated) (NN cAMP) (NNS levels)) (PP (IN in) (NP (NN T) (NNS cells)))) (VP (VBP correlate) (PP (IN with) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (NP (JJ potent) (JJ transcriptional) (NN repressor))) (NP (NP (NN ICER)) (PRN (-LRB- -LRB-) (NP (JJ inducible) (NN cAMP) (JJ early) (NN repressor)) (-RRB- -RRB-))))) (ADVP (RB previously)) (VP (VBN described) (PP (IN in) (NP (DT the) (JJ hypothalamic-pituitary-gonadal) (NN axis)))))))))) (. .))))
(S1 (S (S (ADVP (RB Further)) (, ,) (PP (IN in) (NP (NP (JJ transcriptional) (NNS assays)) (ADJP (FW in) (FW vivo)))) (, ,) (NP (NN ICER)) (VP (VBZ inhibits) (NP (NP (NP (JJ calcineurin-mediated) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN interleukin) (CD 2) (NN promoter))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ Tax-mediated) (NN transactivation)) (PP (IN of) (NP (DT the) (NP (JJ human) (JJ T-lymphotropic) (NN virus) (NN type) (CD I) (-LRB- -LRB-) (NN HTLV-I) (-RRB- -RRB-) (NN promoter))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN ICER))) (PP (IN in) (NP (NN T) (NNS cells)))) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ cAMP-induced) (NN quiescence)) (CC and) (NP (NP (DT the) (JJ persistent) (NN latency)) (PP (IN of) (NP (NN HTLV-I)))))))) (. .))))
(S1 (S (NP (NP (NP (NN Preassociation)) (PP (IN of) (NP (NN STAT1))) (PP (IN with) (NP (NP (NN STAT2)) (CC and) (NP (NN STAT3)))) (PP (IN in) (NP (JJ separate) (NP (NN signalling) (NNS complexes)))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN cytokine)) (NN stimulation)))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (NP (NNS cytokines)) (CC and) (NP (NN growth) (NNS factors))))) (VP (VBP act) (PP (IN through) (NP (NP (DT an) (NN induction)) (PP (IN of) (NP (NP (NN gene) (NN expression)) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (JJ latent) (NN transcription) (NNS factors)) (VP (VBN called) (S (NP (NN STAT) (-LRB- -LRB-) (NN signal) (NNS transducers) (CC and) (NNS activators) (IN of) (NN transcription) (-RRB- -RRB-) (NNS proteins)))))))))))))) (. .)))))
(S1 (S (S (NP (NP (JJ Ligand-induced) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NP (NNS STATs))))) (VP (VBZ promotes) (NP (NP (PRP$ their) (NP (NN homodimer)) (CC and) (NP (NN heterodimer)) (NP (NN formation))) (CC and) (NP (JJ subsequent) (JJ nuclear) (NN translocation)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (NP (NN STAT) (NN protein) (NNS heterocomplexes)) (VP (VBP exist) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN cytokine)) (NN treatment)))))))) (. .))))
(S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ unstimulated) (NN HeLa) (NNS cells)) (VP (VBP are) (VP (VBN ruptured) (PP (IN in) (NP (JJ hypotonic) (NN buffer))) (PP (IN without) (NP (NP (NN salt)) (CC or) (NP (NN detergent)))))))) (, ,) (S (NP (NP (NN immunoadsorption)) (PP (IN of) (NP (CC either) (NP (NN STAT1)) (CC or) (NP (NN STAT2)))) (PP (IN from) (NP (DT the) (VBG resulting) (NN cytosol)))) (VP (VBZ yields) (NP (NP (NN coimmunoadsorption)) (PP (IN of) (NP (DT the) (JJ other) (NP (NN STAT) (NN protein))))))) (. .))))
(S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NN STAT1-STAT3) (NNS heterocomplexes)) (VP (VBP are) (VP (VBN coimmunoadsorbed) (PP (IN from) (NP (JJ hypotonic) (NN cytosol))))) (. .))))
(S1 (S (S (NP (NP (NP (NP (NN STAT1)) (CC and) (NP (NN STAT2))) (CC or) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT3)))) (VP (VBN translated) (PP (IN in) (NP (NN reticulocyte) (NN lysate))) (ADVP (RB spontaneously)))) (VP (VBP form) (NP (NNS heterocomplexes)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN translation) (NNS lysates)) (VP (VBP are) (VP (VBN mixed) (PP (IN at) (NP (CD 0) (NNS degrees) (NN C)))))))) (. .))))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN interferon-alpha)) (JJ /beta-induced) (NN tyrosine) (NN phosphorylation)) (VP (VBZ increases) (NP (NP (DT the) (NN stability)) (PP (IN of) (NP (DT a) (ADJP (ADJP (JJ preexisting)) (, ,) (ADJP (JJ latent))) (, ,) (NP (JJ STAT1-STAT2) (NN signaling) (NN complex))))))))) (. .))))
(S1 (S (S (S (NP (ADJP (RB Newly) (VBN translated)) (NP (NN STAT1))) (VP (VBZ binds) (PP (IN in) (NP (NN equilibrium) (NN fashion))) (PP (TO to) (NP (NP (NN STAT2)) (CC and) (NP (NN STAT3)))))) (, ,) (CC but) (S (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN STAT2)) (CC and) (NP (NN STAT3))) (VP (VBP exist) (PP (IN in) (NP (NP (JJ separate) (NP (NNS heterocomplexes))) (PP (IN with) (NP (NN STAT1))))) (, ,) (ADVP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN STAT1)) (VP (VBZ contains) (NP (NP (DT a) (JJ common) (VBG binding) (NN site)) (PP (IN for) (NP (JJ other) (NP (NN STAT) (NNS proteins)))))))))))))))) (. .))))
(S1 (S (S (S (NP (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN antigen) (CD 2) (-LRB- -LRB-) (NN EBNA2) (-RRB- -RRB-) (NN -oestrogen) (NN receptor) (NN fusion) (NNS proteins)) (VP (VP (VBP complement) (NP (DT the) (JJ EBNA2-deficient) (JJ Epstein-Barr) (NN virus) (NN strain) (NN P3HR1)) (PP (IN in) (NP (NP (NN transformation)) (PP (IN of) (NP (JJ primary) (NN B) (NNS cells)))))) (CC but) (VP (VBP suppress) (NP (NP (NN growth)) (PP (IN of) (NP (JJ human) (NN B) (NN cell) (NN lymphoma) (NNS lines)))))) (. .)))))
(S1 (S (S (S (S (VP (TO To) (VP (VB develop) (NP (NP (DT a) (NN transformation) (NN system)) (PP (IN with) (NP (DT a) (JJ conditional) (NP (JJ Epstein-Barr) (NN virus) (JJ nuclear) (NN antigen) (CD 2) (-LRB- -LRB-) (NN EBNA2) (-RRB- -RRB-) (NN gene)))))))) (, ,) (S (NP (PRP we)) (VP (VBD fused) (NP (NP (DT the) (NP (NN hormone) (NN binding) (NN domain))) (PP (IN of) (NP (DT the) (NN oestrogen) (NN receptor)))) (PP (TO to) (NP (NP (DT the) (NP (NN N)) (CC or) (NP (NN C)) (NP (NN terminus))) (PP (IN of) (NP (NN EBNA2))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NP (NN promoter) (NN transactivation)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ primary) (NN B) (NN cell) (NN transformation)) (NP (NNS assays)))) (NP (DT these) (JJ chimeric) (NP (NN EBNA2)) (NNS proteins)) (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB substitute) (PP (IN for) (NP (JJ wild-type) (NN EBNA2))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN oestrogen)))))))))) (. .))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (NP (DT this) (NN transformation)) (VP (VBZ is) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (JJ double) (NN infection)) (PP (IN of) (NP (NP (DT a) (NN cell)) (PP (IN with) (NP (NP (CD two) (NNS virions)) (, ,) (NP (NP (DT the) (NP (NN P3HR1) (NN virus) (NN genome))) (CC and) (NP (NP (DT a) (NP (NN mini-EBV) (NN plasmid))) (VP (VBG carrying) (NP (DT the) (JJ chimeric) (NP (NN EBNA2) (NN gene)))))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Unexpectedly)) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ same) (NN EBNA2-oestrogen) (NN receptor) (NN fusion) (NN protein))) (PP (IN in) (NP (JJ established) (JJ human) (NN B) (NN cell) (NN lymphoma) (NNS lines)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (NN growth) (NN retardation)) (CC or) (NP (NN growth) (NN arrest))) (PP (IN upon) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN oestrogen)))))))) (. .))))
(S1 (S (S (PP (IN By) (S (VP (VBG titrating) (NP (NP (DT the) (NN oestrogen) (NN concentration)) (PP (IN in) (NP (DT these) (NP (RB stably) (VBN transfected) (NNS cells)))))))) (, ,) (NP (NP (DT the) (NN growth) (NN retarding)) (CC and) (NP (NP (DT the) (VBG transactivating) (NN function)) (PP (IN of) (NP (DT the) (NP (JJ chimeric) (NNS proteins)))))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN dissociated)))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (NN growth) (NN inhibition)) (PP (IN of) (NP (JJ established) (NP (NN B) (NN cell) (NN lymphoma) (NNS lines))))) (VP (VBZ is) (NP (NP (NP (DT a) (JJ novel) (NN function)) (PP (IN of) (NP (NN EBNA2)))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT an) (JJ inducible) (NN system))))))))))))))) (. .))))
(S1 (S (S (NP (NP (PRP It))) (VP (VBZ remains) (ADJP (JJ open)) (SBAR (IN whether) (S (NP (NP (DT the) (NN growth) (NN retarding) (NN property)) (PP (IN of) (NP (NP (DT the) (NP (JJ EBNA2-oestrogen) (NN receptor) (NN fusion) (NN protein))) (PP (IN in) (NP (NN B) (NN cell) (NN lymphoma) (NNS lines)))))) (VP (VBZ is) (ADJP (JJ due) (PP (PP (TO to) (NP (NP (ADJP (RB unphysiologically) (JJ high)) (NN expression)) (PP (IN of) (NP (DT the) (NP (JJ chimeric) (NN protein)))))) (CC or) (PP (TO to) (NP (NP (NN interference)) (PP (IN with) (NP (NP (DT a) (JJ cellular) (NN programme)) (VP (VBG driving) (NP (NP (NN proliferation)) (PP (IN in) (NP (DT these) (NP (NN cell) (NNS lines)))))))))))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Cyclic) (JJ AMP-responsive) (JJ element-dependent) (NN activation)) (PP (IN of) (NP (JJ Epstein-Barr) (NN virus) (NP (NN zebra) (NN promoter)))) (PP (IN by) (NP (JJ human) (NN herpesvirus) (CD 6))) (. .)))))
(S1 (S (S (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN infection)) (PP (IN of) (NP (JJ Epstein-Barr) (NN virus) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ genome-positive) (NN B) (NNS cells))) (PP (IN by) (NP (NP (JJ human) (NN herpesvirus) (CD 6)) (PRN (-LRB- -LRB-) (NP (NN HHV-6)) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (JJ immediate-early) (NN EBV) (NN Zebra) (NN gene)))))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NN virus) (NN replication))))))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP L.Flamand)) (, ,) (NP (NNP I.Stefanescu)) (, ,) (NP (NNP D.V.Ablashi)) (, ,) (CC and) (NP (NNP J.Menezes))) (, ,) (NP (NNP J.Virol.67)) (: :) (NP (CD 6768-6777)) (, ,) (NP (CD 1993))) (-RRB- -RRB-)) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN HHV-6)) (VP (VBZ upregulates) (NP (NP (NN Zebra) (NN gene)) (NN transcription)) (PP (IN through) (NP (NP (DT a) (NP (NP (JJ cyclic) (JJ AMP-responsive) (NN element)) (PRN (-LRB- -LRB-) (NP (NN CRE)) (-RRB- -RRB-)))) (ADJP (JJ located) (PP (IN within) (NP (DT the) (NP (NP (NN Zebra) (NN promoter)) (PRN (-LRB- -LRB-) (NP (NN Zp)) (-RRB- -RRB-)))))))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (JJ human) (NP (NN B-)) (CC or) (NP (NN T-cell)) (NP (NNS lines))) (VP (VBN transfected) (PP (IN with) (NP (NN ZpCat) (NN reporter) (NN gene) (NNS constructs))))))) (, ,) (S (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT a) (NN region)) (VP (VBN designated) (S (NP (NP (DT the) (NP (NN ZII) (NN domain))) (PP (IN of) (NP (NN Zp))))))) (VP (VBZ is) (NP (NP (DT the) (NN target)) (PP (IN of) (NP (NN HHV-6) (NN transactivation))))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (NP (DT the) (NP (NN consensus) (NN AP-1/CRE) (NN site))) (PP (IN within) (NP (NN ZII)))))) (VP (VBD abolished) (NP (NP (DT the) (NN inducibility)) (PP (IN of) (NP (NN Zp))) (PP (IN by) (NP (NN HHV-6)))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN positioning)) (PP (IN of) (NP (DT the) (NP (NN ZII) (JJ domain)))) (ADVP (JJ upstream) (PP (IN of) (NP (DT the) (NP (NN beta-globin) (JJ minimal) (NN promoter)))))) (VP (VBD conferred) (NP (NP (NN responsiveness)) (PP (VBG following) (NP (NN HHV-6) (NN infection)))))))) (. .))))
(S1 (S (S (NP (NP (NN Binding)) (PP (IN of) (NP (DT these) (NNS factors))) (PP (TO to) (NP (NN ZII)))) (VP (VBD was) (VP (VBN prevented) (PP (PP (IN by) (NP (NP (NNS oligonucleotides)) (VP (VBG containing) (NP (NN CRE))))) (CC but) (PP (RB not) (IN by) (NP (NN AP-1) (NN consensus) (NNS sequences)))))) (. .))))
(S1 (S (S (NP (NP (NNS Antibodies)) (PP (PP (IN against) (NP (JJ CRE-binding) (-LRB- -LRB-) (NN CREB) (-RRB- -RRB-) (NN protein))) (CC but) (PP (RB not) (IN against) (NP (NP (NN c-Fos)) (CC or) (NP (NN c-Jun)))))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB supershift) (NP (DT the) (NP (JJ DNA-protein) (NN complex))))))) (, ,) (S (VP (VBG identifying) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (NP (DT the) (NP (NN transcription) (NN factor))) (SBAR (WHNP (WDT which)) (S (VP (VBZ binds) (PP (TO to) (NP (NN ZII))) (PP (IN as) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN CREB) (NN family) (IN of) (NNS proteins))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NP (NN transfection)) (PP (IN of) (NP (NP (NN CREB) (NN protein)) (CC and) (NP (NN protein) (NN kinase) (NN A) (NN expression) (NNS vectors))))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB activate) (NP (NN Zp)) (PP (IN in) (NP (NN Jurkat) (NNS cells))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (JJ phosphorylated) (NN form)) (PP (IN of) (NP (NN CREB) (NN protein)))) (VP (MD can) (VP (VB play) (NP (DT a) (JJ determining) (NN role)) (PP (IN in) (NP (DT the) (NN EBV) (NN reactivation) (NN process)))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Permanent) (NN occupancy)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (NN enhancer)))) (PP (IN by) (NP (NN NF-kappa) (NN B)))) (VP (VBZ is) (VP (VBN needed) (PP (IN for) (NP (NP (JJ persistent) (JJ viral) (NN replication)) (PP (IN in) (NP (NNS monocytes))))))) (. .)))))
(S1 (S (S (S (NP (DT This) (NN work)) (VP (VBD aimed) (S (VP (TO to) (VP (VB ascertain) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (JJ kappaB-responsive) (NNS elements)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1) (-LRB- -LRB-) (NN HIV-1) (-RRB- -RRB-) (NN enhancer)))))) (PP (CONJP (RB not) (RB only)) (PP (IN in) (NP (JJ early) (NN initiation))) (CONJP (CC but) (RB also)) (PP (IN in) (NP (JJ long-term) (NN maintenance))) (PP (IN of) (NP (NP (JJ proviral) (NN transcription)) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NP (JJ monocytic) (NN lineage)))))))))))))) (. .)))))
(S1 (S (S (PP (IN For) (NP (DT this) (NN purpose))) (, ,) (NP (PRP we)) (VP (VBD used) (NP (CD three) (JJ main) (NNS approaches))) (. .))))
(S1 (S (S (NP (DT The) (JJ first)) (VP (VBD was) (S (PP (TO to) (ADVP (RB abruptly)) (VP (VB terminate) (NP (NP (NN tumor) (NN necrosis) (JJ factor-induced) (NP (NN NF-kappaB))) (VP (VBG binding) (PP (TO to) (NP (NP (DT the) (NN enhancer) (NNS sequences)) (PP (IN in) (NP (NN U1) (JJ monocytic) (NNS cells)))))))) (, ,) (S (VP (VBG using) (NP (NP (DT a) (JJ short) (NN pulse)) (PP (IN of) (NP (JJ exogenous) (NN tumor) (NN necrosis) (NN factor))))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ concomitant) (NN decrease)) (PP (IN in) (NP (NP (JJ nuclear) (NP (NN NF-kappaB)) (JJ DNA-binding) (NN activity)) (CC and) (NP (NP (JJ endogenous) (JJ long) (JJ terminal) (NN repeat)) (JJ transcriptional) (NN activity))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ second)) (VP (VBD was) (S (VP (TO to) (VP (VB suppress) (NP (NP (DT the) (JJ permanent) (NP (NN NF-kappaB)) (NN translocation)) (VP (VBN induced) (PP (IN by) (NP (NP (NN HIV-1) (NN replication)) (NP (PRP itself)))))) (PP (IN in) (NP (RB chronically) (JJ infected) (NN U937) (NNS cells)))) (, ,) (S (VP (VBG using) (NP (NP (DT a) (JJ specific) (NN proteasome) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN Z-LLL-H)) (-RRB- -RRB-)))))))) (. .))))
(S1 (S (S (PP (NP (QP (RB As) (RB early) (IN as) (CD 2)) (NN h)) (IN after) (NP (NP (NN addition)) (PP (IN of) (NP (DT the) (NN inhibitor))) (PP (TO to) (NP (DT the) (NN culture) (NN medium))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (CC both) (NP (NP (JJ constitutive) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (CC and) (NP (NN HIV-1) (NN genome) (NN expression)))))) (. .))))
(S1 (S (S (NP (DT The) (JJ third) (NN approach)) (VP (VBD was) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN replication) (NN competence)) (PP (IN in) (NP (NP (NN U937) (NNS cells)) (PP (IN of) (NP (NP (DT an) (JJ infectious) (NN HIV-1) (NN provirus)) (VP (VBG carrying) (NP (NN point) (NNS mutations)) (PP (IN in) (NP (NP (DT the) (NP (JJ kappaB-responsive) (NNS elements))) (PP (IN of) (NP (DT both) (NP (JJ long) (JJ terminal) (NNS repeats)))))))))))))))) (. .))))
(S1 (S (S (PP (VBN Compared) (PP (IN with) (NP (PRP$ its) (JJ wild-type) (NN counterpart)))) (, ,) (NP (DT this) (VBN mutated) (NN provirus)) (VP (VBD showed) (NP (NP (DT a) (ADJP (ADJP (ADJP (RB profoundly) (VBN decreased)) (, ,) (ADJP (JJ Z-LLL-H-insensitive))) (ADJP (ADJP (JJ transcriptional)) (CC and) (ADJP (JJ replicative)))) (NN activity)) (PP (IN in) (NP (NN U937) (NNS monocytes))))) (. .))))
(S1 (S (S (ADVP (RB Together)) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN occupancy)) (PP (IN of) (NP (DT the) (NP (JJ viral) (NN enhancer)))) (PP (IN by) (NP (NN NF-kappaB) (-LRB- -LRB-) (NN p50/p65) (-RRB- -RRB-) (NNS heterodimers)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ ongoing) (NN transcription)) (PP (IN of) (NP (VBN integrated) (NN HIV) (NN provirus))) (PP (PP (IN in) (NP (NNS monocytes))) (, ,) (PP (ADVP (RB even)) (IN in) (NP (NP (NNS cells)) (VP (ADVP (RB chronically)) (VP (VBN infected)) (CC and) (ADVP (RB permanently)) (VP (VBG producing) (NP (JJ functional) (NP (NN HIV) (NN Tat) (NN protein))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN HIV-1) (NN replication))) (S (VP (TO to) (VP (VB activate) (NP (NN NF-kappaB)))))) (VP (VBZ is) (ADJP (JJ crucial) (PP (TO to) (NP (NP (DT the) (ADJP (ADJP (JJ intense)) (ADJP (JJ self-perpetuated)) (ADJP (JJ viral))) (NN transcription)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NP (JJ monocytic) (NN lineage))))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (ADJP (JJ Efficient)) (NP (NN transcription)) (CC and) (NP (NN replication))) (PP (IN of) (NP (JJ simian) (NN immunodeficiency) (NN virus)))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN NF-kappaB)) (CC and) (NP (NN Sp1)) (NP (NN binding) (NNS elements)))))) (. .)))))
(S1 (S (S (S (S (NP (NP (NP (CD Ten) (NNS mutants)) (PP (IN of) (NP (NP (DT the) (NP (NP (JJ simian) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN SIV)) (-RRB- -RRB-)))) (NP (NN SIVmac239))))) (VP (VBG bearing) (NP (NP (NP (NNS deletions)) (PRN (-LRB- -LRB-) (NP (JJ delta)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS substitutions)) (PRN (-LRB- -LRB-) (NP (JJ subst)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (NP (NN NF-kappaB))) (CC and/or) (NP (NN Sp1) (NN binding) (NNS elements)))))) (VP (VBD were) (VP (VBN created)))) (, ,) (CC and) (S (NP (NP (DT the) (JJ replicative) (NNS capacities)) (PP (IN of) (NP (DT the) (NNS mutants)))) (VP (VBD were) (VP (VBN analyzed)))) (. .)))))
(S1 (S (S (NP (NP (DT All) (NNS mutants)) (, ,) (PP (VBG including) (NP (NP (CD one) (ADJP (RB extensively) (VBN mutagenized)) (NN strain)) (VP (ADVP (RB entirely)) (VBG missing) (NP (NP (DT the) (NN NF-kappaB)) (CC and) (NP (CD four) (NN Spl)) (NP (NN binding) (NNS elements)))))) (, ,)) (VP (VBN replicated) (PP (IN with) (NP (JJ wild-type) (NNS kinetics))) (CC and) (PP (TO to) (NP (NP (DT a) (JJ wild-type) (NN level)) (PP (IN in) (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell) (NNS cultures))))) (PP (IN in) (NP (NP (QP (CD 50) (TO to) (CD 100)) (NN %)) (PP (IN of) (NP (DT the) (NNS experiments)))))) (. .))))
(S1 (S (S (NP (NP (CD One) (NN group)) (PP (IN of) (NP (NNS mutants)))) (VP (VBN replicated) (ADVP (ADVP (RB very) (RB similarly)) (PP (TO to) (NP (NN SIVmac239))) (PP (IN in) (NP (NP (NP (NN kinetics)) (CC and) (NP (NN yield))) (PP (IN in) (NP (NN CEMxl74) (NNS cells))))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 2)) (CC x) (NP (NN NFKappaB))) (ADJP (ADJP (JJ &gt;)) (CC or) (ADJP (JJ =)) (NP (NP (NN SlVmac239)) (ADVP (RB approximately)) (NP (NN deltaNFkappaB)) (ADVP (RB approximately)) (NP (NN deltaSpl234)) (ADVP (RB approximately)) (NP (NN substNFkappaB)) (ADVP (RB approximately)) (NP (NN substSpl2)) (ADVP (RB approximately)) (NP (NN substSp23))))) (-RRB- -RRB-))) (, ,) (SBAR (IN while) (S (NP (DT a) (JJ second) (NN group)) (VP (VBD replicated) (PP (PP (IN with) (NP (NP (VBN delayed)) (CC or) (NP (ADJP (RB slightly) (VBN delayed))) (NP (NN kinetics)))) (PP (IN in) (NP (NN CEMxl74) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NP (NN SIVmac239)) (ADJP (JJ &gt;) (NP (NP (NN substSp34)) (ADJP (JJ &gt;) (NP (NP (NN deltaNFkappaBdeltaSpl234)) (ADVP (RB approximately)) (NP (NN deltaNFkappaBdeltaSp1)) (ADJP (JJ &gt;) (NP (NN substSpl234)))))))) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (NP (NNS Reversions)) (CC or) (NP (JJ additional) (NNS mutations))) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (NP (NN U3)) (CC and) (NP (NN R)) (NP (NNS regions))) (PP (IN of) (NP (NP (JJ proviral) (NN DNA)) (PP (IN from) (NP (NP (NN CEMxl74) (NNS cells)) (VP (VBN infected) (PP (IN with) (NP (DT the) (NN SIVmac239) (NNS mutants)))))))))))) (. .))))
(S1 (S (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NNS mutants)) (PP (IN of) (NP (NN SIVmacMER)))) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ macrophage-competent) (NN derivative)) (PP (IN of) (NP (NN SIVmac239)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN tested) (PP (IN in) (NP (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NN cell)) (CC and) (NP (NN CEMx174) (NNS cultures))))))))) (. .))))
(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (JJ most) (VBN mutated) (NNS viruses)))) (VP (VBD was) (VP (VBN suppressed) (PP (IN in) (NP (JJ primary) (NN rhesus) (NN monkey) (JJ alveolar) (NNS macrophages)))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NN SIVmacMER)) (ADVP (RB approximately)) (NP (NN 2xNFkappaB)) (ADVP (RB approximately)) (NP (NN substNFkappaB))) (ADJP (JJ &gt;) (NP (NP (NN deltaNFkappaB)) (ADJP (JJ &gt;) (NP (NN deltaNFkappaBdeltaSpl234) (ADVP (RB approximately)) (NP (NN deltaNFkappaBdeltaSpl))) (ADJP (JJ &gt;) (NP (NP (NN deltaSpl234)) (ADVP (RB approximately)) (NP (NN substSpl2))) (ADJP (JJ &gt;) (NP (NP (NN substSp23)) (ADVP (RB approximately)) (NP (NN substSp34)) (ADVP (RB approximately)) (NP (NN substSpl234))) (ADJP (ADJP (JJ &gt;)) (CC or) (ADJP (JJ =)) (NP (NN SIVmac239))))))))) (-RRB- -RRB-)) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (NP (NN Sp1) (NN binding) (NNS sites))))) (VP (VBD had) (NP (DT the) (ADJP (RBS most) (JJ dramatic)) (NNS effects)) (PP (IN on) (NP (NP (NN SIVmac) (NN replication)) (PP (IN in) (NP (JJ primary) (NN macrophage) (NNS cultures)))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (ADJP (JJ long) (JJ terminal) (JJ repeat-driven) (VBN secreted)) (NP (NN alkaline) (NN phosphatase)) (NN activity)) (PP (IN in) (NP (JJ transient) (NNS assays)))))) (VP (VBD showed) (SBAR (IN that) (S (, ,) (PP (IN unlike) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))) (, ,) (NP (DT the) (NP (NN SIV) (JJ long) (JJ terminal) (NN repeat))) (VP (VBZ possesses) (NP (NP (DT an) (NP (NN enhancer) (NN region))) (ADVP (RB just) (RB upstream) (PP (IN of) (NP (NP (DT the) (NP (NN NF-kappaB) (NN element))) (SBAR (WHNP (WDT which)) (S (VP (VBZ maintains) (NP (NP (JJ significant) (NNS levels)) (PP (IN of) (NP (JJ basal) (NN transcription)))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NN NF-kappaB)) (CC and) (NP (NN Sp1)) (NP (NNS sites))))))))))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN region)) (VP (VBZ is) (ADJP (JJ responsive) (PP (TO to) (NP (NP (NN transactivation)) (PP (IN by) (NP (NN Tat))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT the) (NP (NN SIV) (NN TATA) (NN box))) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJR stronger)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1))))))))))) (. .))))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (ADJP (RB surprisingly) (JJ high) (JJ replicative)) (NN capacity)) (PP (IN of) (NP (NP (NP (NN NF-kappaB)) (CC and) (NP (NN Sp1)) (NP (NN binding) (NN site) (NNS mutants))) (PP (IN of) (NP (NN SIVmac)))))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ unique) (NNS features)) (CC or) (NP (DT the) (NP (NN enhancer/promoter) (NN region))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Inactivation)) (PP (IN of) (NP (NN IkappaBbeta))) (PP (IN by) (NP (NP (DT the) (NP (NN tax) (NN protein))) (PP (IN of) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1))))) (: :)) (NP (NP (DT a) (JJ potential) (NN mechanism)) (PP (IN for) (NP (NP (JJ constitutive) (NN induction)) (PP (IN of) (NP (NN NF-kappaB)))))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (VBG resting) (NN T) (NNS lymphocytes))) (, ,) (NP (DT the) (NP (NN transcription) (NN factor)) (NP (NN NF-kappaB))) (VP (VBZ is) (VP (VBN sequestered) (PP (IN in) (NP (DT the) (NN cytoplasm))) (PP (IN via) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (NP (NNS members)) (PP (IN of) (NP (NP (DT the) (NP (NN I) (NN kappa) (NN B) (NN family))) (PP (IN of) (NP (NNS inhibitors)))))) (, ,) (PP (VBG including) (NP (NP (NN IkappaBalpha)) (CC and) (NP (NN IkappaBbeta)))))))))) (. .)))))
(S1 (S (S (PP (IN During) (NP (JJ normal) (NN T-cell) (NN activation))) (, ,) (NP (NN IkappaBalpha)) (VP (VBZ is) (ADVP (RB rapidly)) (VP (VP (VBN phosphorylated)) (, ,) (VP (VBN ubiquitinated)) (, ,) (CC and) (VP (VBN degraded)) (PP (IN by) (NP (DT the) (NP (NN 26S) (NN proteasome))))) (, ,) (S (ADVP (RB thus)) (VP (VBG permitting) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (JJ functional) (NP (NN NF-kappaB)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NP (PRP$ its) (JJ transient) (NN pattern)) (PP (IN of) (NP (JJ nuclear) (NN induction))) (PP (IN during) (NP (DT an) (JJ immune) (NN response))))))) (, ,) (NP (NN NF-kappaB)) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN activated) (PP (IN in) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (NP (DT the) (NP (NN Tax) (NN transforming) (NN protein))) (PP (IN of) (NP (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD I)) (PRN (-LRB- -LRB-) (NP (NN HTLV-1)) (-RRB- -RRB-)))))))))) (. .))))
(S1 (S (S (NP (JJ Recent) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN HTLV-1) (NP (NN Tax))) (VP (VBZ targets) (NP (NN IkappaBalpha)) (PP (TO to) (NP (DT the) (JJ ubiquitin-proteasome) (NN pathway))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (PRP it))) (VP (VBZ remains) (ADJP (JJ unclear)) (SBAR (WHADVP (WRB how)) (S (NP (DT this) (NP (JJ viral) (NN protein))) (VP (VBZ induces) (NP (DT a) (ADJP (ADJP (JJ persistent)) (CONJP (RB rather) (IN than)) (ADJP (JJ transient))) (NP (NN NF-kappaB)) (NN response)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP provide) (NP (NN evidence) (SBAR (IN that) (S (PP (IN in) (NP (NP (NN addition)) (PP (TO to) (S (VP (VBG acting) (PP (IN on) (NP (NN IkappaBalpha)))))))) (, ,) (NP (NN Tax)) (VP (VBZ stimulates) (NP (NP (DT the) (NN turnover)) (PP (IN Of) (NP (NN IkappaBbeta)))) (PP (IN via) (NP (DT a) (JJ related) (NN targeting) (NN mechanism)))))))) (. .))))
(S1 (S (S (PP (IN Like) (NP (NN IkappaBalpha))) (, ,) (NP (NP (JJ Tax-mediated) (NN breakdown)) (PP (IN of) (NP (NN IkappaBbeta))) (PP (IN in) (NP (VBN transfected) (NN T) (NNS lymphocytes)))) (VP (VBZ is) (VP (VBN blocked) (PP (CC either) (PP (IN by) (NP (JJ cell-permeable) (NN proteasome) (NNS inhibitors))) (CC or) (PP (IN by) (NP (NP (NN mutation)) (PP (IN Of) (NP (NN IkappaBbeta))) (PP (IN at) (NP (NP (CD two) (NN serine) (NNS residues)) (ADJP (JJ present) (PP (IN within) (NP (PRP$ its) (NP (JJ N-terminal) (NN region)))))))))))) (. .))))
(S1 (S (S (PP (IN Despite) (NP (NP (DT the) (JJ dual) (NN specificity)) (PP (IN of) (NP (NN HTLV-1) (NP (NN Tax)))) (PP (IN for) (NP (NP (NN IkappaBalpha)) (CC and) (NP (NN IkappaBbeta)))) (PP (IN at) (NP (DT the) (NN protein) (NN level))))) (, ,) (NP (NN Tax)) (ADVP (RB selectively)) (VP (VBZ stimulates) (NP (NP (JJ NF-kappaB-directed) (NN transcription)) (PP (IN of) (NP (DT the) (NP (NN IkappaBalpha) (NN gene)))))) (. .))))
(S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (NN IkappaBbeta)) (NN protein) (NN expression)) (VP (VBZ is) (ADVP (RB chronically)) (VP (VBN downregulated) (PP (IN in) (NP (JJ HTLV-1-infected) (NN T) (NNS lymphocytes))))) (. .))))
(S1 (S (S (NP (NP (DT These) (NNS findings)) (PP (IN with) (NP (NN IkappaBbeta)))) (VP (VBP provide) (NP (NP (DT a) (JJ potential) (NN mechanism)) (PP (IN for) (NP (NP (DT the) (JJ constitutive) (NN activation)) (PP (IN of) (NP (NN NF-kappaB))) (PP (IN in) (NP (JJ Tax-expressing) (NNS cells))))))) (. .))))
(S1 (S (NP (NP (NP (NP (JJ Genetic) (NN characterization)) (PP (IN of) (NP (NP (NN transactivation)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1) (NN promoter)))))) (: :)) (S (NP (NP (NN Binding)) (PP (IN of) (NP (NN Tax))) (PP (TO to) (NP (JJ Tax-responsive) (NN element) (CD 1)))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (NP (JJ cyclic) (JJ AMP-responsive) (NNS members))) (PP (IN of) (NP (NP (DT the) (NP (NN CREB/ATF) (NN family))) (PP (IN of) (NP (NN transcription) (NNS factors)))))))))) (. .)))))
(S1 (S (S (S (S (VP (TO To) (VP (VB achieve) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN transactivation)) (PP (IN by) (NP (NN Tax))) (PP (IN of) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1) (NP (NP (JJ Tax-responsive) (NN element) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN TRE-1)) (-RRB- -RRB-))))))))))))) (, ,) (S (NP (PRP we)) (VP (VBD developed) (NP (NP (DT a) (JJ genetic) (NN approach)) (PP (IN with) (NP (NN Saccharomyces) (NN cerevisiae)))))) (. .)))))
(S1 (S (S (NP (PRP We)) (VP (VBD constructed) (NP (NP (DT a) (NN yeast) (NN reporter) (NN strain)) (VP (VBG containing) (NP (NP (DT the) (NP (NN lacZ) (NN gene))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (DT the) (NP (NN CYC1) (NN promoter))) (VP (VBN associated) (PP (IN with) (NP (NP (CD three) (NNS copies)) (PP (IN of) (NP (NN TRE-1)))))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (CC either) (NP (DT the) (NP (NP (JJ cyclic) (NN AMP) (NN response) (NN element-binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CREB)) (-RRB- -RRB-)))) (CC or) (NP (NP (NN CREB)) (VP (VBN fused) (PP (TO to) (NP (DT the) (NP (NP (NN GAL4) (NN activation) (NN domain)) (PRN (-LRB- -LRB-) (NP (NN GAD)) (-RRB- -RRB-))))))))) (PP (IN in) (NP (DT this) (NN strain)))) (VP (VBD did) (RB not) (VP (VB modify) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN reporter) (NN gene))))))) (. .))))
(S1 (S (S (NP (NP (NN Tax)) (ADVP (RB alone))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ inactive))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NP (NN reporter) (NN gene))))) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NN coexpression)) (PP (IN of) (NP (NP (NN Tax)) (CC and) (NP (NN CREB)))))))) (. .))))
(S1 (S (S (NP (DT This) (NN effect)) (VP (VBD was) (ADJP (JJR stronger) (PP (IN with) (NP (DT the) (NP (NN GAD-CREB) (NN fusion) (NN protein)))))) (. .))))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (JJ different) (NP (NN CREB) (NNS mutants))) (PP (IN with) (NP (DT this) (JJ genetic) (NN system)))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (DT the) (NP (JJ C-terminal) (CD 92) (NN amino) (NN acid) (NNS residues))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP include) (NP (NP (DT the) (NP (JJ basic) (NN domain))) (CC and) (NP (DT the) (NP (NN leucine) (NN zipper))))))) (, ,)) (VP (VBP are) (ADJP (ADJP (JJ necessary)) (CC and) (ADJP (JJ sufficient))) (S (VP (TO to) (VP (VB mediate) (NP (NP (NN transactivation)) (PP (IN by) (NP (NN Tax))))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB identify) (NP (NP (JJ cellular) (NNS proteins)) (VP (VBG binding) (PP (TO to) (NP (NN TRE-1))) (PP (IN in) (NP (DT a) (JJ Tax-dependent) (NN manner)))))))) (, ,) (S (NP (DT this) (NN strain)) (VP (VBD was) (ADVP (RB also)) (VP (VBN used)) (S (VP (TO to) (VP (VB screen) (NP (NP (DT a) (NN library)) (PP (IN of) (NP (NP (JJ human) (NNS cDNAs)) (VP (VBN fused) (PP (TO to) (NP (NN GAD)))))))))))) (. .))))
(S1 (S (S (S (PP (IN Of) (NP (NP (CD five) (JJ positive) (NNS clones)) (VP (VBN isolated) (PP (IN from) (NP (QP (CD 0.75) (CC x) (CD 10-LRB-6-RRB-)) (NN yeast) (NNS colonies)))))) (, ,) (NP (CD four)) (VP (VBD were) (NP (NP (NNS members)) (PP (IN of) (NP (DT the) (NP (JJ CREB/activating) (NN transcription) (NN factor) (-LRB- -LRB-) (NN ATF) (-RRB- -RRB-) (NN family))))))) (: :) (NP (NP (NN CREB)) (, ,) (NP (NP (CD two) (NNS isoforms) (IN of) (DT the) (JJ cyclic) (JJ AMP-responsive) (NN element) (NN modulator)) (PRN (-LRB- -LRB-) (NP (NN CREM)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN ATF-1))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (DT these) (CD three) (NNS proteins)) (VP (MD can) (VP (VP (VB be) (VP (VBN phosphorylated) (PP (IN by) (NP (NN protein) (NN kinase) (NN A))))) (CC and) (ADVP (RB thus)) (VP (VB form) (NP (DT a) (JJ particular) (NN subgroup)) (PP (IN within) (NP (DT the) (NP (NN CREB/ATF) (NN family))))))) (. .))))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN ATF-2))) (PP (IN in) (NP (FW S.) (FW cerevisiae)))) (VP (VBD did) (RB not) (VP (VB activate) (NP (NN TRE-1)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Tax))))))) (. .))))
(S1 (S (S (NP (DT This)) (VP (VBZ shows) (SBAR (IN that) (S (PP (IN in) (NP (DT a) (JJ eukaryotic) (NN nucleus))) (, ,) (NP (NN Tax)) (ADVP (RB specifically)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT the) (NP (JJ basic) (JJ domain-leucine) (NN zipper) (NN region))) (PP (IN of) (NP (NP (NN ATF-1)) (, ,) (NP (NN CREB)) (, ,) (CC and) (NP (NN CREM)))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (JJ fifth) (NN clone)) (VP (VBN identified) (PP (IN in) (NP (DT this) (NN screening))))) (VP (VBD corresponded) (PP (TO to) (NP (DT the) (NP (NN Ku) (NN autoantigen) (NN p70) (NN subunit))))) (. .))))
(S1 (S (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN fused) (PP (TO to) (NP (NN GAD)))))) (, ,) (S (NP (NP (DT the) (NP (JJ C-terminal) (NN region))) (PP (IN of) (NP (NN Ku)))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB activate) (NP (NN transcription)) (PP (IN via) (NP (NN TRE-1)))))))))) (CC but) (S (NP (DT this) (NN activation)) (VP (VBD was) (RB not) (ADJP (JJ dependent) (PP (IN on) (NP (NN Tax)))))) (. .))))
(S1 (S (NP (NP (NP (NN Role)) (PP (IN of) (NP (NN EGR1))) (PP (IN in) (NP (NP (NN regulation)) (PP (IN of) (NP (NP (JJ stimulus-dependent) (NP (NN CD44)) (NN transcription)) (PP (IN in) (NP (NN B) (NNS lymphocytes))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NP (JJ immediate-early) (NN gene)) (NP (NN egr-1)))) (VP (VBZ encodes) (NP (NP (DT a) (NP (NP (NN transcription) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN EGR1)) (-RRB- -RRB-)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ links) (NP (NP (NP (NN B-cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN BCR)) (-RRB- -RRB-))) (NNS signals)) (PP (TO to) (NP (JJ downstream) (NN activation) (NNS events))) (PP (IN through) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (ADJP (RB previously) (JJ unidentified)) (NP (NN target) (NNS genes))))))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP identify) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (DT the) (NP (NN lymphocyte) (NN homing) (CC and) (NN migration) (NN protein)) (NP (NN CD44))))) (PP (IN as) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (NP (NP (NN EGR1)) (NN regulation)) (PP (IN in) (NP (NN B) (NNS cells)))))))) (. .))))
(S1 (S (S (NP (NP (JJ BCR-induced) (NNS increases)) (PP (IN in) (NP (NP (NN CD44) (NN mRNA)) (NP (NN expression)) (CC and) (NP (NN transcription)) (NP (NNS levels))))) (VP (VBP are) (VP (VBN shown) (S (VP (TO to) (VP (VB occur) (PP (PP (IN in) (NP (ADJP (JJ EGR1-expressing)))) (CC but) (PP (RB not) (IN in) (NP (JJ nonexpressing) (NNS subclones))) (PP (IN of) (NP (DT the) (NP (NN B-cell) (NN line)) (NP (NN WEHI-231)))))))))) (. .))))
(S1 (S (S (NP (NP (NP (NNS Kinetics)) (PP (IN of) (NP (NP (NN egr-1)) (NN transcription)))) (CC and) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (JJ nuclear) (NP (NN EGR1) (NN protein)))))) (VP (VP (VBP precede) (NP (NP (NN CD44)) (NN induction))) (CC and) (VP (VB occur) (PP (IN within) (NP (NP (CD 30) (NN min)) (PP (IN after) (NP (NP (NN stimulation)) (PP (IN in) (NP (DT the) (NP (JJ EGR1-expressing) (NN subclone)))))))))) (. .))))
(S1 (S (S (NP (DT A) (JJ single) (NP (NN EGR1)) (NN binding) (NN motif)) (VP (VBZ is) (VP (VBN demonstrated) (PP (IN at) (NP (NP (NN bp) (CD -301)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN CD44) (NN promoter)))))))) (. .))))
(S1 (S (S (NP (NP (NN Cotransfection)) (PP (IN of) (NP (DT a) (NP (NN CD44) (JJ promoter-chloramphenicol) (NN acetyltransferase) (NN reporter) (NN construct)))) (PP (IN with) (NP (DT an) (NP (NN egr-1) (NN expression) (NN vector))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 6.5-) (TO to) (JJ 8.5-fold)) (NN induction)) (PP (IN of) (NP (NP (JJ transcriptional) (NN activity)) (ADJP (JJ relative) (PP (TO to) (NP (DT an) (NP (JJ empty) (NN expression) (NN vector)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NN EGR1) (NN binding) (NN motif))) (VP (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ necessary) (PP (IN for) (NP (NP (JJ stimulus-induced) (NN expression)) (PP (IN of) (NP (DT a) (NP (NN CD44)) (NP (JJ promoter-chloramphenicol) (NN acetyltransferase) (NN reporter) (NN construct)))) (PP (IN in) (NP (JJ nontransformed) (NN B) (NNS lymphocytes))))))))))) (CC and) (VP (VBD was) (VP (VBN required) (PP (IN for) (NP (NP (NN transactivation)) (PP (IN by) (NP (DT an) (NP (NN EGR1) (NN expression) (NN vector)))) (PP (IN in) (NP (DT a) (NP (NN B-cell) (NN line))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS studies)) (VP (VBP identify) (NP (NN EGR1)) (PP (IN as) (NP (NP (DT an) (JJ intermediary)) (VP (VBG linking) (NP (JJ BCR-derived) (NNS signals)) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN CD44))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN relevance)) (PP (IN of) (NP (DT these) (JJ molecular) (NNS events))) (PP (TO to) (NP (NP (NP (NN BCR)) (NN signal) (NN transduction)) (CC and) (NP (ADJP (ADJP (JJ antigen-stimulated)) (ADJP (JJ B-cell-mediated))) (JJ immune) (NNS responses))))) (VP (VBZ is) (VP (VBN discussed))) (. .))))
(S1 (S (NP (NP (NP (NN Expression)) (PP (IN of) (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN mRNA)))) (PP (IN in) (NP (JJ human) (NNS lymphocytes))) (. .)))))
(S1 (S (S (S (NP (JJ Helix-loop-helix) (-LRB- -LRB-) (JJ HLH) (-RRB- -RRB-) (NN transcription) (NNS factors)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (JJ cellular) (NP (NN growth)) (CC and) (NP (NN differentiation)))))) (. .)))))
(S1 (S (S (NP (DT The) (NP (NP (NN Id)) (PRN (-LRB- -LRB-) (NP (NP (NN inhibitor)) (PP (IN of) (NP (NN DNA) (NP (NN binding)) (CC and) (NP (NN differentiation))))) (-RRB- -RRB-))) (NP (JJ HLH) (NNS proteins)) (, ,)) (PP (IN in) (NP (DT a) (ADJP (RB dominantly) (JJ negative)) (NN fashion))) (, ,) (VP (VBP regulate) (NP (NP (JJ transcriptional) (NNS activities)) (PP (IN of) (NP (JJ basic) (JJ HLH) (NNS proteins))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD examined) (PP (IN by) (NP (JJ northern) (NN hybridization))) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NN Id2)) (CC and) (NP (NN Id3)) (NP (NN mRNA)))) (PP (IN in) (NP (NP (NP (JJ human) (NN leukemia/lymphoma) (NNS lines)) (CC and) (NP (NN patient) (NNS samples))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (VBG resting)) (CC and) (NP (VBN activated) (JJ normal) (JJ human) (NNS lymphocytes))) (PP (IN from) (NP (NP (JJ peripheral) (NN blood)) (PRN (-LRB- -LRB-) (NP (NN PBL)) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (NN Id2) (NN mRNA))) (VP (VBD was) (ADVP (RB abundantly)) (VP (VBN expressed) (PP (IN in) (NP (NP (NP (CD 5/12) (NN T-cell))) (CC and) (NP (CD 3/4) (NN B-cell) (NNS lines))))))) (, ,) (CC and) (S (NP (NN Id3) (NN mRNA)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (NP (CD 4/12) (NN T-cell))) (CC and) (NP (CD 3/4) (NN B-cell) (NNS lines))))))) (. .))))
(S1 (S (S (ADVP (RB Interestingly)) (, ,) (NP (NP (NP (NN Id2))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN Id3))) (, ,) (NP (NN mRNA))) (VP (VBD was) (ADVP (RB strongly)) (VP (VBN expressed) (PP (IN in) (NP (CD 4/5) (NP (NP (NP (NN T-cell) (NNS lines)) (VP (VBN infected) (PP (IN with) (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NP (NN type) (CD I) (-LRB- -LRB-) (NN HTLV-I) (-RRB- -RRB-)))))) (PRN (-LRB- -LRB-) (NP (NP (NN ATL-1k)) (, ,) (NP (NN MT-2)) (, ,) (NP (NN S-LB1))) (-RRB- -RRB-))) (CC and) (NP (NP (NN type) (CD II)) (PRN (-LRB- -LRB-) (NP (NN Mo)) (-RRB- -RRB-))))))) (. .))))
(S1 (S (S (NP (DT Another) (JJ unexpected) (NN finding)) (VP (VBD was) (SBAR (IN that) (S (NP (NP (NN T-cell) (NNS leukemias)) (CC and) (NP (NN T-cell) (NNS lines))) (ADVP (RB often)) (VP (VBD expressed) (NP (CC either) (NP (NP (NN Id2))) (CC or) (NP (NN Id3) (NN mRNA))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (VBG resting) (NN PBL)) (ADVP (RB constitutively)) (VP (VBD expressed) (NP (NP (JJ prominent) (NNS levels)) (PP (IN of) (NP (NP (NN Id2) (NN mRNA)) (, ,) (CONJP (CC but) (RB not)) (NP (NN Id3) (NN mRNA)))))) (. .))))
(S1 (S (S (PP (IN Upon) (NP (NN PHA-stimulation))) (, ,) (S (S (NP (NP (NN Id2)) (NN expression)) (VP (VBD decreased))) (CC and) (S (NP (NP (NN Id3)) (NNS levels)) (VP (VBD increased) (PP (IN with) (NP (JJ biphasic) (NNS kinetics)))))) (. .))))
(S1 (S (S (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (S (NP (PRP$ our) (NNS studies)) (VP (VBD revealed) (NP (NP (NP (CD three) (JJ unexpected) (NNS findings)) (SBAR (WHNP (WDT which)) (S (VP (VBP require) (NP (JJ further) (NN analysis)))))))))) (: :) (S (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (NP (NN expression)) (PP (IN of) (NP (NN Id2) (NN mRNA)))) (VP (VBZ is) (ADVP (RB often)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ lymphocytic) (NN transformation)) (PP (IN by) (NP (NP (NN HTLV-I)) (CC or) (NP (CD -II))))))))) (: ;) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (S (NP (NNS T-cells)) (ADVP (RB usually)) (VP (VBP express) (NP (CC either) (NP (NP (NN Id2))) (CC or) (NP (NN Id3) (NN mRNA))))) (, ,) (CC but) (S (NP (NNS B-cells)) (ADVP (RB often)) (VP (VBP express) (NP (DT both)) (ADVP (RB simultaneously))))) (: ;) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (S (NP (ADJP (ADJP (JJ non-dividing)) (, ,) (ADJP (JJ normal))) (NP (NN PBL))) (VP (VBP express) (NP (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (NN Id2))))) (CC and) (NP (DT no) (NP (NN Id3) (NN mRNA)))))) (: ;) (CC and) (S (PP (IN with) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (JJ cellular) (NN proliferation))))) (, ,) (NP (NP (NNS levels)) (PP (IN of) (NP (NN Id2) (NN mRNA)))) (VP (VBP decrease) (SBAR (IN while) (S (NP (NP (NNS levels)) (PP (IN of) (NP (NN Id3) (NN mRNA)))) (VP (VBP increase)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN regulation)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (DT these) (ADJP (RB closely) (JJ related)) (NP (NNS genes))))))) (VP (VBZ is) (ADJP (JJ disparate))))))))))) (. .))))
(S1 (S (S (S (NP (NN CNI-1493)) (VP (VBZ inhibits) (NP (JJ monocyte/macrophage) (NN tumor) (NN necrosis) (NN factor)) (PP (IN by) (NP (NP (NN suppression)) (PP (IN of) (NP (NN translation) (NN efficiency)))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Tumor) (NN necrosis) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN TNF)) (-RRB- -RRB-))) (VP (VBZ mediates) (NP (NP (NP (DT a) (JJ wide) (NN variety)) (PP (IN of) (NP (NN disease) (NNS states)))) (PP (VBG including) (NP (NP (JJ septic) (NN shock)) (, ,) (NP (NP (ADJP (JJ acute))) (CC and) (NP (ADJP (JJ chronic))) (NP (NN inflammation))) (, ,) (CC and) (NP (NN cachexia)))))) (. .)))))
(S1 (S (S (S (ADVP (RB Recently)) (, ,) (NP (NP (NP (DT a) (JJ multivalent) (NN guanylhydrazone)) (PRN (-LRB- -LRB-) (NP (NN CNI-1493)) (-RRB- -RRB-))) (VP (VBN developed) (PP (IN as) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN macrophage) (NN activation))))))) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VP (VB suppress) (NP (NP (NN TNF)) (NN production))) (CC and) (VP (NN protect) (PP (IN against) (NP (NP (NN tissue) (NN inflammation)) (CC and) (NP (NN endotoxin) (NN lethality))))))))))) (PRN (-LRB- -LSB-) (NP (NP (NP (NP (NNP Bianchi) (, ,) (NNP M.)) (, ,) (NP (NNP Ulrich) (, ,) (NNP P.)) (, ,) (NP (NNP Bloom) (, ,) (NNP O.)) (, ,) (NP (NNP Meistrell) (, ,) (NNP M.)) (, ,) (NP (NNP Zimmerman) (, ,) (NNP G.A.)) (, ,) (NP (NNP Schmidtmayerova) (, ,) (NNP H.)) (, ,) (NP (NNP Bukrinsky) (, ,) (NNP M.)) (, ,) (NP (NNP Donnelley) (, ,) (NNP T.)) (, ,) (NP (NNP Bucala) (, ,) (NNP R.)) (, ,) (NP (NNP Sherry) (, ,) (NNP B.)) (, ,) (NP (NNP Manogue) (, ,) (NNP K.R.)) (, ,) (NP (NNP Tortolani) (, ,) (NNP A.J.)) (, ,) (NP (NNP Cerami) (, ,) (NNP A.)) (CC &amp;) (NP (NNP Tracey) (, ,) (NNP K.J.))) (PRN (-LRB- -LRB-) (NP (CD 1995)) (-RRB- -RRB-)) (NP (NNP Mol.Med.1)) (, ,) (NP (CD 254-266))) (, ,) (CC and) (NP (NP (NP (NNP Bianchi) (, ,) (NNP M.)) (, ,) (NP (NNP Bloom) (, ,) (NNP O.)) (, ,) (NP (NNP Raabe) (, ,) (NNP T.)) (, ,) (NP (NNP Cohen) (, ,) (NNP P.) (NNP S.)) (, ,) (NP (NNP Chesney) (, ,) (NNP J.)) (, ,) (NP (NNP Sherry) (, ,) (NNP B.)) (, ,) (NP (NNP Schmidtmayerova) (, ,) (NNP H.)) (, ,) (NP (NNP Zhang) (, ,) (NNP X.)) (, ,) (NP (NNP Bukrinsky) (, ,) (NNP M.)) (, ,) (NP (NNP Ulrich) (, ,) (NNP P.)) (, ,) (NP (NNP Cerami) (, ,) (NNP A.)) (CC &amp;) (NP (NNP Tracey) (, ,) (NNP J.))) (PRN (-LRB- -LRB-) (NP (CD 1996)) (-RRB- -RRB-)) (NP (NNP J.Exp.Med.)) (, ,) (PP (IN in) (NP (NN press))))) (-RRB- -RSB-)) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VP (VBP have) (ADVP (RB now)) (VP (VBN elucidated) (NP (NP (DT the) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN CNI-1493)) (VP (VBZ inhibits) (NP (NN macrophage) (NP (NN TNF)) (NN synthesis)))))))) (CC and) (VP (VBP show) (ADVP (RB here)) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ acts) (PP (IN through) (NP (NP (NN suppression)) (PP (IN of) (NP (NP (NN TNF)) (NN translation) (NN efficiency)))))))))) (. .))))
(S1 (S (S (NP (NN CNI-1493)) (VP (VBD blocked) (NP (CC neither) (NP (NP (DT the) (NP (NP (NN lipopolysaccharide)) (PRN (-LRB- -LRB-) (NP (NN LPS)) (-RRB- -RRB-))) (JJ -induced) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN TNF) (NN mRNA)))))) (CC nor) (NP (NP (DT the) (NN translocation)) (PP (IN of) (NP (JJ nuclear) (NN factor) (NN NF-kappa) (NN B))) (PP (TO to) (NP (DT the) (NN nucleus))) (PP (IN in) (NP (NP (NNS macrophages)) (VP (VBN activated) (PP (IN by) (NP (NP (CD 15) (NN min)) (PP (IN of) (NP (NN LPS) (NN stimulation)))))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN CNI-1493)) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (JJ early) (NN NF-kappa) (JJ B-mediated) (JJ transcriptional) (NN regulation)) (PP (IN of) (NP (NN TNF)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN synthesis)) (PP (IN of) (NP (NP (DT the) (NP (JJ 26-kDa) (NN membrane) (NN form))) (PP (IN of) (NP (NN TNF)))))) (VP (VBD was) (ADVP (RB effectively)) (VP (VBN blocked) (PP (IN by) (NP (NN CNI-1493))))) (. .))))
(S1 (S (S (NP (NP (RB Further) (NN evidence)) (PP (IN for) (NP (NP (DT the) (JJ translational) (NN suppression)) (PP (IN of) (NP (NN TNF)))))) (VP (VBZ is) (VP (VBN given) (PP (IN by) (NP (NP (NNS experiments)) (VP (VBG using) (NP (NP (NN chloram-phenicol) (NN acetyltransferase) (-LRB- -LRB-) (NN CAT) (-RRB- -RRB-) (VBZ constructs)) (VP (VBG containing) (NP (NP (NP (NNS elements)) (PP (IN of) (NP (DT the) (NP (NN TNF) (NN gene))))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (NN TNF)) (JJ translational) (NN regulation))))))))))))))) (. .))))
(S1 (S (S (NP (NP (CC Both) (DT the) (NP (ADJP (JJ 5'))) (CC and) (NP (ADJP (JJ 3'))) (NP (JJ untranslated) (NNS regions))) (PP (IN of) (NP (DT the) (NP (NN TNF) (NN gene))))) (VP (VBD were) (VP (VBN required)) (S (VP (TO to) (VP (VB elicit) (NP (NP (JJ maximal) (JJ translational) (NN suppression)) (PP (IN by) (NP (NN CNI-1493)))))))) (. .))))
(S1 (S (S (NP (NP (NN Identification)) (PP (IN of) (NP (NP (DT the) (JJ molecular) (NN target)) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NN CNI-1493)) (VP (VBZ inhibits) (NP (NP (NN TNF)) (NN translation)))))))) (VP (MD should) (VP (VB provide) (NP (NP (NN insight)) (PP (IN into) (NP (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN macrophage) (NN activation)))) (CC and) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (NN inflammation))))))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NP (JJ RAR-RXR))) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NP (JJ RXR-RXR))) (NP (NN pathway))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (NN signaling) (NN growth) (NN inhibition)) (PP (IN of) (NP (JJ human) (JJ CD34+) (JJ erythroid) (NN progenitor) (NNS cells))))))) (. .)))))
(S1 (S (S (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NP (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-))) (, ,) (ADJP (JJ similar) (PP (TO to) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))))) (, ,)) (VP (MD can) (VP (VB act) (PP (IN as) (NP (NP (DT a) (JJ bifunctional) (NN regulator)) (PP (IN of) (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (NN bone) (NN marrow) (NNS progenitors)))))))) (, ,) (PP (IN in) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VP (VB stimulate) (NP (NP (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (: -)) (CC or) (NP (NP (NP (NN interleukin-3)) (PRN (-LRB- -LRB-) (NP (NN IL-3)) (-RRB- -RRB-))) (JJ -induced)) (NP (NN GM) (NN colony) (NN formation)))) (, ,) (CC but) (ADVP (RB potently)) (VP (VBP inhibit) (NP (JJ G-CSF-induced) (NN growth))))))))))))) (. .)))))
(S1 (S (S (NP (DT The) (JJ present) (NN study) (, ,)) (S (VP (VBG using) (NP (NP (ADJP (RB highly) (VBN enriched)) (NP (JJ human) (JJ CD34+))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ Lin-) (JJ murine) (NN bone) (NN marrow) (NN progenitor) (NNS cells))))) (, ,) (VP (VBZ demonstrates) (NP (NP (DT a) (ADJP (JJ potent) (JJ inhibitory)) (NN effect)) (PP (IN of) (NP (NN 9-cis-RA))) (PP (IN on) (NP (NP (NP (JJ burst-forming) (JJ unit-erythroid)) (PRN (-LRB- -LRB-) (NP (NN BFU-E)) (-RRB- -RRB-))) (NN colony) (NN formation)))) (ADVP (RB regardless) (PP (IN of) (NP (DT the) (NP (NN cytokine)) (NN stimulating) (NN growth))))) (. .))))
(S1 (S (S (ADVP (RB Specifically)) (, ,) (NP (NN 9-cis-RA)) (ADVP (RB potently)) (VP (VBD inhibited) (NP (NP (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (NP (NN BFU-E) (NN response)) (PP (TO to) (NP (NP (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NN Epo)) (-RRB- -RRB-))))))) (PRN (-LRB- -LRB-) (NP (CD 100) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (PP (NP (PP (NP (NP (NP (NP (NN stem) (NN cell) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN SCF)) (-RRB- -RRB-))) (CC +) (NP (NN Epo)))))))) (PRN (-LRB- -LRB-) (NP (CD 92) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (PP (NP (PP (NP (NP (NN IL-3)) (CC +) (NP (NN Epo))))))) (PRN (-LRB- -LRB-) (NP (CD 97) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (PP (NP (PP (NP (NP (NN IL-4)) (CC +) (NP (NN Epo))))))) (PRN (-LRB- -LRB-) (NP (CD 88) (NN %)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (PP (NP (PP (NP (NP (NN IL-9)) (CC +) (NP (NN Epo))))))) (PRN (-LRB- -LRB-) (NP (CD 100) (NN %)) (-RRB- -RRB-))))) (. .))))
(S1 (S (S (NP (JJ Erythroid) (NN colony) (NN growth)) (VP (VBD was) (ADVP (RB also)) (VP (VBN inhibited)) (SBAR (WHADVP (WRB when)) (S (NP (JJ CD34+) (NNS progenitors)) (VP (VBD were) (VP (VBN seeded) (PP (IN at) (NP (CD one) (NN cell))) (PP (IN per) (NP (NN well))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT a) (JJ direct) (NN action)) (PP (IN of) (NP (NN RA))))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (JJ synthetic) (NNS ligands)) (PP (TO to) (NP (NP (NP (NP (JJ retinoic) (NN acid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS RARs)) (-RRB- -RRB-))) (CC and) (NP (NP (NN retinoid) (NN X) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNS RXRs)) (-RRB- -RRB-)))) (SBAR (WHNP (WDT that)) (S (ADVP (RB selectively)) (VP (VP (VBP bind)) (CC and) (VP (VBP activate)) (NP (NP (NP (NN RAR-RXR))) (CC or) (NP (NP (JJ RXR-RXR))) (NP (NNS dimers))) (, ,) (ADVP (RB respectively)))))))))) (, ,) (S (NP (PRP we)) (VP (VBD dissected) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (DT the) (CD two) (NN retinoid) (NN response) (NNS pathways))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (ADJP (JJ normal)) (NP (JJ myeloid)) (CC and) (NP (JJ erythroid) (NN progenitor)) (NP (NN cell) (NN growth))))))))) (. .))))
(S1 (S (S (NP (NN Transactivation) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (CC both) (NP (NP (NP (DT the) (NP (NN RAR))) (PRN (-LRB- -LRB-) (NP (NN Ro) (CD 13-7410)) (-RRB- -RRB-)))) (CC and) (NP (NP (NP (NN RXR)) (PRN (-LRB- -LRB-) (NP (NP (NN Ro) (CD 25-6603)) (CC and) (NP (NN Ro) (CD 25-7386))) (-RRB- -RRB-)))) (NP (NNS ligands))) (VP (VBD were) (ADJP (RB highly) (JJ selective) (PP (IN at) (NP (CD 100) (NN nmol/L)))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (DT this) (NN concentration))) (, ,) (NP (NN Ro) (CD 13-7410)) (ADVP (RB potently)) (VP (VBD inhibited) (NP (NP (JJ G-CSF-stimulated) (JJ myeloid)) (CONJP (RB as) (RB well) (IN as)) (NP (ADJP (ADJP (NN SCF)) (CC +) (ADJP (JJ Epo-induced))) (JJ erythroid)) (NP (NN colony) (NN growth)))) (. .))))
(S1 (S (S (PP (IN At) (NP (DT the) (JJ same) (NN concentration))) (, ,) (NP (NP (NN Ro) (CD 25-6603)) (CC and) (NP (NN Ro) (CD 25-7386))) (VP (VBD had) (NP (NP (ADJP (JJ little))) (CC or) (NP (DT no)) (NP (NN effect))) (PP (IN on) (NP (JJ G-CSF-induced) (NN colony) (NN formation))) (, ,) (SBAR (IN whereas) (S (NP (PRP they)) (VP (VBD inhibited) (NP (NP (NP (CD 75) (NN %))) (CC and) (NP (NP (CD 53) (NN %))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN of) (NP (ADJP (ADJP (NN SCF)) (CC +) (ADJP (JJ Epo-stimulated))) (NN BFU-E) (NN colony) (NN growth)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (DT the) (NP (JJ RAR-RXR)) (NN response) (NN pathway)) (VP (MD can) (VP (VB signal) (NP (NP (NN growth) (NN inhibition)) (PP (IN of) (NP (ADJP (JJ normal)) (NP (NN bone) (NN marrow) (JJ myeloid)) (CC and) (NP (JJ erythroid) (NN progenitor)) (NP (NNS cells))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (NP (NP (DT a) (JJ unique) (NN involvement)) (PP (IN of) (NP (DT the) (NP (JJ RXR-RXR)) (NN pathway))) (PP (IN in) (S (VP (VBG mediating) (NP (NP (NN growth) (NN inhibition)) (PP (IN of) (NP (NP (NP (JJ erythroid))) (CONJP (CC but) (RB not)) (NP (JJ myeloid) (NN progenitor) (NNS cells)))))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NP (NN A-myb)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN c-myb)) (CC and) (NP (NN B-myb))))) (, ,)) (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (NP (NN Burkitt) (POS 's) (NN lymphoma)) (, ,) (NP (NN sIg+) (JJ B-acute) (JJ lymphoblastic) (NN leukemia)) (, ,) (CC and) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (ADJP (JJ chronic) (JJ lymphocytic)) (NNS leukemias)))))))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (NN A-myb) (NN gene))) (VP (VBZ encodes) (NP (NP (DT a) (NP (NN transcription) (NN factor))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (JJ related) (ADVP (CC both) (ADVP (RB functionally)) (CC and) (ADVP (RB structurally))) (PP (TO to) (NP (DT the) (NP (NN v-myb) (NN oncogene)))))))))) (. .)))))
(S1 (S (S (PP (VBG Following) (NP (PRP$ our) (NNS observations) (SBAR (IN that) (S (NP (NN A-myb)) (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (DT a) (JJ restricted) (NN subset)) (PP (IN of) (NP (JJ normal) (NP (JJ mature) (JJ human) (NN B) (NNS lymphocytes)))))) (, ,) (PP (IN with) (NP (DT the) (NN phenotype) (NP (NN CD38+)) (, ,) (NP (NN CD39-)) (, ,) (NP (JJ slgM-)))))))))) (, ,) (NP (PRP we)) (VP (VBP have) (ADVP (RB now)) (VP (VP (VBN investigated) (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NP (NP (NN A-myb)) (NN expression)) (PP (IN in) (NP (NP (JJ neoplastic) (NP (NN B) (NNS cells))) (VP (VBG representating) (NP (NP (DT the) (JJ whole) (NN spectrum)) (PP (IN of) (NP (NN B-cell) (NN differentiation))))))))))) (CC and) (VP (VBD compared) (NP (PRP it)) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN c-myb)) (CC and) (NP (NN B-myb))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT a) (NN panel)) (PP (IN of) (NP (CD 32) (NP (NN B-cell) (NNS lines)))))) (, ,) (NP (NN A-myb)) (VP (VBD was) (UCP (ADVP (RB very) (RB strongly)) (VP (VBN expressed) (PP (IN in) (NP (JJS most) (NP (NP (NN Burkitt) (POS 's) (NN lymphoma)) (PRN (-LRB- -LRB-) (NP (NN BL)) (-RRB- -RRB-))) (NN cell) (NNS lines)))) (, ,) (CC but) (ADJP (ADJP (JJ weak)) (CC or) (ADJP (JJ negative)) (PP (IN in) (NP (NP (CD 2) (NN pre-B) (NP (NP (JJ acute) (JJ lymphoblastic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN ALL)) (-RRB- -RRB-)))) (, ,) (NP (CD 4) (NP (NP (JJ non-Hodgkin) (POS 's) (NN lymphoma)) (PRN (-LRB- -LRB-) (NP (NN NHL)) (-RRB- -RRB-)))) (, ,) (NP (CD 6) (NP (JJ Epstein-Barr) (JJ virus-immortalized) (JJ lymphoblastoid) (NN cell) (NNS lines))) (, ,) (CC and) (NP (CD 6) (NP (NN myeloma) (NNS lines)))))))) (. .))))
(S1 (S (S (NP (NN Protein) (NN expression)) (VP (VBD paralleled) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NN RNA))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN investigated) (NP (NP (NP (NN A-myb)) (NN expression)) (PP (IN in) (NP (NP (CD 49) (JJ fresh) (NNS cases)) (PP (IN of) (NP (NN B) (NN leukemias)))))))) (. .))))
(S1 (S (S (S (S (PP (IN Among) (NP (CD 24) (NN ALL))) (, ,) (S (S (NP (CD 6)) (VP (VBD were) (PP (IN of) (NP (DT the) (JJ null))))) (CC and) (S (NP (CD 11)) (PP (IN of) (NP (DT the) (JJ common) (NN type)))))) (CC and) (S (NP (DT all) (DT these)) (VP (VBD were) (ADJP (JJ negative) (PP (IN for) (NP (NP (NN A-myb)) (NN expression))))))) (: ;) (S (PP (IN on) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (NP (DT all) (CD 7) (NN B-ALL) (NNS cases)) (PRN (-LRB- -LRB-) (ADJP (JJ slg+)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (CD one) (JJ fresh) (NN BL) (NN case)) (PP (IN with) (NP (NN bone) (NN marrow) (NN infiltration)))) (, ,)) (VP (VBD expressed) (NP (NN A-myb)))) (. .))))
(S1 (S (S (NP (NN A-myb)) (VP (VP (VBD was) (ADJP (JJ undetectable) (PP (IN in) (NP (CD 4) (NP (NP (JJ prolymphocytic) (NNS leukemias)) (PRN (-LRB- -LRB-) (NP (NN PLL)) (-RRB- -RRB-))))))) (CC but) (VP (VBD was) (ADVP (RB strongly)) (VP (VBN expressed) (PP (IN in) (NP (NP (NP (CD 5/20)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (JJ chronic) (JJ lymphocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN CLL)) (-RRB- -RRB-))) (NNS samples)))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (DT the) (JJ latter))) (NP (NN A-myb)) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NN phenotype)) (CC or) (NP (JJ clinical) (NN stage)))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NP (CD one) (NN case)) (PP (IN of) (NP (NN CLL))))) (PP (IN into) (NP (NN Richter) (POS 's) (NN syndrome)))))) (CC and) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (DT the) (NP (NN Richter) (POS 's) (NNS cells))) (VP (VBD expressed) (NP (NP (ADJP (NP (RB about) (RB 25-fold)) (JJR less)) (NP (NN A-myb) (NN RNA))) (PP (IN than) (NP (NP (DT the) (NP (NN CLL) (NNS cells))) (PP (IN from) (NP (DT the) (JJ same) (NN patient)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN pattern)) (PP (IN of) (NP (NP (NN c-myb)) (CC and) (NP (NN B-myb))))) (VP (VBD was) (ADJP (RB clearly) (JJ distinct) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NN A-myb))))))) (. .))))
(S1 (S (S (NP (NP (NN C-myb)) (CC and) (NP (NN B-myb))) (VP (VBD were) (VP (VBN expressed) (PP (IN in) (NP (DT all) (JJ neoplastic) (NNS groups))) (, ,) (PP (IN except) (PP (IN in) (NP (NN CLL) (NNS cells)))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (NN A-myb)) (NN expression) (, ,)) (PP (IN unlike) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN c-myb)) (CC and) (NP (NN B-myb)))))) (, ,) (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (NP (NP (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NN B-cell) (NN neoplasias)))) (PRN (-LRB- -LRB-) (PP (IN in) (NP (JJ particular))) (NP (NP (NN BL)) (CC and) (NP (NN slg+B-ALL))) (-RRB- -RRB-))) (NN representative)) (PP (IN of) (NP (NP (DT a) (JJ specific) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation))))))))) (. .))))
(S1 (S (S (NP (DT This) (NN expression)) (VP (NN may) (PP (IN in) (NP (NN part))) (VP (VBP reflect) (NP (NP (NN expression)) (PP (IN of) (NP (NN A-myb))) (PP (IN by) (NP (NP (DT the) (JJ normal) (JJ germinal) (NN center) (NP (NN B) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (DT the) (JJ normal) (NN counterpart)) (PP (IN of) (NP (DT these) (NP (VBN transformed) (NN B) (NNS cells))))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NNS data)) (VP (VBN presented))) (ADVP (RB strongly)) (VP (VBP support) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (DT this) (NP (NN transcription) (NN factor)))) (PP (PP (IN in) (NP (NN B-cell) (NN differentiation))) (CC and) (ADVP (RB perhaps)) (PP (IN in) (NP (NP (NN B-cell) (NN transformation)) (PP (IN in) (NP (DT some) (NNS neoplasias)))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Lymphoid) (NN cell) (NN resistance)) (PP (TO to) (NP (NNS glucocorticoids))) (PP (IN in) (NP (NN HIV) (NN infection))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (NP (NNS humans)) (VP (VBN infected) (PP (IN with) (NP (DT the) (NN HIV-1) (NN virus)))))) (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ disproportionate) (NN severity)) (PP (IN of) (NP (NP (NP (NNS signs)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN illness)))))) (PP (VBN compared) (PP (TO to) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (JJ CD4+) (JJ infected) (NN T-lymphoid) (NNS cells)))))))) (. .)))))
(S1 (S (S (PP (IN In) (NP (NN part))) (, ,) (NP (DT this)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (JJ altered) (NP (JJ intercellular) (NN signalling) (NNS systems)) (CC and) (NP (JJ intracellular) (NN signal) (NN transduction))))))) (. .))))
(S1 (S (S (NP (NNS Glucocorticoids)) (VP (VBP are) (ADJP (RB well) (JJ known) (PP (IN for) (NP (NP (PRP$ their) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NP (NN vitality)) (CC and) (NP (NN function))) (PP (IN of) (NP (JJ lymphoid) (NNS cells))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NN HIV) (NNS infections)))) (ADVP (RB often)) (VP (VBP show) (NP (NP (ADJP (JJ elevated) (JJ circulating)) (NNS levels)) (PP (IN of) (NP (NN cortisol)))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT some) (NN misfunction)) (PP (IN in) (NP (NP (DT the) (JJ regulatory) (NNS systems)) (SBAR (WHNP (WDT that)) (S (VP (VBP maintain) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT this) (JJ critical) (NN hormone))))))))))))) (. .))))
(S1 (S (S (PP (IN At) (NP (DT the) (JJ cellular) (NN level))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP (CC both) (NP (JJ acute) (NN HIV) (NN infection)) (CC and) (NP (NNS glucocorticoids))) (VP (MD can) (VP (VB cause) (NP (NP (JJ apoptotic) (NN cell) (NN death)) (PP (IN in) (NP (JJ thymic) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (RB chronically) (JJ HIV-infected) (NNS cells)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ resistant) (PP (TO to) (NP (JJ glucocorticoid-evoked) (NN cell) (NN death)))))))) (. .))))
(S1 (S (S (NP (NP (NN Glucocorticoid) (NN receptor-ligand) (NN binding) (NNS studies)) (PP (IN on) (NP (NNS patients) (POS ') (NNS cells)))) (VP (VBP have) (VP (VBN shown) (NP (NP (VBN reduced) (NN affinity)) (PP (IN between) (NP (DT the) (NP (NN receptor) (NN binding) (NNS sites)) (CC and) (NP (NN test) (NNS steroids))))))) (. .))))
(S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NP (RB chronically) (JJ HIV-infected) (NNS cells)) (PP (IN of) (NP (DT the) (NP (JJ lymphoid) (NN CEM) (NN line))))) (VP (VBD displayed) (NP (NP (NN resistance)) (PP (TO to) (NP (JJ glucocorticoid-induced) (NN apoptosis))))) (. .))))
(S1 (S (S (NP (DT These) (NNS cells)) (VP (VBD showed) (NP (NP (VBN reduced) (NNS numbers)) (PP (IN of) (NP (VBG binding) (NNS sites)))) (PP (IN with) (NP (NP (JJ little) (NN alteration)) (PP (IN in) (NP (NP (JJ apparent) (NN affinity)) (PP (IN between) (NP (NP (NN ligand)) (CC and) (NP (NN receptor))))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (NP (PRP it)) (VP (VBZ appears) (SBAR (IN that) (S (NP (EX there)) (VP (MD may) (ADVP (RB often)) (VP (VB be) (NP (NP (NP (NP (NN malfunction)) (PP (IN of) (NP (DT the) (JJ normal) (NN glucocorticoid) (NN response))) (PP (IN in) (NP (JJ HIV-infected) (NNS cells))))) (ADVP (RB probably)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ altered) (NNS interactions)) (PP (IN between) (NP (NP (DT the) (NP (NN glucocorticoid) (NN receptor))) (CC and) (NP (PRP$ its) (NN hormone))))))))))))) (. .))))
(S1 (S (S (NP (JJ Such) (NNS alterations)) (VP (MD may) (VP (VB have) (NP (NP (JJ clinical) (NNS consequences)) (, ,) (PP (VBG including) (NP (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (DT a) (ADJP (RB relatively) (JJR longer)) (NN life) (NN span)) (PP (IN of) (NP (JJ infected) (JJ CD4+) (NNS T-lymphocytes)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ systemic) (NNS effects)) (PP (IN of) (NP (ADJP (RB chronically) (JJ elevated)) (NN cortisol) (NN level))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ Epstein-Barr) (JJ virus-encoded) (JJ nuclear) (NN antigen) (NN EBNA-5)) (VP (VBZ accumulates) (PP (IN in) (NP (JJ PML-containing) (NNS bodies)))) (. .))))
(S1 (S (S (NP (NN EBNA-5)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ Epstein-Barr) (NN virus) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ -encoded) (JJ nuclear) (NNS proteins)) (VP (VBN required) (PP (IN for) (NP (NP (NN immortalization)) (PP (IN of) (NP (JJ human) (NN B) (NNS lymphocytes)))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (NNS nuclei)) (PP (IN of) (NP (JJ EBV-transformed) (JJ lymphoblastoid) (NN cell) (NNS lines))))) (NP (NN EBNA-5)) (VP (VBZ is) (ADVP (RB preferentially)) (VP (VBN targetted) (PP (TO to) (NP (JJ distinct) (JJ nuclear) (NNS foci))))) (. .))))
(S1 (S (S (ADVP (RB Previously)) (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP W.Q.) (NNP Jiang)) (, ,) (NP (NNP L.Szekely)) (, ,) (NP (NNP V.Wendel-Hansen)) (, ,) (NP (NNP N.Ringertz)) (, ,) (NP (NNP G.Klein)) (, ,) (CC and) (NP (NNP A.) (NNP Rosen))) (, ,) (NP (NNP Exp.Cell) (NNP Res)))))) (. .))))
(S1 (S (S (S (NP (NN Heat) (NN shock)) (VP (VBZ induces) (NP (NP (NN HIV-1) (NN replication)) (PP (IN in) (NP (ADJP (RB chronically) (JJ infected)) (NP (JJ promyelocyte) (NN cell) (NN line) (NN OM10.1)))))) (. .)))))
(S1 (S (S (S (NP (NP (DT A) (JJ long) (NN period)) (PP (IN of) (NP (NP (JJ clinical) (NN latency)) (PP (IN before) (NP (NP (NN development)) (PP (IN of) (NP (NNS symptoms)))))))) (VP (VBZ is) (ADJP (JJ characteristic) (PP (IN of) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NN infection))))) (. .)))))
(S1 (S (S (NP (NP (NN OM10.1)) (, ,) (NP (NP (DT a) (NP (JJ promyelocyte) (NN cell) (NN line))) (VP (ADVP (RB latently)) (VBN infected) (PP (IN with) (NP (NN HIV-1))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN developed) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN for) (S (VP (VBG studying) (NP (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (JJ viral) (NN latency)))) (CC and) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN virus) (NN expression))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT this) (ADJP (RB latently) (JJ infected)) (NN cell) (NN line)) (PP (IN with) (NP (NP (NN heat) (NN shock)) (PP (IN at) (NP (CD 42) (NNS degrees) (NN C))) (PP (IN for) (NP (CD 2) (NN h)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (JJ high) (NN level)) (PP (IN of) (NP (NN HIV-1) (NN production)))) (PP (IN without) (NP (NP (NN addition)) (PP (IN of) (NP (DT any) (NP (NNS cytokines)))))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN activation)))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (S (VP (VBG using) (NP (NP (JJ anti-TNF-alpha) (NN antibody)) (CC and) (NP (JJ various) (NNS inhibitors)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NP (NN TNF-alpha)) (NN level)) (PP (IN in) (NP (NN culture) (NNS supernatants)))) (VP (VBD was) (PP (IN below) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (DT an) (NN ELISA) (NN assay) (NN system)))))))) (, ,) (S (NP (NP (NN addition)) (PP (IN of) (NP (NP (JJ anti-TNF-alpha) (NN antibody)) (PP (IN in) (NP (NN culture) (NN medium)))))) (VP (MD could) (ADVP (RB partially)) (VP (VB suppress) (NP (DT the) (NN heat) (NN shock) (JJ induced) (NN HIV-1) (NN production))))) (. .))))
(S1 (S (S (NP (NP (NP (NN Staurosporine)) (PRN (-LRB- -LRB-) (NP (NN PKC) (NN inhibitor)) (-RRB- -RRB-))) (, ,) (NP (NP (NN pentoxifylline)) (PRN (-LRB- -LRB-) (NP (NN NF-kappa) (NN B) (NN inhibitor)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN Ro5-3335)) (PRN (-LRB- -LRB-) (NP (NN HIV-1) (NP (NN Tat)) (NN inhibitor)) (-RRB- -RRB-)))) (ADVP (RB also)) (VP (VBD inhibited) (ADVP (RB significantly)) (NP (DT the) (NN heat) (NN shock) (JJ induced) (NN virus) (NN activation))) (. .))))
(S1 (S (S (PP (IN In) (NP (JJ particular))) (, ,) (NP (NN staurosporine)) (VP (VBD achieved) (NP (NP (ADJP (QP (RB approximately) (CD 90)) (NN %)) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN HIV-1) (NN antigen) (NN expression)) (PP (IN in) (NP (NP (NN heat) (JJ shock-treated) (NN OM10.1)) (PP (IN at) (NP (DT a) (JJ non-toxic) (NN concentration))))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN HIV-1) (NN activation)) (PP (IN with) (NP (NN heat) (NN shock)))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN elucidated) (ADVP (RB yet))))))) (, ,) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN presumed) (NP (NN PKC)) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN HIV-1) (NN activation))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (DT the) (JJ present) (NNS observations)) (VP (MD will) (VP (VB provide) (NP (NP (DT a) (JJ further) (NN insight)) (PP (IN into) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN HIV-1) (NNS infections)))))))) (. .))))
(S1 (S (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN Retinoid) (NN X) (NN Receptor) (NN alpha)))) (VP (VBZ is) (VP (VBN increased) (PP (IN upon) (NP (JJ monocytic) (NN cell) (NN differentiation))))) (. .)))))
(S1 (S (S (S (NP (NP (CD 1) (NN alpha,25-Dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LRB-) (NP (NN VD)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NP (JJ monocytic) (NN differentiation)) (PP (IN of) (NP (CC both) (NP (ADJP (JJ normal))) (CC and) (NP (ADJP (JJ leukemic))) (NP (NNS cells)))))))) (. .)))))
(S1 (S (S (NP (PRP$ Its) (NNS effects)) (VP (VBP are) (VP (VBN mediated) (PP (IN by) (NP (NP (PRP$ its) (NP (JJ nuclear) (NN receptor))) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (NP (JJ Efficient) (NN gene) (NN activation)) (VP (VBZ requires) (NP (NP (DT the) (NN heterodimerization)) (PP (IN of) (NP (NN VDR))) (PP (IN with) (NP (NP (NN Retinoid) (NN X) (NNS Receptors)) (PRN (-LRB- -LRB-) (NP (NN RXR)) (-RRB- -RRB-)))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (DT the) (JJ present) (NN study)) (VP (VBG using) (NP (JJ specific) (NNS antibodies))))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP (NN RXR) (NN alpha) (NN protein)))) (PP (IN in) (NP (NP (NN blood) (JJ mononuclear) (NNS cells)) (PP (PP (IN from) (NP (NP (NP (JJ acute) (JJ myeloid) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN AML)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS cases)) (-RRB- -RRB-)))) (CC and) (PP (IN from) (NP (NP (JJ myelomonocytic) (NN cell) (NNS lines)) (VP (VBN arrested) (PP (IN at) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (NN differentiation))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD observed) (SBAR (IN that) (S (NP (DT the) (NP (NN RXR) (NN alpha)) (NN expression)) (VP (VBD increased) (PP (IN during) (NP (JJ myelomonocytic) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (NP (DT the) (JJS highest) (NNS levels)) (VP (VBD were) (VP (VBN found) (PP (PP (IN in) (NP (NN AML) (NNS samples))) (CC and) (PP (IN in) (NP (NP (JJ myelomonocytic) (NN cell) (NNS lines)) (VP (VBG having) (NP (NP (DT the) (JJS highest) (NNS amounts)) (PP (IN of) (NP (JJ monocytic) (NNS precursors))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NP (JJ fresh) (NP (JJ leukemic) (NNS cells))) (, ,) (SBAR (WHNP (WDT whatever) (FRAG (NP (NP (PRP$ their) (NN stage)) (PP (IN of) (NP (NN differentiation)))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ myelomonocytic) (NN cell) (NNS lines)) (, ,)) (VP (VB respond) (PP (TO to) (NP (NN VD))) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN RXR) (NN alpha)) (NNS levels))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Combinations)) (PP (IN of) (NP (NP (JJ all-trans) (NP (NP (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))) (CC and) (NP (NN VD)))) (, ,)) (PP (IN in) (NP (DT some) (NNS cases))) (, ,) (VP (VBD increased) (NP (DT this) (NN effect))) (. .))))
(S1 (S (S (NP (DT This) (NN response)) (VP (VBZ suggests) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NN RXR) (NN alpha))) (PP (IN in) (NP (JJ monocytic) (NN differentiation))) (PP (IN upon) (NP (NN VD) (NN treatment))))) (. .))))
(S1 (S (S (S (NP (NP (NP (JJ Putative) (NN steroid) (NN binding) (NN domain)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN mineralocorticoid) (NN receptor))))) (, ,) (VP (VBN expressed) (PP (IN in) (NP (FW E.) (FW coli))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN heat) (NN shock) (NNS proteins))))))) (VP (VBZ shows) (NP (ADJP (ADJP (JJ typical)) (ADJP (JJ native))) (NN receptor) (NNS characteristics))) (. .)))))
(S1 (S (S (S (NP (NP (NN Domain) (NN E)) (, ,) (VP (VBN considered) (PP (IN as) (NP (NP (DT the) (NP (NP (JJ putative) (NN hormone) (NN binding) (NN domain)) (PRN (-LRB- -LRB-) (NP (NN HBD)) (-RRB- -RRB-)))) (PP (IN of) (NP (DT the) (NP (NP (JJ human) (NN mineralocorticoid) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN hMR)) (-RRB- -RRB-))))))))) (VP (VBD was) (VP (VBN expressed) (PP (IN in) (NP (FW Escherichia) (FW coli))) (PP (IN as) (NP (NP (DT a) (NN fusion) (NN protein)) (PP (IN with) (NP (CC either) (NP (NP (NN maltose) (NN binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN MBP)) (-RRB- -RRB-))) (CC or) (NP (NP (NN glutathione) (NN S-transferase)) (PRN (-LRB- -LRB-) (NP (NN GST)) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (NP (DT These) (NP (JJ bacterially-produced) (NN MR) (NNS constructs))) (VP (VBD had) (NP (DT no) (NN steroid) (NN binding) (NN activity)) (ADVP (FW per) (FW se))) (. .))))
(S1 (S (S (PP (IN In) (NP (NN fact))) (, ,) (NP (NP (NP (NN heat) (NN shock) (NN protein)) (NN association)) (PRN (-LRB- -LRB-) (NP (NN hsp)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (JJ high) (NN affinity) (NN ligand-binding)) (PP (IN of) (NP (DT the) (NP (NN MR)))))))) (. .))))
(S1 (S (S (PP (IN After) (NP (NP (NN incubation)) (PP (IN of) (NP (VBN purified) (NP (NN MBP-)) (CC or) (NP (NN GST-HBD)))) (PP (IN with) (NP (NP (NN rabbit) (NN reticulocyte) (NN lysate)) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB be) (ADJP (JJ rich) (PP (IN in) (NP (NN heat) (NN shock) (NNS proteins)))))))))))) (, ,) (NP (PRP we)) (VP (VBD obtained) (NP (NP (JJ saturable) (NN binding)) (PP (IN of) (NP (NN -LSB-3H-RSB-aldosterone))))) (. .))))
(S1 (S (S (S (NP (NP (DT The) (NN Kd) (NN value)) (PP (IN for) (NP (NN aldosterone)))) (VP (VBD was) (NP (CD 0.3) (NN nM)))) (CC and) (S (NP (DT the) (NN Bmax)) (VP (VBD =) (NP (CD 32) (NN pmol/mg)))) (. .))))
(S1 (S (S (NP (NN Hormone) (NN binding) (NN specificity)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (NN competition) (NNS studies)) (PP (IN with) (NP (JJ various) (NN steroid) (NNS ligands))))))) (. .))))
(S1 (S (S (NP (NP (NN Sucrose) (NN gradient) (NNS assays)) (VP (VBN performed) (PP (IN with) (NP (NN -LSB-3H-RSB-aldosterone-MBP-HBD))))) (VP (VBD revealed) (NP (NP (NN complex)) (VP (VBG sedimenting) (PP (IN at) (NP (NP (NN 8.3S)) (CC and) (NP (NN 4.9S)))) (PP (IN with) (NP (NN -LSB-3H-RSB-progesterone-MBP-HBD)))))) (. .))))
(S1 (S (S (NP (NP (JJ Western-blot) (NN analysis)) (PP (IN of) (NP (DT the) (NN sedimentation) (NN peak)))) (VP (VBD showed) (NP (NP (DT the) (JJ concomitant) (NN presence)) (PP (PP (IN of) (NP (NN MBP-HBD))) (PP (IN by) (NP (DT a) (NP (JJ monoclonal) (JJ anti-MBP) (NN antibody)))) (, ,) (CC and) (PP (NP (NN hsp90))) (PP (IN by) (NP (DT a) (NP (JJ monoclonal) (JJ anti-hsp) (NN antibody))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (PP (VBG following) (NP (NP (NN incubation)) (PP (IN with) (NP (DT the) (NP (JJ anti-rabbit) (NN hsp90) (JJ monoclonal) (NN antibody)))))) (NP (DT the) (NN sedimenting) (NN gradient)) (VP (VBD showed) (NP (DT a) (NP (NN 10.4S) (NN sedimenting) (NN complex)))) (. .))))
(S1 (S (S (NP (DT These) (NNS analyses)) (VP (VBD demonstrated) (SBAR (SBAR (IN that) (S (NP (DT the) (NN -LSB-3H-RSB-aldosterone-MBP-HBD) (NN complex)) (VP (VBZ is) (ADVP (IN at) (JJS least)) (VP (VBN associated) (PP (IN with) (NP (NN hsp90))) (PP (IN in) (NP (NN reticulocyte) (NN lysate))))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN HBD))) (PP (IN of) (NP (NN hMR)))) (VP (VBZ is) (ADJP (JJ sufficient)) (S (VP (TO to) (VP (VB bind) (NP (NN hsp90)))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Deletions)) (PP (IN of) (NP (NP (NP (DT a) (ADJP (RB relatively) (JJ short)) (NP (NP (NN amino-)) (PRN (-LRB- -LRB-) (NP (CD 729-766)) (-RRB- -RRB-)))) (CC or) (NP (NP (NP (JJ carboxy-terminal)) (PRN (-LRB- -LRB-) (NP (CD 940-984)) (-RRB- -RRB-)))) (NP (NN region))) (PP (IN of) (NP (DT the) (NP (NN HBD) (NN fragment))))))) (VP (VBD eliminated) (NP (DT all) (JJ steroid-binding) (NNS properties))) (. .))))
(S1 (S (S (ADVP (RB Overall)) (, ,) (NP (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN integrity)) (PP (IN of) (NP (NN domain) (NN E)))) (VP (VBZ is) (ADJP (ADJP (JJ necessary)) (CC and) (ADJP (JJ sufficient))) (S (VP (TO to) (VP (VB bind) (NP (NP (NN steroid) (NNS ligands)) (, ,) (NP (NP (NNS agonists)) (CC or) (NP (NNS antagonists)))) (, ,) (PP (IN with) (NP (NP (NNS characteristics)) (ADJP (JJ similar) (PP (TO to) (NP (DT the) (ADJP (JJ entire) (JJ native)) (NP (NN MR)))))))))))))) (. .))))
(S1 (S (S (S (NP (DT The) (NP (JJ myeloid-cell-specific) (NN c-fes) (NN promoter))) (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (NN Sp1)) (, ,) (NP (NN PU.1)) (, ,) (CC and) (NP (DT a) (JJ novel) (NP (NN transcription) (NN factor))))))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (DT the) (NP (NN c-fps/fes) (-LRB- -LRB-) (NN c-fes) (-RRB- -RRB-) (NN proto-oncogene))))) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (JJ normal) (NN development)) (PP (IN of) (NP (NP (JJ myeloid) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NNS macrophages)) (CC and) (NP (NNS neutrophils))) (-RRB- -RRB-))))))))) (. .)))))
(S1 (S (S (NP (NP (NN mRNA)) (PP (IN for) (NP (NN c-fes)))) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (ADVP (RB exclusively)) (IN in) (NP (NP (NP (JJ myeloid) (NNS cells)) (CC and) (NP (JJ vascular) (JJ endothelial) (NNS cells))) (PP (IN in) (NP (JJ adult) (NNS mammals)))))))) (. .))))
(S1 (S (S (SBAR (IN Although) (S (NP (DT a) (NP (NN 13-kilobase-pair) (-LRB- -LRB-) (NN kb) (-RRB- -RRB-) (JJ human) (NN c-fes) (NN transgene))) (VP (VBZ exhibits) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN expression)))) (PP (IN in) (NP (NNS mice)))))) (, ,) (S (NP (NP (DT the) (NNS sequences)) (SBAR (WHNP (WDT that)) (S (VP (VBP confer) (NP (NP (JJ myeloid-cell-specific) (NN expression)) (PP (IN of) (NP (DT the) (NP (JJ human) (NN c-fes) (NN gene))))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN defined))))) (. .))))
(S1 (S (S (NP (NN Transient-transfection) (NNS experiments)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NNS plasmids)) (VP (VBG containing) (NP (NP (NP (CD 446) (NN bp)) (PP (IN of) (NP (NN c-fes) (JJ 5'-flanking) (NNS sequences)))) (VP (VBN linked) (PP (TO to) (NP (DT a) (NN luciferase) (NN reporter) (NN gene))))))) (VP (VBD were) (ADJP (JJ active)) (PP (ADVP (RB exclusively)) (IN in) (NP (JJ myeloid) (NNS cells))))))) (. .))))
(S1 (S (S (NP (NP (DT No) (JJ other) (NN DNA) (NN element)) (PP (IN within) (NP (DT the) (NP (JJ 13-kb) (JJ human) (NN c-fes) (NN locus))))) (VP (VBD contained) (NP (JJ positive) (JJ cis-acting) (NNS elements)) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (DT a) (ADJP (RB weakly) (JJ active)) (NN region)) (PP (IN within) (NP (DT the) (NP (JJ 3'-flanking) (NNS sequences))))))))) (. .))))
(S1 (S (S (NP (NN DNase) (CD I) (NN footprinting) (NNS assays)) (VP (VBD revealed) (NP (NP (NP (CD four) (JJ distinct) (NNS sites)) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (NP (JJ myeloid) (JJ nuclear) (NNS proteins)))))) (PRN (-LRB- -LRB-) (NP (NP (CD -408) (TO to) (CD -386)) (, ,) (NP (CD -293) (TO to) (CD -254)) (, ,) (NP (CD -76) (TO to) (CD -65)) (, ,) (CC and) (NP (CD -34) (TO to) (CD +3))) (-RRB- -RRB-)))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ first) (CD two) (NNS footprints)) (VP (VBD resided) (PP (IN in) (NP (NP (NNS sequences)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (RB largely) (JJ dispensable) (PP (IN for) (NP (JJ transient) (NN activity)))))))))) (. .))))
(S1 (S (S (NP (NP (NNS Plasmids)) (VP (VBG containing) (NP (NP (CD 151) (NN bp)) (PP (IN of) (NP (JJ 5'-flanking) (NNS sequences)))))) (VP (VBP confer) (NP (JJ myeloid-cell-specific) (NN gene) (NN expression))) (. .))))
(S1 (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS analyses)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT the) (NP (JJ 151-bp) (NN region))) (VP (VBZ contains) (NP (NP (JJ nuclear) (NN protein) (NN binding) (NNS sites)) (PP (IN for) (NP (NP (NP (NN Sp1)) (, ,) (NP (NN PU.1)) (, ,) (CC and/or) (NP (NN Elf-1))) (, ,) (CC and) (NP (DT a) (NP (JJ novel) (NN factor)))))))))) (. .))))
(S1 (S (S (NP (DT This) (JJ unidentified) (NN factor)) (VP (VP (VBZ binds) (NP (ADVP (RB immediately) (JJ 3')) (PP (IN of) (NP (DT the) (NP (JJ PU.1/Elf-1) (NNS sites)))))) (CC and) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ myeloid) (NN cell) (JJ specific))))))) (. .))))
(S1 (S (S (NP (NP (NN Mutation)) (PP (IN of) (NP (NP (DT the) (NP (JJ PU.1/Elf-1)) (NN site)) (CC or) (NP (NP (DT the) (NP (JJ 3') (NN site))) (PRN (-LRB- -LRB-) (NP (NN FP4-3')) (-RRB- -RRB-))))) (PP (IN within) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (DT the) (NP (NN c-fes) (NN promoter))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RB substantially) (VBN reduced)) (NN activity)) (PP (IN in) (NP (JJ transient) (NNS transfections)))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (JJ transient-cotransfection) (NN assay)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN PU.1)) (PRN (-LRB- -LRB-) (CC and) (RB not) (NP (NN Elf-1)) (-RRB- -RRB-))) (VP (MD can) (VP (VB transactivate) (NP (NP (DT the) (NP (NN c-fes) (NN promoter))) (PP (IN in) (NP (JJ nonmyeloid) (NN cell) (NNS lines))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (DT the) (NP (JJ human) (NN c-fes) (NN gene))) (VP (VBZ contains) (NP (NP (DT a) (JJ strong) (NP (JJ myeloid-cell-specific) (NN promoter))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN regulated) (PP (IN by) (NP (NP (NN Sp1)) (, ,) (NP (NN PU.1)) (, ,) (CC and) (NP (DT a) (JJ novel) (NP (NN transcription) (NN factor)))))))))))))) (. .))))
(S1 (S (S (S (NP (NN DNA) (NN triplex) (NN formation)) (ADVP (RB selectively)) (VP (VBZ inhibits) (NP (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor) (NN gene)) (NN expression)) (PP (IN in) (NP (JJ human) (NN T) (NNS cells))))) (. .)))))
(S1 (S (S (S (NP (NP (JJ Granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ hemopoietic) (NN growth) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (ADJP (VBN activated)) (NP (NN T) (NNS cells)) (, ,) (NP (NNS fibroblasts)) (, ,) (NP (NNS macrophages)) (, ,) (CC and) (NP (JJ endothelial) (NNS cells)))))))))) (. .)))))
(S1 (S (S (SBAR (IN Although) (S (NP (NN GM-CSF)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ essential) (PP (IN for) (NP (JJ normal) (NN hemopoiesis))))))))))) (, ,) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (NN GM-CSF)))) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (DT some) (NNS diseases)) (PP (JJ such) (IN as) (NP (NP (JJ myeloid) (NN leukemia)) (CC and) (NP (JJ chronic) (NN inflammation)))))))))))) (. .))))
(S1 (S (S (NP (NP (NP (DT An) (NN NF-kappaB/Rel) (NN binding) (NN site)) (PP (IN within) (NP (DT the) (NP (NN GM-CSF) (NN promoter))))) (, ,) (VP (VBN termed) (S (NP (DT the) (NN kappaB) (NN element))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ important) (PP (IN for) (S (VP (VBG controlling) (NP (NP (NN expression)) (PP (IN in) (NP (NP (NN reporter) (NN gene)) (NNS assays))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS stimuli)))) (PP (IN in) (NP (NN T) (NNS cells)))))))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (ADJP (ADJP (JJ oligonucleotide-directed)) (ADJP (JJ triple))) (NN helix) (NN formation)) (PP (IN across) (NP (DT this) (NP (JJ regulatory) (NN sequence))))) (PP (IN as) (NP (NP (DT a) (JJ potential) (NN tool)) (SBAR (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN GM-CSF)) (NN gene) (NN transcription))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN 15-base) (NN oligonucleotide)) (, ,) (NP (NN GM3)) (, ,)) (VP (VBD was) (VP (VBN targeted) (PP (TO to) (NP (NP (NP (DT a) (NP (JJ purine-rich) (NN region))) (PP (IN in) (NP (DT the) (NP (NN GM-CSF) (JJ proximal) (NN promoter))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ overlaps) (NP (DT the) (NP (NN kappaB) (NN element)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Gel) (NN mobility) (NN shift) (NNS assays)) (CC and) (NP (NP (NN DNase) (CD I)) (NN footprinting))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NN GM3)) (VP (VBD formed) (NP (DT a) (JJ sequence-specific) (NN collinear) (NN triplex)) (PP (IN with) (NP (PRP$ its) (NP (JJ double-stranded) (NN DNA) (NN target)))))))) (. .))))
(S1 (S (S (NP (NP (JJ Triplex) (NN formation)) (PP (IN by) (NP (NN GM3)))) (VP (VBD blocked) (NP (NP (NP (JJ recombinant)) (CC and) (NP (JJ nuclear)) (NP (NN NF-kappaB) (NNS proteins) (VBG binding))) (PP (TO to) (NP (DT the) (NP (NN GM-CSF) (NN element)))))) (. .))))
(S1 (S (S (NP (NN GM3)) (ADVP (RB also)) (VP (VBD caused) (NP (NP (JJ selective) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NP (JJ human) (NN T-cell) (JJ lymphotrophic) (NN virus-1) (NN Tax)) (JJ transactivator-induced) (NP (NN luciferase)) (NN activity)) (PP (IN from) (NP (NP (DT a) (NN reporter) (NN construct)) (VP (VBN driven) (PP (IN by) (NP (NP (DT the) (NP (NN GM-CSF) (NN promoter))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))))))))) (. .))))
(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NN GM3)) (VP (VP (ADVP (RB greatly)) (VBD reduced) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (JJ endogenous) (NP (NN GM-CSF) (NN mRNA))) (VP (VBN induced) (PP (IN by) (NP (NP (JJ different) (NNS stimuli)) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells)))))))))) (CC but) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (NN interleukin) (CD 3) (NN mRNA)) (NNS levels)) (PP (IN in) (NP (DT the) (JJ same) (NNS cells))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NP (NN kappaB) (NN element))) (PP (IN in) (NP (DT the) (NP (NN GM-CSF) (NN promoter))))) (VP (VBZ plays) (NP (DT a) (JJ central) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (JJ endogenous) (NP (NN GM-CSF) (NN gene)))))))))) (. .))))
(S1 (S (S (NP (JJ Colinear) (NN triplex) (NN formation)) (VP (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (JJ selective) (JJ transcriptional) (NN repressor)) (PP (IN of) (NP (DT the) (NP (NN GM-CSF) (NN gene))))))) (CC and) (VP (MD may) (VP (VB have) (NP (ADJP (JJ potential) (JJ therapeutic)) (NN application)) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (JJ undesirable) (NN overexpression)) (PP (IN of) (NP (DT this) (NN protein)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NP (NP (NN Induction)) (PP (IN of) (NP (NN CIITA)))) (CC and) (NP (NP (NN modification)) (PP (IN of) (NP (ADJP (FW in) (FW vivo)) (NP (NN HLA-DR) (NN promoter)) (NN occupancy))))) (PP (IN in) (NP (NP (JJ normal) (JJ thymic) (JJ epithelial) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NN IFN-gamma)))))) (: :)) (NP (NP (NP (NNS similarities)) (CC and) (NP (NNS distinctions))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (JJ HLA-DR-constitutive) (NN B) (NNS cells)))))) (. .)))))
(S1 (S (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (NP (DT the) (NP (NN IFN-gamma)) (NN induction)) (PP (IN of) (NP (NP (NN MHC) (NN class) (CD II) (NN gene)) (NN expression))) (PP (IN in) (NP (NP (JJ primary) (NNS cultures)) (PP (IN of) (NP (NP (JJ thymic) (JJ epithelial) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN TEC)) (-RRB- -RRB-))))))) (VP (VBD was) (VP (VBN analyzed))) (. .)))))
(S1 (S (S (NP (DT This) (JJ cellular) (NN system)) (VP (VBZ offers) (NP (DT the) (NN advantage) (SBAR (IN that) (S (NP (NP (NN MHC) (NN class) (CD II)) (NN induction)) (VP (VBZ is) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (NP (`` ``) (JJ physiologic) (NN cell) (NN lineage))) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT this) (NN expression)) (PP (IN within) (NP (DT the) (NN thymus))))))) (, ,) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB participate) (PP (TO to) (NP (NP (DT the) (NP (NN selection)) (CC and) (NP (NN maturation))) (PP (IN of) (NP (DT the) (NP (NN T) (NNS cells))))))))))))))))))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (DT the) (NP (NN MHC) (NN class) (CD II) (NN gene)) (NN expression)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (ADJP (FW de) (FW novo)) (NN transcription)) (PP (IN of) (NP (NP (DT the) (NN gene)) (VP (VBG encoding) (NP (NP (DT the) (NP (NN CIITA) (NN trans-activator))) (, ,) (NP (DT a) (JJ crucial) (NP (NN MHC) (NN class) (CD II) (NN gene) (JJ regulatory) (NN factor))))))))))))))) (. .))))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN anatomy)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN between) (NP (DT the) (NP (NN MHC) (NN class) (CD II) (NN DRA) (NN promoter)) (CC and) (NP (JJ corresponding) (NP (VBG binding) (NNS factors)))))))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (NP (ADJP (FW in) (FW vivo)) (NP (NN DNAse) (NN I)) (NN footprint))))) (. .))))
(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (SBAR (IN that) (S (NP (NP (NN treatment)) (PP (IN with) (NP (NN IFN-gamma)))) (VP (VBZ induces) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN occupancy)) (PP (IN of) (NP (DT the) (NP (NN DRA) (NN gene) (JJ regulatory) (NNS sequences)))) (PP (IN by) (NP (JJ nuclear) (NNS factors))))))))))) (. .))))
(S1 (S (S (NP (DT The) (VBG resulting) (NN occupancy)) (VP (VBZ displays) (NP (NP (JJ strong) (NNS similarities)) (PP (IN with) (NP (NP (DT the) (CD one)) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NP (NN MHC) (NN class) (JJ II-constitutive) (NN B) (NNS cells))) (, ,) (VP (VBN represented) (PP (IN by) (NP (CC both) (DT the) (NP (NN Burkitt) (NN lymphoma) (NN line) (NN Raji)) (CC and) (NP (JJ normal) (JJ tonsil-derived) (NN B) (NNS cells)))))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (DT some) (JJ peculiar) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NP (NP (DT the) (NP (NN TEC))) (, ,) (ADJP (CC either) (ADJP (JJ IFN-gamma-induced)) (CC or) (ADJP (RB not)))) (, ,) (CC and) (NP (DT the) (JJ constitutive) (NP (NN B) (NNS cells))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (CC both) (NP (NP (JJ common) (NNS mechanisms)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT the) (CD one)) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NP (NN CIITA) (NN trans-activator)))))))) (, ,) (CC and) (NP (ADJP (JJ distinct) (JJ tissue-specific)) (NNS constraints))) (VP (VBP contribute) (PP (TO to) (NP (NP (DT the) (JJ transcriptional) (NN control)) (PP (IN of) (NP (ADJP (ADJP (JJ constitutive)) (CC and) (ADJP (JJ IFN-gamma-induced))) (NP (NN MHC) (NN class) (CD II) (NN gene)) (NN expression))))))))) (. .))))
(S1 (S (S (S (NP (NP (JJ Antisense) (NN inhibition)) (PP (IN of) (NP (NP (NN vitamin) (NN D) (NN receptor)) (NN expression)))) (VP (VBZ induces) (NP (NN apoptosis)) (PP (IN in) (NP (JJ monoblastoid) (NN U937) (NNS cells)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (JJ active) (NN vitamin) (NN D3) (NN metabolite) (NN 1,25-dihydroxycholecalciferol)) (PRN (-LRB- -LRB-) (NP (NN 1,25-LRB-OH-RRB-2D3)) (-RRB- -RRB-))) (VP (VBZ acts) (PP (PP (IN as) (NP (NP (DT an) (ADJP (ADJP (JJ antiproliferative)) (CC and) (ADJP (VBG differentiating))) (NN agent)) (PP (IN for) (NP (DT the) (NP (JJ monoblastoid) (NN cell) (NN line) (NN U937)))))) (CC and) (PP (IN as) (NP (NP (DT an) (ADJP (ADJP (JJ important)) (ADJP (JJ immunologic))) (NN mediator)) (VP (VBN implicated) (PP (ADVP (RB particularly)) (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG belonging) (PP (TO to) (NP (DT the) (NP (NN monocyte/macrophage) (NN lineage)))))))))))))) (. .)))))
(S1 (S (S (NP (DT These) (NNS effects)) (VP (VBP are) (VP (VBN controlled) (PP (IN by) (NP (NP (DT the) (NP (NP (NN vitamin) (NN D) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN VDR)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (DT the) (NP (NN steroid) (NN hormone) (NN receptor) (NN family))))))))) (. .))))
(S1 (S (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (VP (TO to) (VP (VB develop) (NP (NP (NP (NN U937)) (NNS transfectants)) (VP (VBG expressing) (NP (JJ antisense) (NP (NN VDR) (NN mRNA))))))) (, ,) (CC and) (VP (TO to) (VP (VB use) (NP (DT these))) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ 1,25-LRB-OH-RRB-2D3-VDR) (NN interaction))) (PP (IN in) (NP (DT this) (NN lineage))))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NP (JJ 2-kb) (NN VDR) (NN cDNA) (NN insert))) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (DT the) (JJ complete) (NP (NN VDR) (NN coding) (NN region)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN cloned) (PP (IN in) (NP (DT an) (JJ antisense) (NN orientation))) (PP (IN into) (NP (DT the) (NN EBV) (NN episomal) (NN vector) (NN pMEP4))) (PP (IN under) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT an) (NP (JJ inducible) (NN promoter))))))) (CC and) (VP (VBN transfected) (PP (IN into) (NP (NN U937)))))) (. .))))
(S1 (S (S (NP (DT The) (NP (NP (JJ resultant) (NN cell) (NN line)) (, ,) (NP (NN DH42))) (, ,)) (VP (VP (VBD was) (ADJP (NN hygromycin) (JJ resistant))) (, ,) (VP (VBD contained) (NP (NN VDR) (NN cDNA))) (, ,) (VP (VBD expressed) (NP (NP (JJR fewer) (NP (NNS VDRs))) (SBAR (IN than) (S (NP (NNS controls)))))) (, ,) (CC and) (VP (VBD showed) (NP (NP (DT a) (JJ substantial) (NN decrease)) (PP (IN in) (NP (NP (JJ antiproliferative) (NN response)) (PP (TO to) (NP (NN 1,25-LRB-OH-RRB-2D3)))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NN 1,25-LRB-OH-RRB-2D3)) (VP (VBD increased) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (NP (NN macrophage) (NN cell) (NN surface) (NN Ags)) (, ,) (PP (VBG including) (NP (NP (NN CD14)) (CC and) (NP (NN CD11b)))))))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN subpopulation)) (PP (IN of) (NP (JJR smaller) (NNS cells)))) (VP (VBD did) (RB not) (VP (VB express) (NP (DT the) (NN differentiation) (NNS markers)) (PP (IN after) (NP (NN cadmium) (NN stimulation))))) (. .))))
(S1 (S (S (NP (NN Cell) (NN cycle) (NN analysis)) (VP (VBD showed) (NP (NP (NP (NNS shifts)) (PP (IN in) (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NNS cells))) (PP (IN from) (NP (NN G1))) (PP (TO to) (NP (NN S) (NN phase)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (RBR more) (JJ pronounced)) (PP (IN after) (NP (NN cadmium) (NN treatment)))))))) (. .))))
(S1 (S (S (S (NP (NP (DT A) (JJ considerable) (NN proportion)) (PP (IN of) (NP (NNS cells)))) (VP (VBD were) (PP (IN outside) (NP (DT the) (NN cycle))))) (CC and) (S (NP (NN DNA) (NN fragmentation)) (VP (VBD confirmed) (NP (NN apoptosis)))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (JJ functional) (NN outcome)) (PP (IN of) (NP (DT the) (NP (NN VDR)) (JJ antisense) (NN transfection)))) (VP (VBZ suggests) (SBAR (IN that) (S (PP (IN in) (NP (DT the) (NP (JJ myelomonocytic) (NN lineage)))) (, ,) (NP (NP (NN VDR)) (NN expression)) (VP (MD may) (VP (VB act) (PP (IN as) (NP (NP (DT a) (JJ protective) (NN mechanism)) (PP (IN against) (NP (VBN programmed) (NN cell) (NN death)))))))))) (. .))))
(S1 (S (NP (NP (NP (NP (NN Binding)) (CC and) (NP (JJ cooperative) (NNS interactions))) (PP (IN between) (NP (CD two) (NP (NN B) (JJ cell-specific) (JJ transcriptional) (NNS coactivators)))) (. .)))))
(S1 (S (S (S (NP (NP (DT The) (NP (NP (NN class) (CD II) (NN transactivator)) (PRN (-LRB- -LRB-) (NP (NN CIITA)) (-RRB- -RRB-)))) (CC and) (NP (NP (NP (NN B) (NN cell) (JJ octamer-binding) (NN protein) (JJ 1/octamer-binding) (NN factor) (NN 1/Oct) (NN coactivator)) (PP (IN from) (NP (NN B) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN Bob1/OBF-1/OCA-B)) (-RRB- -RRB-)))) (VP (VBP represent) (NP (CD two) (NP (NN B) (JJ cell-specific) (JJ transcriptional) (NNS coactivators)))) (. .)))))
(S1 (S (S (NP (NP (NN CIITA)) (CC and) (NP (NN Bob1))) (VP (VBP interact) (PP (IN with) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP bind) (PP (TO to) (NP (NP (NP (VBN conserved) (JJ upstream) (NNS sequences)) (PP (IN in) (NP (NP (NNS promoters)) (PP (IN of) (NP (NN class) (CD II) (JJ major) (NN histocompatibility) (NNS genes)))))) (CC and) (NP (NP (JJ octamer-binding) (NN transcription) (NNS factors)) (NP (NP (NN Oct-1)) (CC and) (NP (NN Oct-2)))))) (, ,) (ADVP (RB respectively)))))))) (. .))))
(S1 (S (S (NP (CC Both) (NP (NN CIITA)) (CC and) (NP (NN Bob1))) (VP (VBP increase) (NP (NP (DT the) (NN expression)) (PP (IN from) (NP (NP (DT the) (NP (NN DRA) (NN promoter))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (DT a) (JJ prototypic) (NP (NN class) (CD II) (NN promoter)))))))))) (. .))))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN CIITA))))) (, ,) (NP (NP (NNS interactions)) (PP (IN between) (NP (NP (NN class) (CD II) (NNS promoters)) (CC and) (NP (NN Bob1))))) (VP (VBP are) (ADJP (JJ independent) (PP (IN of) (NP (DT the) (NP (JJ octamer-binding) (NN site)))))) (. .))))
(S1 (S (S (S (VP (VBG Using) (NP (NP (ADJP (FW in) (FW vivo))) (CC and) (NP (ADJP (FW in) (FW vitro))) (NP (NN binding) (NNS assays))))) (, ,) (S (NP (PRP we)) (VP (VBP confirm) (SBAR (IN that) (S (NP (NN Bob1)) (VP (VBZ binds) (PP (TO to) (NP (NN CIITA)))))))) (. .))))
(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN CIITA)) (VP (CONJP (RB not) (RB only)) (VP (VBZ activates) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN class) (CD II) (NNS genes))))) (CC but) (VP (VBZ recruits) (NP (DT another) (NN B) (JJ cell-specific) (NN coactivator))) (S (VP (TO to) (VP (VB increase) (NP (NP (JJ transcriptional) (NN activity)) (PP (IN of) (NP (NN class) (CD II) (NNS promoters))) (PP (IN in) (NP (NN B) (NNS cells)))))))) (. .))))
(S1 (S (NP (NP (NP (ADJP (ADJP (NN Activation) (NN protein) (JJ 1-dependent)) (ADJP (JJ transcriptional))) (NN activation)) (PP (IN of) (NP (NN interleukin) (CD 2) (NN gene))) (PP (IN by) (NP (NN Ca2+/calmodulin) (NN kinase) (NN type) (NN IV/Gr))) (. .)))))
(S1 (S (S (S (NP (DT The) (NP (JJ Ca2+/calmodulin-dependent) (NN protein) (NN kinase) (-LRB- -LRB-) (NN CaMK) (-RRB- -RRB-) (NN type) (NN IV/Gr))) (VP (VP (VBZ is) (ADVP (RB selectively)) (VP (VBN expressed) (PP (IN in) (NP (NN T) (NNS lymphocytes))))) (CC and) (VP (VBZ is) (VP (VBN activated) (PP (IN after) (NP (NP (VBG signaling)) (PP (IN via) (NP (DT the) (NP (NP (NN T) (NN cell) (NN antigen) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TCR)) (-RRB- -RRB-))))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ mediates) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (JJ Ca-LRB-2+-RRB--dependent)) (ADJP (JJ transcriptional))) (NNS events)) (SBAR (WHNP (WDT that)) (S (VP (VBP follow) (NP (NP (NN TCR)) (NN engagement)))))))))))))) (. .)))))
(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NN CaMKIV/Gr)) (VP (VBZ induces) (NP (DT the) (NP (NP (NN transcription) (NN factor) (NN activation) (NN protein) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-)))) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN synergy)) (PP (PP (IN with) (NP (NN T) (NN cell) (NNS mitogens))) (CC and) (PP (IN with) (NP (DT the) (NP (NN p21ras) (NN oncoprotein)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN CaMKIV/) (NN Gr)) (NN signaling)) (VP (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NN c-fos))))))) (CC but) (VP (VBZ is) (ADJP (JJ independent) (PP (IN of) (NP (NP (NN p21ras)) (CC or) (NP (NN calcineurin))))))) (. .))))
(S1 (S (S (NP (NN AP-1)) (VP (VBZ is) (NP (NP (DT an) (JJ integral) (NN component)) (PP (IN of) (NP (DT the) (NP (JJ nuclear) (NN factor) (IN of) (VBN activated) (NN T) (NNS cells) (-LRB- -LRB-) (NN NFAT) (-RRB- -RRB-) (JJ transcriptional) (NN complex)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (NP (NN interleukin) (CD 2) (NN gene)) (NN expression)) (PP (IN in) (NP (NN T) (NNS cells))))))))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN CaMKIV/Gr)) (VP (VBZ reconstitutes) (NP (NP (DT the) (NN capacity)) (PP (IN of) (NP (NP (DT the) (JJ cytosolic) (NN component)) (PP (IN of) (NP (NN NFAT))))) (S (VP (TO to) (VP (VB direct) (NP (NP (NN transcription)) (PP (IN from) (NP (NP (NN NFAT) (NNS sites)) (PP (IN in) (NP (NN non-T) (NNS cells)))))))))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP reveal) (NP (NP (DT a) (JJ central) (NN role)) (PP (IN for) (NP (NN CaMKIV/Gr))) (PP (IN as) (NP (NP (DT a) (JJ Ca-LRB-2+-RRB--regulated) (NN activator)) (PP (IN of) (NP (NN gene) (NN transcription))) (PP (IN in) (NP (NN T) (NNS lymphocytes))))))) (. .))))
(S1 (S (NP (NP (NP (JJ Cytokine-modulating) (NN activity)) (PP (IN of) (NP (NP (NN tepoxalin)) (, ,) (NP (DT a) (ADJP (ADJP (JJ new)) (ADJP (JJ potential))) (NN antirheumatic)))) (. .)))))
(S1 (S (S (S (NP (NN Tepoxalin)) (VP (VBZ is) (NP (NP (DT a) (JJ new) (JJ dual) (NN cyclooxygenase/5-lipoxygenase) (JJ anti-inflammatory) (NN compound)) (PP (ADVP (RB currently)) (IN under) (NP (JJ clinical) (NN investigation))))) (. .)))))
(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (VP (TO to) (VP (VB possess) (NP (JJ anti-inflammatory) (NN activity)) (PP (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN animal) (NNS models))))))) (CC and) (VP (ADVP (RBR more) (RB recently)) (TO to) (VP (VB inhibit) (NP (NP (NN IL-2)) (JJ induced) (NN signal) (NN transduction))))))))) (. .))))
(S1 (S (S (NP (DT The) (JJ current) (NN study)) (VP (VBD was) (VP (VBN conducted)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (NP (DT the) (NP (NN cytokine)) (NN modulating) (NN activity)) (PP (IN of) (NP (NN tepoxalin)))) (CC and) (NP (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN iron)))) (PP (IN in) (NP (DT these) (NNS effects))))))))) (. .))))
(S1 (S (S (PP (IN In) (NP (NP (NP (JJ human) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN PBMC)) (-RRB- -RRB-))) (VP (VBN stimulated) (PP (IN with) (NP (NN OKT3/PMA)))))) (, ,) (NP (NN tepoxalin)) (VP (VBD inhibited) (NP (NP (NP (NN lymphocyte)) (NN proliferation)) (PP (IN with) (NP (NP (DT an) (NN IC50)) (PP (IN of) (NP (CD 6) (NN microM))))))) (. .))))
(S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (PRP it)) (VP (VBD inhibited) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NP (NN LTB4)) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJ =) (NP (CD 0.5) (NN microM)))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NP (NNS cytokines))) (NP (NP (NN IL-2)) (, ,) (NP (NN IL-6)) (CC and) (NP (NP (NN TNF) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJ =) (NP (QP (CD 10-12)) (NN microM)))) (-RRB- -RRB-))))))))) (. .))))
(S1 (S (S (NP (NN Cytotoxicity)) (VP (VBD was) (RB not) (VP (VBN demonstrated) (PP (IN at) (NP (DT these) (NNS concentrations))))) (. .))))
(S1 (S (S (NP (NP (JJ Add-back) (NNS experiments)) (PP (IN with) (NP (CC either) (NP (NP (NNS cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN IL-2)) (CC or) (NP (NN IL-6))) (-RRB- -RRB-))) (, ,) (NP (NN LTB4)) (CC or) (NP (JJ conditioned) (NNS media))))) (VP (VBD failed) (S (VP (TO to) (VP (VB restore) (NP (DT the) (JJ proliferative) (NN response)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN tepoxalin))))))))) (. .))))
(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ concurrent) (NN addition)) (PP (IN of) (NP (NP (NN iron)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (NP (JJ ferrous)) (CC or) (NP (JJ ferric)) (NP (NN chloride))) (CC and) (NP (JJ other) (NN iron) (NNS salts)))))) (-RRB- -RRB-))))) (VP (VBD reversed) (NP (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN proliferation)))) (VP (VBN caused) (PP (IN by) (NP (NN tepoxalin)))))) (. .))))
(S1 (S (S (NP (NN Tepoxalin)) (ADVP (RB also)) (VP (VBZ inhibits) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NN NF) (NN kappa) (NN B)) (, ,) (NP (NP (DT a) (NP (NN transcription) (NN factor))) (SBAR (WHNP (WDT which)) (S (VP (VBZ acts) (PP (IN on) (NP (JJ several) (NP (NN cytokine) (NNS genes)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Tepoxalin) (POS 's) (NN effect)) (PP (IN on) (NP (NN NF) (NN kappa) (NN B)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN reversed) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN iron) (NNS salts))))))) (. .))))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN tepoxalin)))) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN proliferation)) (PP (IN in) (NP (NN PBMC)))))))) (VP (MD may) (VP (VB be) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (ADJP (JJ due) (PP (TO to) (S (NP (NP (PRP$ its) (NN ability)) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ available) (NN iron)))))))) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (VBN decreased) (NN activation)) (PP (IN of) (NP (NN NF) (NN kappa) (NN B)))) (CC and) (NP (NP (JJ subsequent) (NN inhibition)) (PP (IN of) (NP (NP (NN cytokine)) (NN production))))))))))))))) (. .))))
(S1 (S (S (S (NP (NP (NP (NN Interleukin-7)) (NN signaling)) (PP (IN in) (NP (NP (JJ human) (NN B) (NN cell) (NN precursor) (JJ acute) (JJ lymphoblastic) (NN leukemia) (NNS cells)) (CC and) (NP (JJ murine) (NN BAF3) (NNS cells))))) (VP (VBZ involves) (NP (NP (NP (NN activation)) (PP (IN of) (NP (NP (NN STAT1)) (CC and) (NP (NN STAT5))))) (VP (VBN mediated) (PP (IN via) (NP (DT the) (NP (NN interleukin-7) (NN receptor) (NN alpha) (NN chain))))))) (. .)))))
(S1 (S (S (S (NP (NP (NN Interleukin-7)) (PRN (-LRB- -LRB-) (NP (NN IL-7)) (-RRB- -RRB-))) (VP (VBZ stimulates) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ normal)) (CC and) (NP (JJ leukemic)) (NP (NP (NP (NN B)) (CC and) (NP (NN T)) (NP (NN cell) (NNS precursors))) (CC and) (NP (NN T) (NNS lymphocytes))))))) (. .)))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (DT the) (NN JAK/STAT) (NN pathway)))) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (NN IL-7R)) (NN signaling)))))) (. .))))
(S1 (S (S (NP (PRP We)) (VP (VBD investigated) (SBAR (WHNP (WDT which) (NP (NN STAT) (NNS complexes))) (S (VP (VBP are) (VP (VBN formed) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN of) (NP (NN B) (NN cell) (NN precursor) (JJ acute) (JJ lymphoblastic) (NN leukemia) (-LRB- -LRB-) (NN BCP-ALL) (-RRB- -RRB-) (NNS cells))) (PP (IN with) (NP (NN IL-7)))))))))) (. .))))
(S1 (S (S (NP (NP (NN Gel) (NN retardation) (NNS assays)) (PP (IN with) (NP (JJ STAT-binding) (NNS oligonucleotides)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN IL-7)) (VP (VBZ induces) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (CD two) (JJ major) (NP (NN STAT) (NNS complexes))))) (PP (IN in) (NP (NN BCP-ALL) (NNS cells))))))) (. .))))
(S1 (S (S (NP (NP (NNS Supershifts)) (PP (IN with) (NP (JJ anti-STAT) (NNS antibodies)))) (VP (VBD identified) (NP (DT these)) (PP (IN as) (NP (NP (NP (NN STAT1))) (CC and) (NP (NN STAT5) (NNS complexes))))) (. .))))
(S1 (S (S (NP (NP (DT This) (NN pattern)) (PP (IN of) (NP (NP (NN STAT)) (NN activation)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (DT all) (NN BCP-ALL) (NNS cases)) (SBAR (WHNP (WDT that)) (S (VP (VBP respond) (PP (TO to) (NP (NN IL-7))) (PP (IN in) (NP (NN proliferation) (NNS assays)))))))))) (. .))))
(S1 (S (S (NP (NN IL-7)) (ADVP (RB also)) (VP (VBD induced) (NP (NN STAT/DNA) (NN binding)) (PP (IN in) (NP (NP (NN BCP-ALL) (NNS cases)) (SBAR (WHNP (WDT that)) (S (VP (VBD failed) (S (VP (TO to) (VP (VB proliferate) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN IL-7))))))))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NN IL-7R))) (S (VP (TO to) (VP (VB activate) (NP (DT the) (NN JAK/STAT) (NN pathway)) (ADVP (FW per) (FW se)))))) (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (PP (IN for) (NP (NN proliferation) (NN induction)))))))))) (. .))))
(S1 (S (S (S (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (NP (DT the) (NP (JJ cytoplasmic) (NN domain))) (PP (IN of) (NP (DT the) (NP (NP (NN IL-7) (NN receptor) (NN alpha) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN IL-7R) (NN alpha)) (-RRB- -RRB-))))))) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (NN STAT) (NNS proteins))))))))) (, ,) (S (NP (NP (NP (NNS transfectants)) (PP (IN of) (NP (DT the) (NP (JJ murine) (NN pro-B) (NN cell) (NN line) (NNS BAF3)))))) (VP (VBD were) (VP (VBN made))) (SBAR (WHNP (WDT that)) (S (VP (NN express) (NP (NP (JJ chimeric) (NNS receptors)) (VP (VBG consisting) (PP (IN of) (NP (NP (NP (DT the) (NP (JJ extracellular) (NN domain))) (PP (IN of) (NP (NP (JJ human) (NN granulocyte) (JJ colony-stimulating) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN G-CSF-R)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT the) (NP (NN transmembrane)) (CC and) (NP (JJ intracellular)) (NP (NNS domains))) (PP (IN of) (NP (JJ human) (NN IL-7R) (NN alpha)))))))))))) (. .))))
(S1 (S (S (NP (NP (NN Activation)) (PP (IN of) (NP (NP (DT the) (NP (JJ chimeric) (NN G-CSF-R/IL-7R) (NN alpha))) (PP (IN with) (NP (NN G-CSF)))))) (VP (VP (VBD resulted) (PP (IN in) (NP (DT a) (ADJP (ADJP (JJ full)) (ADJP (JJ proliferative))) (NN response)))) (CC and) (VP (VBD induced) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NP (NN JAK1)) (CONJP (CC but) (RB not)) (NP (NN JAK2))))))) (. .))))
(S1 (S (S (NP (NP (JJ Major) (NP (NN STAT) (NNS complexes))) (VP (VBN activated) (PP (IN by) (NP (NN G-CSF-R/IL-7R) (NN alpha))))) (VP (VBD contained) (NP (NP (NN STAT1)) (CC or) (NP (NN STAT5))) (, ,) (SBAR (IN while) (S (NP (NP (DT some) (NN formation)) (PP (IN of) (NP (JJ STAT3-containing) (NNS complexes)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen)))))) (. .))))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP establish) (SBAR (IN that) (S (NP (NP (NP (NN STAT1)) (CC and) (NP (NN STAT5))) (, ,) (CC and) (ADVP (RB possibly)) (NP (NN STAT3)) (, ,)) (VP (VBP are) (VP (VBN activated) (PP (IN upon) (NP (NP (NN stimulation)) (PP (IN of) (NP (JJ precursor) (NN B) (NNS cells))) (PP (IN with) (NP (NN IL-7)))))))))) (. .))))
(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB further)) (VP (VBP indicate) (SBAR (IN that) (S (NP (DT the) (NP (NN IL-7R) (NN alpha) (NNS chains))) (VP (VP (VBP are) (ADVP (RB directly)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NP (NNS JAKs)) (CC and) (NP (NNS STATs)))))))) (CC and) (VP (VB have) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (JJ proliferative) (NN signaling)) (PP (IN in) (NP (NN precursor) (NN B) (NNS cells)))))))))) (. .))))
